data_5izb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5izb _Structure_validation_residue.Date_analyzed 2017-03-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.405 -0.22 . . . . 75.25 110.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.488 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 3.6 mp -97.21 116.87 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.05 -1.093 . . . . 71.51 108.05 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 tp -83.65 114.38 21.51 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.363 0.665 . . . . 74.43 109.543 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.31 135.53 39.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.135 0.974 . . . . 72.45 110.078 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.53 110.33 16.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.982 0.913 . . . . 71.24 108.538 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -114.48 140.74 48.48 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 110.013 -0.366 . . . . 71.54 110.013 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -116.2 6.94 13.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.314 0.646 . . . . 74.22 109.613 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -60.02 115.5 3.48 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.53 0.732 . . . . 71.42 110.338 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -79.39 123.49 27.55 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.883 0.873 . . . . 64.31 110.107 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.25 172.28 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.968 0.907 . . . . 73.1 109.418 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -72.15 90.45 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.073 -0.714 . . . . 75.4 109.073 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 39' ' ' CYS . 80.7 m -64.48 112.12 2.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.69 0.796 . . . . 74.44 110.665 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -99.33 104.16 16.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.39 1.076 . . . . 72.31 109.367 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.638 ' SG ' HG22 ' A' ' 45' ' ' VAL . 4.1 t -134.12 122.59 23.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.6 -1.259 . . . . 64.01 107.6 168.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.404 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 28.3 p -65.05 87.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.16 0.984 . . . . 64.44 111.978 -175.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.89 -141.29 47.4 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.395 -0.821 . . . . 54.1 114.109 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -143.02 142.56 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.329 1.452 . . . . 71.35 107.977 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mt -134.47 128.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 107.651 -1.24 . . . . 75.22 107.651 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.5 m -91.23 12.57 19.77 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.478 0.711 . . . . 53.14 111.854 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.8 p -65.64 123.21 19.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.541 0.737 . . . . 75.12 110.041 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.52 109.46 3.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.46 -0.941 . . . . 70.33 108.46 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.2 t -84.62 141.21 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.583 -0.735 . . . . 75.03 109.261 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -62.55 121.66 25.8 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.647 0.592 . . . . 70.34 112.645 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.62 -28.7 61.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.033 0.933 . . . . 71.23 112.255 -173.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.24 -35.31 55.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.871 0.468 . . . . 73.34 110.804 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.4 -12.82 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 119.063 -0.494 . . . . 74.32 111.477 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 23' ' ' GLY . 67.1 mt -65.79 111.95 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 109.126 -0.694 . . . . 74.25 109.126 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -87.09 -54.29 4.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.615 0.766 . . . . 71.12 109.65 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 67.3 mtt85 -146.44 134.06 21.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.717 0.807 . . . . 74.34 111.006 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.78 105.83 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.551 -1.277 . . . . 72.34 107.551 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -103.75 120.53 41.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.221 0.609 . . . . 75.34 110.28 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.82 122.96 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.35 0.66 . . . . 72.13 109.272 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 m -108.55 102.43 47.37 Favored Pre-proline 0 C--O 1.25 1.095 0 C-N-CA 124.581 1.152 . . . . 54.55 108.175 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 155.73 27.6 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.6 2.2 . . . . 53.41 111.714 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.13 76.96 0.64 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.769 2.313 . . . . 73.01 112.698 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.56 175.31 51.67 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.241 -0.89 . . . . 72.12 113.712 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -73.15 -47.28 45.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.713 0.805 . . . . 73.45 110.626 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.3 -19.21 74.8 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.396 0.435 . . . . 74.11 113.292 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 12' ' ' CYS . 13.0 m -94.55 132.43 28.79 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.011 0.924 . . . . 74.41 109.351 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.99 -34.68 22.49 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.543 2.162 . . . . 74.54 113.507 -170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -150.61 174.38 13.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 72.45 109.929 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 m -73.02 114.92 11.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.903 -1.147 . . . . 75.01 107.903 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.73 132.64 54.33 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.031 0.532 . . . . 64.55 110.027 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -111.95 109.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.327 -0.99 . . . . 71.42 108.327 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.638 HG22 ' SG ' ' A' ' 14' ' ' CYS . 13.9 t -96.8 108.63 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.078 -0.712 . . . . 71.32 109.078 -173.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.425 HG23 HG21 ' A' ' 27' ' ' ILE . 41.8 mt -95.91 105.82 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.319 -0.623 . . . . 71.14 109.319 175.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -79.68 137.28 37.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.638 -0.875 . . . . 75.3 108.638 165.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 p -97.77 164.09 12.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.022 -0.535 . . . . 74.44 110.217 171.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.86 -20.03 63.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.934 0.894 . . . . 72.22 110.783 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.25 -1.97 51.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.186 0.994 . . . . 74.12 111.31 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 75.3 18.91 2.3 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.019 1.728 . . . . 74.45 113.746 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -79.58 126.03 30.36 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 108.691 -0.855 . . . . 61.42 108.691 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.38 104.7 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.375 -0.972 . . . . 64.35 108.375 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.8 mt -104.46 139.44 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.492 -0.929 . . . . 75.5 108.492 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 15' ' ' SER . 73.4 m -113.56 133.05 55.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.405 -0.961 . . . . 64.3 108.405 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.84 156.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.113 0.565 . . . . 74.13 109.486 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -79.06 139.6 56.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.345 0.658 . . . . 64.14 110.611 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.05 -10.62 29.45 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.878 2.385 . . . . 64.32 113.453 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -101.97 6.46 41.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.629 0.772 . . . . 75.43 111.873 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.51 19.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.808 0.443 . . . . 71.33 110.149 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -65.05 -36.52 84.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.414 0.686 . . . . 75.4 111.597 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -67.63 -35.67 79.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.971 0.508 . . . . 73.02 110.122 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.28 -40.41 81.85 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.536 -0.756 . . . . 72.43 109.893 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -60.44 -34.47 74.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.564 0.746 . . . . 75.45 111.414 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.43 -46.33 83.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.424 0.69 . . . . 74.15 109.885 172.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.4 mt -68.41 -41.34 80.56 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.658 0.783 . . . . 75.35 110.849 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.89 -34.23 77.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.589 0.756 . . . . 75.21 110.503 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.12 -16.77 39.39 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.997 -0.547 . . . . 71.45 111.415 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.0 -38.99 30.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.865 0.466 . . . . 63.11 111.141 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.7 m -74.92 -7.76 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.205 0.602 . . . . 73.43 112.179 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -103.14 21.68 15.38 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.415 0.686 . . . . 71.23 110.1 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -133.94 81.84 1.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.219 1.008 . . . . 73.42 108.523 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -84.66 -36.76 21.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.851 0.86 . . . . 73.32 109.606 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 p -85.26 96.44 9.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 70.21 110.04 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.05 165.02 22.04 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.409 0.684 . . . . 74.14 110.0 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.7 t -75.98 149.37 37.63 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.587 -0.894 . . . . 63.35 108.587 170.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.5 p -73.78 174.86 7.84 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.383 0.673 . . . . 74.33 110.545 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -119.04 87.59 34.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.309 -0.626 . . . . 65.13 109.309 172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.55 -30.42 12.17 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.942 2.428 . . . . 62.24 111.189 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.57 103.11 0.63 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.803 0.841 . . . . 74.25 109.591 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.49 118.2 62.25 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.456 0.473 . . . . 62.51 110.318 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.09 6.44 5.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.718 2.278 . . . . 71.24 112.548 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.01 97.76 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.311 1.044 . . . . 73.4 108.478 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 t -82.8 175.94 9.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.197 -0.911 . . . . 55.01 109.099 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -64.78 105.55 1.02 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.127 -0.694 . . . . 74.14 109.127 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -74.88 161.3 29.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.537 0.735 . . . . 62.41 110.425 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -60.29 143.57 52.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.805 0.842 . . . . 74.31 110.764 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.96 171.38 15.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.26 0.624 . . . . 73.43 110.965 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 123.41 0.684 . . . . 63.12 110.224 178.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 108.057 -1.09 . . . . 72.14 108.057 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.661 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 24.7 mt -89.85 139.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.159 -0.682 . . . . 74.51 109.159 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.499 HD22 HG21 ' A' ' 70' ' ' VAL . 58.9 tp -111.86 114.57 27.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.079 0.552 . . . . 74.11 110.188 -177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -95.72 154.96 16.95 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.788 0.835 . . . . 74.53 109.977 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.52 147.94 43.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.85 0.86 . . . . 55.2 108.911 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 p80 -80.94 140.39 35.29 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.747 0.249 . . . . 74.31 110.993 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -137.65 -51.23 0.62 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.628 -0.879 . . . . 74.5 108.628 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.2 p -95.62 -10.79 28.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.923 0.889 . . . . 72.13 111.612 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.582 ' HB3' ' HB2' ' A' ' 6' ' ' HIS . 46.1 t30 -78.28 99.74 6.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.932 0.493 . . . . 74.41 110.495 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -120.22 15.1 12.26 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.549 1.139 . . . . 74.43 109.313 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.5 46.53 0.57 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.663 -0.648 . . . . 71.31 110.822 -167.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.614 ' SG ' HG21 ' A' ' 33' ' ' THR . 60.6 m -57.16 107.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.687 0.795 . . . . 73.34 111.582 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.96 90.26 4.57 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.75 -1.574 . . . . 74.44 106.75 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.45 156.41 23.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.172 0.989 . . . . 74.32 110.096 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -78.95 59.36 2.62 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.658 0.783 . . . . 75.55 111.3 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 -140.34 41.57 Favored Glycine 0 C--N 1.355 1.628 0 CA-C-N 116.214 -0.448 . . . . 74.02 112.601 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.29 132.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.297 -1.001 . . . . 74.31 108.297 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 mt -128.08 128.84 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.668 -1.234 . . . . 74.32 107.668 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.5 m -90.77 18.95 5.88 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.38 0.672 . . . . 74.53 112.226 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.8 p -78.16 134.2 37.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.22 0.608 . . . . 73.02 110.144 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.87 111.01 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.763 -0.828 . . . . 75.11 108.763 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.62 141.09 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.057 -0.719 . . . . 64.21 109.057 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -58.41 113.71 5.14 Favored Glycine 0 C--N 1.359 1.83 0 O-C-N 124.075 0.86 . . . . 74.55 112.622 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.62 ' HG ' HD22 ' A' ' 66' ' ' LEU . 8.5 mp -52.72 -41.05 63.6 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.155 0.982 . . . . 72.41 111.663 -173.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -67.34 -37.02 82.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.833 0.853 . . . . 63.03 111.519 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -86.8 -15.12 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 122.995 0.184 . . . . 75.12 111.21 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 46' ' ' ILE . 65.3 mt -61.75 110.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 109.511 -0.551 . . . . 75.11 109.511 171.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.71 -55.2 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.917 0.887 . . . . 73.03 110.207 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.661 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 79.2 mtm180 -139.45 153.39 47.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.109 0.564 . . . . 71.05 111.021 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 46' ' ' ILE . 68.7 mt -139.35 118.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.1 1.36 . . . . 72.24 107.87 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -105.03 122.29 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.449 -0.574 . . . . 73.43 109.449 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 m -88.44 127.95 41.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 109.395 -0.594 . . . . 74.43 109.395 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.614 HG21 ' SG ' ' A' ' 12' ' ' CYS . 90.9 m -128.48 81.85 69.79 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.577 0.751 . . . . 72.41 110.311 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.9 156.98 61.62 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.277 1.985 . . . . 54.51 112.256 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.73 83.2 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.351 2.7 . . . . 71.15 111.475 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.51 103.35 0.18 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.674 -0.971 . . . . 72.14 110.674 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 t30 60.98 62.1 1.5 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.065 0.946 . . . . 72.21 110.112 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 167.75 -119.08 0.82 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.191 -0.913 . . . . 70.34 113.172 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.0 m -88.15 151.7 49.45 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 123.934 0.894 . . . . 75.34 110.802 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.4 -39.49 56.06 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.663 2.909 . . . . 71.23 114.306 -168.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -123.22 172.63 8.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.269 0.628 . . . . 65.41 109.707 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 33' ' ' THR . 16.8 m -70.77 115.03 9.45 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.116 0.26 . . . . 65.25 110.718 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 4.3 mm-40 -108.93 109.8 20.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.858 -1.164 . . . . 41.12 107.858 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.39 102.03 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.943 -1.503 . . . . 73.44 106.943 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 14' ' ' CYS . 17.6 t -97.65 106.9 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.356 -0.979 . . . . 74.55 108.356 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 27' ' ' ILE . 56.6 mt -98.56 107.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.279 0.632 . . . . 74.25 109.68 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -83.64 120.69 26.29 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.467 -0.938 . . . . 74.2 108.467 168.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.0 p -84.77 162.71 19.5 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.078 -0.712 . . . . 64.03 109.078 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.83 -19.89 65.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.922 0.889 . . . . 75.0 111.425 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.0 mtm -81.02 -2.62 48.74 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.972 0.909 . . . . 72.51 111.377 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.2 mttp 75.64 15.3 2.67 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.665 1.586 . . . . 61.3 113.127 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -83.44 123.27 29.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.458 -0.571 . . . . 75.21 109.458 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.9 103.1 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 108.057 -1.09 . . . . 74.12 108.057 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.54 120.25 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.906 -1.146 . . . . 72.12 107.906 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.0 m -107.9 130.45 55.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.673 -0.862 . . . . 65.3 108.673 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 165.24 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.373 1.069 . . . . 74.44 110.063 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -88.79 154.24 50.18 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.714 0.806 . . . . 73.15 109.656 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.31 -22.9 39.19 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.383 2.055 . . . . 73.02 113.391 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -73.49 -17.22 61.25 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.748 0.819 . . . . 74.53 112.937 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.22 24.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.361 0.664 . . . . 74.34 111.508 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -72.88 -37.39 67.33 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.894 0.878 . . . . 74.5 112.138 -171.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.046 0.45 . . . . 74.14 110.004 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.8 tp -68.24 -37.87 81.23 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 114.76 -1.109 . . . . 74.2 110.922 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -60.23 -37.85 81.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.745 0.818 . . . . 74.45 110.78 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -65.55 -31.41 72.45 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.003 0.521 . . . . 75.44 111.225 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.62 HD22 ' HG ' ' A' ' 24' ' ' LEU . 91.9 mt -74.96 -38.72 61.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.281 0.633 . . . . 74.25 110.843 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.69 -22.27 64.38 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.335 0.654 . . . . 73.14 110.511 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -87.16 -31.86 20.15 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.45 0.7 . . . . 73.32 111.15 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.51 -25.94 60.66 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 111.861 0.319 . . . . 75.34 111.861 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 HG21 HD22 ' A' ' 3' ' ' LEU . 33.2 m -72.28 -13.23 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 120.681 0.277 . . . . 72.41 110.659 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -92.4 157.28 16.68 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.024 0.929 . . . . 70.42 109.128 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.6 t -70.34 137.91 51.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.636 0.374 . . . . 63.45 110.458 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -149.37 143.5 25.81 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.215 1.006 . . . . 71.23 109.448 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.9 m -76.84 99.1 5.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.025 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -57.49 137.09 56.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 72.11 110.388 174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 p -74.37 122.12 22.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.642 0.777 . . . . 73.43 111.534 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.3 p -72.2 128.94 37.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.858 0.863 . . . . 74.22 110.851 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -80.28 119.73 77.33 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.583 0.753 . . . . 74.2 110.312 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.37 159.72 52.59 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 74.21 112.15 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -87.82 164.6 15.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.185 0.517 . . . . 70.45 110.62 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.68 77.52 56.15 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.166 -1.05 . . . . 74.22 108.166 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.86 152.68 47.19 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.43 2.087 . . . . 73.33 112.789 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.53 120.94 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 109.078 -0.712 . . . . 73.54 109.078 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.9 p -94.76 -71.76 0.65 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.732 0.813 . . . . 72.44 111.253 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -175.89 149.54 0.93 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.408 0.683 . . . . 74.21 109.84 -168.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -87.17 148.7 25.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.298 0.639 . . . . 71.41 110.313 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 ttm-85 -75.65 102.27 5.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.255 0.622 . . . . 74.33 110.157 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.36 96.24 3.95 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.755 0.822 . . . . 74.43 109.518 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.243 0 C-N-CA 123.491 0.716 . . . . 74.24 109.83 177.392 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 85.3 mtp . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.039 -0.726 . . . . 73.4 109.039 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.605 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 3.9 mp -92.28 130.02 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.308 -0.627 . . . . 74.11 109.308 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.1 tp -85.75 106.57 17.1 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.284 -1.006 . . . . 73.54 108.284 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 23.5 mm-40 -84.97 116.77 23.56 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 72.41 109.531 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.31 110.18 22.07 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.133 -0.692 . . . . 64.43 109.133 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -120.97 95.19 4.6 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.714 -0.476 . . . . 74.23 109.714 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -86.79 -27.85 23.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.861 -0.609 . . . . 72.3 109.619 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.4 m -100.12 120.05 39.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.272 1.029 . . . . 73.11 108.449 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -146.5 -117.18 0.07 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 106.66 -1.607 . . . . 65.41 106.66 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.67 -54.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.669 1.188 . . . . 75.12 108.216 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -159.31 136.65 9.83 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 125.514 1.526 . . . . 73.13 107.186 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 85.6 m -74.16 104.57 5.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 38.18 109.988 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.44 89.37 7.39 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 121.636 0.731 . . . . 74.41 110.984 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 t -137.22 157.61 46.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.542 -0.754 . . . . 62.22 109.952 171.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.6 t -78.71 -22.9 45.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.345 0.658 . . . . 73.22 111.082 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.36 160.61 10.26 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.463 -1.055 . . . . 63.54 110.463 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.46 135.54 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.718 0.759 . . . . 74.52 109.249 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 HD12 HG23 ' A' ' 54' ' ' ILE . 5.7 mt -110.55 134.1 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.713 -0.847 . . . . 72.33 108.713 -172.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 p -88.2 24.51 1.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.735 0.814 . . . . 71.12 112.113 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -89.11 155.99 19.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.711 0.804 . . . . 74.33 110.719 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.02 111.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.623 -0.88 . . . . 73.22 108.623 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -87.92 128.42 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.131 -1.063 . . . . 62.13 108.131 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -70.32 135.33 25.51 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.496 0.498 . . . . 70.41 113.603 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.72 -31.59 70.88 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.23 0.612 . . . . 74.24 111.558 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.43 -27.95 66.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.754 0.822 . . . . 63.42 112.157 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 23' ' ' GLY . 20.1 pt -95.69 -22.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 119.489 -0.291 . . . . 71.31 110.721 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 23' ' ' GLY . 82.4 mt -68.53 137.49 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.144 0.578 . . . . 72.13 110.928 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.1 t70 -109.41 -53.55 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.671 0.788 . . . . 70.41 110.392 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.605 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 90.7 mtm180 -144.26 142.22 30.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.868 0.467 . . . . 72.04 111.198 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.52 113.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.133 -1.062 . . . . 75.34 108.133 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 6.9 tt0 -97.34 106.02 18.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.79 -0.448 . . . . 73.01 109.79 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 m -89.78 109.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 108.622 -0.881 . . . . 75.24 108.622 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -105.46 99.75 22.59 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.094 -0.706 . . . . 62.2 109.094 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.58 159.65 48.39 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.708 2.272 . . . . 75.33 112.335 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 41' ' ' LYS . 73.8 Cg_endo -75.49 149.8 35.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.011 2.474 . . . . 75.33 113.063 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.6 -94.53 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.009 -0.541 . . . . 54.42 112.51 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.83 -50.3 51.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.658 0.783 . . . . 64.54 111.247 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.09 -73.44 1.18 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.44 -0.346 . . . . 54.02 112.834 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 97.2 m -114.06 154.82 46.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.682 0.793 . . . . 72.34 109.743 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.69 -20.68 69.38 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 122.644 2.23 . . . . 75.54 112.846 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . 60.1 pttt -142.9 166.69 23.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.718 0.807 . . . . 72.35 109.993 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 35' ' ' PRO . 24.2 m -71.62 124.8 25.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.903 0.481 . . . . 73.5 110.345 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.43 133.64 26.13 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.827 -1.175 . . . . 72.52 107.827 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 59.8 t -114.75 103.17 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.988 0.515 . . . . 75.21 110.446 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.77 108.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.301 0.64 . . . . 62.22 109.864 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.97 116.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.15 0.58 . . . . 73.11 109.441 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -83.39 128.23 34.33 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.268 -1.382 . . . . 73.15 107.268 166.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.7 p -85.1 161.56 19.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.775 -0.824 . . . . 74.11 108.775 167.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -74.73 -3.86 34.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.418 0.687 . . . . 70.41 111.277 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtm -91.1 -1.99 57.67 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.146 0.978 . . . . 72.43 110.102 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 66.74 19.94 10.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.231 1.813 . . . . 75.04 113.102 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.21 123.8 28.25 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.318 -0.993 . . . . 72.43 108.318 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.21 102.05 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.631 -0.878 . . . . 63.21 108.631 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.43 HG23 HD12 ' A' ' 18' ' ' ILE . 65.7 mt -109.09 122.02 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.654 -1.239 . . . . 73.22 107.654 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 28.3 p -109.07 146.96 33.14 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.689 -0.856 . . . . 62.25 108.689 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.78 160.94 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.252 1.021 . . . . 74.42 109.862 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -82.27 149.03 61.05 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-N 115.161 -0.927 . . . . 71.12 110.066 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.32 -38.35 75.73 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.154 2.569 . . . . 73.51 113.806 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -75.44 4.53 7.22 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.417 0.687 . . . . 73.12 112.076 -175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.8 115.94 3.42 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.126 -0.694 . . . . 73.1 109.126 171.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.498 ' HB3' ' HZ2' ' A' ' 61' ' ' LYS . 8.4 mtpm? -64.94 -35.71 82.03 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.985 0.914 . . . . 74.45 112.233 -169.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -69.96 -32.92 71.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.895 0.478 . . . . 74.3 109.95 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.468 HD11 HD21 ' A' ' 66' ' ' LEU . 48.7 tp -65.73 -39.77 91.48 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.363 0.665 . . . . 71.54 110.349 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -64.76 -32.67 74.46 Favored 'General case' 0 C--O 1.243 0.745 0 O-C-N 123.461 0.476 . . . . 72.03 111.283 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -64.41 -42.95 95.77 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 123.825 0.703 . . . . 75.31 109.903 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 63' ' ' LEU . 40.5 tp -62.36 -46.82 86.94 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.843 0.857 . . . . 72.14 111.335 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.98 -37.21 83.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.33 0.652 . . . . 75.41 110.653 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -72.84 -35.17 67.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.475 -0.33 . . . . 73.43 110.714 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -68.29 -38.07 81.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.512 0.725 . . . . 72.41 112.494 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.95 -21.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 120.695 0.283 . . . . 64.52 111.013 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.15 -27.15 19.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.729 0.812 . . . . 55.43 110.825 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -80.83 162.25 24.1 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.996 0.918 . . . . 73.41 109.389 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -73.0 122.86 22.41 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.275 -0.639 . . . . 75.15 109.275 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.7 t -71.87 169.46 15.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.805 0.842 . . . . 71.44 110.331 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.14 126.93 31.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.311 -0.626 . . . . 73.33 109.311 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 t -137.74 160.63 38.7 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.466 1.106 . . . . 73.3 108.836 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 t -68.08 101.21 1.1 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.592 -0.892 . . . . 75.11 108.592 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -74.59 142.74 77.93 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.963 -0.562 . . . . 75.5 109.875 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.6 163.72 31.71 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.08 1.853 . . . . 64.04 111.43 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -51.13 114.38 1.18 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.28 1.032 . . . . 74.12 112.013 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 143.47 98.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.896 0.878 . . . . 72.4 110.356 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.3 158.06 4.02 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.696 2.93 . . . . 63.22 113.94 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.87 115.38 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.724 0.81 . . . . 74.22 110.319 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 t -133.13 101.89 5.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.081 0.952 . . . . 71.21 108.675 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -122.21 157.07 32.42 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.438 0.695 . . . . 75.22 109.78 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -154.85 120.21 5.02 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.456 -0.942 . . . . 75.53 108.456 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -105.2 131.21 52.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.399 0.68 . . . . 75.33 110.112 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 93.96 5.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.146 0.578 . . . . 72.24 110.202 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.763 0.825 . . . . 72.12 109.135 178.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.415 -0.587 . . . . 72.3 109.415 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.6 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 51.7 mt -77.57 133.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.292 -1.003 . . . . 73.35 108.292 174.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.3 tp -101.33 111.89 24.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.89 0.476 . . . . 72.23 110.765 -172.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.55 146.29 25.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.137 0.975 . . . . 74.24 109.928 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.88 133.79 55.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.447 0.699 . . . . 64.44 109.193 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.85 95.73 9.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.336 -0.616 . . . . 71.3 109.336 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -76.69 -59.61 2.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.183 0.593 . . . . 73.43 110.966 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.6 p -74.58 -72.35 0.29 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.498 -0.556 . . . . 75.43 109.498 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.66 89.72 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.47 1.108 . . . . 64.35 113.733 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.06 -61.55 1.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.41 -1.329 . . . . 74.22 107.41 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -133.14 131.92 41.03 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.791 0.836 . . . . 74.14 109.768 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.749 ' SG ' HG22 ' A' ' 33' ' ' THR . 34.6 m -85.0 103.42 14.02 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.622 -0.881 . . . . 64.14 108.622 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.6 mmp_? -100.85 90.55 4.25 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.721 0.772 . . . . 74.43 110.775 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t -133.44 161.82 33.51 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 113.974 -1.467 . . . . 74.42 107.908 166.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -48.06 -32.35 6.62 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.68 1.192 . . . . 73.34 113.666 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.24 -120.27 1.06 Allowed Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.058 -0.817 . . . . 73.25 111.058 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.28 137.0 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.969 -1.123 . . . . 75.22 107.969 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.657 HD13 HG23 ' A' ' 54' ' ' ILE . 9.1 mt -121.01 129.66 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.737 -1.209 . . . . 70.54 107.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.3 m -89.56 20.48 3.94 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.704 0.801 . . . . 64.13 111.521 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.4 p -93.22 143.16 26.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.614 0.766 . . . . 61.33 110.141 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.94 129.45 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.002 -0.74 . . . . 62.33 109.002 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.29 133.55 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.374 -0.972 . . . . 61.33 108.374 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -70.9 131.15 20.68 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.767 0.667 . . . . 38.26 113.074 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mp -59.66 -36.13 75.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.916 0.886 . . . . 75.33 110.907 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -27.6 66.29 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.898 0.879 . . . . 75.02 112.246 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.5 pt -105.44 -20.34 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.596 -0.716 . . . . 72.2 112.428 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG22 HG21 ' A' ' 46' ' ' ILE . 69.6 mt -61.46 106.61 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 109.217 -0.66 . . . . 65.14 109.217 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.11 -52.25 6.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.378 1.071 . . . . 73.44 109.416 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 77.1 mtm180 -146.61 160.03 42.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.74 0.816 . . . . 73.25 110.25 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 3' ' ' LEU . 68.5 mt -136.51 142.1 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.808 -1.182 . . . . 54.2 107.808 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' NE2' ' HH2' ' A' ' 47' ' ' TRP . 6.9 tt0 -124.12 143.94 50.18 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.519 -0.919 . . . . 64.11 108.519 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -113.24 121.01 64.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.84 -0.8 . . . . 63.21 108.84 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.749 HG22 ' SG ' ' A' ' 12' ' ' CYS . 34.7 m -114.28 102.97 55.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 122.975 0.51 . . . . 73.43 109.984 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.41 159.54 43.14 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.007 2.471 . . . . 73.33 112.032 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.89 178.68 5.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.469 2.113 . . . . 63.34 112.87 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.2 9.08 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 116.446 -0.343 . . . . 75.32 113.214 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -77.65 -17.57 57.58 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.152 0.581 . . . . 75.42 111.529 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.3 -42.93 0.67 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.421 -0.672 . . . . 75.41 111.421 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 82.0 m -75.85 120.39 81.45 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.602 0.761 . . . . 71.52 110.626 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.29 -14.31 31.23 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.257 1.971 . . . . 75.35 112.93 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -103.35 146.76 27.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.292 0.637 . . . . 74.43 109.949 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.3 m -86.13 114.91 23.37 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.431 -0.951 . . . . 74.42 108.431 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.16 112.97 19.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.323 0.649 . . . . 72.45 109.941 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.15 103.39 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.462 -0.94 . . . . 64.11 108.462 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 31' ' ' GLN . 58.4 t -92.56 108.46 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 73.31 110.126 -171.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.529 HG21 HG22 ' A' ' 27' ' ' ILE . 65.2 mt -96.44 120.32 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.733 0.813 . . . . 74.42 109.287 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.452 ' HH2' ' NE2' ' A' ' 31' ' ' GLN . 32.3 m-90 -90.47 130.77 36.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.976 -1.12 . . . . 75.22 107.976 166.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.4 p -90.16 169.28 11.28 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.883 -0.784 . . . . 62.42 108.883 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.11 -9.39 58.35 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.655 0.782 . . . . 73.45 111.304 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.8 mtm -88.69 4.66 46.48 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.439 1.095 . . . . 74.41 110.415 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HB3' ' HZ1' ' A' ' 51' ' ' LYS . 9.3 mtpm? 65.49 11.43 7.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.671 1.588 . . . . 71.24 112.206 -175.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.56 122.24 23.6 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.943 -0.762 . . . . 70.55 108.943 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.61 102.03 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.066 0.946 . . . . 74.02 108.714 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.657 HG23 HD13 ' A' ' 18' ' ' ILE . 69.1 mt -109.35 113.82 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.617 -1.253 . . . . 75.01 107.617 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.47 139.59 40.71 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.885 -0.783 . . . . 70.44 108.885 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.08 163.86 35.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 C-N-CA 124.617 1.167 . . . . 65.22 109.837 -171.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -84.25 154.82 63.47 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 115.488 -0.778 . . . . 74.54 110.16 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.48 -22.62 44.77 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.34 2.027 . . . . 71.33 112.862 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -74.6 -3.63 32.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.215 0.82 . . . . 72.33 113.215 -174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.77 117.01 8.31 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.247 -0.649 . . . . 75.02 109.247 171.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -73.96 -35.05 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.124 0.57 . . . . 72.32 111.312 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -58.9 -36.14 74.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.511 0.672 . . . . 72.12 110.173 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.46 -39.4 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.237 -1.347 . . . . 75.41 110.689 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -59.08 -33.27 70.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.836 0.454 . . . . 65.33 112.212 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -61.03 -44.64 97.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.994 -0.548 . . . . 74.21 110.043 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.0 -43.38 87.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.548 -0.751 . . . . 71.43 110.494 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.0 -34.04 77.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.048 0.842 . . . . 75.41 110.875 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -82.5 -31.35 29.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.539 0.335 . . . . 74.4 111.763 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -67.52 -39.21 85.09 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.768 0.427 . . . . 62.3 111.461 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.83 -11.9 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.307 0.243 . . . . 62.34 111.546 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -90.72 57.63 3.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.441 0.696 . . . . 64.42 109.986 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.7 p 46.2 75.84 0.11 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 61.41 114.13 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.26 148.6 25.62 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.865 0.466 . . . . 72.3 110.333 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -76.15 144.57 40.5 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.0 0.92 . . . . 63.51 111.006 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 tp -77.27 123.66 26.77 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.405 0.682 . . . . 73.01 110.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -72.09 108.65 5.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.354 0.662 . . . . 72.05 110.571 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -65.51 127.46 31.95 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 74.33 111.207 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.1 p -106.25 103.45 45.44 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.722 0.809 . . . . 75.44 111.286 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.11 123.47 11.94 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.889 2.393 . . . . 64.41 111.406 171.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -83.55 169.08 15.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.475 0.71 . . . . 74.45 111.827 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.58 110.95 64.79 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.858 0.863 . . . . 74.1 109.981 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.19 153.31 12.52 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.616 2.211 . . . . 64.12 112.291 175.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.87 124.38 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.61 -0.515 . . . . 73.35 109.61 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -75.56 -70.36 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.278 0.631 . . . . 65.12 110.342 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -154.69 176.45 12.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.024 0.53 . . . . 73.12 110.37 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -104.99 178.94 4.42 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.551 1.14 . . . . 64.44 110.18 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -73.55 152.01 40.77 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.781 0.833 . . . . 62.42 111.619 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.4 169.77 23.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.967 0.907 . . . . 75.54 110.305 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.225 0.61 . . . . 75.42 109.498 179.177 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.142 -0.688 . . . . 74.43 109.142 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.1 mm -81.72 137.3 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.748 . . . . 75.54 108.979 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp -110.09 121.55 45.52 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 109.42 -0.585 . . . . 74.1 109.42 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -117.44 140.07 50.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.828 0.851 . . . . 74.31 108.769 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.05 116.3 31.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.441 -0.948 . . . . 74.45 108.441 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 41.0 t60 -81.13 132.47 35.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.208 0.603 . . . . 74.45 110.306 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -135.71 -50.07 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.62 0.768 . . . . 73.04 110.341 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -66.95 158.17 31.47 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.542 0.571 . . . . 70.34 112.542 -170.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -68.44 4.51 1.32 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.446 1.498 . . . . 64.34 114.591 -166.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.5 118.89 5.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.131 -0.692 . . . . 74.33 109.131 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.72 124.6 29.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.883 0.473 . . . . 74.35 111.377 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.4 115.15 3.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.566 1.146 . . . . 74.21 111.644 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -112.95 89.39 3.07 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.414 0.686 . . . . 75.2 109.646 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.49 159.26 42.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.129 0.972 . . . . 75.4 108.593 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.477 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 20.3 m -77.37 64.53 2.76 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.73 0.812 . . . . 62.34 111.556 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.55 -136.17 49.72 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.246 -0.888 . . . . 44.44 113.429 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.21 131.49 71.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 107.938 -1.134 . . . . 75.24 107.938 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.7 mt -120.13 134.23 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.553 -1.277 . . . . 74.24 107.553 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.5 p -85.28 20.88 1.85 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.698 0.799 . . . . 73.14 112.546 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.8 p -79.0 123.82 27.67 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.082 0.553 . . . . 73.13 109.706 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.84 110.75 8.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.828 -1.175 . . . . 61.04 107.828 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.08 133.19 29.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 115.21 -0.905 . . . . 73.14 109.543 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.28 122.99 32.0 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.776 0.672 . . . . 73.24 112.334 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -60.17 -29.7 68.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.163 0.585 . . . . 74.44 110.675 -174.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -65.98 -35.57 80.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.932 0.893 . . . . 73.13 111.799 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 pt -90.57 -21.03 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 118.962 -0.542 . . . . 75.32 111.217 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.3 mt -62.26 127.36 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 118.597 0.635 . . . . 74.42 110.172 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.15 -53.62 2.65 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.2 0.6 . . . . 65.05 110.413 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -133.28 152.26 51.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.803 0.841 . . . . 73.31 110.509 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.69 135.95 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.447 1.499 . . . . 74.51 108.232 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.406 ' NE2' ' HH2' ' A' ' 47' ' ' TRP . 7.7 tt0 -133.74 120.48 20.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.803 0.841 . . . . 74.14 109.516 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.13 110.27 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.887 -0.783 . . . . 73.25 108.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.575 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.3 p -96.69 99.55 5.84 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.875 0.87 . . . . 64.41 109.542 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.66 164.88 7.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.114 2.543 . . . . 75.11 112.719 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.84 52.01 4.06 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.1 2.534 . . . . 74.32 112.252 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.64 93.4 0.29 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.32 -0.855 . . . . 64.13 111.073 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 75.2 -69.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.405 1.482 . . . . 74.34 112.796 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.03 -26.59 64.03 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 114.719 0.648 . . . . 70.05 114.719 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.575 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -128.62 148.53 68.75 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.086 0.554 . . . . 74.34 110.071 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.8 -24.66 4.79 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.587 2.191 . . . . 73.04 113.142 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -142.62 170.95 14.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.19 0.596 . . . . 65.01 110.833 -173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 p -70.21 128.02 34.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.724 0.81 . . . . 63.02 110.062 166.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -161.25 158.46 27.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.07 0.948 . . . . 70.23 108.477 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -131.4 131.65 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.569 0.748 . . . . 61.41 109.043 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 t -103.33 110.58 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.321 1.048 . . . . 73.02 108.437 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.71 120.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.406 ' HH2' ' NE2' ' A' ' 31' ' ' GLN . 27.3 m-90 -92.52 129.4 38.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.544 -1.28 . . . . 64.44 107.544 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.1 p -91.36 172.73 8.33 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.656 0.265 . . . . 72.21 110.366 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.94 -25.0 66.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.971 0.908 . . . . 73.13 110.505 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtm -84.94 2.18 44.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.267 1.027 . . . . 73.2 111.342 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.522 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 7.7 mtpm? 74.48 4.0 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.5 1.52 . . . . 71.55 112.667 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -71.84 123.02 21.75 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.258 -0.645 . . . . 64.23 109.258 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.77 104.73 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.147 -0.933 . . . . 74.01 108.709 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.32 130.35 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.495 -1.298 . . . . 74.45 107.495 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 15' ' ' SER . 9.4 m -107.84 139.01 43.07 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.869 -0.789 . . . . 75.0 108.869 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.13 166.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.78 0.832 . . . . 75.2 109.542 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -88.31 144.22 33.73 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 122.682 0.393 . . . . 52.0 110.331 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -11.23 29.56 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.435 2.09 . . . . 65.03 112.672 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -93.38 18.06 10.33 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.025 0.93 . . . . 72.22 111.644 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.64 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.432 -0.581 . . . . 74.41 109.432 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -67.57 -39.34 84.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.041 0.537 . . . . 74.41 111.787 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -62.54 -35.77 80.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.698 0.799 . . . . 75.34 110.467 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD13 HD12 ' A' ' 66' ' ' LEU . 42.6 tp -72.68 -31.7 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.897 -1.047 . . . . 73.52 110.351 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -55.34 -28.0 50.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.665 0.786 . . . . 64.14 112.137 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -63.81 -49.5 72.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.411 -0.959 . . . . 73.4 108.411 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.414 HD13 HD12 ' A' ' 24' ' ' LEU . 72.9 mt -66.7 -44.93 80.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.155 0.982 . . . . 72.14 111.3 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.8 -41.24 95.22 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.836 0.71 . . . . 73.43 111.235 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -86.51 -23.13 26.02 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.037 0.384 . . . . 74.32 112.037 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.04 -38.25 72.55 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 122.579 0.351 . . . . 73.44 111.705 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -72.1 -15.44 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.975 0.417 . . . . 71.11 110.79 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.55 -152.82 0.23 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.583 1.153 . . . . 75.33 109.108 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -65.65 111.39 3.15 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.059 0.544 . . . . 73.14 111.087 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -119.5 175.32 5.9 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.432 1.093 . . . . 63.1 110.265 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.5 p -88.81 110.11 20.75 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.143 0.977 . . . . 74.2 109.75 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 71.15 10.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.441 -0.948 . . . . 75.2 108.441 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 t -172.41 27.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.124 -1.398 . . . . 71.21 108.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 p -64.8 146.84 54.28 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.399 0.68 . . . . 73.03 110.908 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.2 p -58.5 143.86 80.06 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 124.202 1.001 . . . . 74.42 111.83 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -51.48 143.96 33.82 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 123.155 2.57 . . . . 74.41 114.582 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -100.09 168.19 9.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.937 0.895 . . . . 71.22 109.443 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.64 114.99 25.89 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.307 0.643 . . . . 73.12 110.497 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.47 -35.2 73.07 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.6 2.2 . . . . 72.32 112.25 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.75 138.74 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.243 -1.021 . . . . 63.21 108.243 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.2 t -152.07 137.52 17.67 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.498 0.719 . . . . 71.44 109.622 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.23 178.15 6.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.521 0.728 . . . . 73.04 110.749 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 61.79 75.98 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.234 1.014 . . . . 75.35 108.732 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.97 103.5 1.51 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.307 -0.86 . . . . 73.22 109.128 -174.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.9 101.31 0.2 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.696 0.798 . . . . 71.15 110.433 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 C-N-CA 124.207 1.003 . . . . 65.13 108.677 -179.889 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 119.555 -0.26 . . . . 75.23 111.657 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.59 105.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.469 0.708 . . . . 73.15 110.627 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.5 tp -79.53 116.79 19.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.615 0.766 . . . . 73.43 110.025 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -99.89 131.55 45.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.149 0.98 . . . . 63.22 110.42 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.95 140.66 29.45 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.212 -1.403 . . . . 72.32 107.212 162.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -80.27 144.16 33.09 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 110.232 -0.284 . . . . 72.42 110.232 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.91 142.6 57.24 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.484 -0.932 . . . . 73.43 108.484 163.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -49.22 -35.43 17.3 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.917 0.887 . . . . 72.41 112.72 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -112.72 128.74 56.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.476 1.11 . . . . 74.13 108.701 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.5 140.52 0.81 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.829 0.851 . . . . 73.34 109.211 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.0 94.26 7.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.349 -0.982 . . . . 64.42 108.349 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -59.06 105.26 0.31 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.38 0.672 . . . . 72.34 111.374 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -104.83 95.18 5.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.606 0.717 . . . . 75.32 109.729 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.0 t -128.92 154.17 46.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.228 -1.351 . . . . 61.13 109.325 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -82.5 -25.84 33.11 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 121.643 0.735 . . . . 75.31 110.768 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.42 174.23 13.25 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.038 -1.225 . . . . 63.33 110.038 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -101.16 131.99 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.351 -0.981 . . . . 62.43 108.351 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.16 133.51 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.587 -1.264 . . . . 72.11 107.587 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -76.53 8.21 3.75 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.21 0.819 . . . . 72.25 113.21 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.1 p -59.98 121.09 10.94 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.786 0.834 . . . . 64.44 110.246 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.6 t -72.63 108.86 4.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.368 -0.975 . . . . 65.44 108.368 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -83.03 137.04 21.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-N 115.175 -0.921 . . . . 75.54 108.977 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.35 123.61 33.72 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 124.063 0.852 . . . . 74.53 112.896 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' HG ' HD21 ' A' ' 66' ' ' LEU . 8.5 mp -57.91 -34.25 69.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.685 0.794 . . . . 74.1 111.588 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 -27.39 60.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.357 0.663 . . . . 72.31 111.85 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 pt -93.82 -10.97 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 119.55 -0.262 . . . . 73.41 111.079 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.36 115.58 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.385 -0.598 . . . . 73.44 109.385 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.06 -53.94 3.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.233 0.613 . . . . 72.33 110.73 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -125.99 143.9 50.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.784 0.834 . . . . 72.05 109.947 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -129.85 106.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.433 -1.321 . . . . 71.31 107.433 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.7 122.23 45.64 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.121 0.418 . . . . 73.24 110.483 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.47 122.68 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.768 -0.827 . . . . 73.21 108.768 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -131.84 89.85 37.78 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.613 0.365 . . . . 73.13 111.019 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.04 158.3 30.42 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.24 2.627 . . . . 74.24 112.819 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.32 154.02 56.19 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.488 2.125 . . . . 75.41 112.781 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.84 -84.77 0.12 Allowed Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.193 -0.458 . . . . 63.35 112.331 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -118.3 39.0 3.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.526 1.155 . . . . 75.41 110.338 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.33 -77.14 0.05 OUTLIER Glycine 0 C--N 1.343 0.945 0 CA-C-N 114.593 -1.185 . . . . 53.33 112.128 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -75.8 136.1 70.66 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.026 0.53 . . . . 71.23 109.96 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.55 -10.58 15.88 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.871 2.38 . . . . 73.23 112.282 173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' HB3' ' HZ2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -145.13 173.13 12.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.352 1.461 . . . . 74.21 108.882 -174.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -81.06 113.4 19.22 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.254 -0.647 . . . . 73.44 109.254 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 41' ' ' LYS . 44.6 mt-10 -118.38 122.83 43.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 74.03 109.328 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.5 102.11 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.911 -1.144 . . . . 74.14 107.911 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.75 109.08 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 109.372 -0.603 . . . . 64.34 109.372 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -97.58 126.37 50.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.967 0.907 . . . . 74.35 109.501 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -98.89 131.2 45.16 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.067 -1.086 . . . . 71.05 108.067 169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.1 p -85.89 170.62 12.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.799 0.44 . . . . 64.54 110.234 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.563 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 8.6 mtpm? -71.62 -13.18 61.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.622 0.769 . . . . 73.14 110.487 175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.4 mtm -82.46 -5.74 58.87 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.371 1.068 . . . . 75.21 110.565 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 72.82 10.01 5.48 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.917 1.687 . . . . 74.0 112.557 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -77.01 129.96 36.82 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.431 0.692 . . . . 74.43 110.326 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.93 108.52 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.901 1.28 . . . . 75.15 110.021 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.63 127.67 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.673 -1.232 . . . . 73.5 107.673 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 29.3 m -106.58 152.21 24.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.043 -0.725 . . . . 74.5 109.043 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.14 162.25 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 123.835 0.854 . . . . 72.41 108.926 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -75.26 147.61 83.0 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.709 0.804 . . . . 75.35 110.513 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.33 -21.37 54.37 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.961 2.441 . . . . 64.01 112.019 176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -85.02 3.64 37.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.722 0.809 . . . . 74.44 111.776 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.6 12.05 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.709 0.404 . . . . 71.43 110.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -64.57 -47.42 78.78 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.89 1.276 . . . . 55.12 110.643 -172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -67.41 -32.06 72.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.523 0.729 . . . . 75.3 111.879 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.87 -43.36 98.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.686 1.195 . . . . 73.23 111.378 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -58.87 -31.49 68.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.003 0.921 . . . . 73.51 112.805 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -63.79 -38.93 92.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.302 0.641 . . . . 73.14 110.13 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD21 ' HG ' ' A' ' 24' ' ' LEU . 9.7 mp -72.99 -41.15 64.62 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.387 -0.824 . . . . 74.52 110.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.57 -33.26 75.2 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.254 0.622 . . . . 63.02 111.209 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -82.44 -33.0 28.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.828 0.451 . . . . 74.0 111.634 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -65.52 -46.15 80.73 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.062 0.545 . . . . 75.11 110.895 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.45 -18.48 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.135 0.574 . . . . 73.44 112.547 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -68.85 -55.97 9.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.192 0.597 . . . . 72.23 110.479 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.7 t -162.08 144.76 11.54 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.985 0.514 . . . . 54.13 110.998 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.71 135.08 47.77 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.342 1.057 . . . . 75.2 108.568 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.7 t -107.44 101.93 11.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.1 -1.074 . . . . 70.41 108.1 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.3 tp -79.22 125.7 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.089 0.555 . . . . 72.53 110.476 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.5 p -112.85 125.54 54.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.178 -1.045 . . . . 74.4 108.178 168.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.1 p -86.01 137.77 32.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.65 0.38 . . . . 64.01 110.302 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.0 p -74.92 136.99 73.11 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.811 0.845 . . . . 70.33 111.205 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.31 148.77 77.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.965 2.443 . . . . 72.51 113.005 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -76.28 152.85 36.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.75 0.42 . . . . 74.44 110.18 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 141.07 35.96 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 115.794 -0.639 . . . . 75.2 110.265 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 168.91 22.0 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.455 2.104 . . . . 73.44 111.485 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -115.81 134.56 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.069 0.548 . . . . 64.5 109.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 p -81.06 155.43 26.33 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.153 0.581 . . . . 74.21 110.944 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -77.25 -168.78 1.19 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.777 0.831 . . . . 74.02 112.139 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -145.48 163.14 35.59 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.251 1.02 . . . . 74.22 109.065 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 mtm-85 -58.83 146.7 36.34 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.873 0.869 . . . . 71.12 111.667 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.71 -52.62 3.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.541 0.736 . . . . 71.12 109.915 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.958 0 N-CA-C 108.563 -0.903 . . . . 75.12 108.563 178.146 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.486 -0.931 . . . . 75.51 108.486 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.45 96.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.518 0.727 . . . . 75.12 109.697 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 68.9 tp -80.34 110.59 15.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.632 -0.877 . . . . 75.42 108.632 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -103.92 114.57 28.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.363 1.065 . . . . 71.14 110.33 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.06 117.46 24.04 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.273 -1.38 . . . . 63.24 107.273 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 10' ' ' LEU . 26.2 t60 -78.46 96.57 5.42 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.367 0.603 . . . . 74.43 109.623 -171.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -117.24 -25.69 7.01 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.276 1.03 . . . . 75.1 110.198 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.4 p -68.87 146.65 52.65 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 124.144 0.978 . . . . 74.23 111.019 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.8 89.53 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.949 0.899 . . . . 74.23 109.049 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 6' ' ' HIS . 6.1 tt -144.18 133.48 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.493 -1.669 . . . . 74.34 106.493 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.84 107.61 18.76 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.883 0.473 . . . . 73.32 109.931 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.469 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 63.0 m -67.18 111.33 3.87 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.134 0.574 . . . . 62.24 109.75 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -104.83 90.12 3.38 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.493 0.717 . . . . 74.22 110.313 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 t -134.66 147.02 50.05 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.173 -0.922 . . . . 70.23 109.35 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -91.58 25.37 2.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.873 0.869 . . . . 64.44 112.044 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.5 174.29 17.87 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.125 -0.39 . . . . 63.52 112.125 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 m -107.9 137.47 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.634 0.774 . . . . 74.45 110.881 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 5.3 mt -119.74 135.82 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.249 1.02 . . . . 62.11 108.375 -174.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.5 m -79.74 11.93 2.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.526 0.936 . . . . 74.52 113.526 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -57.93 125.93 25.21 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.421 1.088 . . . . 64.22 111.699 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.17 111.49 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.383 0.611 . . . . 74.34 109.545 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.6 141.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.136 0.975 . . . . 65.55 108.519 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -65.61 123.71 25.41 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 123.67 0.606 . . . . 63.31 112.363 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' HD22 ' A' ' 66' ' ' LEU . 8.2 mp -59.51 -28.13 66.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.989 0.915 . . . . 74.42 112.281 -170.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -79.22 -25.24 42.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.902 0.481 . . . . 75.11 111.413 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.09 -14.42 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 119.321 -0.371 . . . . 74.3 111.144 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.501 HG21 HG21 ' A' ' 46' ' ' ILE . 54.7 mt -63.45 107.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.55 -0.537 . . . . 64.14 109.55 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -96.82 -43.7 7.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.482 0.713 . . . . 65.41 110.964 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 68.5 mtt180 -140.15 141.16 36.07 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.163 0.985 . . . . 71.42 109.614 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.418 HG12 HG12 ' A' ' 46' ' ' ILE . 59.3 mt -130.62 108.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.47 1.108 . . . . 74.31 108.513 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -109.45 120.08 41.4 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.81 0.444 . . . . 54.33 110.429 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.7 115.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 N-CA-C 108.84 -0.8 . . . . 74.32 108.84 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.8 p -106.48 122.4 42.1 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.07 0.948 . . . . 72.13 109.595 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 91.8 Cg_endo -81.85 145.2 14.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.657 2.238 . . . . 73.41 112.457 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 41' ' ' LYS . 55.1 Cg_endo -67.63 147.24 75.83 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.914 2.409 . . . . 74.05 111.945 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.58 -135.75 5.32 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.838 -0.164 . . . . 73.24 112.789 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -72.32 -53.23 13.01 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.807 0.843 . . . . 73.02 112.106 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.38 -51.45 8.48 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 111.608 -0.597 . . . . 74.2 111.608 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 8.5 m -108.63 132.99 20.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.907 -0.775 . . . . 72.24 108.907 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.22 -40.6 18.95 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.848 2.365 . . . . 73.52 112.829 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . 19.1 ptpt -149.6 174.35 12.64 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.07 0.948 . . . . 72.13 109.732 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -66.57 110.89 3.35 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.013 -1.106 . . . . 64.31 108.013 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -128.67 152.17 48.69 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.294 -1.002 . . . . 71.13 108.294 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.38 102.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.468 -1.308 . . . . 71.33 107.468 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -91.13 109.52 21.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.557 -0.905 . . . . 74.03 108.557 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.501 HG21 HG21 ' A' ' 27' ' ' ILE . 45.1 mt -95.48 113.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.328 -0.851 . . . . 73.2 109.49 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.3 m-90 -85.22 132.11 34.33 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.373 -1.343 . . . . 75.41 107.373 167.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.8 p -87.82 169.06 12.38 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.589 -0.523 . . . . 75.44 109.589 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -64.95 -24.05 67.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.756 0.822 . . . . 72.23 111.645 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.5 mtm -91.53 9.36 32.33 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.916 0.886 . . . . 73.32 110.918 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 70.18 18.16 7.02 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.41 1.484 . . . . 74.34 114.023 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -75.59 122.37 23.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.95 -0.759 . . . . 73.3 108.95 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.64 104.76 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.625 1.17 . . . . 74.23 108.851 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -111.75 140.53 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.624 -0.88 . . . . 72.54 108.624 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.8 m -110.4 133.29 53.41 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.494 -0.928 . . . . 63.34 108.494 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 32.7 m -126.66 153.38 35.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 124.509 1.124 . . . . 74.42 109.005 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.92 139.52 43.02 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.126 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.31 -33.59 97.79 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.34 2.693 . . . . 72.53 113.165 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -89.14 14.72 10.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.403 0.681 . . . . 75.23 112.337 -174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.67 33.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.048 0.539 . . . . 73.31 109.848 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.78 -49.75 70.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.293 1.437 . . . . 73.32 112.652 -174.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -67.46 -31.05 70.95 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.728 0.811 . . . . 74.45 110.454 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.4 tp -74.78 -38.0 62.25 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.064 -0.971 . . . . 75.03 110.43 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -57.98 -29.78 65.52 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.805 0.842 . . . . 73.01 111.733 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -61.37 -52.23 65.48 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.008 0.817 . . . . 74.44 109.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.416 HD22 ' HG ' ' A' ' 24' ' ' LEU . 95.4 mt -62.62 -47.87 81.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.17 0.588 . . . . 75.5 111.739 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -57.34 -48.03 80.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.805 0.842 . . . . 72.13 110.395 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.14 87.04 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.398 -0.819 . . . . 73.4 111.311 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -74.98 -47.51 28.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.594 0.59 . . . . 73.4 112.594 -173.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.86 -27.63 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.047 0.539 . . . . 73.43 112.097 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -91.31 125.48 36.08 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.621 0.769 . . . . 74.21 108.961 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m 63.14 32.88 14.9 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.341 1.056 . . . . 65.03 110.825 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.71 102.24 0.07 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.327 1.451 . . . . 74.4 110.493 -172.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.7 t -91.6 176.43 6.54 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.326 0.65 . . . . 71.41 110.291 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.85 105.89 3.98 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.708 -0.849 . . . . 62.4 108.708 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 p -87.3 59.73 5.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.182 0.993 . . . . 75.44 110.611 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t 64.42 178.47 0.18 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.009 1.324 . . . . 75.5 111.538 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -126.4 151.26 72.31 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.163 0.985 . . . . 73.43 109.493 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.43 135.8 63.58 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.57 2.18 . . . . 74.42 111.582 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -73.05 168.26 19.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.86 0.864 . . . . 73.34 111.468 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.31 131.01 92.14 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.497 0.719 . . . . 74.23 110.926 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.1 163.27 0.91 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.674 2.916 . . . . 73.45 113.318 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.538 HG23 ' HG2' ' A' ' 85' ' ' LYS . 9.9 p -53.86 130.35 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.079 0.951 . . . . 73.31 111.518 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -81.11 19.71 0.88 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.255 0.835 . . . . 63.22 113.255 -170.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.538 ' HG2' HG23 ' A' ' 83' ' ' VAL . 31.8 mmmt -74.87 142.96 44.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.636 0.374 . . . . 65.4 110.758 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -139.32 110.23 6.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.993 -1.484 . . . . 75.42 106.993 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -79.98 90.31 5.36 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.764 0.426 . . . . 75.3 111.568 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.34 85.33 5.17 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.248 -1.019 . . . . 74.51 108.248 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.778 0.831 . . . . 55.0 109.019 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.641 -0.503 . . . . 74.15 109.641 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mp -72.42 101.59 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.834 0.853 . . . . 72.34 109.047 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp -81.2 121.99 26.83 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.416 0.686 . . . . 75.32 109.665 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -120.06 144.94 47.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.984 0.913 . . . . 72.41 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.28 130.96 50.67 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.678 -1.601 . . . . 73.11 106.678 163.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.418 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 3.3 p80 -79.16 115.21 18.68 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.388 0.613 . . . . 73.14 110.074 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -87.29 -29.98 21.21 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.598 0.759 . . . . 72.15 109.191 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 m -70.74 92.43 0.88 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.516 -0.765 . . . . 74.43 109.141 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -110.7 34.79 3.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.489 0.716 . . . . 71.12 110.186 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.69 -59.9 2.59 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.89 -0.782 . . . . 75.13 108.89 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -149.35 131.08 15.03 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.378 1.071 . . . . 75.2 109.817 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 m -99.99 105.36 17.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.82 -1.178 . . . . 74.01 107.82 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -89.18 90.18 8.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.889 0.476 . . . . 74.35 110.604 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 45' ' ' VAL . 91.9 m -134.46 104.46 6.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.289 -1.004 . . . . 75.24 108.289 167.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -68.0 -16.62 64.13 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.87 0.868 . . . . 73.53 112.078 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.7 169.99 42.79 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.36 -0.696 . . . . 62.14 111.36 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.19 132.51 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 108.96 -0.756 . . . . 73.14 108.96 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.2 mt -109.99 117.32 54.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.825 -1.546 . . . . 71.22 106.825 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -85.57 14.72 5.27 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.98 0.912 . . . . 65.55 111.926 -172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.1 m -74.91 141.85 44.07 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.327 1.051 . . . . 75.23 109.817 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.82 118.61 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.009 -0.737 . . . . 73.01 109.009 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.32 131.89 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.157 -0.683 . . . . 74.23 109.157 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -64.03 127.84 36.19 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-O 119.578 -0.568 . . . . 73.13 113.387 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.85 -29.13 68.07 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.369 0.668 . . . . 73.12 111.826 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -68.31 -38.03 81.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.859 0.464 . . . . 71.43 110.649 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 pt -87.3 -22.48 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 118.884 -0.579 . . . . 75.41 110.913 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 23' ' ' GLY . 65.6 mt -66.59 129.66 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.088 0.404 . . . . 54.41 110.032 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 37.8 t70 -119.67 -49.39 2.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.369 0.668 . . . . 63.01 110.654 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 69.5 mtp180 -126.25 137.14 53.49 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.127 0.971 . . . . 75.15 110.317 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -128.09 106.8 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.089 -1.078 . . . . 74.22 108.089 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -108.97 127.22 53.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.893 0.877 . . . . 75.32 109.644 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.46 130.81 36.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 N-CA-C 109.107 -0.701 . . . . 72.32 109.107 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 25.0 p -124.79 81.39 61.52 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.573 0.749 . . . . 74.33 110.731 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.18 157.72 49.98 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.753 2.302 . . . . 70.33 112.035 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 71.6 Cg_endo -70.7 161.22 46.81 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.018 2.479 . . . . 70.32 113.286 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.96 -121.88 1.04 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.199 -0.76 . . . . 64.04 111.199 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -81.49 -33.41 31.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.241 0.616 . . . . 74.2 110.056 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.69 -60.29 0.99 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-N 116.249 -0.432 . . . . 60.42 113.889 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 27.5 m -81.28 122.41 81.23 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.994 0.518 . . . . 73.33 109.675 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.55 -39.25 46.03 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 121.957 1.771 . . . . 74.35 111.9 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -123.16 171.76 9.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.249 1.02 . . . . 71.54 110.98 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.9 m -88.22 112.19 22.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.133 -1.062 . . . . 75.44 108.133 168.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.07 167.95 20.89 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.229 1.012 . . . . 63.41 108.514 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.38 116.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 72.12 109.161 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG22 ' SG ' ' A' ' 14' ' ' CYS . 48.7 t -91.88 109.3 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.204 0.602 . . . . 72.11 109.76 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.8 124.43 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.988 0.915 . . . . 74.35 109.662 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.1 m-90 -96.26 125.06 40.51 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.026 -1.102 . . . . 61.44 108.026 165.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -82.71 159.0 22.68 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.388 -0.967 . . . . 71.23 108.388 167.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 25.8 pttm -73.75 0.93 11.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.221 0.608 . . . . 72.51 112.338 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.8 mtm -101.98 8.89 40.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.114 0.966 . . . . 62.3 110.331 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 65.84 26.58 11.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.947 1.699 . . . . 72.42 113.827 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.17 123.55 29.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.145 -1.058 . . . . 74.31 108.145 168.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.6 t -94.44 112.85 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 65.11 109.307 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.0 mt -118.47 128.42 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.397 -0.964 . . . . 63.35 108.397 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.3 m -106.51 119.1 38.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.48 -1.304 . . . . 54.13 107.48 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.54 165.47 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.251 1.02 . . . . 75.03 110.679 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -88.99 141.04 29.23 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 123.962 0.905 . . . . 74.23 110.529 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.43 -30.62 87.26 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.083 2.522 . . . . 74.21 114.202 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.41 9.55 8.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.85 0.685 . . . . 73.01 112.85 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 119.95 13.28 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 109.709 -0.478 . . . . 64.13 109.709 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -64.75 -39.62 93.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.503 0.721 . . . . 75.42 110.849 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -62.77 -35.57 80.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.485 0.714 . . . . 70.03 110.584 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.89 -34.52 76.82 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.016 0.926 . . . . 71.21 110.192 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -60.58 -29.34 69.12 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.716 0.635 . . . . 72.41 111.82 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -57.83 -53.2 60.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 108.998 -0.741 . . . . 64.51 108.998 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -45.59 89.35 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.727 -1.124 . . . . 74.12 110.258 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.79 -40.81 98.48 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 124.047 0.842 . . . . 72.13 111.096 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -82.8 -24.7 33.27 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.23 0.456 . . . . 72.33 112.23 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -78.91 -32.2 45.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.452 0.301 . . . . 72.02 111.201 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.36 -1.78 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 111.778 0.288 . . . . 75.23 111.778 175.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -92.12 -176.42 4.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.32 1.048 . . . . 72.44 111.268 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -72.23 83.7 1.03 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.229 1.012 . . . . 74.1 111.33 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.633 ' HE2' ' HB2' ' A' ' 75' ' ' LEU . 23.6 tptm -164.88 94.07 0.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.957 -1.127 . . . . 75.43 107.957 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -87.97 37.25 0.8 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.981 0.912 . . . . 72.41 111.553 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.633 ' HB2' ' HE2' ' A' ' 73' ' ' LYS . 97.2 mt -132.77 100.82 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.142 0.977 . . . . 74.33 108.618 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -128.78 -160.23 1.01 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.698 1.199 . . . . 74.44 108.524 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.4 t -70.38 176.37 4.04 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.92 0.488 . . . . 73.32 110.275 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.6 p -57.37 132.87 81.47 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.302 0.641 . . . . 72.32 111.193 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.83 145.52 97.08 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.227 2.618 . . . . 74.54 112.417 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -134.18 166.58 22.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.727 0.811 . . . . 75.23 110.882 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.82 120.28 2.86 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.002 1.321 . . . . 63.25 107.92 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.12 -32.34 94.52 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.472 2.114 . . . . 75.4 111.557 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.24 72.53 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.414 -1.328 . . . . 75.05 107.414 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.4 p -76.83 -53.09 8.37 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.858 -0.61 . . . . 70.44 109.67 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.69 124.47 29.05 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.634 -0.876 . . . . 73.13 108.634 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 59.2 59.63 2.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.243 1.017 . . . . 72.21 109.319 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.09 76.92 0.24 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.038 -0.983 . . . . 74.43 112.705 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.04 135.44 52.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.94 0.896 . . . . 61.35 111.831 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 C-N-CA 123.996 0.919 . . . . 71.51 109.47 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.973 -0.38 . . . . 75.21 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.47 134.96 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.213 -1.032 . . . . 74.12 108.213 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.8 tp -102.45 110.09 21.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.846 0.458 . . . . 74.13 110.126 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.34 145.75 26.39 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.953 0.901 . . . . 73.2 110.252 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.09 113.9 21.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.211 1.004 . . . . 65.35 108.68 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -80.97 136.19 35.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.116 0.566 . . . . 73.31 110.333 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -151.4 -25.77 0.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.252 -0.885 . . . . 74.11 109.818 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -65.36 119.36 10.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.905 0.482 . . . . 62.15 110.644 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.86 93.57 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.124 0.969 . . . . 63.33 110.854 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt -152.34 136.36 16.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.242 -1.392 . . . . 74.22 107.242 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -51.55 102.55 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.519 1.137 . . . . 75.31 110.387 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.9 104.49 2.51 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.577 -0.527 . . . . 74.34 109.577 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -83.98 88.31 7.15 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.21 -1.033 . . . . 72.32 108.21 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -135.67 125.39 25.44 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.465 -1.243 . . . . 72.24 108.48 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -79.91 76.24 6.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.314 0.646 . . . . 71.2 110.285 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.54 -127.0 43.68 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.0 -1.0 . . . . 37.28 112.933 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -142.9 136.11 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.566 1.146 . . . . 73.2 108.534 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mt -118.36 120.11 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.94 -1.133 . . . . 75.31 107.94 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -91.44 30.95 1.21 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.833 0.853 . . . . 73.33 112.573 -172.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -90.35 143.43 26.76 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.286 0.634 . . . . 71.3 109.615 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.81 134.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.969 0.793 . . . . 73.24 109.872 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.66 132.37 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.584 -0.895 . . . . 73.03 108.584 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -68.83 133.41 27.08 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.523 0.515 . . . . 73.15 112.677 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.13 -25.09 67.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.72 0.808 . . . . 74.35 111.441 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -72.33 -35.84 68.7 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.46 0.704 . . . . 75.34 110.425 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.602 ' HB ' ' HE1' ' A' ' 50' ' ' MET . 17.0 pt -87.9 -18.29 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 117.846 0.294 . . . . 73.33 110.812 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 23' ' ' GLY . 64.5 mt -68.61 121.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 123.103 0.561 . . . . 65.42 109.938 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -99.82 -49.3 4.4 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.321 0.649 . . . . 72.03 109.813 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -138.11 149.88 46.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 71.34 110.281 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.474 HG12 HG12 ' A' ' 46' ' ' ILE . 59.3 mt -137.82 112.98 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.17 1.388 . . . . 73.24 108.018 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -108.29 114.47 28.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.075 0.55 . . . . 73.23 109.585 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.26 133.71 29.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.523 -0.917 . . . . 71.13 108.523 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.447 ' OG1' ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -135.09 141.18 37.14 Favored Pre-proline 0 C--O 1.252 1.2 0 N-CA-C 112.37 0.507 . . . . 75.43 112.37 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.62 174.57 12.01 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.538 2.825 . . . . 64.54 112.517 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.16 55.14 5.49 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.859 2.372 . . . . 42.4 112.1 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.62 -168.51 41.37 Favored Glycine 0 C--O 1.246 0.878 0 N-CA-C 110.948 -0.861 . . . . 54.51 110.948 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.4 m120 58.2 30.84 20.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.363 1.065 . . . . 71.24 111.965 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.06 -33.68 3.62 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.818 -0.628 . . . . 72.34 112.806 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' OG1' ' A' ' 33' ' ' THR . 60.8 m -98.91 141.27 22.61 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 123.304 0.642 . . . . 72.35 110.265 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.76 -32.09 24.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.586 2.191 . . . . 74.05 112.799 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -144.08 172.28 13.11 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.538 0.735 . . . . 64.04 109.848 -173.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.4 m -68.65 115.2 7.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.249 -0.648 . . . . 64.31 109.249 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -133.22 156.12 48.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.455 -0.572 . . . . 70.25 109.455 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.9 t -129.67 105.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.381 -1.34 . . . . 72.12 107.381 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.96 109.72 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.654 -0.703 . . . . 72.04 109.378 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.474 HG12 HG12 ' A' ' 30' ' ' ILE . 43.5 mt -97.83 116.99 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.794 0.838 . . . . 74.11 110.033 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -90.56 137.71 32.14 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.317 -0.994 . . . . 73.43 108.317 168.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.9 p -98.03 173.49 7.02 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.601 0.36 . . . . 61.35 111.214 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.98 -22.78 62.14 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.614 0.765 . . . . 75.41 110.98 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.602 ' HE1' ' HB ' ' A' ' 26' ' ' ILE . 4.4 mpp? -76.84 -3.1 36.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.494 0.718 . . . . 72.35 111.09 170.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 76.02 12.81 2.8 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.068 1.747 . . . . 65.43 112.947 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -76.82 136.86 38.95 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 122.74 0.416 . . . . 75.04 110.218 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.99 102.62 11.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 O-C-N 124.558 1.161 . . . . 72.35 108.787 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.3 mt -98.25 138.72 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.246 -1.02 . . . . 74.43 108.246 172.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -107.9 134.01 51.43 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.105 -1.443 . . . . 64.12 107.105 170.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.23 152.97 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 122.837 0.455 . . . . 74.43 109.844 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -75.7 135.43 71.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 115.107 -0.951 . . . . 74.33 110.643 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.98 -5.73 15.33 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.554 2.169 . . . . 73.25 112.969 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -86.89 -18.46 30.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.297 0.639 . . . . 74.54 111.539 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.2 122.07 8.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 112.088 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.12 -47.32 86.42 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 73.34 111.066 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -58.98 -38.04 78.2 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.097 0.873 . . . . 74.22 110.54 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.56 -30.83 69.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.476 1.11 . . . . 72.24 111.595 -174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.6 -43.16 97.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.368 0.667 . . . . 73.1 112.283 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -64.45 -27.05 68.73 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.5 0.5 . . . . 75.42 111.336 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.42 -46.13 42.07 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.367 -0.605 . . . . 75.42 109.367 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.22 -27.5 67.24 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.877 0.871 . . . . 73.35 111.108 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -81.98 -56.42 3.97 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.156 0.582 . . . . 72.4 111.026 172.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -78.1 -15.08 59.2 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.21 0.818 . . . . 74.52 113.21 -162.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.5 m -67.16 -32.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.06 0.846 . . . . 74.34 110.591 173.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.23 113.33 22.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.477 -0.935 . . . . 70.03 108.477 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.6 m 62.03 42.58 9.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.829 1.251 . . . . 61.03 111.178 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -44.61 117.03 1.17 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.162 1.385 . . . . 71.2 112.715 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 p -97.72 157.93 15.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.383 1.073 . . . . 74.45 110.066 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.59 129.01 36.5 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.11 -0.7 . . . . 71.34 109.11 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 t -138.43 24.86 2.68 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.918 0.887 . . . . 75.44 109.499 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -145.74 174.18 11.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 115.273 -0.876 . . . . 64.42 109.64 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.3 p -63.15 127.13 90.53 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.59 0.756 . . . . 64.12 110.061 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.35 86.74 1.13 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.487 2.125 . . . . 61.11 112.167 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -77.19 170.57 16.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.729 -1.123 . . . . 74.21 110.39 174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.39 111.74 15.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.383 0.673 . . . . 74.42 109.707 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.3 -176.49 2.99 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.492 2.128 . . . . 74.53 110.96 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.4 88.81 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 107.642 -1.244 . . . . 75.14 107.642 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -68.81 89.29 0.39 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.694 -1.139 . . . . 64.54 111.166 -171.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' HB2' ' HZ3' ' A' ' 85' ' ' LYS . 10.1 mtmp? -103.42 -162.16 0.89 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.511 1.124 . . . . 74.21 109.053 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -70.29 112.42 6.61 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.53 -0.544 . . . . 71.32 109.53 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.26 145.39 53.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.144 1.378 . . . . 72.22 111.4 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.18 149.54 27.87 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.924 0.89 . . . . 73.34 111.324 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 C-N-CA 124.201 1.0 . . . . 61.22 108.835 179.096 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 108.611 -0.885 . . . . 63.31 108.611 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.592 ' HB ' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mp -67.88 104.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.694 0.621 . . . . 71.55 109.436 -176.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.3 tp -80.24 117.2 20.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.023 -0.732 . . . . 74.43 109.023 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.93 148.62 27.44 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.875 0.87 . . . . 74.0 110.323 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.41 142.93 26.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.634 -1.166 . . . . 62.1 108.033 168.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' CE1' ' SG ' ' A' ' 12' ' ' CYS . 63.7 t60 -81.09 137.9 35.97 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.992 -0.373 . . . . 73.22 109.992 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -115.27 157.38 23.85 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.914 0.885 . . . . 74.52 109.923 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -61.2 -40.84 95.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.991 0.916 . . . . 75.21 111.55 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.6 67.15 9.88 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.812 0.815 . . . . 74.11 109.257 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt -170.23 97.36 0.27 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.89 -1.522 . . . . 70.35 106.89 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -68.88 137.3 53.75 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.441 0.696 . . . . 72.45 110.612 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.609 ' SG ' HG22 ' A' ' 33' ' ' THR . 73.1 m -101.82 102.96 13.64 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.854 -0.424 . . . . 72.31 109.854 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -115.3 88.95 2.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.18 0.592 . . . . 75.55 109.646 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.6 t -134.95 158.65 43.76 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.975 -0.75 . . . . 64.34 108.975 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -67.54 -27.17 66.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.469 0.708 . . . . 71.11 112.57 -175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.51 -156.83 27.14 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.022 -0.831 . . . . 74.34 111.022 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.75 136.61 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.27 -0.641 . . . . 75.04 109.27 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 54' ' ' ILE . 46.4 mt -103.94 134.93 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.1 0.96 . . . . 75.55 109.548 -172.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -85.88 28.19 0.81 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.559 1.143 . . . . 74.32 113.094 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.3 p -109.55 145.39 36.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.099 0.56 . . . . 74.01 110.866 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.79 111.67 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.634 -1.247 . . . . 71.14 107.634 168.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.44 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.394 -0.965 . . . . 73.22 108.394 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -58.99 126.94 44.11 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.803 0.69 . . . . 64.43 112.688 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.98 -31.59 70.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.416 0.686 . . . . 74.14 111.509 -173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.59 -37.35 82.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.33 0.652 . . . . 72.0 111.205 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 23' ' ' GLY . 20.9 pt -82.97 -24.19 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 119.634 -0.222 . . . . 74.14 110.541 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.64 120.1 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.447 0.699 . . . . 72.45 110.653 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -101.67 -40.92 6.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.424 0.69 . . . . 75.31 110.796 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.592 ' HG3' ' HB ' ' A' ' 2' ' ' ILE . 14.3 ttm180 -152.79 135.81 15.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.827 -0.435 . . . . 74.23 109.827 -163.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.484 HG12 HG12 ' A' ' 46' ' ' ILE . 67.4 mt -133.47 113.39 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.76 1.224 . . . . 73.22 109.079 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -109.69 125.63 52.85 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.925 0.49 . . . . 62.24 109.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.35 111.75 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.871 -0.789 . . . . 74.15 108.871 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.609 HG22 ' SG ' ' A' ' 12' ' ' CYS . 71.5 m -110.5 106.48 57.9 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.008 0.923 . . . . 74.42 111.185 -176.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -66.96 162.55 37.48 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.01 2.473 . . . . 71.42 112.765 166.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -85.43 152.74 10.53 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.514 2.142 . . . . 74.51 111.791 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 -146.34 9.65 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.962 -0.455 . . . . 50.33 111.962 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -71.78 -53.59 12.88 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.245 0.618 . . . . 75.41 111.466 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.25 -27.2 72.15 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.347 0.499 . . . . 73.42 114.347 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' SG ' ' NE2' ' A' ' 6' ' ' HIS . 60.3 m -127.79 116.06 20.8 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.457 0.703 . . . . 74.33 109.933 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.61 -20.88 46.54 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.327 2.018 . . . . 63.33 113.895 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.85 169.97 16.78 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.413 0.685 . . . . 75.42 111.554 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -86.98 117.26 25.59 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.782 0.833 . . . . 72.1 109.055 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.09 159.24 42.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.215 0.606 . . . . 75.14 109.385 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.87 104.13 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.202 -1.777 . . . . 74.53 106.202 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.83 107.39 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.617 -0.882 . . . . 75.53 108.617 -167.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.484 HG12 HG12 ' A' ' 30' ' ' ILE . 52.1 mt -96.98 114.08 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 114.764 -1.107 . . . . 75.13 109.563 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 29' ' ' ARG . 31.1 m-90 -86.73 125.71 34.08 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.35 -1.352 . . . . 72.31 107.35 166.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.6 p -84.04 162.8 20.23 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.61 -0.515 . . . . 72.24 109.61 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -21.84 64.38 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.602 0.761 . . . . 71.11 111.149 175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtm -84.73 -1.5 56.33 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.101 1.361 . . . . 72.31 111.421 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 70.28 19.94 6.36 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.528 1.531 . . . . 73.03 113.357 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.42 126.91 32.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.359 -0.608 . . . . 74.03 109.359 168.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.9 t -89.01 105.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.058 0.943 . . . . 74.31 108.916 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.617 HG23 HD12 ' A' ' 18' ' ' ILE . 73.1 mt -111.84 117.75 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.387 1.075 . . . . 65.04 108.416 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.7 m -105.95 125.52 51.09 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.068 -1.086 . . . . 75.31 108.068 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.83 165.97 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.713 0.805 . . . . 74.11 110.541 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.09 142.4 55.47 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.767 0.827 . . . . 75.24 110.765 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.77 -11.78 32.8 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.471 2.114 . . . . 72.44 113.304 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.2 -6.48 58.98 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.387 0.675 . . . . 75.12 111.314 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.14 114.89 2.34 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.158 -0.682 . . . . 72.13 109.158 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -36.18 73.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.748 0.819 . . . . 65.13 110.173 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.422 0.689 . . . . 72.31 110.423 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.24 -28.55 68.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.577 1.151 . . . . 74.32 111.048 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -61.53 -26.95 68.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.813 0.845 . . . . 73.44 111.954 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.27 -50.06 72.44 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.441 0.696 . . . . 75.15 109.674 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.2 -45.07 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.323 1.014 . . . . 74.23 110.301 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.58 -34.07 76.24 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.089 0.868 . . . . 72.24 111.178 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -89.68 -22.34 22.3 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 112.518 0.562 . . . . 75.23 112.518 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.4 -38.3 41.93 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.875 0.47 . . . . 73.52 111.124 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.7 m -63.07 -32.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 121.291 0.567 . . . . 74.31 110.727 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -68.6 152.55 45.21 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.325 1.05 . . . . 74.33 109.269 171.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -64.46 81.28 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.813 0.845 . . . . 64.43 112.428 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -84.28 -79.3 0.22 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.833 0.853 . . . . 73.1 109.401 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.7 p 176.32 163.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.947 1.299 . . . . 73.54 110.129 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.1 108.0 19.58 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.684 0.794 . . . . 73.1 108.887 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.8 t -56.44 125.42 21.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.2 1.0 . . . . 71.24 109.978 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.9 m -61.86 99.37 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.142 0.977 . . . . 72.15 111.93 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.7 p -74.07 115.63 44.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.761 0.824 . . . . 64.03 109.895 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.63 163.43 30.28 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.566 2.177 . . . . 74.01 113.044 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.56 134.31 51.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.979 0.912 . . . . 74.33 110.752 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.22 140.21 63.83 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.342 1.057 . . . . 55.11 112.122 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.08 -16.46 40.44 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.687 2.258 . . . . 74.44 111.957 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.18 81.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 107.581 -1.266 . . . . 63.54 107.581 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -73.12 -51.45 17.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.601 -1.181 . . . . 61.33 110.026 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -100.24 147.87 25.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.553 0.741 . . . . 73.41 110.545 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -153.13 177.48 10.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.343 1.057 . . . . 74.3 109.31 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -74.04 79.23 1.71 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.779 0.8 . . . . 73.4 109.31 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -164.67 162.08 21.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.688 1.195 . . . . 65.33 109.16 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 C-N-CA 123.609 0.764 . . . . 51.12 109.091 -177.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.829 0.347 . . . . 64.05 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.3 mt -137.78 119.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.5 1.12 . . . . 74.05 108.249 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 70' ' ' VAL . 60.2 tp -90.78 107.38 19.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.41 -0.589 . . . . 74.44 109.41 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -83.11 142.69 31.07 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.351 0.661 . . . . 71.34 109.349 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.31 115.99 26.93 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.46 -0.941 . . . . 72.1 108.46 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.6 ' HE1' ' HB3' ' A' ' 10' ' ' LEU . 17.9 t60 -84.08 102.51 12.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 65.3 110.173 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -104.92 -54.43 2.5 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.813 -0.81 . . . . 73.44 108.813 170.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.6 p -66.35 140.5 58.09 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.792 0.837 . . . . 64.32 111.479 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.13 119.56 9.77 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.63 0.772 . . . . 61.43 111.012 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.6 ' HB3' ' HE1' ' A' ' 6' ' ' HIS . 6.2 tt -157.98 134.33 9.52 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.316 -1.735 . . . . 73.0 106.316 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.18 94.7 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.251 0.969 . . . . 65.41 110.693 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.9 m -74.02 102.25 4.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.622 0.769 . . . . 53.04 109.688 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -87.82 90.52 8.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.46 0.648 . . . . 72.02 110.325 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' HG22 ' A' ' 45' ' ' VAL . 73.0 m -135.62 95.96 3.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.403 -1.271 . . . . 75.33 107.866 166.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -82.88 -4.47 58.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.869 0.867 . . . . 71.5 111.545 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.6 160.59 29.05 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.983 -0.847 . . . . 51.22 110.983 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.64 134.61 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.077 -0.712 . . . . 72.14 109.077 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.27 120.72 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.17 -1.419 . . . . 74.13 107.17 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.5 m -83.16 3.44 30.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 74.55 112.523 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.7 p -70.4 128.28 35.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.439 0.695 . . . . 72.31 110.47 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.71 109.07 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 108.003 -1.11 . . . . 74.42 108.003 175.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.83 142.05 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.822 -0.807 . . . . 75.53 108.822 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.03 129.51 21.06 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.413 0.446 . . . . 53.21 113.766 -173.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 66' ' ' LEU . 9.6 mp -61.41 -24.41 66.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.042 0.937 . . . . 70.35 112.096 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -70.98 -34.81 71.77 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.572 0.749 . . . . 75.11 111.033 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.3 pt -95.72 -17.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.492 0.317 . . . . 71.24 111.759 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.24 125.77 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 109.796 -0.446 . . . . 74.52 109.796 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -118.52 -45.44 2.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.521 -0.309 . . . . 75.32 111.553 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 77.7 mtt180 -125.06 125.17 43.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.912 -0.403 . . . . 71.23 109.912 -169.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.88 110.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.498 1.119 . . . . 74.33 108.189 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -104.38 124.54 49.39 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 122.911 0.484 . . . . 63.35 110.208 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -85.01 119.81 34.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.0 -1.111 . . . . 74.34 108.0 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.724 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.8 p -108.11 91.53 8.1 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.9 0.88 . . . . 61.31 109.863 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.67 162.47 41.16 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.11 2.54 . . . . 72.34 112.085 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.92 -167.76 0.52 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.283 1.989 . . . . 65.24 111.934 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.54 -126.52 7.79 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.793 -0.523 . . . . 64.31 111.793 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.38 -11.82 59.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.684 0.793 . . . . 74.15 111.268 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.58 -80.23 0.52 Allowed Glycine 0 C--N 1.35 1.308 0 O-C-N 123.626 0.579 . . . . 63.52 112.461 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.724 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 66.4 m -128.79 162.4 51.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.106 0.963 . . . . 65.04 110.7 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -58.98 -36.89 96.0 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.581 2.187 . . . . 63.14 113.829 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -128.3 166.63 18.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.728 0.811 . . . . 72.22 110.254 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m -88.42 111.19 21.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.22 -1.03 . . . . 75.24 108.22 170.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.56 172.53 13.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.446 1.098 . . . . 74.11 108.187 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -131.17 124.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.86 0.864 . . . . 74.43 109.117 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG22 ' SG ' ' A' ' 14' ' ' CYS . 27.3 t -92.37 143.3 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.811 0.844 . . . . 73.41 109.0 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.6 116.47 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.111 0.965 . . . . 73.15 108.55 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 31.1 m-90 -93.71 124.56 37.78 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.88 -0.785 . . . . 73.53 108.88 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 p -80.97 173.25 12.8 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.037 0.836 . . . . 75.02 109.93 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -72.78 -17.92 61.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.769 0.827 . . . . 74.45 110.865 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.6 mtm -83.75 0.0 49.08 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.287 1.035 . . . . 70.34 110.637 172.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 76.68 11.52 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.976 1.71 . . . . 75.14 112.904 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.87 134.73 37.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 71.31 111.31 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -91.56 103.82 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 125.039 1.462 . . . . 71.43 108.594 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.6 121.54 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.631 -1.248 . . . . 74.44 107.631 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.0 m -105.16 138.52 41.23 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.715 -0.846 . . . . 50.25 108.715 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.95 165.55 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.318 1.447 . . . . 73.14 109.195 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -82.54 147.08 55.04 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 119.215 -0.422 . . . . 73.23 109.967 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.76 -19.24 64.34 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.685 2.257 . . . . 73.22 112.337 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -90.79 14.38 13.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.59 0.756 . . . . 72.34 111.747 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.76 15.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.0 -0.741 . . . . 70.41 109.0 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -59.13 -44.76 92.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.136 0.974 . . . . 74.35 112.744 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -63.74 -42.52 97.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.44 0.696 . . . . 75.05 110.229 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.79 -34.44 71.48 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.632 1.208 . . . . 74.14 111.33 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.542 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 79.6 mm-40 -55.56 -46.03 77.22 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.618 0.574 . . . . 74.53 111.518 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -59.41 -30.15 68.26 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 63.04 111.022 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 24' ' ' LEU . 9.3 mp -78.69 -39.49 36.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.797 0.839 . . . . 73.43 110.688 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.0 -26.23 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.935 0.894 . . . . 73.31 110.319 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.3 mmt180 -90.74 -28.14 18.47 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.898 0.479 . . . . 73.41 111.164 173.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 73' ' ' LYS . 64.5 t-80 -62.29 -34.24 76.2 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.289 0.636 . . . . 73.23 110.882 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 HG22 HD23 ' A' ' 3' ' ' LEU . 32.1 m -68.51 -15.87 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 116.085 -0.507 . . . . 71.52 111.91 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.02 41.9 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.731 0.812 . . . . 74.02 111.198 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t 52.27 64.79 1.71 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.962 1.305 . . . . 41.14 111.438 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 69' ' ' HIS . 55.3 tptt -67.13 134.4 51.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.163 -0.926 . . . . 73.51 110.185 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.5 p -75.17 168.1 20.63 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.67 0.788 . . . . 74.43 113.119 -172.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 pp -121.7 171.67 8.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.344 1.058 . . . . 72.13 111.315 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -114.07 -176.12 2.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.689 0.796 . . . . 74.33 110.038 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.9 m -131.02 142.9 50.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.336 1.054 . . . . 61.35 108.909 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -110.98 136.71 20.77 Favored Pre-proline 0 CA--C 1.553 1.062 0 N-CA-C 109.142 -0.688 . . . . 73.43 109.142 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.51 175.3 3.57 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.412 2.075 . . . . 74.12 113.395 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.92 155.28 27.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.491 -0.777 . . . . 75.11 111.058 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.64 149.42 93.21 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.62 1.168 . . . . 74.41 110.82 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.81 154.14 63.75 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 121.815 1.677 . . . . 73.41 111.569 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.4 128.33 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.458 0.703 . . . . 72.22 112.113 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -85.13 155.3 21.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.212 -0.662 . . . . 55.14 109.212 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -102.56 140.05 37.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.485 0.314 . . . . 74.13 110.669 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -112.64 138.36 49.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.458 1.103 . . . . 70.53 108.996 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -75.63 103.99 5.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.56 0.744 . . . . 71.35 109.521 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.88 85.2 7.39 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.534 -0.543 . . . . 61.14 109.534 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.905 -0.776 . . . . 62.53 108.905 177.427 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 108.782 -0.822 . . . . 70.43 108.782 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.47 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 52.5 mt -76.51 109.84 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.966 -0.383 . . . . 74.41 109.966 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -82.52 108.18 15.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.763 0.425 . . . . 74.42 110.223 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -90.93 118.56 30.42 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.563 -0.532 . . . . 53.04 109.563 174.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.86 106.56 15.63 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.993 -1.114 . . . . 75.44 107.993 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -124.5 136.74 54.25 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.94 0.896 . . . . 62.25 109.414 -172.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -100.14 169.23 9.3 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.504 1.122 . . . . 72.14 108.29 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.3 p -49.2 112.14 0.59 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.842 0.857 . . . . 72.45 112.913 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.416 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 27.6 t-20 -69.8 169.35 13.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.809 0.844 . . . . 75.01 108.807 166.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.55 -43.18 11.74 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.168 0.987 . . . . 73.44 110.036 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -167.99 107.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.054 0.942 . . . . 74.52 109.481 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 33' ' ' THR . 75.4 m -73.51 115.83 13.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.115 0.566 . . . . 72.55 109.952 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -72.74 90.85 1.43 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.285 0.634 . . . . 72.54 111.686 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 45' ' ' VAL . 91.4 m -134.2 112.52 11.16 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.782 -1.192 . . . . 54.1 107.782 164.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.0 p -60.94 -35.07 75.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.962 0.905 . . . . 73.13 110.532 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.54 -176.65 37.84 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.054 -0.975 . . . . 60.41 111.692 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 m -111.15 135.1 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.065 0.946 . . . . 75.34 109.224 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.4 132.49 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.403 0.681 . . . . 75.51 109.35 -173.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.7 m -97.1 48.3 1.05 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.869 0.868 . . . . 51.35 111.388 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.5 p -109.6 129.7 55.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.417 0.687 . . . . 64.15 109.51 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.6 t -72.95 111.73 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.539 -0.912 . . . . 74.42 108.539 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -76.06 145.04 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.676 0.79 . . . . 74.2 109.61 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.48 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -61.4 120.04 20.93 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 119.65 -0.528 . . . . 71.53 111.821 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.1 -23.95 65.88 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.906 0.883 . . . . 74.32 112.239 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -72.64 -34.4 67.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.826 0.85 . . . . 75.12 111.059 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 pt -95.75 -18.78 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 118.844 -0.598 . . . . 72.51 111.527 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 23' ' ' GLY . 64.6 mt -60.86 107.48 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.946 -0.761 . . . . 52.23 108.946 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.49 -55.3 2.79 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.821 -0.627 . . . . 75.32 110.745 -171.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 47.5 mtm180 -137.79 125.07 21.74 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.473 0.709 . . . . 74.44 109.838 -175.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.43 106.58 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.221 -1.029 . . . . 62.11 108.221 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -104.85 117.32 33.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.212 0.605 . . . . 74.33 109.551 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.45 135.94 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.561 -0.533 . . . . 74.32 109.561 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.548 HG22 ' SG ' ' A' ' 12' ' ' CYS . 18.8 m -130.57 127.56 22.36 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 109.545 -0.539 . . . . 73.14 109.545 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.17 171.87 15.61 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.439 2.093 . . . . 75.21 111.658 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -85.0 -173.65 1.52 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.499 2.132 . . . . 72.11 111.993 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.63 -133.84 8.25 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.55 -0.583 . . . . 65.1 111.827 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.57 119.46 31.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.935 0.494 . . . . 73.14 109.898 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.76 -90.43 0.53 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.822 -0.911 . . . . 37.91 110.822 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 9' ' ' ASN . 34.2 m -84.13 112.52 41.66 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.281 -1.007 . . . . 63.35 108.281 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.54 -20.98 15.34 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.353 2.035 . . . . 72.44 113.32 -169.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HZ1' ' HB2' ' A' ' 14' ' ' CYS . 28.2 mtmm -104.13 155.34 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.025 0.53 . . . . 73.14 110.233 -171.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.9 m -82.93 111.5 18.87 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 104.959 -2.237 . . . . 70.54 104.959 160.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.35 131.58 18.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 75.1 110.32 -163.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.2 t -110.63 109.37 28.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.512 -0.922 . . . . 73.34 108.512 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 14' ' ' CYS . 44.4 t -92.79 108.48 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.647 0.779 . . . . 74.04 109.274 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.11 116.29 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.179 0.992 . . . . 65.4 109.535 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -88.57 137.05 32.67 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.876 -0.787 . . . . 74.2 108.876 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.453 ' HG1' ' HB2' ' A' ' 52' ' ' LYS . 61.1 p -95.93 173.22 7.55 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 115.583 -0.735 . . . . 73.52 110.184 172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -68.53 -23.51 64.54 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.705 0.802 . . . . 75.21 111.19 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.9 mtm -85.83 5.81 30.95 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.847 0.859 . . . . 72.43 110.828 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 67.14 23.26 9.61 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.117 1.367 . . . . 75.34 113.129 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HB2' ' HG1' ' A' ' 48' ' ' THR . 5.2 mptp? -76.37 125.39 29.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 172.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.5 t -85.37 105.76 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 124.543 1.152 . . . . 73.42 108.27 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.73 117.75 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.386 -0.968 . . . . 72.43 108.386 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.39 117.62 34.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.375 -1.343 . . . . 54.04 107.375 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.24 162.29 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.963 0.905 . . . . 65.0 110.45 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -85.31 138.5 36.42 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.635 -0.711 . . . . 73.52 110.594 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.85 -19.77 35.24 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.294 2.663 . . . . 61.53 114.26 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -73.42 -18.0 61.19 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.824 0.45 . . . . 73.42 110.258 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.32 116.69 2.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.713 0.805 . . . . 75.23 111.663 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HB2' ' HZ2' ' A' ' 61' ' ' LYS . 9.1 mtmp? -68.51 -40.68 80.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.307 1.043 . . . . 75.2 111.133 -173.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -60.9 -39.56 89.77 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.376 0.67 . . . . 75.21 109.622 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 62.7 tp -66.35 -45.26 80.78 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-N 114.952 -1.022 . . . . 71.4 110.34 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -61.71 -42.46 98.98 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.932 0.77 . . . . 74.01 109.831 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -60.23 -39.81 87.99 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.661 -0.7 . . . . 74.02 110.728 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' O ' HG11 ' A' ' 70' ' ' VAL . 55.5 tp -72.32 -33.91 67.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.262 -0.881 . . . . 75.13 111.003 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 91.5 mt -68.63 -35.31 77.12 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.508 0.723 . . . . 75.32 109.874 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -68.41 -41.65 80.13 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.275 0.63 . . . . 73.43 110.276 172.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -69.45 -32.56 71.58 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.677 -0.692 . . . . 71.34 112.222 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 66' ' ' LEU . 30.3 m -74.47 -19.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 122.169 -0.332 . . . . 74.2 111.502 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.27 -58.35 2.88 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.471 0.709 . . . . 74.34 109.39 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -111.46 104.69 13.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.306 1.042 . . . . 72.13 108.762 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.45 115.7 19.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.0 0.92 . . . . 74.43 109.897 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.7 p -131.8 161.33 33.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.659 1.184 . . . . 74.4 107.935 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp 61.91 55.15 2.65 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.945 0.879 . . . . 74.12 109.417 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.6 p -76.64 77.09 3.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.203 -0.908 . . . . 53.33 109.382 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 p -73.18 97.92 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.169 -0.923 . . . . 64.12 110.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 48.8 m -140.05 103.99 6.76 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.997 0.919 . . . . 74.25 108.644 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.16 154.0 28.61 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.847 2.365 . . . . 75.53 112.327 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -68.54 97.44 0.78 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.874 -0.787 . . . . 72.1 108.874 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 136.5 96.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.238 -0.892 . . . . 74.2 110.782 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.07 -17.49 31.67 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.209 1.939 . . . . 74.34 111.886 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.456 HG12 HH21 ' A' ' 87' ' ' ARG . 96.2 t -82.9 104.88 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.04 0.936 . . . . 71.43 109.088 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -73.67 124.4 25.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.196 0.598 . . . . 62.34 110.198 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -67.92 144.38 55.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.72 0.808 . . . . 74.43 110.87 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 66.27 85.09 0.15 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.21 1.404 . . . . 74.14 109.423 -165.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.456 HH21 HG12 ' A' ' 83' ' ' VAL . 32.4 ttm180 -88.85 124.85 34.58 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.751 -0.833 . . . . 63.23 108.751 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.71 74.19 8.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.429 0.691 . . . . 71.32 109.147 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 C-N-CA 124.741 1.216 . . . . 74.41 108.537 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.925 0.393 . . . . 72.11 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.647 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 70.0 mt -122.94 110.04 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.754 -0.832 . . . . 71.12 108.754 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.25 114.03 20.47 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.907 -0.775 . . . . 73.4 108.907 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.69 144.93 30.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.549 0.739 . . . . 71.23 110.026 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.96 115.38 30.35 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.622 0.769 . . . . 62.31 109.529 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -80.89 96.94 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.512 -0.551 . . . . 73.45 109.512 178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -106.76 -11.19 15.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.273 -0.876 . . . . 74.43 109.426 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -70.79 104.86 3.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.241 0.617 . . . . 73.4 110.197 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 4.1 p-10 -82.01 26.6 0.51 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.632 1.173 . . . . 75.4 112.224 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 mt -75.21 -167.52 0.64 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.029 1.332 . . . . 74.4 110.328 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -56.83 92.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.597 0.713 . . . . 74.32 110.238 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.3 m -72.62 101.64 3.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.77 -0.826 . . . . 73.14 108.77 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -102.06 102.69 13.21 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 73.02 110.4 -168.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.0 t -103.79 156.32 17.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.959 -1.019 . . . . 63.54 109.448 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -99.15 5.66 46.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.483 0.713 . . . . 75.02 111.169 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 55' ' ' CYS . . . 89.59 157.15 32.79 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.069 -0.812 . . . . 74.54 111.069 -170.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.89 131.35 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.131 0.966 . . . . 72.53 109.664 -169.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 54' ' ' ILE . 12.7 mt -122.44 135.75 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 108.956 -0.757 . . . . 74.43 108.956 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.1 p -76.31 16.15 0.5 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.375 0.88 . . . . 72.12 113.375 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.6 p -77.24 113.59 15.16 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.311 0.645 . . . . 70.14 110.521 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.22 109.9 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.649 -1.241 . . . . 75.33 107.649 169.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -78.82 138.16 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.8 -0.815 . . . . 72.32 108.8 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.46 128.68 46.04 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.967 0.792 . . . . 44.41 112.938 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.0 -24.97 67.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.446 0.698 . . . . 73.24 111.602 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.1 -20.19 52.7 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.643 0.777 . . . . 64.41 111.416 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 pt -109.36 -11.9 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 118.983 -0.532 . . . . 75.21 112.307 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.64 108.75 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.162 -0.681 . . . . 75.24 109.162 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -89.22 -53.9 4.35 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.256 0.623 . . . . 73.22 109.997 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.647 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 47.2 mtt180 -140.45 148.24 40.87 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.719 -0.673 . . . . 75.24 110.67 -175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 46' ' ' ILE . 67.3 mt -130.68 107.85 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.809 -1.182 . . . . 71.44 107.809 173.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.22 122.55 43.85 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.766 -0.457 . . . . 61.41 109.766 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 m -97.74 120.72 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.687 -0.688 . . . . 73.02 110.304 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 m -104.99 103.31 40.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.395 1.078 . . . . 71.11 109.185 175.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.52 162.97 30.08 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.822 2.348 . . . . 65.41 112.296 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.81 91.12 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.866 2.377 . . . . 73.35 112.436 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.62 -111.1 3.56 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.926 -0.579 . . . . 64.44 112.713 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -146.33 -50.98 0.22 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.796 0.838 . . . . 73.44 109.967 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' HA3' ' HB2' ' A' ' 9' ' ' ASN . . . -63.49 -36.09 92.9 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.211 -0.449 . . . . 75.12 113.956 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.4 m -86.16 137.56 34.99 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.177 0.591 . . . . 62.02 109.879 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.45 -18.28 38.54 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.476 2.117 . . . . 75.55 112.537 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -151.02 172.62 15.43 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.642 0.777 . . . . 73.15 110.991 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.2 m -86.09 133.63 33.87 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.876 -1.056 . . . . 74.05 108.612 167.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -151.82 145.67 25.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.545 0.338 . . . . 71.04 110.308 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.18 106.46 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.558 -0.905 . . . . 74.52 108.558 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.09 110.99 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.227 0.611 . . . . 75.31 109.636 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 30' ' ' ILE . 53.7 mt -95.35 126.5 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.879 0.871 . . . . 72.12 109.829 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -98.64 139.06 34.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.337 -0.616 . . . . 75.14 109.337 168.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.43 ' HG1' ' HB2' ' A' ' 52' ' ' LYS . 68.6 p -87.86 173.3 9.03 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.801 0.688 . . . . 61.05 109.898 169.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.37 -19.24 61.05 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.037 0.535 . . . . 73.45 111.226 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.4 mtm -81.51 -2.8 51.12 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.701 0.801 . . . . 75.05 110.409 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 71.55 21.82 4.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.043 1.737 . . . . 74.14 112.512 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' HB2' ' HG1' ' A' ' 48' ' ' THR . 4.5 mptp? -74.85 137.22 41.68 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.186 0.594 . . . . 71.53 109.807 172.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.2 t -99.39 111.98 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.795 1.238 . . . . 75.22 109.469 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 18' ' ' ILE . 70.6 mt -124.51 144.58 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.077 -1.082 . . . . 75.53 108.077 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 80.7 m -107.65 156.96 18.48 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.036 -0.727 . . . . 61.54 109.036 169.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.4 153.05 25.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.422 1.089 . . . . 75.14 109.011 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.459 ' OD1' ' HB2' ' A' ' 60' ' ' ALA . 21.2 p-10 -71.43 133.78 84.92 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.864 0.466 . . . . 71.45 109.977 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.501 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 58.7 Cg_exo -51.26 -34.77 50.53 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.059 2.506 . . . . 74.32 114.178 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' A' ' 58' ' ' PRO . 6.2 mpt_? -95.67 22.42 7.21 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.924 0.489 . . . . 73.25 111.544 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.459 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . . . -69.24 131.54 45.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.578 -0.527 . . . . 63.13 109.578 172.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -60.24 -51.05 71.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.996 0.918 . . . . 74.22 110.916 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -61.95 -36.66 82.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.576 -0.738 . . . . 74.14 111.107 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -64.96 -45.15 86.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.659 0.599 . . . . 71.23 110.871 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -63.71 -30.98 72.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.086 0.554 . . . . 75.3 111.142 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -65.74 -39.28 90.96 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.113 -0.494 . . . . 73.34 110.136 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.36 -41.49 76.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.222 0.609 . . . . 75.32 111.014 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.58 -35.49 80.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.506 0.722 . . . . 72.41 110.139 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -74.14 -37.72 63.98 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.787 0.835 . . . . 72.12 111.291 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -66.77 -51.31 57.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.182 0.593 . . . . 73.43 111.926 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.28 -22.39 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.02 111.355 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -82.75 1.93 36.4 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.687 0.795 . . . . 62.2 111.468 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.2 t 75.41 103.56 0.07 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.279 1.432 . . . . 55.42 111.852 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.83 -77.31 0.38 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.778 1.231 . . . . 64.14 109.294 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -163.69 154.87 16.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 72.52 109.946 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.67 134.69 52.79 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 72.33 109.14 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -81.03 135.27 35.82 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.581 0.752 . . . . 42.24 109.042 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -68.35 101.09 1.15 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.015 0.526 . . . . 72.0 109.935 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.0 p -56.42 118.41 21.86 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.98 0.912 . . . . 73.54 110.795 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.63 150.49 60.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.924 2.416 . . . . 73.42 113.112 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.87 118.31 8.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.534 0.734 . . . . 64.11 110.172 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 79.57 36.95 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.081 0.952 . . . . 72.0 108.795 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.64 154.41 44.35 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.737 2.291 . . . . 70.01 112.542 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.89 111.95 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.362 -0.977 . . . . 71.31 108.362 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 m -81.22 159.81 24.46 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.983 0.913 . . . . 71.44 111.063 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.77 121.7 15.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.823 0.849 . . . . 63.4 111.206 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -149.81 138.5 20.87 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.508 1.123 . . . . 75.43 108.795 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.9 88.05 5.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 106.731 -1.581 . . . . 71.32 106.731 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.39 -61.89 1.47 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.543 0.737 . . . . 74.1 109.692 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.456 0 C-N-CA 124.852 1.261 . . . . 74.25 110.775 -177.191 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HE3' ' HA ' ' A' ' 1' ' ' MET . 3.4 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.499 0.185 . . . . 73.24 111.499 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.9 mt -87.43 140.36 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.252 0.621 . . . . 73.45 109.534 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.409 ' HB2' HG23 ' A' ' 70' ' ' VAL . 59.2 tp -112.18 122.69 48.44 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.387 -0.597 . . . . 73.34 109.387 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -120.4 157.01 30.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.602 1.561 . . . . 75.3 110.363 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.13 144.7 30.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.78 -0.822 . . . . 72.12 108.78 165.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -82.28 108.0 15.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.972 0.509 . . . . 74.02 111.592 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -88.02 166.34 14.54 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.395 -0.965 . . . . 74.31 108.395 165.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.0 p 58.18 83.61 0.11 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.988 1.715 . . . . 74.11 110.801 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.87 28.68 0.41 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.878 1.271 . . . . 73.34 112.281 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.57 -54.56 34.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.961 0.904 . . . . 74.35 109.389 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -156.44 149.09 23.71 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.493 0.717 . . . . 74.31 109.584 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 m -109.31 125.2 52.07 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.596 -0.89 . . . . 74.14 108.596 168.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -108.21 86.55 2.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.033 0.444 . . . . 73.13 110.913 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.675 ' SG ' HG23 ' A' ' 45' ' ' VAL . 88.8 m -137.39 97.54 3.49 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.65 1.18 . . . . 64.34 108.733 167.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -73.62 -42.16 61.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.442 0.697 . . . . 74.35 110.549 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.5 133.52 10.12 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.62 -0.992 . . . . 62.1 110.62 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.55 132.92 61.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 CA-C-N 117.576 0.688 . . . . 71.14 109.519 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.48 ' O ' HG11 ' A' ' 56' ' ' VAL . 23.6 pt -131.7 115.48 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.382 1.073 . . . . 74.45 108.441 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -91.4 37.63 0.95 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.734 0.778 . . . . 73.45 110.446 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -70.08 134.4 48.17 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.593 -1.185 . . . . 64.14 108.137 170.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.73 112.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-O 121.455 0.645 . . . . 73.44 110.35 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 t -92.53 138.94 18.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.095 -1.076 . . . . 74.44 108.095 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -64.13 125.82 32.76 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.796 0.685 . . . . 71.42 112.226 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.68 -23.32 66.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.752 0.821 . . . . 75.21 111.616 -177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -64.26 -38.76 92.18 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.485 1.114 . . . . 64.03 110.395 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.5 pt -101.19 -12.41 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.271 -0.422 . . . . 74.44 111.934 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 23' ' ' GLY . 83.9 mt -67.02 113.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.417 -0.586 . . . . 72.41 109.417 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.2 -55.4 3.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.312 1.045 . . . . 74.03 110.809 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -142.23 149.29 39.43 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.568 0.747 . . . . 64.23 110.634 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.2 mt -136.09 107.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.657 1.583 . . . . 65.22 106.864 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.66 121.93 41.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.264 0.626 . . . . 74.2 109.491 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.26 113.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.578 -0.527 . . . . 75.44 109.578 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.657 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 61.2 p -97.02 116.36 66.02 Favored Pre-proline 0 CA--C 1.57 1.75 0 C-N-CA 123.912 0.885 . . . . 73.51 110.028 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.73 148.9 29.3 Favored 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.233 2.622 . . . . 72.4 114.18 -172.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.16 -172.79 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.405 2.736 . . . . 72.23 113.941 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.74 -115.71 4.4 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.669 -0.696 . . . . 64.21 112.389 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.19 -31.18 58.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.821 0.448 . . . . 65.42 111.595 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.53 -69.08 1.43 Allowed Glycine 0 C--N 1.352 1.437 0 O-C-N 123.716 0.635 . . . . 74.22 111.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.657 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 3.5 m -105.46 153.37 39.81 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.657 0.783 . . . . 73.01 108.959 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.29 -28.73 47.13 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.188 1.926 . . . . 73.52 112.009 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -147.0 169.5 19.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.866 1.666 . . . . 72.2 107.438 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -74.27 114.71 12.94 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.424 -0.954 . . . . 75.43 108.424 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.79 157.75 30.34 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.036 -0.727 . . . . 73.11 109.036 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.0 t -131.17 111.58 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.073 -1.084 . . . . 75.33 108.073 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG23 ' SG ' ' A' ' 14' ' ' CYS . 58.6 t -91.05 108.54 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 109.054 -0.721 . . . . 74.14 109.054 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.9 mt -100.38 123.11 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.944 -0.762 . . . . 75.11 108.944 177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -92.36 133.49 35.81 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.801 -1.185 . . . . 75.12 107.801 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 p -93.99 168.27 11.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.229 -0.656 . . . . 73.14 109.229 169.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.29 -16.75 64.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.65 0.78 . . . . 75.51 111.168 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.1 mtm -80.38 -5.23 56.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.44 1.096 . . . . 74.41 110.766 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm 69.42 15.88 8.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.672 1.589 . . . . 74.13 112.038 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -81.71 122.48 27.71 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 108.57 -0.9 . . . . 73.04 108.57 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.6 t -85.12 100.92 8.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 107.918 -1.142 . . . . 73.2 107.918 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -101.31 118.23 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.669 -1.234 . . . . 75.11 107.669 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.58 134.18 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.841 -1.17 . . . . 65.35 107.841 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 18' ' ' ILE . 22.8 m -126.64 164.47 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.194 0.998 . . . . 72.42 108.756 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -83.64 158.88 62.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.299 -0.63 . . . . 72.34 109.299 170.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 -12.66 32.13 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.417 2.078 . . . . 74.42 112.274 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -83.95 -2.87 57.39 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.683 0.793 . . . . 73.22 111.932 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.9 121.06 12.56 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.866 0.466 . . . . 73.45 110.298 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -63.67 -46.76 84.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.46 1.104 . . . . 75.55 111.059 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.435 ' O ' HD11 ' A' ' 66' ' ' LEU . 57.5 p-90 -60.45 -36.75 78.98 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.843 -1.071 . . . . 75.05 110.772 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.9 tp -64.34 -39.55 94.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.877 0.871 . . . . 74.03 111.618 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -58.91 -36.49 74.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.122 0.569 . . . . 55.41 112.103 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -59.03 -44.45 91.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.858 -1.064 . . . . 74.25 109.901 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD11 ' O ' ' A' ' 62' ' ' TRP . 8.5 mp -68.01 -44.55 76.28 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.09 0.956 . . . . 74.43 110.618 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.68 -35.33 77.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.909 0.883 . . . . 74.5 110.834 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.82 -39.99 34.08 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.229 0.611 . . . . 75.53 111.321 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -73.79 -16.09 61.17 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.088 0.773 . . . . 74.52 113.088 -173.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 3' ' ' LEU . 35.2 m -86.68 -11.06 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 117.743 0.247 . . . . 75.42 111.654 175.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -93.32 -102.82 0.13 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.013 0.525 . . . . 72.0 112.094 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.0 m -97.78 4.2 49.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.876 0.87 . . . . 72.23 112.097 -168.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -54.88 126.06 22.77 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.681 0.792 . . . . 74.11 110.006 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 m -57.08 127.85 34.03 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.368 1.067 . . . . 75.01 111.642 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.97 164.5 15.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.078 -0.341 . . . . 72.35 110.078 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m 64.99 179.67 0.18 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.651 1.18 . . . . 62.51 111.885 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.6 t -164.51 -173.16 2.94 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.716 -0.846 . . . . 75.02 108.716 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.4 p -60.73 137.98 93.22 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.478 -0.773 . . . . 71.32 110.025 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.99 155.37 8.72 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.002 2.468 . . . . 71.32 113.708 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -62.06 140.52 58.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.023 0.929 . . . . 74.4 110.135 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 137.22 91.64 Favored Pre-proline 0 N--CA 1.485 1.281 0 O-C-N 123.74 0.65 . . . . 73.41 111.144 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.48 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.021 2.481 . . . . 74.1 113.146 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.5 p -163.23 128.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.188 0.995 . . . . 73.22 109.149 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 p -107.85 141.29 39.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.651 . . . . 71.12 109.332 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -67.64 122.55 18.29 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.83 0.852 . . . . 73.34 108.749 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -83.27 153.64 24.56 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.99 0.916 . . . . 75.33 111.48 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -73.86 -39.06 64.23 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.884 . . . . 70.14 109.678 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -172.56 102.56 0.15 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.036 0.934 . . . . 75.14 109.583 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 C-N-CA 123.397 0.679 . . . . 54.13 109.255 176.134 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' HG13 ' A' ' 70' ' ' VAL . 41.0 tpp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.743 0.306 . . . . 75.03 110.718 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.43 134.91 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.531 0.732 . . . . 74.12 109.47 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.55 129.51 37.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.235 0.614 . . . . 73.1 109.76 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -115.41 152.82 32.18 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.683 1.193 . . . . 74.01 110.46 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.6 152.58 36.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 72.25 108.952 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -79.59 97.06 6.34 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 122.319 1.057 . . . . 75.35 110.289 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.83 -1.84 31.33 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.715 -1.129 . . . . 73.41 109.872 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -71.88 -63.36 1.15 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 75.34 109.22 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.7 t30 53.63 64.46 1.83 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.457 1.103 . . . . 74.14 111.425 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -133.26 -168.29 2.07 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.607 1.163 . . . . 72.35 108.943 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -61.18 86.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.059 0.933 . . . . 74.54 109.615 164.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.6 m -61.6 113.35 2.66 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.137 -1.392 . . . . 70.33 110.406 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -104.37 95.51 5.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.875 0.87 . . . . 75.14 110.188 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -133.84 159.22 41.31 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.78 -1.193 . . . . 73.21 107.78 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.484 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 13.3 m -59.84 -12.44 7.5 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.543 1.312 . . . . 73.14 114.543 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.64 -104.7 3.19 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.612 -0.995 . . . . 60.25 110.612 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.5 t -129.06 135.18 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 117.617 0.709 . . . . 73.31 109.752 174.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.89 134.43 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 107.082 -1.451 . . . . 74.54 107.082 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.7 t -82.77 13.6 3.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.347 0.659 . . . . 62.13 112.699 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.3 p -83.08 123.47 29.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.964 0.506 . . . . 70.2 111.635 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.4 t -75.49 114.38 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.924 -1.139 . . . . 72.02 107.924 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 t -98.41 131.78 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.913 0.885 . . . . 75.3 109.528 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.57 137.26 27.13 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.958 0.786 . . . . 54.01 113.552 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 -31.27 72.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.189 0.995 . . . . 72.11 111.2 -171.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -63.49 -33.07 74.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.552 -1.203 . . . . 74.24 112.086 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.4 pt -99.8 -17.62 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 119.328 -0.368 . . . . 64.21 111.087 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.7 115.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.197 -0.668 . . . . 73.34 109.197 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -98.3 -53.45 3.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.818 0.847 . . . . 74.43 109.857 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -140.58 145.18 36.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.749 0.819 . . . . 73.41 110.601 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.9 107.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 73.44 109.183 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.453 ' HG2' HG23 ' A' ' 33' ' ' THR . 7.2 tt0 -95.75 130.89 42.52 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.713 0.405 . . . . 74.42 111.003 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -86.76 114.33 25.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 108.684 -0.858 . . . . 72.21 108.684 171.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.592 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 p -117.69 82.42 16.21 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.844 0.857 . . . . 74.31 110.694 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -65.61 161.86 36.79 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.289 2.659 . . . . 74.43 113.091 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.78 175.93 10.44 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.821 2.347 . . . . 63.11 112.109 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.66 -114.66 2.8 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.692 -0.686 . . . . 60.15 112.34 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -69.21 -24.82 64.08 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.562 0.745 . . . . 73.42 112.174 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.68 -84.41 1.36 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.4 m -70.34 143.29 90.52 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.337 0.655 . . . . 37.08 110.898 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.47 -10.25 14.7 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.465 2.11 . . . . 74.11 112.899 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -151.0 160.36 43.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.34 110.817 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 m -79.03 116.09 19.12 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.888 -0.412 . . . . 71.33 109.888 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HB2' ' HG1' ' A' ' 33' ' ' THR . 40.6 mt-10 -132.14 149.39 52.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.641 0.776 . . . . 71.0 109.934 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' HG23 ' A' ' 56' ' ' VAL . 58.0 t -118.59 108.87 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.779 -1.563 . . . . 75.21 106.779 169.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG22 ' SG ' ' A' ' 14' ' ' CYS . 23.7 t -92.07 133.87 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 123.945 0.898 . . . . 73.33 108.929 -172.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.36 106.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.117 0.967 . . . . 74.3 108.638 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -81.59 124.3 29.41 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.834 -1.173 . . . . 75.31 107.834 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -91.92 169.4 10.7 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 123.641 0.588 . . . . 74.13 110.057 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.57 -13.62 61.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.994 0.918 . . . . 74.34 111.249 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.3 mtt -95.26 12.78 27.75 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.213 1.005 . . . . 73.55 110.838 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 51' ' ' LYS . 6.6 mtpm? 73.64 2.56 4.29 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.579 1.552 . . . . 74.43 113.759 173.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -71.26 124.36 24.33 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.214 0.461 . . . . 61.11 109.859 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.55 101.81 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.523 -1.288 . . . . 64.32 107.523 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.42 136.42 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.641 1.176 . . . . 75.54 108.006 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 15' ' ' SER . 11.3 m -126.06 127.82 46.43 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 71.41 108.32 -172.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG23 ' HB ' ' A' ' 44' ' ' VAL . 15.7 m -137.52 161.45 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 75.22 110.868 -168.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.62 144.03 36.86 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 123.944 0.898 . . . . 75.41 110.345 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.2 -6.95 20.0 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.756 2.304 . . . . 64.41 113.752 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -23.28 38.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.371 0.668 . . . . 64.13 110.752 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 120.8 8.06 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.638 0.775 . . . . 62.33 111.315 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -63.27 -47.36 82.7 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.195 1.398 . . . . 73.13 111.916 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -55.96 -39.87 72.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 75.45 110.116 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -72.34 -38.92 68.5 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 114.039 -1.437 . . . . 75.03 111.344 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -58.04 -42.62 85.77 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.515 0.726 . . . . 71.41 109.992 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.3 mtm105 -60.66 -36.46 78.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.303 -0.862 . . . . 72.25 110.884 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 mt -76.78 -39.73 50.59 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.619 0.768 . . . . 75.31 111.237 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.94 -35.55 81.53 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.4 0.68 . . . . 75.12 110.051 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -73.53 -47.5 40.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.15 -0.932 . . . . 73.23 109.615 175.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -63.25 -47.92 80.38 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.616 0.766 . . . . 74.2 111.932 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.445 HG13 ' SD ' ' A' ' 1' ' ' MET . 23.1 m -69.96 -22.27 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.882 0.473 . . . . 74.42 111.283 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -90.75 -30.79 16.84 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.781 0.832 . . . . 71.31 110.929 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 t -86.32 -74.53 0.42 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.802 0.841 . . . . 74.0 109.206 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -176.62 160.77 2.03 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.507 0.723 . . . . 74.51 110.933 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.2 p -109.66 -177.44 3.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.094 0.958 . . . . 54.03 109.514 170.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 pp -145.0 -178.9 6.28 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.403 0.681 . . . . 72.44 109.843 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -72.67 97.18 2.12 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.274 -0.639 . . . . 71.13 109.274 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 t -81.57 179.27 7.91 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.345 1.058 . . . . 75.41 110.319 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.6 p -65.19 147.69 98.4 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 118.634 -0.698 . . . . 60.33 110.52 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.48 108.72 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 124.074 3.183 . . . . 75.04 112.756 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.19 -178.34 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.649 1.18 . . . . 70.4 109.37 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.98 140.88 97.65 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 123.441 0.697 . . . . 65.13 111.058 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.61 146.5 19.88 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.635 2.89 . . . . 75.41 114.697 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.42 117.41 25.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.905 -1.146 . . . . 75.13 107.905 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.9 p -60.79 144.76 51.85 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.369 0.668 . . . . 73.0 110.244 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.23 87.97 0.18 Allowed 'General case' 0 C--N 1.349 0.575 0 CA-C-O 121.664 0.745 . . . . 73.51 110.394 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.97 160.45 14.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.866 -1.061 . . . . 75.3 108.802 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.04 115.87 8.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.012 -0.736 . . . . 71.44 109.012 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.89 -67.85 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.994 -0.743 . . . . 74.51 108.994 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 N-CA-C 108.313 -0.995 . . . . 75.05 108.313 175.067 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.019 0.438 . . . . 74.32 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.402 HD11 ' HG2' ' A' ' 29' ' ' ARG . 30.8 mt -120.24 132.19 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 71.35 108.047 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.8 tp -106.6 125.59 51.19 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.68 -0.859 . . . . 65.13 108.68 170.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -119.43 114.9 23.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.627 0.771 . . . . 73.03 109.598 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.88 121.11 27.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.676 -1.602 . . . . 71.3 106.676 161.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.467 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 2.0 p80 -80.11 100.02 8.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.695 0.759 . . . . 74.4 109.795 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -70.43 -38.65 74.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.222 -1.029 . . . . 70.1 108.222 168.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -68.64 93.39 0.51 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.537 -1.21 . . . . 74.51 110.269 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -82.03 66.15 7.47 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.838 0.827 . . . . 71.54 109.434 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -83.29 -177.96 6.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.059 -0.973 . . . . 64.34 108.848 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -71.95 94.92 1.51 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.078 -0.712 . . . . 75.03 109.078 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.0 m -67.04 100.45 0.75 Allowed 'General case' 0 C--N 1.353 0.723 0 CA-C-O 121.254 0.55 . . . . 64.53 109.679 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.57 87.75 3.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.244 1.018 . . . . 71.21 108.485 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.64 158.95 43.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.782 -1.192 . . . . 54.32 107.782 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.519 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 19.0 m -61.65 1.95 0.21 Allowed 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 114.389 1.255 . . . . 74.44 114.389 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 -93.82 1.75 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.508 -0.637 . . . . 74.12 111.508 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.91 132.5 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.993 -0.743 . . . . 70.23 108.993 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.4 mt -118.65 129.07 75.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.202 -1.777 . . . . 74.34 106.202 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 p -82.82 34.79 0.45 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.775 0.83 . . . . 74.24 112.315 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.4 p -110.23 133.74 52.93 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.793 0.837 . . . . 74.33 110.25 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.46 117.54 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 108.089 -1.078 . . . . 63.02 108.089 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.9 t -84.01 136.42 22.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 109.286 -0.635 . . . . 73.41 109.286 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -61.47 119.08 16.95 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.095 0.872 . . . . 54.24 113.048 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.68 -16.51 57.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.791 0.836 . . . . 74.25 112.102 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -84.51 -36.49 22.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.979 0.912 . . . . 71.21 110.789 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 pt -85.45 -15.72 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 119.592 -0.242 . . . . 74.42 111.364 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 23' ' ' GLY . 89.9 mt -68.94 131.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 63.45 110.858 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -122.75 -48.43 2.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.342 0.657 . . . . 60.22 111.202 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 19.1 mtp180 -126.04 129.03 48.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.841 0.457 . . . . 74.12 110.4 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.3 mt -122.12 107.68 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.066 1.346 . . . . 70.51 108.143 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -105.19 122.66 46.37 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.096 -0.705 . . . . 74.12 109.096 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.57 131.69 33.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.669 -0.863 . . . . 63.03 108.669 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 90.3 m -124.48 85.11 56.32 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.776 0.83 . . . . 72.52 110.759 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.5 145.58 71.21 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.258 1.972 . . . . 73.54 110.111 160.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.74 140.31 46.34 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.977 1.784 . . . . 71.52 112.217 -174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.49 -169.13 20.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.746 -0.542 . . . . 64.34 111.746 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -73.58 77.99 1.48 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.957 0.884 . . . . 71.22 110.583 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.45 -52.45 0.48 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.491 -1.231 . . . . 73.15 110.794 -173.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -101.67 113.05 65.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.334 0.654 . . . . 63.43 109.827 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.41 -16.21 9.56 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.621 2.214 . . . . 54.22 113.361 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -103.2 146.72 28.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.566 0.746 . . . . 75.0 110.798 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.3 m -89.5 112.07 23.14 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.678 -1.601 . . . . 71.22 106.678 160.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.63 170.61 21.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.537 0.735 . . . . 74.34 110.215 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -132.82 120.72 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 63.32 108.368 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.3 110.58 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.249 -0.649 . . . . 71.41 109.249 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.9 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 74.41 109.828 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 31.4 m-90 -91.74 117.42 29.74 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.545 -1.28 . . . . 74.33 107.545 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.8 p -89.27 172.99 8.65 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.847 0.356 . . . . 72.3 111.164 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.32 -16.46 61.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.313 1.445 . . . . 74.4 110.842 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 70.7 mtp -96.93 3.72 51.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.363 1.065 . . . . 74.32 110.649 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 66.41 26.57 10.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.573 1.549 . . . . 71.1 112.684 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.74 124.12 30.56 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.827 -0.805 . . . . 72.21 108.827 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.1 t -90.56 105.74 16.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.265 -1.013 . . . . 74.04 108.265 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.25 126.7 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.984 -0.746 . . . . 72.23 108.984 -176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 15' ' ' SER . 2.4 m -108.92 120.96 44.06 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 108.028 -1.101 . . . . 75.1 108.028 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.03 166.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.793 0.837 . . . . 64.31 109.522 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.74 146.15 72.14 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-O 119.391 -0.337 . . . . 70.32 110.404 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -51.75 -34.78 55.73 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.232 2.622 . . . . 72.24 113.72 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.7 11.28 11.28 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.65 0.982 . . . . 75.42 113.65 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.93 123.56 19.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.149 0.431 . . . . 72.33 109.99 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -65.7 -45.63 82.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.192 0.997 . . . . 72.22 112.414 -170.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -61.88 -33.69 74.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.191 0.596 . . . . 55.12 110.668 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.92 -33.98 74.64 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.138 -0.937 . . . . 73.34 110.676 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -59.46 -33.33 71.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.495 0.718 . . . . 74.23 112.235 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -64.33 -37.23 86.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.66 0.784 . . . . 73.04 110.392 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.0 mt -79.0 -36.05 41.89 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.135 0.974 . . . . 74.41 111.158 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.3 -33.01 74.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.76 0.824 . . . . 75.13 109.658 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.74 -51.05 45.57 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.61 -0.885 . . . . 64.23 108.61 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -61.71 -50.03 74.06 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.23 0.956 . . . . 64.13 112.438 -171.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.66 -32.18 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.811 0.445 . . . . 72.41 111.396 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.03 177.88 7.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.898 0.879 . . . . 75.34 110.579 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.0 t 59.11 26.94 15.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.71 1.204 . . . . 72.21 110.65 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.472 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 6.7 ttpm? 64.37 112.58 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.395 1.478 . . . . 71.23 110.134 -166.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.6 t -67.24 105.5 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.064 0.459 . . . . 71.21 109.903 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.2 tp -106.45 139.81 40.34 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.486 1.114 . . . . 74.25 108.832 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -74.31 132.87 42.46 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.341 -0.614 . . . . 63.03 109.341 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 11.5 38.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.96 0.904 . . . . 73.01 110.949 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 p -61.77 126.6 87.4 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.265 0.626 . . . . 72.35 109.712 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.0 -163.52 0.22 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.805 2.337 . . . . 74.14 112.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -142.9 157.05 44.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.833 0.853 . . . . 73.42 109.685 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.96 128.23 28.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.591 0.756 . . . . 74.35 109.537 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -80.87 177.34 8.08 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.87 2.38 . . . . 75.43 110.603 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.67 125.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 108.849 -0.797 . . . . 74.24 108.849 173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.4 p -119.6 79.8 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.788 0.804 . . . . 64.15 110.401 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.57 90.43 3.92 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.218 -1.03 . . . . 71.11 108.218 169.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -78.49 83.6 4.68 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.59 -1.186 . . . . 74.11 109.042 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -78.64 128.93 34.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 70.11 109.955 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.98 171.1 7.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.033 0.933 . . . . 73.22 109.646 172.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 109.385 -0.598 . . . . 70.11 109.385 174.677 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtp . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.266 -0.642 . . . . 74.15 109.266 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.481 ' HB ' ' HD3' ' A' ' 29' ' ' ARG . 78.1 mt -107.05 118.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.577 -0.898 . . . . 74.45 108.577 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.2 tp -79.32 116.61 19.67 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.262 -1.014 . . . . 75.24 108.262 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -115.65 131.36 56.96 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.223 -1.028 . . . . 74.25 108.223 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.91 124.37 46.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.249 -1.019 . . . . 74.45 108.249 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 4.4 p80 -82.79 117.48 22.72 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.346 0.593 . . . . 75.13 109.864 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.14 -18.91 14.34 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.223 1.009 . . . . 71.15 109.337 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.2 m -86.66 135.84 33.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.547 1.139 . . . . 72.41 109.741 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -71.9 138.7 48.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.375 0.67 . . . . 74.31 109.933 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -158.22 171.69 19.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.859 0.863 . . . . 70.22 109.681 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.524 ' HZ2' ' HB3' ' A' ' 11' ' ' LYS . 3.9 mmmp? -69.76 91.3 0.62 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.835 -0.62 . . . . 73.41 109.474 175.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.3 m -66.04 112.14 3.71 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.627 -0.879 . . . . 64.41 108.627 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' NE ' HG13 ' A' ' 53' ' ' VAL . 13.5 ptm180 -112.56 89.92 3.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.016 0.913 . . . . 74.44 112.121 -161.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.0 t -132.11 95.18 3.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.792 -1.095 . . . . 74.33 108.075 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t -99.12 8.17 45.15 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.808 0.843 . . . . 64.13 110.231 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.62 139.2 2.58 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.41 -1.076 . . . . 65.52 110.41 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -104.23 134.18 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.249 -0.648 . . . . 74.1 109.249 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.9 mt -108.06 124.68 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.374 -0.973 . . . . 72.25 108.374 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.7 m -85.23 27.56 0.79 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.855 0.862 . . . . 54.33 112.529 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.4 p -88.91 129.28 35.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.67 0.788 . . . . 72.34 109.798 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.8 111.17 8.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.127 -1.434 . . . . 73.35 107.127 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.61 131.5 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.898 -0.779 . . . . 75.54 108.898 -176.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.0 131.76 39.68 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.548 -0.584 . . . . 54.11 112.62 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -57.79 -30.51 65.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.922 0.889 . . . . 74.53 112.427 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.6 -40.27 96.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.792 0.837 . . . . 61.32 110.88 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 pt -98.05 -12.56 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 116.21 -0.45 . . . . 74.44 111.333 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 107.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.191 0 N-CA-C 107.884 -1.154 . . . . 75.11 107.884 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -97.7 -46.97 5.79 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.258 0.623 . . . . 63.45 110.267 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HD3' ' HB ' ' A' ' 2' ' ' ILE . 7.3 tpp180 -142.67 125.4 15.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.746 0.819 . . . . 72.52 109.55 -174.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.23 105.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.776 -1.194 . . . . 72.13 107.776 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -98.28 119.45 36.98 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.137 -0.32 . . . . 73.12 110.137 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 127.31 40.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 107.897 -1.149 . . . . 72.11 107.897 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.572 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 67.6 m -124.75 93.53 45.93 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.432 -0.804 . . . . 65.35 110.291 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.57 154.65 70.93 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.136 2.557 . . . . 75.34 112.124 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -74.55 166.34 29.62 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.886 2.39 . . . . 73.31 112.697 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.6 -168.12 39.5 Favored Glycine 0 N--CA 1.466 0.674 0 CA-C-N 115.53 -0.759 . . . . 44.21 111.397 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.96 -28.05 68.7 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.251 0.621 . . . . 73.04 110.303 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.74 -67.39 1.39 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.812 -0.631 . . . . 73.3 112.305 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.0 m -71.92 117.77 60.93 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.747 0.419 . . . . 72.43 111.18 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.44 -16.63 21.62 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.291 1.994 . . . . 72.42 113.005 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -149.52 170.1 19.4 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.224 1.01 . . . . 72.21 110.274 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.6 m -86.27 126.07 34.04 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.171 -1.048 . . . . 62.52 108.171 166.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.572 ' HG3' ' HB ' ' A' ' 33' ' ' THR . 5.4 pt-20 -148.63 157.48 43.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.211 1.004 . . . . 72.23 109.308 -171.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -130.81 110.5 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.908 -1.145 . . . . 74.01 107.908 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -97.94 109.51 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 109.894 -0.41 . . . . 72.31 109.894 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.89 118.42 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.629 0.772 . . . . 75.1 109.768 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -93.1 135.77 33.98 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.033 -0.728 . . . . 75.35 109.033 167.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.5 p -87.55 170.05 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.357 0.41 . . . . 72.4 110.149 170.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -63.36 -27.55 69.39 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.225 0.61 . . . . 73.04 111.18 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.425 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 54.6 mtm -80.1 1.79 26.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.546 1.138 . . . . 75.53 111.543 176.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttm 66.74 31.5 7.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.08 1.752 . . . . 73.41 112.406 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' HZ2' ' HB3' ' A' ' 50' ' ' MET . 14.1 mptt -81.25 123.31 28.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.342 -0.984 . . . . 73.13 108.342 170.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG13 ' NE ' ' A' ' 13' ' ' ARG . 21.5 t -82.99 105.33 12.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 124.64 1.213 . . . . 74.13 108.67 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.75 136.12 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.967 -1.123 . . . . 71.21 107.967 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.53 145.73 35.82 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.993 -0.743 . . . . 74.21 108.993 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.44 155.92 13.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.162 1.385 . . . . 74.41 108.221 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -92.39 148.2 35.97 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 122.869 0.468 . . . . 65.11 110.319 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.47 -5.86 17.04 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.664 2.243 . . . . 73.3 112.813 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -79.24 -23.49 43.67 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.922 0.889 . . . . 73.53 111.144 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.17 119.86 7.61 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.405 0.682 . . . . 52.22 110.209 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -65.03 -44.0 90.54 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.659 0.783 . . . . 74.31 112.052 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -59.18 -38.09 78.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.541 0.737 . . . . 74.21 110.217 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.8 tp -72.86 -37.3 67.41 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.95 -1.023 . . . . 73.42 110.678 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -61.12 -35.56 77.38 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.407 0.683 . . . . 73.1 109.363 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -60.44 -39.79 88.78 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.778 0.831 . . . . 74.41 110.732 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.09 -51.24 33.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.279 -0.873 . . . . 64.43 109.507 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -24.2 66.24 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.191 0.997 . . . . 72.45 111.525 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -76.95 -54.39 6.63 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.739 1.216 . . . . 74.02 110.419 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 75' ' ' LEU . 50.9 t-80 -84.99 -20.11 31.02 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.073 0.768 . . . . 70.44 113.073 -167.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.5 m -65.91 -30.61 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.084 0.402 . . . . 74.4 110.687 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -64.05 152.07 41.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.611 0.765 . . . . 73.33 109.639 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -50.32 89.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.585 1.154 . . . . 63.44 112.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -132.31 175.01 9.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.735 1.214 . . . . 73.32 110.084 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -102.39 165.52 11.07 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.304 -0.862 . . . . 63.14 109.798 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.51 ' HB3' ' HE2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -163.97 152.58 13.41 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.923 0.889 . . . . 74.12 109.606 175.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 p -101.26 136.35 41.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.238 -1.023 . . . . 75.43 108.238 168.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 p -76.39 148.8 37.11 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.83 -0.433 . . . . 72.42 109.83 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 p -103.6 112.34 65.57 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.924 0.89 . . . . 74.3 110.089 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.49 125.39 4.42 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.926 2.417 . . . . 60.4 112.136 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.93 150.87 35.92 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.909 0.484 . . . . 74.33 110.011 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.76 107.84 4.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.459 -0.941 . . . . 63.11 108.459 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.97 130.16 22.35 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.182 1.921 . . . . 65.13 112.661 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -61.6 126.63 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.251 0.548 . . . . 72.14 110.242 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.5 m -103.34 64.99 0.84 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.824 -0.806 . . . . 53.25 108.824 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -105.04 115.88 31.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.123 -0.944 . . . . 75.54 108.603 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -83.06 128.09 34.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.974 -0.75 . . . . 73.34 108.974 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -74.54 90.73 2.25 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.628 0.371 . . . . 64.55 110.167 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.94 20.86 6.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.064 1.346 . . . . 64.53 113.798 171.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 124.744 1.217 . . . . 73.12 112.276 177.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.824 -0.435 . . . . 74.33 109.824 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.437 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 41.4 mt -107.36 132.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.176 0.99 . . . . 61.32 108.412 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.49 108.75 20.34 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.222 -0.659 . . . . 73.23 109.222 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -81.89 140.83 33.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.16 0.584 . . . . 73.14 109.538 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.419 ' HB2' ' HE2' ' A' ' 7' ' ' TYR . . . -118.29 117.4 29.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.034 0.934 . . . . 75.34 108.744 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.468 ' HE1' ' HB2' ' A' ' 10' ' ' LEU . 52.4 t60 -95.91 97.89 9.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.317 0.647 . . . . 74.22 110.477 -174.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' HE2' ' HB2' ' A' ' 5' ' ' ALA . 96.4 m-85 -121.4 -2.6 9.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.216 1.006 . . . . 73.2 110.918 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 38.5 p -86.98 133.35 33.59 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.863 0.865 . . . . 73.21 109.831 175.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -68.6 86.27 0.31 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.309 0.643 . . . . 62.24 110.521 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HB2' ' HE1' ' A' ' 6' ' ' HIS . 54.3 mt -122.34 172.65 8.16 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.375 1.07 . . . . 73.13 108.87 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -92.84 97.88 11.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.613 0.765 . . . . 74.41 109.102 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.2 m -73.65 106.16 5.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.145 -0.687 . . . . 71.2 109.145 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -99.53 95.84 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.008 0.432 . . . . 75.24 110.942 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' HG22 ' A' ' 45' ' ' VAL . 86.3 m -130.06 115.67 17.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.866 0.866 . . . . 74.22 109.694 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -71.14 87.6 0.79 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.351 0.66 . . . . 72.22 110.282 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.42 -155.82 52.6 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.504 -0.771 . . . . 65.14 112.537 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 136.61 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.938 -0.764 . . . . 75.44 108.938 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.68 114.64 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.024 -1.102 . . . . 74.43 108.024 -175.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 t -89.07 29.28 1.07 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.854 0.861 . . . . 73.32 111.72 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -81.75 123.72 29.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.111 0.564 . . . . 72.03 109.663 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.1 109.81 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 107.963 -1.125 . . . . 64.11 107.963 168.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.15 134.64 27.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 108.194 -1.039 . . . . 73.53 108.194 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -59.21 119.18 16.88 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.832 0.708 . . . . 61.13 112.693 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HG ' HD22 ' A' ' 66' ' ' LEU . 9.2 mp -58.49 -30.07 66.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.246 0.618 . . . . 74.13 111.181 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -69.21 -34.09 74.34 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.609 0.763 . . . . 72.22 112.226 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.0 pt -95.05 -8.0 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 119.301 -0.38 . . . . 74.44 111.843 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.2 mt -70.27 130.46 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.149 -0.686 . . . . 75.33 109.149 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.09 -53.64 2.66 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.925 -0.58 . . . . 54.43 109.621 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 70.4 mtt180 -135.21 147.89 49.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.679 0.791 . . . . 70.43 110.048 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -138.98 126.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.708 1.203 . . . . 64.11 108.726 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.463 HE22 ' HH2' ' A' ' 47' ' ' TRP . 7.8 tt0 -110.19 125.77 53.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.279 0.632 . . . . 74.4 109.637 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.55 121.97 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.318 -0.623 . . . . 74.14 109.318 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.9 m -113.98 102.12 54.54 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.091 0.956 . . . . 72.23 109.473 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.82 160.34 33.59 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.758 2.972 . . . . 70.21 112.905 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.41 -11.6 18.96 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.72 2.28 . . . . 71.14 113.29 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.97 159.73 20.39 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.396 -1.082 . . . . 74.3 110.396 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.42 77.11 0.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.415 1.086 . . . . 72.23 110.589 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.83 -93.53 0.17 Allowed Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.592 -0.731 . . . . 71.13 111.557 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -129.81 145.02 55.35 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.949 0.9 . . . . 63.22 109.732 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.72 -24.46 75.71 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.874 2.383 . . . . 64.32 114.692 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm -102.55 153.78 19.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.016 0.526 . . . . 74.31 110.692 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.5 p -82.14 114.04 20.4 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.612 -0.885 . . . . 74.13 108.612 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -133.95 135.74 43.73 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.683 0.793 . . . . 73.23 109.92 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 67.9 t -118.39 103.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.916 -0.772 . . . . 75.21 108.916 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' SG ' ' A' ' 14' ' ' CYS . 36.6 t -94.57 107.23 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.837 -0.801 . . . . 71.33 108.837 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.67 134.56 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.735 0.814 . . . . 73.2 109.608 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.463 ' HH2' HE22 ' A' ' 31' ' ' GLN . 26.8 m-90 -107.37 132.43 53.16 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.921 -1.14 . . . . 75.23 107.921 166.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -80.78 177.77 8.82 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.49 -0.559 . . . . 71.23 109.49 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -68.03 -30.27 69.46 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.688 0.395 . . . . 61.33 110.945 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.42 ' N ' ' SD ' ' A' ' 50' ' ' MET . 3.1 mpp? -81.08 2.69 26.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.854 0.862 . . . . 74.35 110.895 174.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt 72.91 25.04 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.769 1.628 . . . . 74.12 112.933 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -77.75 125.77 29.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.616 -0.513 . . . . 74.43 109.616 173.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.03 112.48 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.401 1.08 . . . . 75.52 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.35 120.16 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.442 -1.318 . . . . 75.45 107.442 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.3 m -104.89 116.54 32.15 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.096 -1.076 . . . . 72.14 108.096 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 m -109.97 164.32 6.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 C-N-CA 124.201 1.001 . . . . 74.52 109.912 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.82 146.18 68.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 116.076 -0.511 . . . . 73.15 109.816 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.68 -29.6 69.41 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.329 2.019 . . . . 71.13 112.503 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -81.2 9.52 6.78 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 112.461 0.541 . . . . 74.42 112.461 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.66 32.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.898 0.479 . . . . 65.41 110.022 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -66.57 -42.23 87.35 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.203 1.401 . . . . 73.41 111.703 -166.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -68.65 -37.72 79.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.612 1.165 . . . . 71.45 111.013 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.5 -29.46 70.73 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.717 1.207 . . . . 75.01 111.345 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 90.9 mm-40 -54.77 -38.38 67.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.987 0.915 . . . . 72.41 112.32 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.23 -41.54 93.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.649 0.779 . . . . 74.23 110.337 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.46 HD22 ' HG ' ' A' ' 24' ' ' LEU . 63.8 mt -70.51 -37.71 74.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.083 -0.962 . . . . 75.1 110.651 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.36 -30.65 71.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.26 0.624 . . . . 75.23 111.383 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 9.0 mmt180 -87.31 -29.52 21.54 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.24 0.216 . . . . 74.42 110.673 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.506 ' HE1' ' HB3' ' A' ' 75' ' ' LEU . 81.7 t60 -73.31 -32.88 64.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.872 0.469 . . . . 74.11 112.188 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.52 -4.5 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.631 0.372 . . . . 75.12 111.899 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.87 -160.3 0.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.02 1.328 . . . . 73.31 110.358 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -68.58 79.67 0.28 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.426 0.69 . . . . 64.33 110.238 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -153.77 120.11 5.48 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.122 0.969 . . . . 73.54 108.649 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.0 t -78.75 -179.68 6.67 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.271 1.028 . . . . 73.51 110.867 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' HB3' ' HE1' ' A' ' 69' ' ' HIS . 3.5 pp -138.15 175.29 9.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.232 1.013 . . . . 72.34 109.309 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.2 p -118.74 129.79 55.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.994 -0.743 . . . . 74.54 108.994 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.7 p -67.65 122.78 18.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.062 0.545 . . . . 74.11 109.868 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -75.36 147.4 82.47 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.037 0.935 . . . . 72.0 110.604 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.46 82.33 1.41 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.532 2.155 . . . . 72.31 111.338 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -133.8 176.29 8.7 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 62.44 109.815 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.96 96.26 2.31 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.557 -1.275 . . . . 73.42 107.557 164.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.2 169.58 17.87 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.563 2.175 . . . . 72.44 113.391 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.2 t -76.27 135.53 26.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.801 -1.185 . . . . 74.34 107.801 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -55.35 106.37 0.23 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.665 0.786 . . . . 73.03 111.221 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -86.71 104.57 16.22 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.192 -0.67 . . . . 75.12 109.192 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -82.74 96.53 8.2 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.973 -1.121 . . . . 75.15 107.973 175.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -139.37 110.55 6.92 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.435 -1.32 . . . . 72.23 107.435 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.59 -169.78 2.17 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.343 1.057 . . . . 73.23 109.152 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.364 0 C-N-CA 123.134 0.574 . . . . 61.42 110.614 178.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.082 -0.34 . . . . 75.53 110.082 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.13 115.73 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.456 -0.942 . . . . 73.3 108.456 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 62.3 tp -79.24 121.25 24.83 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.349 -0.611 . . . . 75.22 109.349 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.13 139.55 51.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.861 0.864 . . . . 75.2 110.124 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.67 110.36 21.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.426 -1.324 . . . . 75.12 107.426 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -82.11 132.5 35.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.66 -0.496 . . . . 73.41 109.66 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.2 163.45 8.21 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.211 1.004 . . . . 74.32 109.838 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -56.94 148.71 20.43 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 113.24 0.83 . . . . 74.02 113.24 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.658 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 29.0 m-80 -142.39 170.46 15.67 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.917 1.287 . . . . 70.11 109.658 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.5 mt -105.79 -15.52 14.92 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.306 -0.861 . . . . 72.43 111.299 166.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -136.24 110.7 8.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 74.02 109.865 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.4 m -106.63 110.94 23.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.823 0.849 . . . . 45.44 109.581 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -80.81 91.05 5.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.291 0.636 . . . . 74.54 110.402 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.65 147.43 48.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.498 0.719 . . . . 72.21 110.608 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -87.12 0.73 54.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.146 0.978 . . . . 74.13 111.957 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.55 -92.67 1.63 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.267 -0.733 . . . . 62.01 111.267 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.12 132.26 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.532 0.733 . . . . 73.11 109.617 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mt -129.4 112.2 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 105.802 -1.925 . . . . 72.41 105.802 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 t -85.45 27.87 0.79 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.843 0.682 . . . . 55.51 112.843 -171.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.2 p -79.02 119.46 22.19 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.401 -0.592 . . . . 74.51 109.401 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.86 112.43 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 75.44 108.384 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.69 140.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.136 0.574 . . . . 72.55 109.923 -173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -66.4 127.76 29.59 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.597 0.561 . . . . 74.25 112.875 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.88 -32.59 70.86 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.284 1.034 . . . . 74.33 111.982 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -74.29 -22.62 59.21 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.905 0.882 . . . . 73.54 112.311 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 pt -103.98 -12.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.616 0.366 . . . . 74.31 111.234 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 23' ' ' GLY . 75.6 mt -68.5 115.26 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.772 -0.825 . . . . 74.42 108.772 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 -52.29 5.51 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.054 0.942 . . . . 70.31 109.968 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -141.01 142.08 34.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.544 0.738 . . . . 65.43 110.459 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.62 105.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.08 -1.452 . . . . 75.34 107.08 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -111.77 122.2 47.16 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.483 0.713 . . . . 72.24 110.096 -175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.31 123.76 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.688 -0.856 . . . . 75.02 108.688 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.789 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 33.3 p -103.75 121.83 46.76 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 108.906 -0.776 . . . . 73.41 108.906 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.09 154.8 14.71 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.052 2.501 . . . . 74.14 113.931 -171.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.71 169.0 17.2 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.464 2.11 . . . . 72.41 112.573 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.26 -102.66 1.2 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.677 -0.569 . . . . 63.42 111.677 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -81.37 87.42 6.16 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.022 -0.733 . . . . 74.11 109.022 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 9' ' ' ASN . . . 150.23 -73.71 0.28 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.564 -0.744 . . . . 50.32 111.35 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.789 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 61.2 m -127.13 155.06 76.66 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.732 0.813 . . . . 74.24 109.711 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.93 -18.17 52.08 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.413 2.075 . . . . 74.24 113.44 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -150.81 171.18 17.61 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.392 0.677 . . . . 71.33 110.495 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 m -79.43 115.56 19.14 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 64.43 109.116 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 23.3 mt-10 -127.49 158.44 37.39 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.626 0.77 . . . . 75.25 108.976 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.0 106.22 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.734 -0.839 . . . . 74.13 108.734 175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.31 111.49 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.51 0.724 . . . . 74.44 109.871 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.468 HG22 HG22 ' A' ' 27' ' ' ILE . 56.9 mt -95.98 125.25 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.021 0.929 . . . . 75.41 109.836 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -98.63 140.1 33.36 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.902 -0.777 . . . . 73.12 108.902 167.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.0 p -88.64 171.18 10.21 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.847 -0.427 . . . . 63.34 109.847 169.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -71.59 -18.57 62.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.306 0.642 . . . . 73.32 111.442 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.1 mtm -87.42 6.1 35.54 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.903 0.881 . . . . 75.42 110.766 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 63.0 43.74 6.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.183 1.393 . . . . 74.12 112.893 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -91.43 122.88 34.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.662 -1.236 . . . . 64.13 107.662 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.39 111.4 18.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 O-C-N 124.496 1.123 . . . . 72.4 108.255 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.67 145.34 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.853 -1.166 . . . . 71.31 107.853 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.7 m -116.77 150.01 38.99 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.101 -0.703 . . . . 72.01 109.101 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.8 m -141.87 158.57 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.878 0.871 . . . . 71.34 109.615 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -73.59 137.21 77.44 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.808 0.843 . . . . 74.22 110.78 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.34 -16.83 44.2 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.878 2.385 . . . . 73.43 113.789 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.09 2.1 56.59 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.292 0.637 . . . . 75.33 112.444 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 123.82 20.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.938 0.495 . . . . 63.22 109.993 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.08 -33.37 67.86 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.446 0.698 . . . . 74.01 111.88 -172.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.421 ' O ' HD11 ' A' ' 66' ' ' LEU . 54.0 p-90 -63.17 -42.48 99.41 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.247 -0.649 . . . . 75.42 109.247 174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.075 0.95 . . . . 63.41 110.661 176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -60.48 -40.19 90.39 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.648 0.779 . . . . 64.03 111.978 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.53 -45.55 77.15 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.825 0.703 . . . . 74.54 109.983 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' HG11 ' A' ' 70' ' ' VAL . 10.2 mp -66.65 -48.3 69.83 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.306 -0.861 . . . . 64.54 110.994 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.19 -33.68 69.52 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.676 0.791 . . . . 75.22 111.712 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -84.16 -33.68 24.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.97 0.508 . . . . 75.33 111.385 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -86.38 -15.88 39.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.637 0.775 . . . . 65.44 112.72 -173.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 66' ' ' LEU . 27.1 m -70.5 -11.55 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 112.205 0.446 . . . . 75.03 112.205 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.22 -163.05 0.06 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.472 1.109 . . . . 74.24 111.0 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.1 p -78.69 20.25 0.46 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.358 0.663 . . . . 54.54 112.394 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -63.56 107.53 1.16 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.128 0.971 . . . . 74.44 109.861 173.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.2 p -78.92 141.03 37.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.526 0.731 . . . . 75.15 111.448 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.99 61.48 6.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.047 0.939 . . . . 74.1 109.467 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -68.48 -44.02 75.69 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.291 0.636 . . . . 73.24 110.44 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 p -72.46 87.49 1.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.764 0.826 . . . . 72.4 110.286 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.7 p -119.96 143.47 35.39 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.87 0.868 . . . . 74.52 109.372 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 175.66 10.97 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.528 2.152 . . . . 73.34 112.522 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -120.91 161.14 22.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.983 0.913 . . . . 75.15 110.309 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.67 98.02 49.84 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.115 0.966 . . . . 71.24 109.392 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 129.17 12.45 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.548 2.165 . . . . 62.23 113.06 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.62 128.02 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.251 0.548 . . . . 72.43 110.196 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 t -128.94 128.69 44.27 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.179 0.992 . . . . 61.52 108.58 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.04 149.32 45.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.556 0.743 . . . . 73.22 111.499 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -126.71 125.98 42.71 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.585 -1.265 . . . . 72.35 107.585 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.78 85.92 4.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.228 0.611 . . . . 74.33 109.469 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.85 119.82 9.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.374 1.07 . . . . 64.33 109.336 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.587 0.755 . . . . 63.01 109.583 -178.075 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 tpp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.358 -0.608 . . . . 71.11 109.358 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.46 109.45 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.798 -0.816 . . . . 74.13 108.798 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.8 tp -86.97 118.08 26.11 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.002 -0.74 . . . . 72.1 109.002 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -119.37 156.49 30.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.092 0.957 . . . . 74.21 110.145 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.44 150.38 39.66 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.711 0.804 . . . . 53.3 109.06 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -79.75 97.93 6.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.03 0.532 . . . . 73.2 110.762 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -103.38 -60.92 1.49 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.404 0.681 . . . . 72.44 110.237 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.1 p -122.63 120.97 35.29 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.232 0.539 . . . . 71.04 111.018 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -172.6 155.69 3.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.608 1.563 . . . . 74.22 106.913 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.52 -60.58 2.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.487 -0.931 . . . . 75.42 108.487 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -145.68 140.4 27.24 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.417 -0.811 . . . . 74.5 110.058 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.47 103.95 11.56 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.7 -1.222 . . . . 61.0 107.7 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -83.85 87.5 7.09 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.104 -0.498 . . . . 64.21 111.829 -168.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' A' ' 45' ' ' VAL . 70.8 m -136.81 150.74 48.51 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.37 1.068 . . . . 72.13 108.619 167.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 t -119.47 20.24 12.49 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.758 0.823 . . . . 74.24 110.634 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.74 172.05 12.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.729 -0.549 . . . . 37.5 111.729 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.67 134.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.745 0.307 . . . . 74.25 110.228 -174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.5 120.79 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.315 -0.994 . . . . 74.14 108.315 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 m -87.78 57.88 4.58 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.506 0.67 . . . . 72.52 110.683 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -116.17 131.35 56.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.485 -0.779 . . . . 73.44 109.325 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.93 124.66 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 123.749 0.656 . . . . 75.12 109.397 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.85 127.06 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.677 -0.861 . . . . 75.44 108.677 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -65.2 135.63 37.01 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.778 0.674 . . . . 73.01 113.483 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.76 -27.32 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.084 0.554 . . . . 75.33 110.355 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -72.7 -20.1 61.28 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.685 -1.143 . . . . 74.54 112.164 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 pt -105.45 -24.31 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 119.198 -0.43 . . . . 74.13 111.951 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 23' ' ' GLY . 88.3 mt -61.09 128.07 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.256 0.622 . . . . 72.22 111.125 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.49 -44.43 4.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.813 0.845 . . . . 75.53 111.371 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -148.37 133.79 18.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.171 0.588 . . . . 74.54 110.084 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.09 106.68 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.017 -1.105 . . . . 74.31 108.017 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.87 126.69 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.862 -0.792 . . . . 74.03 108.862 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -86.15 123.8 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.96 -0.755 . . . . 75.25 108.96 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 32.9 p -117.12 89.86 31.72 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.96 0.904 . . . . 73.14 110.771 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.66 150.01 39.26 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.438 2.759 . . . . 51.51 111.948 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.02 158.26 52.79 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.085 2.524 . . . . 72.14 113.475 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.49 -136.57 5.16 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.991 -0.844 . . . . 61.31 110.991 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -86.89 73.72 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.367 0.667 . . . . 63.4 109.3 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.32 -63.12 0.32 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.365 -0.694 . . . . 73.2 111.365 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 67.8 m -80.84 115.69 57.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.998 -0.741 . . . . 72.43 108.998 176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.23 -41.97 68.5 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.64 2.227 . . . . 75.44 113.102 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HB3' ' HZ3' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -149.22 172.9 14.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.673 -0.694 . . . . 71.35 111.024 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -70.3 110.46 5.27 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.658 -0.701 . . . . 73.23 109.309 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' A' ' 41' ' ' LYS . 47.6 mt-10 -142.27 166.36 24.89 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.365 0.666 . . . . 71.14 109.555 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.92 111.02 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.922 -1.14 . . . . 65.1 107.922 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -92.46 120.14 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 122.858 0.463 . . . . 74.34 109.776 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.79 120.62 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.926 0.89 . . . . 75.12 109.714 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -97.21 130.41 44.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.58 -1.267 . . . . 75.42 107.58 168.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.0 p -89.9 168.9 11.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.191 -0.67 . . . . 72.12 109.191 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -68.87 -23.53 64.23 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.915 0.388 . . . . 75.03 110.504 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.3 mtm -75.43 -4.88 42.07 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.306 1.043 . . . . 64.0 111.344 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 74.71 16.64 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 125.777 1.631 . . . . 74.12 112.512 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 129.03 34.72 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.817 0.847 . . . . 74.3 109.265 172.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.67 108.77 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.554 1.141 . . . . 74.14 109.671 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.07 120.24 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.14 0.976 . . . . 72.01 108.468 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 63.8 m -105.07 119.54 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.599 -1.26 . . . . 73.5 107.599 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.8 165.31 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.894 0.878 . . . . 71.31 110.459 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -83.33 145.55 48.79 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.713 0.805 . . . . 72.3 110.337 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.39 -31.94 93.32 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.373 2.716 . . . . 73.31 113.923 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -86.7 9.79 17.73 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.233 0.613 . . . . 74.45 111.792 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.93 129.43 41.39 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 122.895 0.478 . . . . 71.2 109.983 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -58.36 -51.2 70.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.72 1.208 . . . . 74.22 112.187 -168.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -71.86 -29.77 64.73 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.325 1.05 . . . . 72.41 110.437 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.21 -36.73 85.03 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 123.646 0.778 . . . . 74.23 110.787 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -57.18 -39.27 74.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.083 0.553 . . . . 74.03 111.673 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -55.2 -45.52 75.86 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.245 0.966 . . . . 74.55 109.328 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.17 -51.09 61.12 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.311 -0.859 . . . . 62.14 110.978 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.31 -36.0 68.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.783 0.833 . . . . 75.24 111.888 -172.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -84.71 -43.49 14.27 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 122.905 0.128 . . . . 71.04 111.161 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -67.89 -35.23 78.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.638 0.607 . . . . 71.43 112.638 -170.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.2 m -63.05 -30.08 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.011 0.525 . . . . 71.04 111.162 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.6 -73.79 0.31 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.717 -0.845 . . . . 74.34 108.717 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.7 t 179.02 152.28 0.35 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.02 1.328 . . . . 73.13 109.18 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -167.77 169.17 11.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.969 0.907 . . . . 72.53 110.213 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 t -60.66 149.72 34.31 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.395 0.678 . . . . 71.11 109.891 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -50.81 109.19 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.369 1.068 . . . . 71.1 111.152 -170.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 t -121.21 78.77 1.45 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.199 0.999 . . . . 74.44 108.7 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.2 m -141.33 148.06 39.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.04 -0.982 . . . . 72.04 108.956 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.8 p -122.83 151.13 60.3 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.679 0.792 . . . . 75.34 110.061 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.3 138.53 66.77 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.222 1.948 . . . . 72.43 111.517 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 168.69 10.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.562 0.745 . . . . 63.11 111.576 -173.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.03 95.35 34.34 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.164 0.985 . . . . 65.34 109.108 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.22 -65.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.529 2.153 . . . . 54.53 113.242 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.48 135.37 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.122 0.569 . . . . 74.34 110.537 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -129.42 167.54 17.66 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.84 -0.8 . . . . 72.24 108.84 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -73.88 95.62 2.47 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.597 -0.52 . . . . 70.44 109.597 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -80.89 140.97 35.04 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.255 -0.884 . . . . 75.11 110.333 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -77.19 133.16 39.0 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.07 -0.715 . . . . 70.32 109.07 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.39 162.14 36.03 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.148 0.979 . . . . 73.54 109.329 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 C-N-CA 123.729 0.811 . . . . 60.51 109.533 -179.416 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.405 -0.22 . . . . 65.34 110.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.49 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 3.6 mp -97.21 116.87 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.05 -1.093 . . . . 71.44 108.05 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 tp -83.65 114.38 21.51 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.363 0.665 . . . . 64.14 109.543 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.31 135.53 39.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.135 0.974 . . . . 72.45 110.078 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.53 110.33 16.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.982 0.913 . . . . 71.24 108.538 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -114.48 140.74 48.48 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 110.013 -0.366 . . . . 64.0 110.013 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -116.2 6.94 13.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.314 0.646 . . . . 74.22 109.613 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -60.02 115.5 3.48 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.53 0.732 . . . . 71.42 110.338 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -79.39 123.49 27.55 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.883 0.873 . . . . 64.31 110.107 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.25 172.28 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.968 0.907 . . . . 72.33 109.418 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -72.15 90.45 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.073 -0.714 . . . . 74.53 109.073 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 80.7 m -64.48 112.12 2.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.69 0.796 . . . . 61.41 110.665 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -99.33 104.16 16.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.39 1.076 . . . . 72.31 109.367 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.669 ' SG ' HG22 ' A' ' 45' ' ' VAL . 4.1 t -134.12 122.59 23.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.6 -1.259 . . . . 54.3 107.6 168.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.404 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 28.3 p -65.05 87.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.16 0.984 . . . . 64.44 111.978 -175.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.89 -141.29 47.4 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.395 -0.821 . . . . 54.1 114.109 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -143.02 142.56 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.329 1.452 . . . . 71.35 107.977 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mt -134.47 128.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 107.651 -1.24 . . . . 62.51 107.651 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.5 m -91.23 12.57 19.77 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.478 0.711 . . . . 35.35 111.854 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.8 p -65.64 123.21 19.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.541 0.737 . . . . 50.32 110.041 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.52 109.46 3.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.46 -0.941 . . . . 62.41 108.46 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.2 t -84.62 141.21 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.583 -0.735 . . . . 74.51 109.261 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -62.55 121.66 25.8 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.647 0.592 . . . . 70.34 112.645 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.62 -28.7 61.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.033 0.933 . . . . 71.23 112.255 -173.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.24 -35.31 55.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.871 0.468 . . . . 73.34 110.804 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.4 -12.82 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 119.063 -0.494 . . . . 72.03 111.477 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 23' ' ' GLY . 67.1 mt -65.79 111.95 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 109.126 -0.694 . . . . 73.34 109.126 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -87.09 -54.29 4.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.615 0.766 . . . . 71.12 109.65 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 67.3 mtt85 -146.44 134.06 21.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.717 0.807 . . . . 74.34 111.006 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.78 105.83 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.551 -1.277 . . . . 72.34 107.551 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -103.75 120.53 41.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.221 0.609 . . . . 64.41 110.28 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.82 122.96 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.35 0.66 . . . . 52.52 109.272 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 m -108.55 102.43 47.37 Favored Pre-proline 0 C--O 1.25 1.095 0 C-N-CA 124.581 1.152 . . . . 54.55 108.175 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 155.73 27.6 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.6 2.2 . . . . 52.14 111.714 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.13 76.96 0.64 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.769 2.313 . . . . 73.01 112.698 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.56 175.31 51.67 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.241 -0.89 . . . . 72.12 113.712 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -73.15 -47.28 45.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.713 0.805 . . . . 70.55 110.626 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.3 -19.21 74.8 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.396 0.435 . . . . 74.11 113.292 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.0 m -94.55 132.43 28.79 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.011 0.924 . . . . 74.41 109.351 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.99 -34.68 22.49 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.543 2.162 . . . . 74.54 113.507 -170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -150.61 174.38 13.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 72.45 109.929 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 m -73.02 114.92 11.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.903 -1.147 . . . . 65.41 107.903 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.73 132.64 54.33 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.031 0.532 . . . . 64.55 110.027 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -111.95 109.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.327 -0.99 . . . . 71.42 108.327 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.669 HG22 ' SG ' ' A' ' 14' ' ' CYS . 13.9 t -96.8 108.63 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.078 -0.712 . . . . 62.11 109.078 -173.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.409 HG23 HG23 ' A' ' 27' ' ' ILE . 41.8 mt -95.91 105.82 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.319 -0.623 . . . . 71.14 109.319 175.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -79.68 137.28 37.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.638 -0.875 . . . . 75.3 108.638 165.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 p -97.77 164.09 12.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.022 -0.535 . . . . 63.21 110.217 171.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.86 -20.03 63.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.934 0.894 . . . . 72.22 110.783 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.25 -1.97 51.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.186 0.994 . . . . 62.41 111.31 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 75.3 18.91 2.3 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.019 1.728 . . . . 71.42 113.746 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -79.58 126.03 30.36 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 108.691 -0.855 . . . . 60.41 108.691 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.38 104.7 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.375 -0.972 . . . . 42.54 108.375 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.8 mt -104.46 139.44 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.492 -0.929 . . . . 72.41 108.492 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 15' ' ' SER . 73.4 m -113.56 133.05 55.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.405 -0.961 . . . . 63.04 108.405 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.84 156.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.113 0.565 . . . . 72.24 109.486 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -79.06 139.6 56.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.345 0.658 . . . . 34.4 110.611 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.05 -10.62 29.45 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.878 2.385 . . . . 63.41 113.453 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -101.97 6.46 41.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.629 0.772 . . . . 54.31 111.873 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.51 19.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.808 0.443 . . . . 70.31 110.149 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -65.05 -36.52 84.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.414 0.686 . . . . 63.42 111.597 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -67.63 -35.67 79.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.971 0.508 . . . . 70.45 110.122 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.28 -40.41 81.85 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.536 -0.756 . . . . 60.15 109.893 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -60.44 -34.47 74.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.564 0.746 . . . . 75.45 111.414 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.43 -46.33 83.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.424 0.69 . . . . 74.15 109.885 172.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.4 mt -68.41 -41.34 80.56 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.658 0.783 . . . . 75.23 110.849 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.89 -34.23 77.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.589 0.756 . . . . 62.12 110.503 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.12 -16.77 39.39 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.997 -0.547 . . . . 71.45 111.415 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.0 -38.99 30.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.865 0.466 . . . . 63.11 111.141 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.7 m -74.92 -7.76 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.205 0.602 . . . . 63.41 112.179 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -103.14 21.68 15.38 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.415 0.686 . . . . 52.32 110.1 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -133.94 81.84 1.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.219 1.008 . . . . 73.42 108.523 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -84.66 -36.76 21.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.851 0.86 . . . . 72.2 109.606 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 p -85.26 96.44 9.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 70.21 110.04 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.05 165.02 22.04 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.409 0.684 . . . . 71.1 110.0 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.7 t -75.98 149.37 37.63 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.587 -0.894 . . . . 53.34 108.587 170.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.5 p -73.78 174.86 7.84 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.383 0.673 . . . . 64.23 110.545 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -119.04 87.59 34.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.309 -0.626 . . . . 63.11 109.309 172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.55 -30.42 12.17 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.942 2.428 . . . . 61.44 111.189 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.57 103.11 0.63 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.803 0.841 . . . . 74.25 109.591 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.49 118.2 62.25 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.456 0.473 . . . . 54.12 110.318 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.09 6.44 5.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.718 2.278 . . . . 71.24 112.548 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.01 97.76 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.311 1.044 . . . . 64.15 108.478 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 t -82.8 175.94 9.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.197 -0.911 . . . . 55.01 109.099 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -64.78 105.55 1.02 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.127 -0.694 . . . . 73.14 109.127 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -74.88 161.3 29.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.537 0.735 . . . . 62.41 110.425 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -60.29 143.57 52.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.805 0.842 . . . . 74.31 110.764 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.96 171.38 15.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.26 0.624 . . . . 73.43 110.965 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 123.41 0.684 . . . . 44.41 110.224 178.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 108.057 -1.09 . . . . 61.21 108.057 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.68 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 24.7 mt -89.85 139.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.159 -0.682 . . . . 74.43 109.159 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.51 HD22 HG21 ' A' ' 70' ' ' VAL . 58.9 tp -111.86 114.57 27.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.079 0.552 . . . . 74.11 110.188 -177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -95.72 154.96 16.95 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.788 0.835 . . . . 74.53 109.977 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.52 147.94 43.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.85 0.86 . . . . 55.04 108.911 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 p80 -80.94 140.39 35.29 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.747 0.249 . . . . 60.03 110.993 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -137.65 -51.23 0.62 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.628 -0.879 . . . . 74.5 108.628 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.2 p -95.62 -10.79 28.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.923 0.889 . . . . 72.13 111.612 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' ' 6' ' ' HIS . 46.1 t30 -78.28 99.74 6.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.932 0.493 . . . . 74.41 110.495 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' ' HA2' ' A' ' 38' ' ' GLY . 1.7 tt -120.22 15.1 12.26 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.549 1.139 . . . . 55.05 109.313 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.5 46.53 0.57 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.663 -0.648 . . . . 71.31 110.822 -167.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.621 ' SG ' HG21 ' A' ' 33' ' ' THR . 60.6 m -57.16 107.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.687 0.795 . . . . 73.34 111.582 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.96 90.26 4.57 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.75 -1.574 . . . . 73.13 106.75 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.45 156.41 23.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.172 0.989 . . . . 74.32 110.096 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -78.95 59.36 2.62 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.658 0.783 . . . . 73.22 111.3 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 -140.34 41.57 Favored Glycine 0 C--N 1.355 1.628 0 CA-C-N 116.214 -0.448 . . . . 74.02 112.601 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.29 132.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.297 -1.001 . . . . 74.31 108.297 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 mt -128.08 128.84 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.668 -1.234 . . . . 61.12 107.668 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.5 m -90.77 18.95 5.88 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.38 0.672 . . . . 74.53 112.226 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.8 p -78.16 134.2 37.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.22 0.608 . . . . 24.14 110.144 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.87 111.01 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.763 -0.828 . . . . 75.11 108.763 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.62 141.09 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.057 -0.719 . . . . 64.21 109.057 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -58.41 113.71 5.14 Favored Glycine 0 C--N 1.359 1.83 0 O-C-N 124.075 0.86 . . . . 74.55 112.622 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HG ' HD21 ' A' ' 66' ' ' LEU . 8.5 mp -52.72 -41.05 63.6 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.155 0.982 . . . . 72.41 111.663 -173.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -67.34 -37.02 82.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.833 0.853 . . . . 63.03 111.519 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -86.8 -15.12 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 122.995 0.184 . . . . 70.22 111.21 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 46' ' ' ILE . 65.3 mt -61.75 110.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 109.511 -0.551 . . . . 75.11 109.511 171.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.71 -55.2 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.917 0.887 . . . . 73.03 110.207 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.68 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 79.2 mtm180 -139.45 153.39 47.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.109 0.564 . . . . 71.05 111.021 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 46' ' ' ILE . 68.7 mt -139.35 118.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.1 1.36 . . . . 63.41 107.87 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -105.03 122.29 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.449 -0.574 . . . . 73.43 109.449 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 m -88.44 127.95 41.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 109.395 -0.594 . . . . 74.43 109.395 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.621 HG21 ' SG ' ' A' ' 12' ' ' CYS . 90.9 m -128.48 81.85 69.79 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.577 0.751 . . . . 72.41 110.311 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.9 156.98 61.62 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.277 1.985 . . . . 54.51 112.256 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.73 83.2 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.351 2.7 . . . . 71.15 111.475 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.51 103.35 0.18 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.674 -0.971 . . . . 72.14 110.674 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 t30 60.98 62.1 1.5 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.065 0.946 . . . . 72.21 110.112 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' HA2' ' HG ' ' A' ' 10' ' ' LEU . . . 167.75 -119.08 0.82 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.191 -0.913 . . . . 70.34 113.172 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.0 m -88.15 151.7 49.45 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 123.934 0.894 . . . . 64.34 110.802 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.4 -39.49 56.06 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.663 2.909 . . . . 71.12 114.306 -168.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -123.22 172.63 8.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.269 0.628 . . . . 65.41 109.707 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' THR . 16.8 m -70.77 115.03 9.45 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.116 0.26 . . . . 44.34 110.718 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 4.3 mm-40 -108.93 109.8 20.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.858 -1.164 . . . . 41.12 107.858 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.39 102.03 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.943 -1.503 . . . . 73.44 106.943 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.625 HG22 ' SG ' ' A' ' 14' ' ' CYS . 17.6 t -97.65 106.9 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.356 -0.979 . . . . 72.04 108.356 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 27' ' ' ILE . 56.6 mt -98.56 107.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.279 0.632 . . . . 73.05 109.68 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -83.64 120.69 26.29 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.467 -0.938 . . . . 74.2 108.467 168.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.0 p -84.77 162.71 19.5 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.078 -0.712 . . . . 54.32 109.078 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.83 -19.89 65.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.922 0.889 . . . . 75.0 111.425 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.0 mtm -81.02 -2.62 48.74 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.972 0.909 . . . . 72.51 111.377 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.2 mttp 75.64 15.3 2.67 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.665 1.586 . . . . 54.45 113.127 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -83.44 123.27 29.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.458 -0.571 . . . . 70.11 109.458 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.9 103.1 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 108.057 -1.09 . . . . 55.14 108.057 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.54 120.25 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.906 -1.146 . . . . 64.34 107.906 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.0 m -107.9 130.45 55.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.673 -0.862 . . . . 65.3 108.673 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 165.24 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.373 1.069 . . . . 74.44 110.063 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -88.79 154.24 50.18 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.714 0.806 . . . . 72.31 109.656 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.31 -22.9 39.19 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.383 2.055 . . . . 73.02 113.391 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -73.49 -17.22 61.25 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.748 0.819 . . . . 74.53 112.937 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.22 24.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.361 0.664 . . . . 74.34 111.508 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -72.88 -37.39 67.33 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.894 0.878 . . . . 74.5 112.138 -171.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.046 0.45 . . . . 74.14 110.004 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.8 tp -68.24 -37.87 81.23 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 114.76 -1.109 . . . . 74.2 110.922 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -60.23 -37.85 81.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.745 0.818 . . . . 74.45 110.78 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -65.55 -31.41 72.45 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.003 0.521 . . . . 75.44 111.225 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.57 HD21 ' HG ' ' A' ' 24' ' ' LEU . 91.9 mt -74.96 -38.72 61.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.281 0.633 . . . . 74.23 110.843 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.69 -22.27 64.38 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.335 0.654 . . . . 70.14 110.511 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -87.16 -31.86 20.15 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.45 0.7 . . . . 73.32 111.15 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.51 -25.94 60.66 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 111.861 0.319 . . . . 75.34 111.861 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG21 HD22 ' A' ' 3' ' ' LEU . 33.2 m -72.28 -13.23 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 120.681 0.277 . . . . 72.41 110.659 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -92.4 157.28 16.68 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.024 0.929 . . . . 62.35 109.128 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.6 t -70.34 137.91 51.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.636 0.374 . . . . 63.45 110.458 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -149.37 143.5 25.81 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.215 1.006 . . . . 71.23 109.448 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.9 m -76.84 99.1 5.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.199 -0.455 . . . . 72.35 110.025 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 75' ' ' LEU . 2.0 pt? -57.49 137.09 56.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 72.11 110.388 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 p -74.37 122.12 22.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.642 0.777 . . . . 73.32 111.534 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.3 p -72.2 128.94 37.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.858 0.863 . . . . 74.22 110.851 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -80.28 119.73 77.33 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.583 0.753 . . . . 64.33 110.312 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.37 159.72 52.59 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 61.22 112.15 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -87.82 164.6 15.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.185 0.517 . . . . 70.45 110.62 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.68 77.52 56.15 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.166 -1.05 . . . . 73.31 108.166 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.86 152.68 47.19 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.43 2.087 . . . . 73.33 112.789 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.53 120.94 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 109.078 -0.712 . . . . 71.24 109.078 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.9 p -94.76 -71.76 0.65 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.732 0.813 . . . . 72.44 111.253 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -175.89 149.54 0.93 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.408 0.683 . . . . 74.21 109.84 -168.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -87.17 148.7 25.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.298 0.639 . . . . 71.04 110.313 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 ttm-85 -75.65 102.27 5.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.255 0.622 . . . . 74.33 110.157 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.36 96.24 3.95 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.755 0.822 . . . . 74.43 109.518 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.243 0 C-N-CA 123.491 0.716 . . . . 54.14 109.83 177.392 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 85.3 mtp . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.039 -0.726 . . . . 70.2 109.039 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.617 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 3.9 mp -92.28 130.02 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.308 -0.627 . . . . 74.11 109.308 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.1 tp -85.75 106.57 17.1 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.284 -1.006 . . . . 73.54 108.284 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 23.5 mm-40 -84.97 116.77 23.56 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 72.41 109.531 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.31 110.18 22.07 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.133 -0.692 . . . . 64.43 109.133 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -120.97 95.19 4.6 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.714 -0.476 . . . . 74.23 109.714 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -86.79 -27.85 23.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.861 -0.609 . . . . 72.3 109.619 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.4 m -100.12 120.05 39.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.272 1.029 . . . . 65.42 108.449 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -146.5 -117.18 0.07 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 106.66 -1.607 . . . . 65.41 106.66 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.67 -54.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.669 1.188 . . . . 54.1 108.216 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -159.31 136.65 9.83 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 125.514 1.526 . . . . 65.42 107.186 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 85.6 m -74.16 104.57 5.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 34.42 109.988 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.44 89.37 7.39 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 121.636 0.731 . . . . 74.14 110.984 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 t -137.22 157.61 46.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.542 -0.754 . . . . 62.22 109.952 171.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.6 t -78.71 -22.9 45.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.345 0.658 . . . . 73.22 111.082 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.36 160.61 10.26 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.463 -1.055 . . . . 61.13 110.463 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.46 135.54 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.718 0.759 . . . . 63.44 109.249 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 54' ' ' ILE . 5.7 mt -110.55 134.1 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.713 -0.847 . . . . 65.44 108.713 -172.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 p -88.2 24.51 1.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.735 0.814 . . . . 71.12 112.113 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -89.11 155.99 19.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.711 0.804 . . . . 65.13 110.719 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.02 111.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.623 -0.88 . . . . 73.22 108.623 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -87.92 128.42 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.131 -1.063 . . . . 51.41 108.131 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -70.32 135.33 25.51 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.496 0.498 . . . . 70.41 113.603 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.72 -31.59 70.88 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.23 0.612 . . . . 55.45 111.558 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.43 -27.95 66.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.754 0.822 . . . . 63.42 112.157 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 23' ' ' GLY . 20.1 pt -95.69 -22.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 119.489 -0.291 . . . . 63.25 110.721 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 23' ' ' GLY . 82.4 mt -68.53 137.49 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.144 0.578 . . . . 72.13 110.928 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.1 t70 -109.41 -53.55 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.671 0.788 . . . . 70.41 110.392 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 90.7 mtm180 -144.26 142.22 30.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.868 0.467 . . . . 72.04 111.198 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.52 113.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.133 -1.062 . . . . 75.34 108.133 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 6.9 tt0 -97.34 106.02 18.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.79 -0.448 . . . . 73.01 109.79 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 m -89.78 109.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 108.622 -0.881 . . . . 75.24 108.622 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -105.46 99.75 22.59 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.094 -0.706 . . . . 62.2 109.094 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.58 159.65 48.39 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.708 2.272 . . . . 75.33 112.335 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' HB3' ' HA ' ' A' ' 41' ' ' LYS . 73.8 Cg_endo -75.49 149.8 35.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.011 2.474 . . . . 75.33 113.063 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.6 -94.53 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.009 -0.541 . . . . 54.42 112.51 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.83 -50.3 51.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.658 0.783 . . . . 64.54 111.247 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.09 -73.44 1.18 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.44 -0.346 . . . . 54.02 112.834 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 97.2 m -114.06 154.82 46.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.682 0.793 . . . . 62.3 109.743 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.69 -20.68 69.38 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 122.644 2.23 . . . . 75.54 112.846 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . 60.1 pttt -142.9 166.69 23.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.718 0.807 . . . . 63.44 109.993 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' A' ' 35' ' ' PRO . 24.2 m -71.62 124.8 25.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.903 0.481 . . . . 73.3 110.345 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.43 133.64 26.13 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.827 -1.175 . . . . 72.52 107.827 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 59.8 t -114.75 103.17 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.988 0.515 . . . . 53.44 110.446 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.77 108.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.301 0.64 . . . . 61.11 109.864 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.97 116.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.15 0.58 . . . . 72.11 109.441 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -83.39 128.23 34.33 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.268 -1.382 . . . . 73.15 107.268 166.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.7 p -85.1 161.56 19.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.775 -0.824 . . . . 74.11 108.775 167.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -74.73 -3.86 34.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.418 0.687 . . . . 70.41 111.277 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtm -91.1 -1.99 57.67 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.146 0.978 . . . . 72.43 110.102 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 66.74 19.94 10.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.231 1.813 . . . . 75.04 113.102 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.21 123.8 28.25 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.318 -0.993 . . . . 64.4 108.318 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.21 102.05 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.631 -0.878 . . . . 62.23 108.631 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 18' ' ' ILE . 65.7 mt -109.09 122.02 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.654 -1.239 . . . . 73.22 107.654 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 28.3 p -109.07 146.96 33.14 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.689 -0.856 . . . . 62.25 108.689 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.78 160.94 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.252 1.021 . . . . 74.33 109.862 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -82.27 149.03 61.05 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-N 115.161 -0.927 . . . . 71.12 110.066 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.32 -38.35 75.73 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.154 2.569 . . . . 73.51 113.806 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -75.44 4.53 7.22 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.417 0.687 . . . . 73.12 112.076 -175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.8 115.94 3.42 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.126 -0.694 . . . . 73.1 109.126 171.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.94 -35.71 82.03 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.985 0.914 . . . . 63.32 112.233 -169.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -69.96 -32.92 71.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.895 0.478 . . . . 73.44 109.95 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.456 HD12 HD23 ' A' ' 66' ' ' LEU . 48.7 tp -65.73 -39.77 91.48 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.363 0.665 . . . . 63.33 110.349 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -64.76 -32.67 74.46 Favored 'General case' 0 C--O 1.243 0.745 0 O-C-N 123.461 0.476 . . . . 72.03 111.283 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -64.41 -42.95 95.77 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 123.825 0.703 . . . . 62.33 109.903 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 HD12 ' A' ' 63' ' ' LEU . 40.5 tp -62.36 -46.82 86.94 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.843 0.857 . . . . 63.32 111.335 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.98 -37.21 83.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.33 0.652 . . . . 75.41 110.653 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -72.84 -35.17 67.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.475 -0.33 . . . . 73.43 110.714 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -68.29 -38.07 81.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.512 0.725 . . . . 70.45 112.494 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.95 -21.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 120.695 0.283 . . . . 53.32 111.013 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.15 -27.15 19.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.729 0.812 . . . . 55.43 110.825 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -80.83 162.25 24.1 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.996 0.918 . . . . 73.41 109.389 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -73.0 122.86 22.41 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.275 -0.639 . . . . 74.31 109.275 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.7 t -71.87 169.46 15.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.805 0.842 . . . . 71.44 110.331 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.14 126.93 31.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.311 -0.626 . . . . 72.01 109.311 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 t -137.74 160.63 38.7 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.466 1.106 . . . . 61.13 108.836 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 t -68.08 101.21 1.1 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.592 -0.892 . . . . 75.11 108.592 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -74.59 142.74 77.93 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.963 -0.562 . . . . 75.5 109.875 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.6 163.72 31.71 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.08 1.853 . . . . 61.42 111.43 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -51.13 114.38 1.18 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.28 1.032 . . . . 74.12 112.013 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 143.47 98.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.896 0.878 . . . . 72.4 110.356 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.3 158.06 4.02 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.696 2.93 . . . . 63.22 113.94 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.87 115.38 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.724 0.81 . . . . 72.14 110.319 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 t -133.13 101.89 5.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.081 0.952 . . . . 71.21 108.675 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -122.21 157.07 32.42 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.438 0.695 . . . . 72.1 109.78 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -154.85 120.21 5.02 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.456 -0.942 . . . . 75.53 108.456 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -105.2 131.21 52.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.399 0.68 . . . . 75.33 110.112 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 93.96 5.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.146 0.578 . . . . 61.13 110.202 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.763 0.825 . . . . 72.12 109.135 178.732 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HG3' HG22 ' A' ' 27' ' ' ILE . 1.3 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.415 -0.587 . . . . 72.3 109.415 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.61 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 51.7 mt -77.57 133.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.292 -1.003 . . . . 73.35 108.292 174.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.3 tp -101.33 111.89 24.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.89 0.476 . . . . 65.4 110.765 -172.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.55 146.29 25.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.137 0.975 . . . . 74.24 109.928 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.88 133.79 55.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.447 0.699 . . . . 64.44 109.193 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.85 95.73 9.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.336 -0.616 . . . . 71.3 109.336 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -76.69 -59.61 2.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.183 0.593 . . . . 72.23 110.966 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.6 p -74.58 -72.35 0.29 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.498 -0.556 . . . . 75.43 109.498 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 56.66 89.72 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.47 1.108 . . . . 64.35 113.733 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.06 -61.55 1.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.41 -1.329 . . . . 74.22 107.41 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -133.14 131.92 41.03 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.791 0.836 . . . . 74.14 109.768 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.781 ' SG ' HG21 ' A' ' 33' ' ' THR . 34.6 m -85.0 103.42 14.02 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.622 -0.881 . . . . 64.14 108.622 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 3.6 mmp_? -100.85 90.55 4.25 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.721 0.772 . . . . 74.43 110.775 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t -133.44 161.82 33.51 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 113.974 -1.467 . . . . 74.42 107.908 166.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -48.06 -32.35 6.62 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.68 1.192 . . . . 73.34 113.666 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.24 -120.27 1.06 Allowed Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.058 -0.817 . . . . 73.25 111.058 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.28 137.0 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.969 -1.123 . . . . 75.22 107.969 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.675 HD12 HG23 ' A' ' 54' ' ' ILE . 9.1 mt -121.01 129.66 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.737 -1.209 . . . . 42.14 107.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.3 m -89.56 20.48 3.94 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.704 0.801 . . . . 64.13 111.521 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.4 p -93.22 143.16 26.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.614 0.766 . . . . 53.54 110.141 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.94 129.45 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.002 -0.74 . . . . 62.33 109.002 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.29 133.55 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.374 -0.972 . . . . 60.41 108.374 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -70.9 131.15 20.68 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.767 0.667 . . . . 25.21 113.074 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mp -59.66 -36.13 75.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.916 0.886 . . . . 75.33 110.907 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -59.5 -27.6 66.29 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.898 0.879 . . . . 75.02 112.246 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.5 pt -105.44 -20.34 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.596 -0.716 . . . . 71.13 112.428 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 46' ' ' ILE . 69.6 mt -61.46 106.61 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 109.217 -0.66 . . . . 65.14 109.217 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.11 -52.25 6.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.378 1.071 . . . . 72.03 109.416 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.61 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 77.1 mtm180 -146.61 160.03 42.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.74 0.816 . . . . 64.35 110.25 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 3' ' ' LEU . 68.5 mt -136.51 142.1 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.808 -1.182 . . . . 54.2 107.808 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.453 ' NE2' ' HH2' ' A' ' 47' ' ' TRP . 6.9 tt0 -124.12 143.94 50.18 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.519 -0.919 . . . . 64.11 108.519 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -113.24 121.01 64.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.84 -0.8 . . . . 52.53 108.84 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.781 HG21 ' SG ' ' A' ' 12' ' ' CYS . 34.7 m -114.28 102.97 55.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 122.975 0.51 . . . . 73.43 109.984 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.41 159.54 43.14 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.007 2.471 . . . . 73.33 112.032 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.89 178.68 5.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.469 2.113 . . . . 63.34 112.87 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.2 9.08 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 116.446 -0.343 . . . . 75.32 113.214 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -77.65 -17.57 57.58 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.152 0.581 . . . . 75.42 111.529 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.3 -42.93 0.67 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.421 -0.672 . . . . 45.03 111.421 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 82.0 m -75.85 120.39 81.45 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.602 0.761 . . . . 71.52 110.626 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.29 -14.31 31.23 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.257 1.971 . . . . 75.35 112.93 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -103.35 146.76 27.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.292 0.637 . . . . 74.43 109.949 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.3 m -86.13 114.91 23.37 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.431 -0.951 . . . . 74.42 108.431 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.16 112.97 19.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.323 0.649 . . . . 72.45 109.941 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.15 103.39 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.462 -0.94 . . . . 63.43 108.462 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 31' ' ' GLN . 58.4 t -92.56 108.46 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.44 110.126 -171.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 27' ' ' ILE . 65.2 mt -96.44 120.32 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.733 0.813 . . . . 65.11 109.287 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.453 ' HH2' ' NE2' ' A' ' 31' ' ' GLN . 32.3 m-90 -90.47 130.77 36.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.976 -1.12 . . . . 74.51 107.976 166.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.4 p -90.16 169.28 11.28 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.883 -0.784 . . . . 55.25 108.883 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.11 -9.39 58.35 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.655 0.782 . . . . 65.41 111.304 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.8 mtm -88.69 4.66 46.48 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.439 1.095 . . . . 74.41 110.415 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? 65.49 11.43 7.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.671 1.588 . . . . 71.24 112.206 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.56 122.24 23.6 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.943 -0.762 . . . . 62.23 108.943 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.61 102.03 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.066 0.946 . . . . 72.41 108.714 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.675 HG23 HD12 ' A' ' 18' ' ' ILE . 69.1 mt -109.35 113.82 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.617 -1.253 . . . . 75.01 107.617 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.47 139.59 40.71 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.885 -0.783 . . . . 70.44 108.885 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.08 163.86 35.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 C-N-CA 124.617 1.167 . . . . 65.22 109.837 -171.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -84.25 154.82 63.47 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 115.488 -0.778 . . . . 73.31 110.16 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.48 -22.62 44.77 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.34 2.027 . . . . 61.13 112.862 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -74.6 -3.63 32.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.215 0.82 . . . . 72.33 113.215 -174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.77 117.01 8.31 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.247 -0.649 . . . . 75.02 109.247 171.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -73.96 -35.05 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.124 0.57 . . . . 64.05 111.312 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -58.9 -36.14 74.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.511 0.672 . . . . 72.12 110.173 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.46 -39.4 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.237 -1.347 . . . . 75.41 110.689 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -59.08 -33.27 70.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.836 0.454 . . . . 61.32 112.212 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -61.03 -44.64 97.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.994 -0.548 . . . . 74.14 110.043 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.0 -43.38 87.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.548 -0.751 . . . . 71.43 110.494 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt -64.0 -34.04 77.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.048 0.842 . . . . 75.41 110.875 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -82.5 -31.35 29.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.539 0.335 . . . . 74.4 111.763 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -67.52 -39.21 85.09 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.768 0.427 . . . . 62.14 111.461 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.83 -11.9 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.307 0.243 . . . . 62.34 111.546 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 76.6 mt-30 -90.72 57.63 3.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.441 0.696 . . . . 64.42 109.986 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.7 p 46.2 75.84 0.11 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 55.11 114.13 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.26 148.6 25.62 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.865 0.466 . . . . 72.3 110.333 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -76.15 144.57 40.5 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.0 0.92 . . . . 63.51 111.006 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 tp -77.27 123.66 26.77 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.405 0.682 . . . . 73.01 110.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -72.09 108.65 5.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.354 0.662 . . . . 72.05 110.571 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -65.51 127.46 31.95 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 74.33 111.207 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.1 p -106.25 103.45 45.44 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.722 0.809 . . . . 51.42 111.286 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.11 123.47 11.94 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.889 2.393 . . . . 61.25 111.406 171.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -83.55 169.08 15.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.475 0.71 . . . . 74.45 111.827 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.58 110.95 64.79 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.858 0.863 . . . . 62.12 109.981 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.19 153.31 12.52 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.616 2.211 . . . . 64.12 112.291 175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.87 124.38 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.61 -0.515 . . . . 73.35 109.61 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -75.56 -70.36 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.278 0.631 . . . . 65.12 110.342 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -154.69 176.45 12.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.024 0.53 . . . . 73.12 110.37 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -104.99 178.94 4.42 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.551 1.14 . . . . 64.44 110.18 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -73.55 152.01 40.77 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.781 0.833 . . . . 62.42 111.619 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.4 169.77 23.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.967 0.907 . . . . 64.11 110.305 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.225 0.61 . . . . 75.42 109.498 179.177 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.142 -0.688 . . . . 74.43 109.142 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.1 mm -81.72 137.3 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.748 . . . . 71.05 108.979 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp -110.09 121.55 45.52 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 109.42 -0.585 . . . . 73.15 109.42 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -117.44 140.07 50.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.828 0.851 . . . . 74.31 108.769 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.05 116.3 31.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.441 -0.948 . . . . 74.45 108.441 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 41.0 t60 -81.13 132.47 35.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.208 0.603 . . . . 73.43 110.306 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -135.71 -50.07 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.62 0.768 . . . . 71.41 110.341 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -66.95 158.17 31.47 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.542 0.571 . . . . 64.33 112.542 -170.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -68.44 4.51 1.32 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.446 1.498 . . . . 64.31 114.591 -166.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.5 118.89 5.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.131 -0.692 . . . . 72.32 109.131 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.72 124.6 29.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.883 0.473 . . . . 64.41 111.377 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.4 115.15 3.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.566 1.146 . . . . 74.21 111.644 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -112.95 89.39 3.07 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.414 0.686 . . . . 54.33 109.646 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.49 159.26 42.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.129 0.972 . . . . 75.4 108.593 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.477 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 20.3 m -77.37 64.53 2.76 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.73 0.812 . . . . 62.34 111.556 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.55 -136.17 49.72 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.246 -0.888 . . . . 44.44 113.429 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.21 131.49 71.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 107.938 -1.134 . . . . 73.03 107.938 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.7 mt -120.13 134.23 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.553 -1.277 . . . . 74.24 107.553 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.5 p -85.28 20.88 1.85 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.698 0.799 . . . . 73.14 112.546 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.8 p -79.0 123.82 27.67 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.082 0.553 . . . . 73.13 109.706 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.84 110.75 8.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.828 -1.175 . . . . 43.44 107.828 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.08 133.19 29.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 115.21 -0.905 . . . . 65.41 109.543 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -59.28 122.99 32.0 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.776 0.672 . . . . 52.43 112.334 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' H ' HD22 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -60.17 -29.7 68.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.163 0.585 . . . . 74.44 110.675 -174.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -65.98 -35.57 80.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.932 0.893 . . . . 64.32 111.799 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 pt -90.57 -21.03 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 118.962 -0.542 . . . . 75.32 111.217 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 23' ' ' GLY . 70.3 mt -62.26 127.36 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 118.597 0.635 . . . . 64.42 110.172 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.15 -53.62 2.65 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.2 0.6 . . . . 65.05 110.413 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -133.28 152.26 51.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.803 0.841 . . . . 73.31 110.509 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.69 135.95 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.447 1.499 . . . . 74.51 108.232 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.402 ' NE2' ' HH2' ' A' ' 47' ' ' TRP . 7.7 tt0 -133.74 120.48 20.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.803 0.841 . . . . 74.14 109.516 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.13 110.27 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.887 -0.783 . . . . 73.25 108.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.3 p -96.69 99.55 5.84 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.875 0.87 . . . . 64.41 109.542 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.66 164.88 7.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.114 2.543 . . . . 75.11 112.719 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.84 52.01 4.06 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.1 2.534 . . . . 52.34 112.252 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.64 93.4 0.29 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.32 -0.855 . . . . 63.43 111.073 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 75.2 -69.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.405 1.482 . . . . 74.34 112.796 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.03 -26.59 64.03 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 114.719 0.648 . . . . 70.05 114.719 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -128.62 148.53 68.75 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.086 0.554 . . . . 74.34 110.071 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.8 -24.66 4.79 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.587 2.191 . . . . 72.31 113.142 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -142.62 170.95 14.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.19 0.596 . . . . 65.01 110.833 -173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 p -70.21 128.02 34.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.724 0.81 . . . . 63.02 110.062 166.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -161.25 158.46 27.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.07 0.948 . . . . 70.23 108.477 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -131.4 131.65 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.569 0.748 . . . . 61.41 109.043 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 t -103.33 110.58 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.321 1.048 . . . . 73.02 108.437 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.71 120.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.402 ' HH2' ' NE2' ' A' ' 31' ' ' GLN . 27.3 m-90 -92.52 129.4 38.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.544 -1.28 . . . . 64.44 107.544 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.1 p -91.36 172.73 8.33 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.656 0.265 . . . . 72.21 110.366 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.94 -25.0 66.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.971 0.908 . . . . 73.13 110.505 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtm -84.94 2.18 44.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.267 1.027 . . . . 72.53 111.342 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? 74.48 4.0 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.5 1.52 . . . . 71.55 112.667 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -71.84 123.02 21.75 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.258 -0.645 . . . . 54.15 109.258 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.77 104.73 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.147 -0.933 . . . . 70.04 108.709 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.32 130.35 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.495 -1.298 . . . . 74.45 107.495 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 15' ' ' SER . 9.4 m -107.84 139.01 43.07 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.869 -0.789 . . . . 75.0 108.869 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.13 166.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.78 0.832 . . . . 75.2 109.542 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -88.31 144.22 33.73 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 122.682 0.393 . . . . 52.0 110.331 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -11.23 29.56 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.435 2.09 . . . . 62.12 112.672 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -93.38 18.06 10.33 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.025 0.93 . . . . 72.22 111.644 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.64 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.432 -0.581 . . . . 72.12 109.432 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -67.57 -39.34 84.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.041 0.537 . . . . 62.43 111.787 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -62.54 -35.77 80.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.698 0.799 . . . . 61.22 110.467 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 HD12 ' A' ' 66' ' ' LEU . 42.6 tp -72.68 -31.7 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.897 -1.047 . . . . 73.52 110.351 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -55.34 -28.0 50.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.665 0.786 . . . . 64.14 112.137 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -63.81 -49.5 72.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.411 -0.959 . . . . 73.4 108.411 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.465 HD11 HD12 ' A' ' 24' ' ' LEU . 72.9 mt -66.7 -44.93 80.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.155 0.982 . . . . 72.14 111.3 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.8 -41.24 95.22 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.836 0.71 . . . . 73.15 111.235 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -86.51 -23.13 26.02 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.037 0.384 . . . . 73.23 112.037 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.04 -38.25 72.55 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 122.579 0.351 . . . . 72.11 111.705 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -72.1 -15.44 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.975 0.417 . . . . 62.45 110.79 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.55 -152.82 0.23 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.583 1.153 . . . . 75.33 109.108 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -65.65 111.39 3.15 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.059 0.544 . . . . 73.1 111.087 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -119.5 175.32 5.9 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.432 1.093 . . . . 53.04 110.265 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.5 p -88.81 110.11 20.75 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.143 0.977 . . . . 74.2 109.75 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 71.15 10.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.441 -0.948 . . . . 75.2 108.441 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 t -172.41 27.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.124 -1.398 . . . . 71.21 108.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 p -64.8 146.84 54.28 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.399 0.68 . . . . 73.03 110.908 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.2 p -58.5 143.86 80.06 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 124.202 1.001 . . . . 74.42 111.83 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -51.48 143.96 33.82 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 123.155 2.57 . . . . 74.41 114.582 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -100.09 168.19 9.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.937 0.895 . . . . 71.22 109.443 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.64 114.99 25.89 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.307 0.643 . . . . 73.12 110.497 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.47 -35.2 73.07 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.6 2.2 . . . . 72.32 112.25 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.75 138.74 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.243 -1.021 . . . . 62.35 108.243 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.2 t -152.07 137.52 17.67 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.498 0.719 . . . . 71.44 109.622 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.23 178.15 6.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.521 0.728 . . . . 73.04 110.749 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 61.79 75.98 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.234 1.014 . . . . 75.35 108.732 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.97 103.5 1.51 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.307 -0.86 . . . . 73.22 109.128 -174.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.9 101.31 0.2 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.696 0.798 . . . . 71.15 110.433 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 C-N-CA 124.207 1.003 . . . . 61.3 108.677 -179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 119.555 -0.26 . . . . 75.23 111.657 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.59 105.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.469 0.708 . . . . 73.15 110.627 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.5 tp -79.53 116.79 19.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.615 0.766 . . . . 73.43 110.025 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -99.89 131.55 45.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.149 0.98 . . . . 54.32 110.42 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.95 140.66 29.45 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.212 -1.403 . . . . 72.32 107.212 162.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -80.27 144.16 33.09 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 110.232 -0.284 . . . . 72.42 110.232 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.91 142.6 57.24 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.484 -0.932 . . . . 73.42 108.484 163.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -49.22 -35.43 17.3 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.917 0.887 . . . . 72.41 112.72 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -112.72 128.74 56.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.476 1.11 . . . . 72.3 108.701 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.5 140.52 0.81 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.829 0.851 . . . . 73.34 109.211 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.0 94.26 7.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.349 -0.982 . . . . 54.42 108.349 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -59.06 105.26 0.31 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.38 0.672 . . . . 72.34 111.374 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 5.0 mmp_? -104.83 95.18 5.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.606 0.717 . . . . 75.32 109.729 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.0 t -128.92 154.17 46.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.228 -1.351 . . . . 61.13 109.325 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -82.5 -25.84 33.11 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 121.643 0.735 . . . . 75.31 110.768 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.42 174.23 13.25 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.038 -1.225 . . . . 63.21 110.038 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -101.16 131.99 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.351 -0.981 . . . . 62.43 108.351 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.16 133.51 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.587 -1.264 . . . . 72.11 107.587 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -76.53 8.21 3.75 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.21 0.819 . . . . 51.41 113.21 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.1 p -59.98 121.09 10.94 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.786 0.834 . . . . 64.44 110.246 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.6 t -72.63 108.86 4.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.368 -0.975 . . . . 63.4 108.368 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -83.03 137.04 21.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-N 115.175 -0.921 . . . . 75.54 108.977 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.35 123.61 33.72 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 124.063 0.852 . . . . 61.43 112.896 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HG ' HD21 ' A' ' 66' ' ' LEU . 8.5 mp -57.91 -34.25 69.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.685 0.794 . . . . 74.1 111.588 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 -27.39 60.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.357 0.663 . . . . 72.31 111.85 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 pt -93.82 -10.97 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 119.55 -0.262 . . . . 73.41 111.079 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.36 115.58 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.385 -0.598 . . . . 73.44 109.385 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.06 -53.94 3.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.233 0.613 . . . . 72.33 110.73 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 5.9 mpt_? -125.99 143.9 50.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.784 0.834 . . . . 64.13 109.947 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -129.85 106.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.433 -1.321 . . . . 71.31 107.433 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -105.7 122.23 45.64 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.121 0.418 . . . . 73.22 110.483 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.47 122.68 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.768 -0.827 . . . . 73.21 108.768 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -131.84 89.85 37.78 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.613 0.365 . . . . 73.11 111.019 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.04 158.3 30.42 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.24 2.627 . . . . 74.22 112.819 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.32 154.02 56.19 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.488 2.125 . . . . 75.41 112.781 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.84 -84.77 0.12 Allowed Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.193 -0.458 . . . . 63.35 112.331 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -118.3 39.0 3.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.526 1.155 . . . . 75.41 110.338 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.33 -77.14 0.05 OUTLIER Glycine 0 C--N 1.343 0.945 0 CA-C-N 114.593 -1.185 . . . . 53.33 112.128 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -75.8 136.1 70.66 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.026 0.53 . . . . 55.3 109.96 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.55 -10.58 15.88 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.871 2.38 . . . . 73.23 112.282 173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -145.13 173.13 12.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.352 1.461 . . . . 71.12 108.882 -174.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -81.06 113.4 19.22 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.254 -0.647 . . . . 64.04 109.254 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG3' ' HG3' ' A' ' 41' ' ' LYS . 44.6 mt-10 -118.38 122.83 43.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 74.03 109.328 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.5 102.11 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.911 -1.144 . . . . 74.14 107.911 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.75 109.08 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 109.372 -0.603 . . . . 64.34 109.372 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -97.58 126.37 50.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.967 0.907 . . . . 72.34 109.501 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.2 m-90 -98.89 131.2 45.16 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.067 -1.086 . . . . 71.05 108.067 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.1 p -85.89 170.62 12.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.799 0.44 . . . . 64.54 110.234 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.62 -13.18 61.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.622 0.769 . . . . 73.14 110.487 175.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.4 mtm -82.46 -5.74 58.87 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.371 1.068 . . . . 75.21 110.565 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 72.82 10.01 5.48 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.917 1.687 . . . . 74.0 112.557 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -77.01 129.96 36.82 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.431 0.692 . . . . 71.3 110.326 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.93 108.52 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.901 1.28 . . . . 75.15 110.021 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.63 127.67 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.673 -1.232 . . . . 73.5 107.673 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 29.3 m -106.58 152.21 24.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.043 -0.725 . . . . 52.31 109.043 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.14 162.25 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 123.835 0.854 . . . . 63.24 108.926 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -75.26 147.61 83.0 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.709 0.804 . . . . 63.13 110.513 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.33 -21.37 54.37 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.961 2.441 . . . . 64.01 112.019 176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -85.02 3.64 37.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.722 0.809 . . . . 74.44 111.776 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.6 12.05 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.709 0.404 . . . . 71.43 110.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -64.57 -47.42 78.78 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.89 1.276 . . . . 41.35 110.643 -172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -67.41 -32.06 72.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.523 0.729 . . . . 75.3 111.879 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.87 -43.36 98.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.686 1.195 . . . . 73.23 111.378 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -58.87 -31.49 68.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.003 0.921 . . . . 73.51 112.805 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -63.79 -38.93 92.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.302 0.641 . . . . 73.14 110.13 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.527 HD21 ' HG ' ' A' ' 24' ' ' LEU . 9.7 mp -72.99 -41.15 64.62 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.387 -0.824 . . . . 74.52 110.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.57 -33.26 75.2 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.254 0.622 . . . . 63.02 111.209 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -82.44 -33.0 28.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.828 0.451 . . . . 65.53 111.634 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -65.52 -46.15 80.73 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.062 0.545 . . . . 74.12 110.895 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.45 -18.48 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.135 0.574 . . . . 43.24 112.547 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -68.85 -55.97 9.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.192 0.597 . . . . 72.23 110.479 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.7 t -162.08 144.76 11.54 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.985 0.514 . . . . 54.13 110.998 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.71 135.08 47.77 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.342 1.057 . . . . 75.2 108.568 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.7 t -107.44 101.93 11.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.1 -1.074 . . . . 70.41 108.1 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.3 tp -79.22 125.7 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.089 0.555 . . . . 72.53 110.476 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.5 p -112.85 125.54 54.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.178 -1.045 . . . . 74.4 108.178 168.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.1 p -86.01 137.77 32.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.65 0.38 . . . . 64.01 110.302 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.0 p -74.92 136.99 73.11 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.811 0.845 . . . . 63.33 111.205 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.31 148.77 77.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.965 2.443 . . . . 63.32 113.005 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -76.28 152.85 36.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.75 0.42 . . . . 74.44 110.18 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 141.07 35.96 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 115.794 -0.639 . . . . 62.14 110.265 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 168.91 22.0 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.455 2.104 . . . . 72.52 111.485 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -115.81 134.56 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.069 0.548 . . . . 64.5 109.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 p -81.06 155.43 26.33 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.153 0.581 . . . . 61.11 110.944 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -77.25 -168.78 1.19 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.777 0.831 . . . . 74.02 112.139 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -145.48 163.14 35.59 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.251 1.02 . . . . 74.22 109.065 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 mtm-85 -58.83 146.7 36.34 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.873 0.869 . . . . 65.21 111.667 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.71 -52.62 3.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.541 0.736 . . . . 60.44 109.915 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.958 0 N-CA-C 108.563 -0.903 . . . . 75.12 108.563 178.146 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.486 -0.931 . . . . 75.51 108.486 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.45 96.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.518 0.727 . . . . 75.12 109.697 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 68.9 tp -80.34 110.59 15.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.632 -0.877 . . . . 70.53 108.632 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -103.92 114.57 28.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.363 1.065 . . . . 71.14 110.33 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.06 117.46 24.04 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.273 -1.38 . . . . 63.24 107.273 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 10' ' ' LEU . 26.2 t60 -78.46 96.57 5.42 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.367 0.603 . . . . 72.05 109.623 -171.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -117.24 -25.69 7.01 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.276 1.03 . . . . 73.3 110.198 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.4 p -68.87 146.65 52.65 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 124.144 0.978 . . . . 74.23 111.019 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.8 89.53 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.949 0.899 . . . . 74.15 109.049 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.445 ' HB3' ' CE1' ' A' ' 6' ' ' HIS . 6.1 tt -144.18 133.48 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.493 -1.669 . . . . 74.34 106.493 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.84 107.61 18.76 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.883 0.473 . . . . 73.32 109.931 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 63.0 m -67.18 111.33 3.87 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.134 0.574 . . . . 62.24 109.75 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -104.83 90.12 3.38 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.493 0.717 . . . . 74.22 110.313 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 t -134.66 147.02 50.05 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.173 -0.922 . . . . 53.43 109.35 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -91.58 25.37 2.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.873 0.869 . . . . 64.44 112.044 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.5 174.29 17.87 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.125 -0.39 . . . . 63.52 112.125 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 m -107.9 137.47 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.634 0.774 . . . . 53.23 110.881 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 5.3 mt -119.74 135.82 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.249 1.02 . . . . 62.11 108.375 -174.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.5 m -79.74 11.93 2.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.526 0.936 . . . . 74.52 113.526 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -57.93 125.93 25.21 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.421 1.088 . . . . 61.14 111.699 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.17 111.49 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.383 0.611 . . . . 72.12 109.545 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.6 141.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.136 0.975 . . . . 63.34 108.519 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -65.61 123.71 25.41 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 123.67 0.606 . . . . 63.31 112.363 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.51 -28.13 66.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.989 0.915 . . . . 74.42 112.281 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -79.22 -25.24 42.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.902 0.481 . . . . 75.11 111.413 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.09 -14.42 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 119.321 -0.371 . . . . 74.25 111.144 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 23' ' ' GLY . 54.7 mt -63.45 107.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.55 -0.537 . . . . 64.14 109.55 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -96.82 -43.7 7.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.482 0.713 . . . . 65.41 110.964 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 68.5 mtt180 -140.15 141.16 36.07 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.163 0.985 . . . . 71.42 109.614 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 46' ' ' ILE . 59.3 mt -130.62 108.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.47 1.108 . . . . 51.3 108.513 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -109.45 120.08 41.4 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.81 0.444 . . . . 54.33 110.429 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.7 115.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 N-CA-C 108.84 -0.8 . . . . 65.03 108.84 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.47 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.8 p -106.48 122.4 42.1 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.07 0.948 . . . . 50.33 109.595 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 91.8 Cg_endo -81.85 145.2 14.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.657 2.238 . . . . 73.41 112.457 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 41' ' ' LYS . 55.1 Cg_endo -67.63 147.24 75.83 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.914 2.409 . . . . 74.05 111.945 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.58 -135.75 5.32 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.838 -0.164 . . . . 73.24 112.789 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -72.32 -53.23 13.01 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.807 0.843 . . . . 73.02 112.106 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.38 -51.45 8.48 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 111.608 -0.597 . . . . 74.2 111.608 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 8.5 m -108.63 132.99 20.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.907 -0.775 . . . . 72.24 108.907 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.22 -40.6 18.95 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.848 2.365 . . . . 73.52 112.829 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . 19.1 ptpt -149.6 174.35 12.64 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.07 0.948 . . . . 72.13 109.732 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -66.57 110.89 3.35 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.013 -1.106 . . . . 60.15 108.013 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -128.67 152.17 48.69 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.294 -1.002 . . . . 71.13 108.294 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.38 102.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.468 -1.308 . . . . 71.32 107.468 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -91.13 109.52 21.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.557 -0.905 . . . . 74.03 108.557 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG23 HG23 ' A' ' 27' ' ' ILE . 45.1 mt -95.48 113.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.328 -0.851 . . . . 73.2 109.49 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.3 m-90 -85.22 132.11 34.33 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.373 -1.343 . . . . 75.41 107.373 167.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.8 p -87.82 169.06 12.38 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.589 -0.523 . . . . 64.54 109.589 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -64.95 -24.05 67.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.756 0.822 . . . . 72.23 111.645 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.5 mtm -91.53 9.36 32.33 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.916 0.886 . . . . 73.32 110.918 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 70.18 18.16 7.02 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.41 1.484 . . . . 64.25 114.023 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -75.59 122.37 23.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.95 -0.759 . . . . 71.52 108.95 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.64 104.76 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.625 1.17 . . . . 50.21 108.851 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -111.75 140.53 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.624 -0.88 . . . . 62.31 108.624 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.8 m -110.4 133.29 53.41 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.494 -0.928 . . . . 43.53 108.494 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 32.7 m -126.66 153.38 35.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 124.509 1.124 . . . . 74.41 109.005 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.92 139.52 43.02 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.01 -0.541 . . . . 74.54 110.126 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.31 -33.59 97.79 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.34 2.693 . . . . 71.22 113.165 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -89.14 14.72 10.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.403 0.681 . . . . 72.44 112.337 -174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.67 33.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.048 0.539 . . . . 73.31 109.848 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.78 -49.75 70.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.293 1.437 . . . . 73.32 112.652 -174.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -67.46 -31.05 70.95 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.728 0.811 . . . . 64.11 110.454 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.4 tp -74.78 -38.0 62.25 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.064 -0.971 . . . . 74.31 110.43 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -57.98 -29.78 65.52 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.805 0.842 . . . . 73.01 111.733 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -61.37 -52.23 65.48 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.008 0.817 . . . . 74.44 109.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.62 -47.87 81.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.17 0.588 . . . . 73.22 111.739 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -57.34 -48.03 80.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.805 0.842 . . . . 44.4 110.395 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.14 87.04 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.398 -0.819 . . . . 73.4 111.311 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -74.98 -47.51 28.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.594 0.59 . . . . 73.4 112.594 -173.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.86 -27.63 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.047 0.539 . . . . 72.41 112.097 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -91.31 125.48 36.08 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.621 0.769 . . . . 74.21 108.961 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m 63.14 32.88 14.9 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.341 1.056 . . . . 65.03 110.825 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.71 102.24 0.07 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.327 1.451 . . . . 74.4 110.493 -172.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.7 t -91.6 176.43 6.54 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.326 0.65 . . . . 71.41 110.291 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.85 105.89 3.98 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.708 -0.849 . . . . 62.4 108.708 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 p -87.3 59.73 5.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.182 0.993 . . . . 75.44 110.611 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t 64.42 178.47 0.18 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.009 1.324 . . . . 75.5 111.538 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -126.4 151.26 72.31 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.163 0.985 . . . . 73.43 109.493 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.43 135.8 63.58 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.57 2.18 . . . . 73.34 111.582 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -73.05 168.26 19.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.86 0.864 . . . . 73.34 111.468 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.31 131.01 92.14 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.497 0.719 . . . . 74.23 110.926 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.1 163.27 0.91 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.674 2.916 . . . . 73.45 113.318 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.529 HG22 ' HG2' ' A' ' 85' ' ' LYS . 9.9 p -53.86 130.35 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.079 0.951 . . . . 73.31 111.518 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -81.11 19.71 0.88 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.255 0.835 . . . . 63.22 113.255 -170.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.529 ' HG2' HG22 ' A' ' 83' ' ' VAL . 31.8 mmmt -74.87 142.96 44.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.636 0.374 . . . . 64.52 110.758 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -139.32 110.23 6.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.993 -1.484 . . . . 75.42 106.993 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -79.98 90.31 5.36 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.764 0.426 . . . . 73.11 111.568 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.34 85.33 5.17 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.248 -1.019 . . . . 72.23 108.248 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.778 0.831 . . . . 55.0 109.019 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.641 -0.503 . . . . 74.15 109.641 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mp -72.42 101.59 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.834 0.853 . . . . 71.14 109.047 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp -81.2 121.99 26.83 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.416 0.686 . . . . 75.32 109.665 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -120.06 144.94 47.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.984 0.913 . . . . 71.11 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.28 130.96 50.67 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.678 -1.601 . . . . 61.53 106.678 163.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.439 ' HD2' ' O ' ' A' ' 8' ' ' THR . 12.5 p-80 -79.16 115.21 18.68 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.388 0.613 . . . . 73.14 110.074 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -87.29 -29.98 21.21 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.598 0.759 . . . . 72.15 109.191 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.439 ' O ' ' HD2' ' A' ' 6' ' ' HIS . 24.4 m -70.74 92.43 0.88 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.516 -0.765 . . . . 74.43 109.141 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -110.7 34.79 3.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.489 0.716 . . . . 71.12 110.186 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.69 -59.9 2.59 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.89 -0.782 . . . . 75.13 108.89 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -149.35 131.08 15.03 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.378 1.071 . . . . 75.2 109.817 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 m -99.99 105.36 17.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.82 -1.178 . . . . 74.01 107.82 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -89.18 90.18 8.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.889 0.476 . . . . 72.1 110.604 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 45' ' ' VAL . 91.9 m -134.46 104.46 6.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.289 -1.004 . . . . 75.24 108.289 167.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -68.0 -16.62 64.13 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.87 0.868 . . . . 73.53 112.078 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.7 169.99 42.79 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.36 -0.696 . . . . 62.14 111.36 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.19 132.51 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 108.96 -0.756 . . . . 62.52 108.96 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.2 mt -109.99 117.32 54.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.825 -1.546 . . . . 71.04 106.825 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -85.57 14.72 5.27 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.98 0.912 . . . . 63.02 111.926 -172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.1 m -74.91 141.85 44.07 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.327 1.051 . . . . 74.14 109.817 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.82 118.61 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.009 -0.737 . . . . 73.01 109.009 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.32 131.89 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.157 -0.683 . . . . 74.23 109.157 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -64.03 127.84 36.19 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-O 119.578 -0.568 . . . . 73.13 113.387 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' HG ' HD11 ' A' ' 66' ' ' LEU . 10.2 mp -59.85 -29.13 68.07 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.369 0.668 . . . . 55.42 111.826 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -68.31 -38.03 81.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.859 0.464 . . . . 43.33 110.649 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 pt -87.3 -22.48 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 118.884 -0.579 . . . . 74.55 110.913 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 23' ' ' GLY . 65.6 mt -66.59 129.66 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.088 0.404 . . . . 41.43 110.032 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 37.8 t70 -119.67 -49.39 2.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.369 0.668 . . . . 52.03 110.654 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 69.5 mtp180 -126.25 137.14 53.49 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.127 0.971 . . . . 73.14 110.317 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -128.09 106.8 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.089 -1.078 . . . . 74.22 108.089 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -108.97 127.22 53.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.893 0.877 . . . . 75.32 109.644 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.46 130.81 36.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 N-CA-C 109.107 -0.701 . . . . 63.24 109.107 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.724 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 25.0 p -124.79 81.39 61.52 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.573 0.749 . . . . 74.33 110.731 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.18 157.72 49.98 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.753 2.302 . . . . 70.33 112.035 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 71.6 Cg_endo -70.7 161.22 46.81 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.018 2.479 . . . . 63.4 113.286 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.96 -121.88 1.04 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.199 -0.76 . . . . 64.04 111.199 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -81.49 -33.41 31.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.241 0.616 . . . . 71.21 110.056 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.69 -60.29 0.99 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-N 116.249 -0.432 . . . . 60.42 113.889 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.724 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 27.5 m -81.28 122.41 81.23 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.994 0.518 . . . . 73.33 109.675 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.55 -39.25 46.03 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 121.957 1.771 . . . . 74.35 111.9 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -123.16 171.76 9.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.249 1.02 . . . . 44.11 110.98 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.9 m -88.22 112.19 22.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.133 -1.062 . . . . 74.22 108.133 168.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.07 167.95 20.89 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.229 1.012 . . . . 63.41 108.514 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.38 116.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 72.12 109.161 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG22 ' SG ' ' A' ' 14' ' ' CYS . 48.7 t -91.88 109.3 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.204 0.602 . . . . 72.11 109.76 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.8 124.43 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.988 0.915 . . . . 74.35 109.662 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.1 m-90 -96.26 125.06 40.51 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.026 -1.102 . . . . 61.44 108.026 165.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -82.71 159.0 22.68 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.388 -0.967 . . . . 70.32 108.388 167.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 25.8 pttm -73.75 0.93 11.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.221 0.608 . . . . 72.13 112.338 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.8 mtm -101.98 8.89 40.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.114 0.966 . . . . 62.21 110.331 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 65.84 26.58 11.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.947 1.699 . . . . 71.33 113.827 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.17 123.55 29.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.145 -1.058 . . . . 74.31 108.145 168.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.6 t -94.44 112.85 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 64.15 109.307 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.0 mt -118.47 128.42 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.397 -0.964 . . . . 61.32 108.397 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.3 m -106.51 119.1 38.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.48 -1.304 . . . . 45.4 107.48 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.54 165.47 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.251 1.02 . . . . 75.03 110.679 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -88.99 141.04 29.23 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 123.962 0.905 . . . . 71.22 110.529 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.43 -30.62 87.26 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.083 2.522 . . . . 64.23 114.202 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.41 9.55 8.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.85 0.685 . . . . 73.01 112.85 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 119.95 13.28 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 109.709 -0.478 . . . . 52.21 109.709 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -64.75 -39.62 93.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.503 0.721 . . . . 75.42 110.849 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -62.77 -35.57 80.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.485 0.714 . . . . 70.03 110.584 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.89 -34.52 76.82 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.016 0.926 . . . . 70.12 110.192 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -60.58 -29.34 69.12 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.716 0.635 . . . . 72.41 111.82 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -57.83 -53.2 60.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 108.998 -0.741 . . . . 64.21 108.998 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.44 HD11 ' HG ' ' A' ' 24' ' ' LEU . 4.1 mm? -63.69 -45.59 89.35 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.727 -1.124 . . . . 74.12 110.258 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.79 -40.81 98.48 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 124.047 0.842 . . . . 65.23 111.096 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -82.8 -24.7 33.27 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.23 0.456 . . . . 72.33 112.23 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -78.91 -32.2 45.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.452 0.301 . . . . 72.02 111.201 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.36 -1.78 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 111.778 0.288 . . . . 75.23 111.778 175.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -92.12 -176.42 4.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.32 1.048 . . . . 72.44 111.268 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -72.23 83.7 1.03 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.229 1.012 . . . . 71.41 111.33 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.646 ' HE2' ' HB2' ' A' ' 75' ' ' LEU . 23.6 tptm -164.88 94.07 0.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.957 -1.127 . . . . 75.43 107.957 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -87.97 37.25 0.8 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.981 0.912 . . . . 70.4 111.553 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' ' HE2' ' A' ' 73' ' ' LYS . 97.2 mt -132.77 100.82 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.142 0.977 . . . . 74.33 108.618 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -128.78 -160.23 1.01 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.698 1.199 . . . . 74.44 108.524 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.4 t -70.38 176.37 4.04 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.92 0.488 . . . . 73.32 110.275 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.6 p -57.37 132.87 81.47 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.302 0.641 . . . . 72.32 111.193 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.83 145.52 97.08 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.227 2.618 . . . . 74.54 112.417 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -134.18 166.58 22.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.727 0.811 . . . . 71.0 110.882 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.82 120.28 2.86 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.002 1.321 . . . . 53.11 107.92 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.12 -32.34 94.52 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.472 2.114 . . . . 75.4 111.557 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.24 72.53 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.414 -1.328 . . . . 63.11 107.414 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.4 p -76.83 -53.09 8.37 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.858 -0.61 . . . . 70.44 109.67 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.69 124.47 29.05 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.634 -0.876 . . . . 73.13 108.634 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 59.2 59.63 2.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.243 1.017 . . . . 72.21 109.319 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.09 76.92 0.24 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.038 -0.983 . . . . 74.32 112.705 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.04 135.44 52.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.94 0.896 . . . . 61.35 111.831 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 C-N-CA 123.996 0.919 . . . . 54.51 109.47 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.973 -0.38 . . . . 75.21 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.47 134.96 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.213 -1.032 . . . . 74.12 108.213 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.8 tp -102.45 110.09 21.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.846 0.458 . . . . 71.44 110.126 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.34 145.75 26.39 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.953 0.901 . . . . 73.2 110.252 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.09 113.9 21.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.211 1.004 . . . . 65.35 108.68 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -80.97 136.19 35.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.116 0.566 . . . . 73.31 110.333 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -151.4 -25.77 0.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.252 -0.885 . . . . 73.35 109.818 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -65.36 119.36 10.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.905 0.482 . . . . 62.15 110.644 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.86 93.57 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.124 0.969 . . . . 62.03 110.854 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt -152.34 136.36 16.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.242 -1.392 . . . . 74.22 107.242 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HD2' ' H ' ' A' ' 11' ' ' LYS . 12.1 mptt -51.55 102.55 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.519 1.137 . . . . 75.31 110.387 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.9 104.49 2.51 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.577 -0.527 . . . . 74.34 109.577 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -83.98 88.31 7.15 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.21 -1.033 . . . . 61.13 108.21 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -135.67 125.39 25.44 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.465 -1.243 . . . . 71.34 108.48 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -79.91 76.24 6.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.314 0.646 . . . . 71.2 110.285 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.54 -127.0 43.68 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.0 -1.0 . . . . 32.54 112.933 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -142.9 136.11 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.566 1.146 . . . . 55.23 108.534 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mt -118.36 120.11 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.94 -1.133 . . . . 75.31 107.94 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -91.44 30.95 1.21 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.833 0.853 . . . . 73.33 112.573 -172.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -90.35 143.43 26.76 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.286 0.634 . . . . 71.3 109.615 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.81 134.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.969 0.793 . . . . 73.03 109.872 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.66 132.37 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.584 -0.895 . . . . 73.03 108.584 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -68.83 133.41 27.08 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.523 0.515 . . . . 73.15 112.677 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.13 -25.09 67.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.72 0.808 . . . . 50.15 111.441 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -72.33 -35.84 68.7 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.46 0.704 . . . . 70.55 110.425 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.0 pt -87.9 -18.29 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 117.846 0.294 . . . . 60.21 110.812 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 23' ' ' GLY . 64.5 mt -68.61 121.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 123.103 0.561 . . . . 65.42 109.938 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -99.82 -49.3 4.4 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.321 0.649 . . . . 65.11 109.813 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -138.11 149.88 46.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 64.03 110.281 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 46' ' ' ILE . 59.3 mt -137.82 112.98 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.17 1.388 . . . . 73.24 108.018 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -108.29 114.47 28.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.075 0.55 . . . . 73.1 109.585 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.26 133.71 29.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.523 -0.917 . . . . 51.52 108.523 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.412 HG21 ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -135.09 141.18 37.14 Favored Pre-proline 0 C--O 1.252 1.2 0 N-CA-C 112.37 0.507 . . . . 75.43 112.37 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.62 174.57 12.01 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.538 2.825 . . . . 61.54 112.517 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.16 55.14 5.49 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.859 2.372 . . . . 41.21 112.1 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.62 -168.51 41.37 Favored Glycine 0 C--O 1.246 0.878 0 N-CA-C 110.948 -0.861 . . . . 53.32 110.948 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.4 m120 58.2 30.84 20.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.363 1.065 . . . . 71.24 111.965 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.06 -33.68 3.62 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.818 -0.628 . . . . 72.34 112.806 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 33' ' ' THR . 60.8 m -98.91 141.27 22.61 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 123.304 0.642 . . . . 62.22 110.265 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.76 -32.09 24.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.586 2.191 . . . . 74.05 112.799 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -144.08 172.28 13.11 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.538 0.735 . . . . 43.12 109.848 -173.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.4 m -68.65 115.2 7.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.249 -0.648 . . . . 64.31 109.249 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -133.22 156.12 48.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.455 -0.572 . . . . 70.25 109.455 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.9 t -129.67 105.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.381 -1.34 . . . . 72.12 107.381 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.96 109.72 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.654 -0.703 . . . . 71.42 109.378 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 30' ' ' ILE . 43.5 mt -97.83 116.99 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.794 0.838 . . . . 74.11 110.033 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -90.56 137.71 32.14 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.317 -0.994 . . . . 73.43 108.317 168.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' HE1' ' A' ' 50' ' ' MET . 45.9 p -98.03 173.49 7.02 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.601 0.36 . . . . 61.35 111.214 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.98 -22.78 62.14 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.614 0.765 . . . . 62.34 110.98 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.462 ' HE1' ' HB ' ' A' ' 48' ' ' THR . 4.4 mpp? -76.84 -3.1 36.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.494 0.718 . . . . 71.24 111.09 170.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 76.02 12.81 2.8 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.068 1.747 . . . . 53.23 112.947 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -76.82 136.86 38.95 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 122.74 0.416 . . . . 64.0 110.218 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.99 102.62 11.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 O-C-N 124.558 1.161 . . . . 72.35 108.787 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.3 mt -98.25 138.72 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.246 -1.02 . . . . 74.43 108.246 172.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -107.9 134.01 51.43 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.105 -1.443 . . . . 64.12 107.105 170.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.23 152.97 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 122.837 0.455 . . . . 65.32 109.844 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -75.7 135.43 71.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 115.107 -0.951 . . . . 74.33 110.643 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.98 -5.73 15.33 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.554 2.169 . . . . 72.3 112.969 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -86.89 -18.46 30.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.297 0.639 . . . . 74.54 111.539 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.2 122.07 8.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.24 112.088 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.12 -47.32 86.42 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 62.41 111.066 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -58.98 -38.04 78.2 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.097 0.873 . . . . 74.12 110.54 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.56 -30.83 69.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.476 1.11 . . . . 72.24 111.595 -174.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.6 -43.16 97.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.368 0.667 . . . . 73.1 112.283 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -64.45 -27.05 68.73 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.5 0.5 . . . . 75.42 111.336 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.42 -46.13 42.07 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.367 -0.605 . . . . 72.5 109.367 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.22 -27.5 67.24 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.877 0.871 . . . . 73.35 111.108 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -81.98 -56.42 3.97 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.156 0.582 . . . . 72.4 111.026 172.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -78.1 -15.08 59.2 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.21 0.818 . . . . 74.52 113.21 -162.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.5 m -67.16 -32.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.06 0.846 . . . . 74.34 110.591 173.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.23 113.33 22.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.477 -0.935 . . . . 53.15 108.477 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.6 m 62.03 42.58 9.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.829 1.251 . . . . 61.03 111.178 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -44.61 117.03 1.17 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.162 1.385 . . . . 71.2 112.715 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 p -97.72 157.93 15.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.383 1.073 . . . . 73.34 110.066 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.59 129.01 36.5 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.11 -0.7 . . . . 70.54 109.11 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 t -138.43 24.86 2.68 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.918 0.887 . . . . 75.44 109.499 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -145.74 174.18 11.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 115.273 -0.876 . . . . 53.43 109.64 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.3 p -63.15 127.13 90.53 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.59 0.756 . . . . 63.32 110.061 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.35 86.74 1.13 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.487 2.125 . . . . 61.11 112.167 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -77.19 170.57 16.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.729 -1.123 . . . . 74.21 110.39 174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.39 111.74 15.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.383 0.673 . . . . 74.42 109.707 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.3 -176.49 2.99 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.492 2.128 . . . . 74.53 110.96 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.4 88.81 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 107.642 -1.244 . . . . 70.34 107.642 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -68.81 89.29 0.39 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.694 -1.139 . . . . 63.22 111.166 -171.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -103.42 -162.16 0.89 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.511 1.124 . . . . 74.21 109.053 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -70.29 112.42 6.61 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.53 -0.544 . . . . 71.14 109.53 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.26 145.39 53.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.144 1.378 . . . . 64.44 111.4 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.18 149.54 27.87 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.924 0.89 . . . . 73.34 111.324 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 C-N-CA 124.201 1.0 . . . . 61.22 108.835 179.096 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 108.611 -0.885 . . . . 63.31 108.611 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.586 ' HB ' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mp -67.88 104.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.694 0.621 . . . . 70.33 109.436 -176.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD22 HG21 ' A' ' 70' ' ' VAL . 37.3 tp -80.24 117.2 20.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.023 -0.732 . . . . 74.43 109.023 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.93 148.62 27.44 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.875 0.87 . . . . 74.0 110.323 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.41 142.93 26.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.634 -1.166 . . . . 62.1 108.033 168.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' CE1' ' SG ' ' A' ' 12' ' ' CYS . 63.7 t60 -81.09 137.9 35.97 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.992 -0.373 . . . . 73.13 109.992 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -115.27 157.38 23.85 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.914 0.885 . . . . 74.52 109.923 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -61.2 -40.84 95.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.991 0.916 . . . . 72.33 111.55 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.6 67.15 9.88 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.812 0.815 . . . . 74.11 109.257 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt -170.23 97.36 0.27 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.89 -1.522 . . . . 52.13 106.89 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -68.88 137.3 53.75 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.441 0.696 . . . . 72.45 110.612 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' SG ' HG21 ' A' ' 33' ' ' THR . 73.1 m -101.82 102.96 13.64 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.854 -0.424 . . . . 72.31 109.854 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -115.3 88.95 2.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.18 0.592 . . . . 65.45 109.646 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.6 t -134.95 158.65 43.76 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.975 -0.75 . . . . 64.34 108.975 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -67.54 -27.17 66.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.469 0.708 . . . . 71.11 112.57 -175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.51 -156.83 27.14 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.022 -0.831 . . . . 74.34 111.022 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.75 136.61 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.27 -0.641 . . . . 75.04 109.27 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.638 HD12 HG23 ' A' ' 54' ' ' ILE . 46.4 mt -103.94 134.93 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.1 0.96 . . . . 72.24 109.548 -172.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -85.88 28.19 0.81 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.559 1.143 . . . . 61.51 113.094 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.3 p -109.55 145.39 36.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.099 0.56 . . . . 74.01 110.866 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.79 111.67 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.634 -1.247 . . . . 63.21 107.634 168.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.44 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.394 -0.965 . . . . 73.22 108.394 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -58.99 126.94 44.11 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.803 0.69 . . . . 64.43 112.688 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HG ' HD11 ' A' ' 66' ' ' LEU . 9.1 mp -59.98 -31.59 70.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.416 0.686 . . . . 71.02 111.509 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.59 -37.35 82.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.33 0.652 . . . . 72.0 111.205 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 23' ' ' GLY . 20.9 pt -82.97 -24.19 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 119.634 -0.222 . . . . 73.44 110.541 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.64 120.1 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.447 0.699 . . . . 71.42 110.653 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -101.67 -40.92 6.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.424 0.69 . . . . 75.31 110.796 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HG3' ' HB ' ' A' ' 2' ' ' ILE . 14.3 ttm180 -152.79 135.81 15.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.827 -0.435 . . . . 73.3 109.827 -163.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 46' ' ' ILE . 67.4 mt -133.47 113.39 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.76 1.224 . . . . 73.22 109.079 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -109.69 125.63 52.85 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.925 0.49 . . . . 62.23 109.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.35 111.75 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.871 -0.789 . . . . 41.22 108.871 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.632 HG21 ' SG ' ' A' ' 12' ' ' CYS . 71.5 m -110.5 106.48 57.9 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.008 0.923 . . . . 62.41 111.185 -176.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -66.96 162.55 37.48 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.01 2.473 . . . . 71.42 112.765 166.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -85.43 152.74 10.53 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.514 2.142 . . . . 74.51 111.791 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 -146.34 9.65 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.962 -0.455 . . . . 14.1 111.962 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -71.78 -53.59 12.88 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.245 0.618 . . . . 72.03 111.466 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.25 -27.2 72.15 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.347 0.499 . . . . 73.42 114.347 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' SG ' ' NE2' ' A' ' 6' ' ' HIS . 60.3 m -127.79 116.06 20.8 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.457 0.703 . . . . 74.33 109.933 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.61 -20.88 46.54 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.327 2.018 . . . . 63.33 113.895 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.85 169.97 16.78 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.413 0.685 . . . . 53.34 111.554 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -86.98 117.26 25.59 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.782 0.833 . . . . 63.34 109.055 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.09 159.24 42.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.215 0.606 . . . . 75.14 109.385 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.87 104.13 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.202 -1.777 . . . . 64.24 106.202 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.83 107.39 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.617 -0.882 . . . . 75.53 108.617 -167.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 30' ' ' ILE . 52.1 mt -96.98 114.08 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 114.764 -1.107 . . . . 75.13 109.563 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 29' ' ' ARG . 31.1 m-90 -86.73 125.71 34.08 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.35 -1.352 . . . . 72.31 107.35 166.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.6 p -84.04 162.8 20.23 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.61 -0.515 . . . . 64.33 109.61 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -21.84 64.38 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.602 0.761 . . . . 53.43 111.149 175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtm -84.73 -1.5 56.33 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.101 1.361 . . . . 72.31 111.421 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 70.28 19.94 6.36 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.528 1.531 . . . . 72.22 113.357 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.42 126.91 32.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.359 -0.608 . . . . 74.03 109.359 168.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.9 t -89.01 105.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.058 0.943 . . . . 74.31 108.916 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.638 HG23 HD12 ' A' ' 18' ' ' ILE . 73.1 mt -111.84 117.75 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.387 1.075 . . . . 63.1 108.416 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.7 m -105.95 125.52 51.09 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.068 -1.086 . . . . 60.11 108.068 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.83 165.97 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.713 0.805 . . . . 63.31 110.541 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.09 142.4 55.47 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.767 0.827 . . . . 71.34 110.765 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.77 -11.78 32.8 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.471 2.114 . . . . 60.45 113.304 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.2 -6.48 58.98 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.387 0.675 . . . . 75.12 111.314 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.14 114.89 2.34 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.158 -0.682 . . . . 62.41 109.158 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -36.18 73.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.748 0.819 . . . . 65.13 110.173 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.422 0.689 . . . . 72.31 110.423 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.24 -28.55 68.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.577 1.151 . . . . 74.32 111.048 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -61.53 -26.95 68.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.813 0.845 . . . . 62.11 111.954 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.27 -50.06 72.44 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.441 0.696 . . . . 75.15 109.674 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.414 HD11 ' HG ' ' A' ' 24' ' ' LEU . 3.7 mm? -69.2 -45.07 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.323 1.014 . . . . 74.23 110.301 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.58 -34.07 76.24 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.089 0.868 . . . . 63.22 111.178 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -89.68 -22.34 22.3 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 112.518 0.562 . . . . 75.23 112.518 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.4 -38.3 41.93 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.875 0.47 . . . . 73.43 111.124 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 3' ' ' LEU . 35.7 m -63.07 -32.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 121.291 0.567 . . . . 74.31 110.727 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -68.6 152.55 45.21 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.325 1.05 . . . . 74.33 109.269 171.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -64.46 81.28 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.813 0.845 . . . . 64.43 112.428 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -84.28 -79.3 0.22 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.833 0.853 . . . . 73.1 109.401 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.7 p 176.32 163.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.947 1.299 . . . . 64.04 110.129 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.1 108.0 19.58 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.684 0.794 . . . . 73.1 108.887 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.8 t -56.44 125.42 21.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.2 1.0 . . . . 71.24 109.978 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.9 m -61.86 99.37 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.142 0.977 . . . . 62.24 111.93 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.7 p -74.07 115.63 44.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.761 0.824 . . . . 54.42 109.895 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.63 163.43 30.28 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.566 2.177 . . . . 73.22 113.044 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.56 134.31 51.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.979 0.912 . . . . 71.55 110.752 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.22 140.21 63.83 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.342 1.057 . . . . 50.23 112.122 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.08 -16.46 40.44 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.687 2.258 . . . . 74.44 111.957 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.18 81.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 107.581 -1.266 . . . . 63.54 107.581 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -73.12 -51.45 17.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.601 -1.181 . . . . 50.45 110.026 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -100.24 147.87 25.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.553 0.741 . . . . 73.41 110.545 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -153.13 177.48 10.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.343 1.057 . . . . 74.3 109.31 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -74.04 79.23 1.71 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.779 0.8 . . . . 65.15 109.31 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -164.67 162.08 21.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.688 1.195 . . . . 60.41 109.16 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 C-N-CA 123.609 0.764 . . . . 51.12 109.091 -177.781 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.829 0.347 . . . . 64.05 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.3 mt -137.78 119.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.5 1.12 . . . . 74.05 108.249 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 70' ' ' VAL . 60.2 tp -90.78 107.38 19.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.41 -0.589 . . . . 64.24 109.41 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -83.11 142.69 31.07 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.351 0.661 . . . . 71.34 109.349 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.31 115.99 26.93 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.46 -0.941 . . . . 72.1 108.46 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.627 ' HE1' ' HB3' ' A' ' 10' ' ' LEU . 17.9 t60 -84.08 102.51 12.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 65.3 110.173 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -104.92 -54.43 2.5 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.813 -0.81 . . . . 73.44 108.813 170.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.6 p -66.35 140.5 58.09 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.792 0.837 . . . . 64.22 111.479 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.13 119.56 9.77 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.63 0.772 . . . . 43.52 111.012 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.627 ' HB3' ' HE1' ' A' ' 6' ' ' HIS . 6.2 tt -157.98 134.33 9.52 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.316 -1.735 . . . . 63.11 106.316 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.18 94.7 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.251 0.969 . . . . 65.41 110.693 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.9 m -74.02 102.25 4.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.622 0.769 . . . . 53.04 109.688 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -87.82 90.52 8.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.46 0.648 . . . . 71.01 110.325 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG22 ' A' ' 45' ' ' VAL . 73.0 m -135.62 95.96 3.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.403 -1.271 . . . . 75.33 107.866 166.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -82.88 -4.47 58.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.869 0.867 . . . . 71.5 111.545 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.6 160.59 29.05 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.983 -0.847 . . . . 45.1 110.983 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.64 134.61 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.077 -0.712 . . . . 52.41 109.077 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.27 120.72 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.17 -1.419 . . . . 74.13 107.17 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.5 m -83.16 3.44 30.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 64.24 112.523 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.7 p -70.4 128.28 35.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.439 0.695 . . . . 72.31 110.47 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.71 109.07 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 108.003 -1.11 . . . . 34.12 108.003 175.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.83 142.05 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.822 -0.807 . . . . 72.21 108.822 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.03 129.51 21.06 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.413 0.446 . . . . 53.21 113.766 -173.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 66' ' ' LEU . 9.6 mp -61.41 -24.41 66.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.042 0.937 . . . . 63.13 112.096 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -70.98 -34.81 71.77 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.572 0.749 . . . . 75.11 111.033 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.3 pt -95.72 -17.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.492 0.317 . . . . 71.24 111.759 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.24 125.77 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 109.796 -0.446 . . . . 74.52 109.796 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -118.52 -45.44 2.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.521 -0.309 . . . . 75.32 111.553 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 77.7 mtt180 -125.06 125.17 43.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.912 -0.403 . . . . 71.23 109.912 -169.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.88 110.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.498 1.119 . . . . 74.21 108.189 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -104.38 124.54 49.39 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 122.911 0.484 . . . . 63.35 110.208 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -85.01 119.81 34.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.0 -1.111 . . . . 73.12 108.0 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.739 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.8 p -108.11 91.53 8.1 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.9 0.88 . . . . 61.14 109.863 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.67 162.47 41.16 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.11 2.54 . . . . 72.34 112.085 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.92 -167.76 0.52 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.283 1.989 . . . . 65.24 111.934 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.54 -126.52 7.79 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.793 -0.523 . . . . 64.31 111.793 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.38 -11.82 59.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.684 0.793 . . . . 74.15 111.268 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.58 -80.23 0.52 Allowed Glycine 0 C--N 1.35 1.308 0 O-C-N 123.626 0.579 . . . . 63.52 112.461 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.739 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 66.4 m -128.79 162.4 51.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.106 0.963 . . . . 65.04 110.7 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -58.98 -36.89 96.0 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.581 2.187 . . . . 63.14 113.829 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -128.3 166.63 18.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.728 0.811 . . . . 72.22 110.254 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m -88.42 111.19 21.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.22 -1.03 . . . . 75.21 108.22 170.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.56 172.53 13.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.446 1.098 . . . . 74.11 108.187 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -131.17 124.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.86 0.864 . . . . 74.43 109.117 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG22 ' SG ' ' A' ' 14' ' ' CYS . 27.3 t -92.37 143.3 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.811 0.844 . . . . 73.41 109.0 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.6 116.47 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.111 0.965 . . . . 73.15 108.55 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 31.1 m-90 -93.71 124.56 37.78 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.88 -0.785 . . . . 73.53 108.88 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 p -80.97 173.25 12.8 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.037 0.836 . . . . 75.02 109.93 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -72.78 -17.92 61.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.769 0.827 . . . . 72.43 110.865 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.6 mtm -83.75 0.0 49.08 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.287 1.035 . . . . 70.34 110.637 172.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 76.68 11.52 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.976 1.71 . . . . 75.14 112.904 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.87 134.73 37.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 70.01 111.31 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -91.56 103.82 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 125.039 1.462 . . . . 63.13 108.594 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.6 121.54 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.631 -1.248 . . . . 74.44 107.631 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.0 m -105.16 138.52 41.23 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.715 -0.846 . . . . 50.25 108.715 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.95 165.55 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.318 1.447 . . . . 72.11 109.195 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -82.54 147.08 55.04 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 119.215 -0.422 . . . . 73.23 109.967 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.76 -19.24 64.34 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.685 2.257 . . . . 73.22 112.337 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -90.79 14.38 13.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.59 0.756 . . . . 53.4 111.747 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.76 15.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.0 -0.741 . . . . 63.24 109.0 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -59.13 -44.76 92.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.136 0.974 . . . . 72.41 112.744 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -63.74 -42.52 97.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.44 0.696 . . . . 75.05 110.229 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.79 -34.44 71.48 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.632 1.208 . . . . 72.23 111.33 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.555 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 79.6 mm-40 -55.56 -46.03 77.22 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.618 0.574 . . . . 74.53 111.518 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -59.41 -30.15 68.26 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 52.35 111.022 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 24' ' ' LEU . 9.3 mp -78.69 -39.49 36.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.797 0.839 . . . . 64.23 110.688 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.0 -26.23 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.935 0.894 . . . . 73.31 110.319 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.3 mmt180 -90.74 -28.14 18.47 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.898 0.479 . . . . 71.21 111.164 173.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 73' ' ' LYS . 64.5 t-80 -62.29 -34.24 76.2 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.289 0.636 . . . . 73.23 110.882 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 HG21 HD22 ' A' ' 3' ' ' LEU . 32.1 m -68.51 -15.87 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 116.085 -0.507 . . . . 71.52 111.91 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.02 41.9 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.731 0.812 . . . . 74.02 111.198 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t 52.27 64.79 1.71 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.962 1.305 . . . . 41.14 111.438 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 69' ' ' HIS . 55.3 tptt -67.13 134.4 51.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.163 -0.926 . . . . 73.51 110.185 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.5 p -75.17 168.1 20.63 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.67 0.788 . . . . 74.43 113.119 -172.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 pp -121.7 171.67 8.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.344 1.058 . . . . 72.13 111.315 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -114.07 -176.12 2.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.689 0.796 . . . . 74.33 110.038 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.9 m -131.02 142.9 50.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.336 1.054 . . . . 61.35 108.909 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -110.98 136.71 20.77 Favored Pre-proline 0 CA--C 1.553 1.062 0 N-CA-C 109.142 -0.688 . . . . 63.43 109.142 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.51 175.3 3.57 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.412 2.075 . . . . 74.12 113.395 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.92 155.28 27.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.491 -0.777 . . . . 53.45 111.058 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.64 149.42 93.21 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.62 1.168 . . . . 62.33 110.82 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.81 154.14 63.75 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 121.815 1.677 . . . . 61.3 111.569 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.4 128.33 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.458 0.703 . . . . 72.22 112.113 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -85.13 155.3 21.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.212 -0.662 . . . . 53.14 109.212 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -102.56 140.05 37.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.485 0.314 . . . . 74.13 110.669 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -112.64 138.36 49.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.458 1.103 . . . . 65.51 108.996 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -75.63 103.99 5.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.56 0.744 . . . . 71.35 109.521 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.88 85.2 7.39 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.534 -0.543 . . . . 61.14 109.534 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.905 -0.776 . . . . 54.02 108.905 177.427 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 108.782 -0.822 . . . . 51.43 108.782 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 52.5 mt -76.51 109.84 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.966 -0.383 . . . . 73.24 109.966 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -82.52 108.18 15.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.763 0.425 . . . . 74.01 110.223 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -90.93 118.56 30.42 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.563 -0.532 . . . . 53.04 109.563 174.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.86 106.56 15.63 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.993 -1.114 . . . . 71.24 107.993 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -124.5 136.74 54.25 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.94 0.896 . . . . 53.5 109.414 -172.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -100.14 169.23 9.3 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.504 1.122 . . . . 70.43 108.29 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.3 p -49.2 112.14 0.59 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.842 0.857 . . . . 71.4 112.913 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.416 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 27.6 t-20 -69.8 169.35 13.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.809 0.844 . . . . 74.3 108.807 166.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.55 -43.18 11.74 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.168 0.987 . . . . 65.14 110.036 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -167.99 107.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.054 0.942 . . . . 74.25 109.481 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' SG ' HG21 ' A' ' 33' ' ' THR . 75.4 m -73.51 115.83 13.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.115 0.566 . . . . 72.55 109.952 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -72.74 90.85 1.43 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.285 0.634 . . . . 72.24 111.686 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.563 ' SG ' HG22 ' A' ' 45' ' ' VAL . 91.4 m -134.2 112.52 11.16 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.782 -1.192 . . . . 54.1 107.782 164.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.0 p -60.94 -35.07 75.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.962 0.905 . . . . 73.13 110.532 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.54 -176.65 37.84 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.054 -0.975 . . . . 60.41 111.692 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 m -111.15 135.1 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.065 0.946 . . . . 75.34 109.224 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.4 132.49 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.403 0.681 . . . . 75.51 109.35 -173.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.7 m -97.1 48.3 1.05 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.869 0.868 . . . . 43.12 111.388 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.5 p -109.6 129.7 55.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.417 0.687 . . . . 64.15 109.51 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.6 t -72.95 111.73 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.539 -0.912 . . . . 64.43 108.539 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -76.06 145.04 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.676 0.79 . . . . 74.2 109.61 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -61.4 120.04 20.93 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 119.65 -0.528 . . . . 71.53 111.821 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.1 -23.95 65.88 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.906 0.883 . . . . 72.22 112.239 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -72.64 -34.4 67.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.826 0.85 . . . . 75.12 111.059 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 pt -95.75 -18.78 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 118.844 -0.598 . . . . 61.13 111.527 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 23' ' ' GLY . 64.6 mt -60.86 107.48 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.946 -0.761 . . . . 44.53 108.946 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.49 -55.3 2.79 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.821 -0.627 . . . . 75.32 110.745 -171.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 47.5 mtm180 -137.79 125.07 21.74 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.473 0.709 . . . . 74.44 109.838 -175.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.43 106.58 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.221 -1.029 . . . . 44.43 108.221 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -104.85 117.32 33.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.212 0.605 . . . . 74.33 109.551 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.45 135.94 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.561 -0.533 . . . . 74.32 109.561 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.575 HG21 ' SG ' ' A' ' 12' ' ' CYS . 18.8 m -130.57 127.56 22.36 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 109.545 -0.539 . . . . 73.14 109.545 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.17 171.87 15.61 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.439 2.093 . . . . 35.32 111.658 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -85.0 -173.65 1.52 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.499 2.132 . . . . 70.21 111.993 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.63 -133.84 8.25 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.55 -0.583 . . . . 65.1 111.827 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.57 119.46 31.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.935 0.494 . . . . 73.14 109.898 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.76 -90.43 0.53 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.822 -0.911 . . . . 25.23 110.822 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 9' ' ' ASN . 34.2 m -84.13 112.52 41.66 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.281 -1.007 . . . . 51.24 108.281 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.54 -20.98 15.34 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.353 2.035 . . . . 72.44 113.32 -169.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.13 155.34 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.025 0.53 . . . . 73.14 110.233 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.9 m -82.93 111.5 18.87 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 104.959 -2.237 . . . . 70.54 104.959 160.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.35 131.58 18.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 75.1 110.32 -163.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.2 t -110.63 109.37 28.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.512 -0.922 . . . . 73.34 108.512 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 ' SG ' ' A' ' 14' ' ' CYS . 44.4 t -92.79 108.48 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.647 0.779 . . . . 74.04 109.274 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.11 116.29 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.179 0.992 . . . . 55.05 109.535 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -88.57 137.05 32.67 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.876 -0.787 . . . . 71.54 108.876 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -95.93 173.22 7.55 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 115.583 -0.735 . . . . 73.52 110.184 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -68.53 -23.51 64.54 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.705 0.802 . . . . 75.21 111.19 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.9 mtm -85.83 5.81 30.95 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.847 0.859 . . . . 72.43 110.828 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 67.14 23.26 9.61 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.117 1.367 . . . . 71.14 113.129 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -76.37 125.39 29.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.5 t -85.37 105.76 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 124.543 1.152 . . . . 73.42 108.27 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.73 117.75 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.386 -0.968 . . . . 72.43 108.386 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.39 117.62 34.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.375 -1.343 . . . . 54.04 107.375 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.24 162.29 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.963 0.905 . . . . 53.14 110.45 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -85.31 138.5 36.42 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.635 -0.711 . . . . 73.52 110.594 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.85 -19.77 35.24 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.294 2.663 . . . . 53.41 114.26 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -73.42 -18.0 61.19 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.824 0.45 . . . . 73.42 110.258 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.32 116.69 2.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.713 0.805 . . . . 75.23 111.663 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.51 -40.68 80.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.307 1.043 . . . . 75.2 111.133 -173.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -60.9 -39.56 89.77 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.376 0.67 . . . . 75.21 109.622 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 62.7 tp -66.35 -45.26 80.78 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-N 114.952 -1.022 . . . . 53.35 110.34 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -61.71 -42.46 98.98 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.932 0.77 . . . . 72.13 109.831 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -60.23 -39.81 87.99 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.661 -0.7 . . . . 74.02 110.728 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 70' ' ' VAL . 55.5 tp -72.32 -33.91 67.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.262 -0.881 . . . . 64.43 111.003 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 91.5 mt -68.63 -35.31 77.12 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.508 0.723 . . . . 54.53 109.874 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -68.41 -41.65 80.13 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.275 0.63 . . . . 72.34 110.276 172.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -69.45 -32.56 71.58 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.677 -0.692 . . . . 71.34 112.222 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 66' ' ' LEU . 30.3 m -74.47 -19.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 122.169 -0.332 . . . . 64.13 111.502 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.27 -58.35 2.88 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.471 0.709 . . . . 74.34 109.39 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -111.46 104.69 13.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.306 1.042 . . . . 72.13 108.762 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -127.45 115.7 19.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.0 0.92 . . . . 74.43 109.897 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.7 p -131.8 161.33 33.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.659 1.184 . . . . 74.4 107.935 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp 61.91 55.15 2.65 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.945 0.879 . . . . 74.12 109.417 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.6 p -76.64 77.09 3.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.203 -0.908 . . . . 53.33 109.382 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 p -73.18 97.92 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.169 -0.923 . . . . 64.12 110.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 48.8 m -140.05 103.99 6.76 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.997 0.919 . . . . 74.25 108.644 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.16 154.0 28.61 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.847 2.365 . . . . 75.53 112.327 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -68.54 97.44 0.78 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.874 -0.787 . . . . 72.1 108.874 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 136.5 96.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.238 -0.892 . . . . 74.2 110.782 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.07 -17.49 31.67 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.209 1.939 . . . . 41.44 111.886 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 HH21 ' A' ' 87' ' ' ARG . 96.2 t -82.9 104.88 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.04 0.936 . . . . 71.43 109.088 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -73.67 124.4 25.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.196 0.598 . . . . 62.34 110.198 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -67.92 144.38 55.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.72 0.808 . . . . 74.24 110.87 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 66.27 85.09 0.15 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.21 1.404 . . . . 73.15 109.423 -165.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.469 HH21 HG13 ' A' ' 83' ' ' VAL . 32.4 ttm180 -88.85 124.85 34.58 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.751 -0.833 . . . . 55.54 108.751 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.71 74.19 8.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.429 0.691 . . . . 62.4 109.147 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 C-N-CA 124.741 1.216 . . . . 74.41 108.537 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.925 0.393 . . . . 72.11 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.652 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 70.0 mt -122.94 110.04 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.754 -0.832 . . . . 65.15 108.754 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.25 114.03 20.47 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.907 -0.775 . . . . 71.34 108.907 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.69 144.93 30.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.549 0.739 . . . . 63.21 110.026 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.96 115.38 30.35 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.622 0.769 . . . . 62.31 109.529 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 10.1 t60 -80.89 96.94 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.512 -0.551 . . . . 73.45 109.512 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -106.76 -11.19 15.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.273 -0.876 . . . . 72.42 109.426 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -70.79 104.86 3.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.241 0.617 . . . . 73.4 110.197 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.5 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 4.1 p-10 -82.01 26.6 0.51 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.632 1.173 . . . . 75.4 112.224 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 mt -75.21 -167.52 0.64 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.029 1.332 . . . . 74.4 110.328 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -56.83 92.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.597 0.713 . . . . 74.32 110.238 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.3 m -72.62 101.64 3.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.77 -0.826 . . . . 72.3 108.77 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -102.06 102.69 13.21 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 73.02 110.4 -168.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.0 t -103.79 156.32 17.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.959 -1.019 . . . . 62.22 109.448 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -99.15 5.66 46.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.483 0.713 . . . . 75.02 111.169 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 55' ' ' CYS . . . 89.59 157.15 32.79 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.069 -0.812 . . . . 74.54 111.069 -170.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.89 131.35 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.131 0.966 . . . . 72.53 109.664 -169.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 HG23 ' A' ' 54' ' ' ILE . 12.7 mt -122.44 135.75 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 108.956 -0.757 . . . . 74.43 108.956 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.1 p -76.31 16.15 0.5 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.375 0.88 . . . . 61.42 113.375 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.6 p -77.24 113.59 15.16 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.311 0.645 . . . . 70.14 110.521 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.22 109.9 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.649 -1.241 . . . . 75.33 107.649 169.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -78.82 138.16 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.8 -0.815 . . . . 61.53 108.8 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -60.46 128.68 46.04 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.967 0.792 . . . . 44.41 112.938 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.0 -24.97 67.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.446 0.698 . . . . 65.2 111.602 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.1 -20.19 52.7 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.643 0.777 . . . . 64.41 111.416 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 pt -109.36 -11.9 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 118.983 -0.532 . . . . 75.21 112.307 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.0 mt -63.64 108.75 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.162 -0.681 . . . . 72.13 109.162 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -89.22 -53.9 4.35 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.256 0.623 . . . . 71.34 109.997 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 47.2 mtt180 -140.45 148.24 40.87 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.719 -0.673 . . . . 65.12 110.67 -175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 46' ' ' ILE . 67.3 mt -130.68 107.85 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.809 -1.182 . . . . 70.22 107.809 173.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.22 122.55 43.85 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.766 -0.457 . . . . 61.41 109.766 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 m -97.74 120.72 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.687 -0.688 . . . . 64.04 110.304 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . 60.1 m -104.99 103.31 40.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.395 1.078 . . . . 64.54 109.185 175.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.52 162.97 30.08 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.822 2.348 . . . . 60.21 112.296 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.81 91.12 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.866 2.377 . . . . 73.22 112.436 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.62 -111.1 3.56 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.926 -0.579 . . . . 64.44 112.713 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -146.33 -50.98 0.22 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.796 0.838 . . . . 71.5 109.967 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 9' ' ' ASN . . . -63.49 -36.09 92.9 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.211 -0.449 . . . . 63.3 113.956 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.4 m -86.16 137.56 34.99 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.177 0.591 . . . . 62.02 109.879 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.45 -18.28 38.54 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.476 2.117 . . . . 64.24 112.537 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -151.02 172.62 15.43 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.642 0.777 . . . . 73.15 110.991 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.2 m -86.09 133.63 33.87 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.876 -1.056 . . . . 74.05 108.612 167.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -151.82 145.67 25.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.545 0.338 . . . . 70.13 110.308 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.18 106.46 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.558 -0.905 . . . . 54.11 108.558 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.09 110.99 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.227 0.611 . . . . 75.31 109.636 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 30' ' ' ILE . 53.7 mt -95.35 126.5 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.879 0.871 . . . . 72.12 109.829 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -98.64 139.06 34.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.337 -0.616 . . . . 73.43 109.337 168.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -87.86 173.3 9.03 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.801 0.688 . . . . 45.45 109.898 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.37 -19.24 61.05 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.037 0.535 . . . . 73.32 111.226 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.4 mtm -81.51 -2.8 51.12 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.701 0.801 . . . . 71.21 110.409 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 71.55 21.82 4.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.043 1.737 . . . . 74.14 112.512 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -74.85 137.22 41.68 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.186 0.594 . . . . 71.53 109.807 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.2 t -99.39 111.98 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.795 1.238 . . . . 75.22 109.469 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.456 HG23 HD12 ' A' ' 18' ' ' ILE . 70.6 mt -124.51 144.58 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.077 -1.082 . . . . 71.34 108.077 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 80.7 m -107.65 156.96 18.48 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.036 -0.727 . . . . 53.04 109.036 169.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.4 153.05 25.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.422 1.089 . . . . 65.22 109.011 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 60' ' ' ALA . 21.2 p-10 -71.43 133.78 84.92 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.864 0.466 . . . . 71.45 109.977 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 58.7 Cg_exo -51.26 -34.77 50.53 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.059 2.506 . . . . 74.32 114.178 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD2' ' HB2' ' A' ' 58' ' ' PRO . 6.2 mpt_? -95.67 22.42 7.21 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.924 0.489 . . . . 73.25 111.544 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.477 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . . . -69.24 131.54 45.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.578 -0.527 . . . . 63.13 109.578 172.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -60.24 -51.05 71.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.996 0.918 . . . . 64.0 110.916 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -61.95 -36.66 82.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.576 -0.738 . . . . 71.42 111.107 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -64.96 -45.15 86.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.659 0.599 . . . . 42.33 110.871 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -63.71 -30.98 72.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.086 0.554 . . . . 75.3 111.142 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -65.74 -39.28 90.96 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.113 -0.494 . . . . 73.34 110.136 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.36 -41.49 76.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.222 0.609 . . . . 74.44 111.014 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.58 -35.49 80.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.506 0.722 . . . . 72.41 110.139 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -74.14 -37.72 63.98 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.787 0.835 . . . . 72.12 111.291 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -66.77 -51.31 57.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.182 0.593 . . . . 72.02 111.926 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.28 -22.39 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.02 111.355 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -82.75 1.93 36.4 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.687 0.795 . . . . 41.12 111.468 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.2 t 75.41 103.56 0.07 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.279 1.432 . . . . 55.42 111.852 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.83 -77.31 0.38 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.778 1.231 . . . . 55.32 109.294 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -163.69 154.87 16.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 72.52 109.946 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.67 134.69 52.79 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 72.33 109.14 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -81.03 135.27 35.82 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.581 0.752 . . . . 42.24 109.042 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -68.35 101.09 1.15 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.015 0.526 . . . . 72.0 109.935 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.0 p -56.42 118.41 21.86 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.98 0.912 . . . . 73.54 110.795 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.63 150.49 60.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.924 2.416 . . . . 73.42 113.112 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.87 118.31 8.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.534 0.734 . . . . 62.11 110.172 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 79.57 36.95 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.081 0.952 . . . . 72.0 108.795 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.64 154.41 44.35 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.737 2.291 . . . . 64.24 112.542 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.89 111.95 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.362 -0.977 . . . . 64.44 108.362 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 m -81.22 159.81 24.46 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.983 0.913 . . . . 53.3 111.063 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.77 121.7 15.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.823 0.849 . . . . 63.4 111.206 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -149.81 138.5 20.87 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.508 1.123 . . . . 75.43 108.795 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.9 88.05 5.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 106.731 -1.581 . . . . 65.31 106.731 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.39 -61.89 1.47 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.543 0.737 . . . . 74.1 109.692 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.456 0 C-N-CA 124.852 1.261 . . . . 61.35 110.775 -177.191 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HE1' ' HG ' ' A' ' 24' ' ' LEU . 3.4 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.499 0.185 . . . . 73.24 111.499 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.9 mt -87.43 140.36 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.252 0.621 . . . . 73.45 109.534 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 70' ' ' VAL . 59.2 tp -112.18 122.69 48.44 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.387 -0.597 . . . . 72.31 109.387 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -120.4 157.01 30.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.602 1.561 . . . . 75.3 110.363 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.13 144.7 30.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.78 -0.822 . . . . 72.12 108.78 165.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -82.28 108.0 15.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.972 0.509 . . . . 74.02 111.592 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -88.02 166.34 14.54 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.395 -0.965 . . . . 72.53 108.395 165.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.0 p 58.18 83.61 0.11 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.988 1.715 . . . . 54.41 110.801 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.87 28.68 0.41 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.878 1.271 . . . . 72.14 112.281 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.57 -54.56 34.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.961 0.904 . . . . 74.35 109.389 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -156.44 149.09 23.71 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.493 0.717 . . . . 74.31 109.584 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 m -109.31 125.2 52.07 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.596 -0.89 . . . . 74.14 108.596 168.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -108.21 86.55 2.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.033 0.444 . . . . 73.13 110.913 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG22 ' A' ' 45' ' ' VAL . 88.8 m -137.39 97.54 3.49 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.65 1.18 . . . . 64.34 108.733 167.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -73.62 -42.16 61.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.442 0.697 . . . . 65.25 110.549 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.5 133.52 10.12 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.62 -0.992 . . . . 62.1 110.62 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.55 132.92 61.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 CA-C-N 117.576 0.688 . . . . 71.14 109.519 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 56' ' ' VAL . 23.6 pt -131.7 115.48 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.382 1.073 . . . . 74.45 108.441 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -91.4 37.63 0.95 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.734 0.778 . . . . 73.45 110.446 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -70.08 134.4 48.17 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.593 -1.185 . . . . 64.14 108.137 170.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.73 112.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-O 121.455 0.645 . . . . 64.24 110.35 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 t -92.53 138.94 18.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.095 -1.076 . . . . 74.44 108.095 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -64.13 125.82 32.76 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.796 0.685 . . . . 71.42 112.226 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' HG ' ' HE1' ' A' ' 1' ' ' MET . 10.4 mp -61.68 -23.32 66.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.752 0.821 . . . . 75.01 111.616 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -64.26 -38.76 92.18 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.485 1.114 . . . . 64.03 110.395 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.5 pt -101.19 -12.41 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.271 -0.422 . . . . 74.44 111.934 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 23' ' ' GLY . 83.9 mt -67.02 113.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.417 -0.586 . . . . 63.4 109.417 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.2 -55.4 3.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.312 1.045 . . . . 74.03 110.809 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -142.23 149.29 39.43 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.568 0.747 . . . . 62.53 110.634 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 46' ' ' ILE . 62.2 mt -136.09 107.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.657 1.583 . . . . 65.22 106.864 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.66 121.93 41.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.264 0.626 . . . . 74.2 109.491 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.26 113.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.578 -0.527 . . . . 70.34 109.578 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 61.2 p -97.02 116.36 66.02 Favored Pre-proline 0 CA--C 1.57 1.75 0 C-N-CA 123.912 0.885 . . . . 73.51 110.028 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.73 148.9 29.3 Favored 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.233 2.622 . . . . 72.4 114.18 -172.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.16 -172.79 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.405 2.736 . . . . 72.23 113.941 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.74 -115.71 4.4 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.669 -0.696 . . . . 64.21 112.389 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.19 -31.18 58.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.821 0.448 . . . . 65.42 111.595 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.53 -69.08 1.43 Allowed Glycine 0 C--N 1.352 1.437 0 O-C-N 123.716 0.635 . . . . 74.22 111.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 3.5 m -105.46 153.37 39.81 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.657 0.783 . . . . 73.01 108.959 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.29 -28.73 47.13 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.188 1.926 . . . . 61.34 112.009 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -147.0 169.5 19.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.866 1.666 . . . . 72.2 107.438 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -74.27 114.71 12.94 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.424 -0.954 . . . . 71.35 108.424 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.79 157.75 30.34 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.036 -0.727 . . . . 73.11 109.036 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.0 t -131.17 111.58 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.073 -1.084 . . . . 75.33 108.073 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG22 ' SG ' ' A' ' 14' ' ' CYS . 58.6 t -91.05 108.54 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 109.054 -0.721 . . . . 72.22 109.054 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 30' ' ' ILE . 55.9 mt -100.38 123.11 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.944 -0.762 . . . . 63.23 108.944 177.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -92.36 133.49 35.81 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.801 -1.185 . . . . 72.24 107.801 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 p -93.99 168.27 11.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.229 -0.656 . . . . 73.14 109.229 169.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.29 -16.75 64.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.65 0.78 . . . . 72.24 111.168 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.1 mtm -80.38 -5.23 56.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.44 1.096 . . . . 74.11 110.766 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm 69.42 15.88 8.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.672 1.589 . . . . 73.02 112.038 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -81.71 122.48 27.71 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 108.57 -0.9 . . . . 53.12 108.57 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.6 t -85.12 100.92 8.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 107.918 -1.142 . . . . 65.12 107.918 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -101.31 118.23 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.669 -1.234 . . . . 72.2 107.669 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.58 134.18 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.841 -1.17 . . . . 65.35 107.841 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 18' ' ' ILE . 22.8 m -126.64 164.47 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.194 0.998 . . . . 70.31 108.756 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -83.64 158.88 62.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.299 -0.63 . . . . 72.33 109.299 170.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 -12.66 32.13 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.417 2.078 . . . . 74.42 112.274 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -83.95 -2.87 57.39 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.683 0.793 . . . . 73.22 111.932 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.9 121.06 12.56 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.866 0.466 . . . . 61.52 110.298 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -63.67 -46.76 84.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.46 1.104 . . . . 75.51 111.059 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.448 ' O ' HD13 ' A' ' 66' ' ' LEU . 57.5 p-90 -60.45 -36.75 78.98 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.843 -1.071 . . . . 75.05 110.772 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.9 tp -64.34 -39.55 94.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.877 0.871 . . . . 61.52 111.618 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -58.91 -36.49 74.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.122 0.569 . . . . 55.41 112.103 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -59.03 -44.45 91.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.858 -1.064 . . . . 72.34 109.901 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 62' ' ' TRP . 8.5 mp -68.01 -44.55 76.28 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.09 0.956 . . . . 74.13 110.618 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.68 -35.33 77.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.909 0.883 . . . . 54.23 110.834 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.82 -39.99 34.08 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.229 0.611 . . . . 72.35 111.321 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -73.79 -16.09 61.17 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.088 0.773 . . . . 74.52 113.088 -173.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 3' ' ' LEU . 35.2 m -86.68 -11.06 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 117.743 0.247 . . . . 75.42 111.654 175.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -93.32 -102.82 0.13 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.013 0.525 . . . . 71.41 112.094 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.0 m -97.78 4.2 49.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.876 0.87 . . . . 55.3 112.097 -168.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -54.88 126.06 22.77 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.681 0.792 . . . . 64.23 110.006 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 m -57.08 127.85 34.03 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.368 1.067 . . . . 75.01 111.642 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.97 164.5 15.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.078 -0.341 . . . . 54.34 110.078 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m 64.99 179.67 0.18 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.651 1.18 . . . . 62.22 111.885 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.6 t -164.51 -173.16 2.94 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.716 -0.846 . . . . 74.44 108.716 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.4 p -60.73 137.98 93.22 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.478 -0.773 . . . . 71.32 110.025 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.99 155.37 8.72 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.002 2.468 . . . . 71.32 113.708 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -62.06 140.52 58.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.023 0.929 . . . . 74.4 110.135 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 137.22 91.64 Favored Pre-proline 0 N--CA 1.485 1.281 0 O-C-N 123.74 0.65 . . . . 54.32 111.144 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.48 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.021 2.481 . . . . 74.1 113.146 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.5 p -163.23 128.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.188 0.995 . . . . 64.43 109.149 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 p -107.85 141.29 39.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.651 . . . . 65.3 109.332 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -67.64 122.55 18.29 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.83 0.852 . . . . 54.22 108.749 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -83.27 153.64 24.56 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.99 0.916 . . . . 75.33 111.48 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -73.86 -39.06 64.23 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.884 . . . . 70.14 109.678 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -172.56 102.56 0.15 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.036 0.934 . . . . 75.14 109.583 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 C-N-CA 123.397 0.679 . . . . 51.55 109.255 176.134 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 70' ' ' VAL . 41.0 tpp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.743 0.306 . . . . 75.03 110.718 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.43 134.91 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.531 0.732 . . . . 73.01 109.47 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.55 129.51 37.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.235 0.614 . . . . 72.31 109.76 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -115.41 152.82 32.18 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.683 1.193 . . . . 74.01 110.46 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.6 152.58 36.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 71.33 108.952 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -79.59 97.06 6.34 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 122.319 1.057 . . . . 75.35 110.289 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.83 -1.84 31.33 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.715 -1.129 . . . . 41.54 109.872 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -71.88 -63.36 1.15 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 75.34 109.22 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.7 t30 53.63 64.46 1.83 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.457 1.103 . . . . 74.14 111.425 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -133.26 -168.29 2.07 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.607 1.163 . . . . 64.42 108.943 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -61.18 86.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.059 0.933 . . . . 74.54 109.615 164.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.6 m -61.6 113.35 2.66 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.137 -1.392 . . . . 70.33 110.406 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -104.37 95.51 5.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.875 0.87 . . . . 60.53 110.188 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.526 ' SG ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -133.84 159.22 41.31 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.78 -1.193 . . . . 72.33 107.78 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.484 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 13.3 m -59.84 -12.44 7.5 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.543 1.312 . . . . 73.14 114.543 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.64 -104.7 3.19 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.612 -0.995 . . . . 60.25 110.612 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.5 t -129.06 135.18 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 117.617 0.709 . . . . 73.31 109.752 174.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.89 134.43 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 107.082 -1.451 . . . . 74.54 107.082 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.7 t -82.77 13.6 3.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.347 0.659 . . . . 54.44 112.699 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.3 p -83.08 123.47 29.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.964 0.506 . . . . 70.2 111.635 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.4 t -75.49 114.38 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.924 -1.139 . . . . 71.13 107.924 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 t -98.41 131.78 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.913 0.885 . . . . 63.5 109.528 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.57 137.26 27.13 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.958 0.786 . . . . 54.01 113.552 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 -31.27 72.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.189 0.995 . . . . 64.24 111.2 -171.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -63.49 -33.07 74.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.552 -1.203 . . . . 74.24 112.086 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.4 pt -99.8 -17.62 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 119.328 -0.368 . . . . 64.21 111.087 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.7 115.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.197 -0.668 . . . . 64.1 109.197 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -98.3 -53.45 3.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.818 0.847 . . . . 74.43 109.857 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -140.58 145.18 36.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.749 0.819 . . . . 73.41 110.601 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.9 107.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 73.44 109.183 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HG2' HG23 ' A' ' 33' ' ' THR . 7.2 tt0 -95.75 130.89 42.52 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.713 0.405 . . . . 45.51 111.003 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -86.76 114.33 25.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 108.684 -0.858 . . . . 72.21 108.684 171.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.608 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 p -117.69 82.42 16.21 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.844 0.857 . . . . 73.21 110.694 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -65.61 161.86 36.79 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.289 2.659 . . . . 74.43 113.091 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.78 175.93 10.44 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.821 2.347 . . . . 60.21 112.109 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.66 -114.66 2.8 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.692 -0.686 . . . . 60.15 112.34 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -69.21 -24.82 64.08 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.562 0.745 . . . . 73.42 112.174 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.68 -84.41 1.36 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.775 -0.53 . . . . 45.5 111.775 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.608 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.4 m -70.34 143.29 90.52 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.337 0.655 . . . . 24.13 110.898 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.47 -10.25 14.7 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.465 2.11 . . . . 74.11 112.899 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -151.0 160.36 43.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.34 110.817 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 m -79.03 116.09 19.12 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.888 -0.412 . . . . 71.33 109.888 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -132.14 149.39 52.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.641 0.776 . . . . 71.0 109.934 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.59 108.87 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.779 -1.563 . . . . 55.54 106.779 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG22 ' SG ' ' A' ' 14' ' ' CYS . 23.7 t -92.07 133.87 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 123.945 0.898 . . . . 73.33 108.929 -172.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.36 106.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.117 0.967 . . . . 74.3 108.638 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -81.59 124.3 29.41 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.834 -1.173 . . . . 75.31 107.834 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -91.92 169.4 10.7 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 123.641 0.588 . . . . 74.13 110.057 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.57 -13.62 61.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.994 0.918 . . . . 74.21 111.249 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.3 mtt -95.26 12.78 27.75 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.213 1.005 . . . . 73.55 110.838 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? 73.64 2.56 4.29 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.579 1.552 . . . . 74.43 113.759 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -71.26 124.36 24.33 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.214 0.461 . . . . 61.11 109.859 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.55 101.81 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.523 -1.288 . . . . 64.32 107.523 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.42 136.42 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.641 1.176 . . . . 75.54 108.006 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 15' ' ' SER . 11.3 m -126.06 127.82 46.43 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 71.41 108.32 -172.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.52 161.45 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 43.42 110.868 -168.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.62 144.03 36.86 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 123.944 0.898 . . . . 75.41 110.345 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.2 -6.95 20.0 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.756 2.304 . . . . 64.41 113.752 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -23.28 38.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.371 0.668 . . . . 64.13 110.752 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 120.8 8.06 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.638 0.775 . . . . 62.04 111.315 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -63.27 -47.36 82.7 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.195 1.398 . . . . 73.13 111.916 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -55.96 -39.87 72.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 75.45 110.116 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -72.34 -38.92 68.5 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 114.039 -1.437 . . . . 73.11 111.344 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -58.04 -42.62 85.77 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.515 0.726 . . . . 54.11 109.992 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.3 mtm105 -60.66 -36.46 78.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.303 -0.862 . . . . 72.25 110.884 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 mt -76.78 -39.73 50.59 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.619 0.768 . . . . 75.31 111.237 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.94 -35.55 81.53 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.4 0.68 . . . . 74.24 110.051 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -73.53 -47.5 40.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.15 -0.932 . . . . 73.23 109.615 175.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -63.25 -47.92 80.38 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.616 0.766 . . . . 74.2 111.932 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.453 HG12 ' SD ' ' A' ' 1' ' ' MET . 23.1 m -69.96 -22.27 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.882 0.473 . . . . 74.42 111.283 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -90.75 -30.79 16.84 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.781 0.832 . . . . 71.31 110.929 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 t -86.32 -74.53 0.42 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.802 0.841 . . . . 74.0 109.206 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -176.62 160.77 2.03 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.507 0.723 . . . . 74.51 110.933 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.2 p -109.66 -177.44 3.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.094 0.958 . . . . 54.03 109.514 170.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 pp -145.0 -178.9 6.28 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.403 0.681 . . . . 44.24 109.843 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -72.67 97.18 2.12 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.274 -0.639 . . . . 71.13 109.274 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 t -81.57 179.27 7.91 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.345 1.058 . . . . 75.41 110.319 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.6 p -65.19 147.69 98.4 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 118.634 -0.698 . . . . 60.33 110.52 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.48 108.72 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 124.074 3.183 . . . . 75.04 112.756 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.19 -178.34 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.649 1.18 . . . . 64.34 109.37 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.98 140.88 97.65 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 123.441 0.697 . . . . 44.31 111.058 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.61 146.5 19.88 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.635 2.89 . . . . 75.14 114.697 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.42 117.41 25.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.905 -1.146 . . . . 60.35 107.905 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.9 p -60.79 144.76 51.85 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.369 0.668 . . . . 64.2 110.244 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.23 87.97 0.18 Allowed 'General case' 0 C--N 1.349 0.575 0 CA-C-O 121.664 0.745 . . . . 55.31 110.394 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.97 160.45 14.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.866 -1.061 . . . . 70.21 108.802 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.04 115.87 8.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.012 -0.736 . . . . 64.23 109.012 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.89 -67.85 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.994 -0.743 . . . . 72.51 108.994 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 N-CA-C 108.313 -0.995 . . . . 75.05 108.313 175.067 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.019 0.438 . . . . 74.32 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' HG2' ' A' ' 29' ' ' ARG . 30.8 mt -120.24 132.19 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 43.23 108.047 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.8 tp -106.6 125.59 51.19 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.68 -0.859 . . . . 62.15 108.68 170.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -119.43 114.9 23.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.627 0.771 . . . . 73.03 109.598 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.88 121.11 27.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.676 -1.602 . . . . 61.32 106.676 161.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.47 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 2.0 p80 -80.11 100.02 8.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.695 0.759 . . . . 74.4 109.795 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -70.43 -38.65 74.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.222 -1.029 . . . . 70.1 108.222 168.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -68.64 93.39 0.51 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.537 -1.21 . . . . 74.51 110.269 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -82.03 66.15 7.47 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.838 0.827 . . . . 71.54 109.434 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -83.29 -177.96 6.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.059 -0.973 . . . . 64.34 108.848 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -71.95 94.92 1.51 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.078 -0.712 . . . . 53.22 109.078 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.0 m -67.04 100.45 0.75 Allowed 'General case' 0 C--N 1.353 0.723 0 CA-C-O 121.254 0.55 . . . . 64.53 109.679 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.57 87.75 3.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.244 1.018 . . . . 71.21 108.485 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.64 158.95 43.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.782 -1.192 . . . . 54.32 107.782 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.519 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 19.0 m -61.65 1.95 0.21 Allowed 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 114.389 1.255 . . . . 71.34 114.389 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 -93.82 1.75 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.508 -0.637 . . . . 74.12 111.508 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.91 132.5 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.993 -0.743 . . . . 70.23 108.993 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.4 mt -118.65 129.07 75.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.202 -1.777 . . . . 74.34 106.202 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 p -82.82 34.79 0.45 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.775 0.83 . . . . 70.02 112.315 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.4 p -110.23 133.74 52.93 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.793 0.837 . . . . 74.33 110.25 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.46 117.54 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 108.089 -1.078 . . . . 63.02 108.089 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.9 t -84.01 136.42 22.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 109.286 -0.635 . . . . 71.04 109.286 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -61.47 119.08 16.95 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.095 0.872 . . . . 54.24 113.048 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HG ' HD11 ' A' ' 66' ' ' LEU . 9.3 mp -62.68 -16.51 57.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.791 0.836 . . . . 74.03 112.102 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -84.51 -36.49 22.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.979 0.912 . . . . 71.21 110.789 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 pt -85.45 -15.72 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 119.592 -0.242 . . . . 71.14 111.364 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 23' ' ' GLY . 89.9 mt -68.94 131.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 63.45 110.858 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -122.75 -48.43 2.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.342 0.657 . . . . 60.22 111.202 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 19.1 mtp180 -126.04 129.03 48.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.841 0.457 . . . . 74.1 110.4 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.3 mt -122.12 107.68 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.066 1.346 . . . . 70.51 108.143 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -105.19 122.66 46.37 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.096 -0.705 . . . . 72.13 109.096 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.57 131.69 33.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.669 -0.863 . . . . 63.03 108.669 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.47 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 90.3 m -124.48 85.11 56.32 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.776 0.83 . . . . 71.44 110.759 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.5 145.58 71.21 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.258 1.972 . . . . 73.54 110.111 160.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.74 140.31 46.34 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.977 1.784 . . . . 71.52 112.217 -174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.49 -169.13 20.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.746 -0.542 . . . . 55.22 111.746 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -73.58 77.99 1.48 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.957 0.884 . . . . 71.22 110.583 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.45 -52.45 0.48 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.491 -1.231 . . . . 73.15 110.794 -173.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -101.67 113.05 65.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.334 0.654 . . . . 63.43 109.827 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.41 -16.21 9.56 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.621 2.214 . . . . 54.22 113.361 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -103.2 146.72 28.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.566 0.746 . . . . 73.2 110.798 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.3 m -89.5 112.07 23.14 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.678 -1.601 . . . . 71.22 106.678 160.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.63 170.61 21.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.537 0.735 . . . . 74.34 110.215 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -132.82 120.72 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 63.32 108.368 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.3 110.58 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.249 -0.649 . . . . 71.41 109.249 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.9 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 60.12 109.828 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 31.4 m-90 -91.74 117.42 29.74 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.545 -1.28 . . . . 74.21 107.545 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.8 p -89.27 172.99 8.65 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.847 0.356 . . . . 71.14 111.164 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.32 -16.46 61.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.313 1.445 . . . . 60.13 110.842 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.406 ' HB2' ' HD3' ' A' ' 52' ' ' LYS . 70.7 mtp -96.93 3.72 51.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.363 1.065 . . . . 71.05 110.649 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 66.41 26.57 10.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.573 1.549 . . . . 64.44 112.684 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HD3' ' HB2' ' A' ' 50' ' ' MET . 4.4 mptp? -83.74 124.12 30.56 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.827 -0.805 . . . . 72.21 108.827 169.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.1 t -90.56 105.74 16.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.265 -1.013 . . . . 74.04 108.265 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.25 126.7 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.984 -0.746 . . . . 72.23 108.984 -176.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 15' ' ' SER . 2.4 m -108.92 120.96 44.06 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 108.028 -1.101 . . . . 65.44 108.028 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.03 166.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.793 0.837 . . . . 60.42 109.522 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.74 146.15 72.14 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-O 119.391 -0.337 . . . . 70.32 110.404 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -51.75 -34.78 55.73 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.232 2.622 . . . . 62.04 113.72 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.7 11.28 11.28 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.65 0.982 . . . . 75.42 113.65 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.93 123.56 19.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.149 0.431 . . . . 72.24 109.99 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -65.7 -45.63 82.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.192 0.997 . . . . 51.42 112.414 -170.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -61.88 -33.69 74.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.191 0.596 . . . . 53.22 110.668 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.92 -33.98 74.64 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.138 -0.937 . . . . 73.34 110.676 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -59.46 -33.33 71.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.495 0.718 . . . . 74.23 112.235 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -64.33 -37.23 86.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.66 0.784 . . . . 72.22 110.392 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 24' ' ' LEU . 85.0 mt -79.0 -36.05 41.89 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.135 0.974 . . . . 74.41 111.158 -178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.3 -33.01 74.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.76 0.824 . . . . 74.0 109.658 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.74 -51.05 45.57 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.61 -0.885 . . . . 63.44 108.61 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -61.71 -50.03 74.06 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.23 0.956 . . . . 64.13 112.438 -171.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.66 -32.18 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.811 0.445 . . . . 72.41 111.396 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.03 177.88 7.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.898 0.879 . . . . 75.34 110.579 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.0 t 59.11 26.94 15.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.71 1.204 . . . . 72.21 110.65 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? 64.37 112.58 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.395 1.478 . . . . 71.0 110.134 -166.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.6 t -67.24 105.5 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.064 0.459 . . . . 53.13 109.903 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.2 tp -106.45 139.81 40.34 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.486 1.114 . . . . 74.25 108.832 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -74.31 132.87 42.46 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.341 -0.614 . . . . 53.33 109.341 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 11.5 38.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.96 0.904 . . . . 73.01 110.949 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 p -61.77 126.6 87.4 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.265 0.626 . . . . 72.35 109.712 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.0 -163.52 0.22 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.805 2.337 . . . . 71.33 112.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -142.9 157.05 44.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.833 0.853 . . . . 73.42 109.685 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.96 128.23 28.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.591 0.756 . . . . 71.54 109.537 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -80.87 177.34 8.08 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.87 2.38 . . . . 75.43 110.603 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.67 125.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 108.849 -0.797 . . . . 74.24 108.849 173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.4 p -119.6 79.8 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.788 0.804 . . . . 64.15 110.401 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.57 90.43 3.92 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.218 -1.03 . . . . 70.02 108.218 169.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -78.49 83.6 4.68 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.59 -1.186 . . . . 64.25 109.042 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -78.64 128.93 34.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 70.11 109.955 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.98 171.1 7.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.033 0.933 . . . . 73.22 109.646 172.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 109.385 -0.598 . . . . 65.22 109.385 174.677 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtp . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.266 -0.642 . . . . 54.05 109.266 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' ARG . 78.1 mt -107.05 118.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.577 -0.898 . . . . 74.45 108.577 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.2 tp -79.32 116.61 19.67 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.262 -1.014 . . . . 63.34 108.262 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -115.65 131.36 56.96 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.223 -1.028 . . . . 74.25 108.223 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.91 124.37 46.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.249 -1.019 . . . . 74.45 108.249 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 4.4 p80 -82.79 117.48 22.72 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.346 0.593 . . . . 75.13 109.864 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.14 -18.91 14.34 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.223 1.009 . . . . 71.15 109.337 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.2 m -86.66 135.84 33.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.547 1.139 . . . . 72.41 109.741 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -71.9 138.7 48.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.375 0.67 . . . . 74.31 109.933 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -158.22 171.69 19.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.859 0.863 . . . . 70.22 109.681 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -69.76 91.3 0.62 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.835 -0.62 . . . . 73.41 109.474 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.3 m -66.04 112.14 3.71 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.627 -0.879 . . . . 51.23 108.627 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' NE ' HG11 ' A' ' 53' ' ' VAL . 13.5 ptm180 -112.56 89.92 3.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.016 0.913 . . . . 74.31 112.121 -161.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.0 t -132.11 95.18 3.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.792 -1.095 . . . . 74.33 108.075 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t -99.12 8.17 45.15 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.808 0.843 . . . . 64.13 110.231 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.62 139.2 2.58 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.41 -1.076 . . . . 43.3 110.41 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -104.23 134.18 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.249 -0.648 . . . . 62.32 109.249 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.9 mt -108.06 124.68 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.374 -0.973 . . . . 72.25 108.374 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.7 m -85.23 27.56 0.79 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.855 0.862 . . . . 53.1 112.529 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.4 p -88.91 129.28 35.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.67 0.788 . . . . 70.14 109.798 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.8 111.17 8.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.127 -1.434 . . . . 71.02 107.127 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.61 131.5 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.898 -0.779 . . . . 64.13 108.898 -176.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.0 131.76 39.68 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.548 -0.584 . . . . 54.11 112.62 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -57.79 -30.51 65.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.922 0.889 . . . . 64.2 112.427 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.6 -40.27 96.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.792 0.837 . . . . 51.34 110.88 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 pt -98.05 -12.56 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 116.21 -0.45 . . . . 70.31 111.333 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 107.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.191 0 N-CA-C 107.884 -1.154 . . . . 73.51 107.884 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -97.7 -46.97 5.79 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.258 0.623 . . . . 63.45 110.267 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HD3' ' HB ' ' A' ' 2' ' ' ILE . 7.3 tpp180 -142.67 125.4 15.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.746 0.819 . . . . 72.52 109.55 -174.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.23 105.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.776 -1.194 . . . . 72.13 107.776 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -98.28 119.45 36.98 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.137 -0.32 . . . . 73.12 110.137 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 127.31 40.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 107.897 -1.149 . . . . 72.11 107.897 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.59 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 67.6 m -124.75 93.53 45.93 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.432 -0.804 . . . . 65.35 110.291 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.57 154.65 70.93 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.136 2.557 . . . . 75.34 112.124 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -74.55 166.34 29.62 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.886 2.39 . . . . 72.31 112.697 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.6 -168.12 39.5 Favored Glycine 0 N--CA 1.466 0.674 0 CA-C-N 115.53 -0.759 . . . . 44.21 111.397 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.96 -28.05 68.7 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.251 0.621 . . . . 72.11 110.303 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.74 -67.39 1.39 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.812 -0.631 . . . . 73.3 112.305 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.0 m -71.92 117.77 60.93 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.747 0.419 . . . . 72.43 111.18 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.44 -16.63 21.62 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.291 1.994 . . . . 72.42 113.005 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -149.52 170.1 19.4 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.224 1.01 . . . . 61.5 110.274 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.6 m -86.27 126.07 34.04 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.171 -1.048 . . . . 53.2 108.171 166.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.59 ' HG3' ' HB ' ' A' ' 33' ' ' THR . 5.4 pt-20 -148.63 157.48 43.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.211 1.004 . . . . 34.4 109.308 -171.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -130.81 110.5 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.908 -1.145 . . . . 74.01 107.908 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -97.94 109.51 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 109.894 -0.41 . . . . 63.53 109.894 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.89 118.42 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.629 0.772 . . . . 63.11 109.768 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -93.1 135.77 33.98 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.033 -0.728 . . . . 72.13 109.033 167.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.5 p -87.55 170.05 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.357 0.41 . . . . 53.32 110.149 170.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -63.36 -27.55 69.39 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.225 0.61 . . . . 54.33 111.18 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.6 mtm -80.1 1.79 26.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.546 1.138 . . . . 75.53 111.543 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttm 66.74 31.5 7.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.08 1.752 . . . . 73.41 112.406 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.25 123.31 28.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.342 -0.984 . . . . 73.13 108.342 170.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG11 ' NE ' ' A' ' 13' ' ' ARG . 21.5 t -82.99 105.33 12.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 124.64 1.213 . . . . 74.13 108.67 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.75 136.12 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.967 -1.123 . . . . 71.21 107.967 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.53 145.73 35.82 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.993 -0.743 . . . . 62.25 108.993 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.44 155.92 13.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.162 1.385 . . . . 64.52 108.221 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -92.39 148.2 35.97 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 122.869 0.468 . . . . 65.11 110.319 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.47 -5.86 17.04 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.664 2.243 . . . . 73.3 112.813 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -79.24 -23.49 43.67 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.922 0.889 . . . . 72.31 111.144 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.17 119.86 7.61 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.405 0.682 . . . . 52.22 110.209 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -65.03 -44.0 90.54 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.659 0.783 . . . . 62.23 112.052 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -59.18 -38.09 78.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.541 0.737 . . . . 74.21 110.217 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.8 tp -72.86 -37.3 67.41 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.95 -1.023 . . . . 73.42 110.678 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -61.12 -35.56 77.38 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.407 0.683 . . . . 73.1 109.363 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -60.44 -39.79 88.78 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.778 0.831 . . . . 74.41 110.732 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.09 -51.24 33.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.279 -0.873 . . . . 64.43 109.507 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -24.2 66.24 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.191 0.997 . . . . 72.45 111.525 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -76.95 -54.39 6.63 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.739 1.216 . . . . 61.34 110.419 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.404 ' NE2' ' HB3' ' A' ' 75' ' ' LEU . 50.9 t-80 -84.99 -20.11 31.02 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.073 0.768 . . . . 70.44 113.073 -167.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.5 m -65.91 -30.61 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.084 0.402 . . . . 73.53 110.687 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -64.05 152.07 41.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.611 0.765 . . . . 73.14 109.639 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -50.32 89.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.585 1.154 . . . . 63.44 112.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -132.31 175.01 9.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.735 1.214 . . . . 73.32 110.084 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -102.39 165.52 11.07 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.304 -0.862 . . . . 60.25 109.798 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HB3' ' NE2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -163.97 152.58 13.41 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.923 0.889 . . . . 74.12 109.606 175.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 p -101.26 136.35 41.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.238 -1.023 . . . . 75.43 108.238 168.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 p -76.39 148.8 37.11 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.83 -0.433 . . . . 52.35 109.83 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 p -103.6 112.34 65.57 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.924 0.89 . . . . 74.3 110.089 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.49 125.39 4.42 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.926 2.417 . . . . 60.4 112.136 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.93 150.87 35.92 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.909 0.484 . . . . 55.05 110.011 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.76 107.84 4.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.459 -0.941 . . . . 41.51 108.459 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.97 130.16 22.35 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.182 1.921 . . . . 63.23 112.661 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -61.6 126.63 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.251 0.548 . . . . 72.14 110.242 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.5 m -103.34 64.99 0.84 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.824 -0.806 . . . . 53.25 108.824 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -105.04 115.88 31.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.123 -0.944 . . . . 65.33 108.603 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -83.06 128.09 34.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.974 -0.75 . . . . 64.43 108.974 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -74.54 90.73 2.25 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.628 0.371 . . . . 64.55 110.167 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.94 20.86 6.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.064 1.346 . . . . 61.21 113.798 171.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 124.744 1.217 . . . . 73.12 112.276 177.962 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.824 -0.435 . . . . 74.33 109.824 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 41.4 mt -107.36 132.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.176 0.99 . . . . 61.32 108.412 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.49 108.75 20.34 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.222 -0.659 . . . . 55.51 109.222 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -81.89 140.83 33.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.16 0.584 . . . . 73.14 109.538 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.42 ' HB1' ' HE2' ' A' ' 7' ' ' TYR . . . -118.29 117.4 29.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.034 0.934 . . . . 75.34 108.744 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.465 ' HE1' ' HB2' ' A' ' 10' ' ' LEU . 52.4 t60 -95.91 97.89 9.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.317 0.647 . . . . 74.22 110.477 -174.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' A' ' 5' ' ' ALA . 96.4 m-85 -121.4 -2.6 9.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.216 1.006 . . . . 73.2 110.918 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.4 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 38.5 p -86.98 133.35 33.59 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.863 0.865 . . . . 73.21 109.831 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -68.6 86.27 0.31 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.309 0.643 . . . . 62.24 110.521 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 6' ' ' HIS . 54.3 mt -122.34 172.65 8.16 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.375 1.07 . . . . 54.45 108.87 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -92.84 97.88 11.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.613 0.765 . . . . 74.41 109.102 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.2 m -73.65 106.16 5.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.145 -0.687 . . . . 71.2 109.145 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -99.53 95.84 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.008 0.432 . . . . 64.15 110.942 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 45' ' ' VAL . 86.3 m -130.06 115.67 17.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.866 0.866 . . . . 74.22 109.694 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -71.14 87.6 0.79 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.351 0.66 . . . . 72.22 110.282 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.42 -155.82 52.6 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.504 -0.771 . . . . 45.4 112.537 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 136.61 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.938 -0.764 . . . . 75.44 108.938 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.68 114.64 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.024 -1.102 . . . . 74.43 108.024 -175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 t -89.07 29.28 1.07 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.854 0.861 . . . . 53.15 111.72 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -81.75 123.72 29.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.111 0.564 . . . . 72.03 109.663 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.1 109.81 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 107.963 -1.125 . . . . 61.44 107.963 168.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.15 134.64 27.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 108.194 -1.039 . . . . 71.13 108.194 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -59.21 119.18 16.88 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.832 0.708 . . . . 61.13 112.693 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' HD21 ' A' ' 66' ' ' LEU . 9.2 mp -58.49 -30.07 66.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.246 0.618 . . . . 72.53 111.181 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -69.21 -34.09 74.34 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.609 0.763 . . . . 61.34 112.226 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.0 pt -95.05 -8.0 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 119.301 -0.38 . . . . 74.44 111.843 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.2 mt -70.27 130.46 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.149 -0.686 . . . . 75.33 109.149 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.09 -53.64 2.66 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.925 -0.58 . . . . 54.43 109.621 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.442 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 70.4 mtt180 -135.21 147.89 49.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.679 0.791 . . . . 70.43 110.048 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -138.98 126.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.708 1.203 . . . . 64.11 108.726 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 47.1 tt0 -110.19 125.77 53.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.279 0.632 . . . . 74.4 109.637 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.55 121.97 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.318 -0.623 . . . . 54.12 109.318 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.9 m -113.98 102.12 54.54 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.091 0.956 . . . . 72.23 109.473 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.82 160.34 33.59 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.758 2.972 . . . . 70.11 112.905 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.41 -11.6 18.96 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.72 2.28 . . . . 54.53 113.29 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.97 159.73 20.39 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.396 -1.082 . . . . 74.3 110.396 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.42 77.11 0.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.415 1.086 . . . . 65.11 110.589 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . 144.83 -93.53 0.17 Allowed Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.592 -0.731 . . . . 71.13 111.557 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -129.81 145.02 55.35 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.949 0.9 . . . . 63.22 109.732 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.72 -24.46 75.71 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.874 2.383 . . . . 64.32 114.692 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm -102.55 153.78 19.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.016 0.526 . . . . 74.31 110.692 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.5 p -82.14 114.04 20.4 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.612 -0.885 . . . . 74.13 108.612 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -133.95 135.74 43.73 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.683 0.793 . . . . 72.44 109.92 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 67.9 t -118.39 103.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.916 -0.772 . . . . 75.21 108.916 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG22 ' SG ' ' A' ' 14' ' ' CYS . 36.6 t -94.57 107.23 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.837 -0.801 . . . . 71.33 108.837 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.67 134.56 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.735 0.814 . . . . 73.2 109.608 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -107.37 132.43 53.16 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.921 -1.14 . . . . 75.23 107.921 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -80.78 177.77 8.82 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.49 -0.559 . . . . 71.23 109.49 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -68.03 -30.27 69.46 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.688 0.395 . . . . 53.11 110.945 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 50' ' ' MET . 3.1 mpp? -81.08 2.69 26.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.854 0.862 . . . . 72.01 110.895 174.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt 72.91 25.04 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.769 1.628 . . . . 74.12 112.933 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -77.75 125.77 29.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.616 -0.513 . . . . 54.12 109.616 173.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.03 112.48 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.401 1.08 . . . . 75.52 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.35 120.16 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.442 -1.318 . . . . 75.41 107.442 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.3 m -104.89 116.54 32.15 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.096 -1.076 . . . . 72.14 108.096 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 m -109.97 164.32 6.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 C-N-CA 124.201 1.001 . . . . 74.52 109.912 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.82 146.18 68.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 116.076 -0.511 . . . . 73.15 109.816 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.68 -29.6 69.41 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.329 2.019 . . . . 64.44 112.503 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -81.2 9.52 6.78 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 112.461 0.541 . . . . 74.42 112.461 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.66 32.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.898 0.479 . . . . 65.12 110.022 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -66.57 -42.23 87.35 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.203 1.401 . . . . 73.41 111.703 -166.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -68.65 -37.72 79.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.612 1.165 . . . . 71.45 111.013 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.5 -29.46 70.73 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.717 1.207 . . . . 72.1 111.345 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 90.9 mm-40 -54.77 -38.38 67.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.987 0.915 . . . . 72.41 112.32 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.23 -41.54 93.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.649 0.779 . . . . 64.25 110.337 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.439 HD21 ' HG ' ' A' ' 24' ' ' LEU . 63.8 mt -70.51 -37.71 74.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.083 -0.962 . . . . 70.32 110.651 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.36 -30.65 71.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.26 0.624 . . . . 74.33 111.383 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 9.0 mmt180 -87.31 -29.52 21.54 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.24 0.216 . . . . 64.32 110.673 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -73.31 -32.88 64.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.872 0.469 . . . . 74.11 112.188 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.52 -4.5 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.631 0.372 . . . . 74.45 111.899 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.87 -160.3 0.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.02 1.328 . . . . 73.31 110.358 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -68.58 79.67 0.28 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.426 0.69 . . . . 64.33 110.238 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -153.77 120.11 5.48 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.122 0.969 . . . . 73.54 108.649 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.0 t -78.75 -179.68 6.67 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.271 1.028 . . . . 73.51 110.867 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 pp -138.15 175.29 9.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.232 1.013 . . . . 71.24 109.309 174.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.2 p -118.74 129.79 55.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.994 -0.743 . . . . 74.54 108.994 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.7 p -67.65 122.78 18.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.062 0.545 . . . . 74.11 109.868 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -75.36 147.4 82.47 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.037 0.935 . . . . 72.0 110.604 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.46 82.33 1.41 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.532 2.155 . . . . 54.21 111.338 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -133.8 176.29 8.7 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 62.44 109.815 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.96 96.26 2.31 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.557 -1.275 . . . . 73.42 107.557 164.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.2 169.58 17.87 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.563 2.175 . . . . 72.44 113.391 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.2 t -76.27 135.53 26.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.801 -1.185 . . . . 72.24 107.801 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -55.35 106.37 0.23 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.665 0.786 . . . . 73.03 111.221 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -86.71 104.57 16.22 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.192 -0.67 . . . . 75.12 109.192 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -82.74 96.53 8.2 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.973 -1.121 . . . . 75.15 107.973 175.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -139.37 110.55 6.92 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.435 -1.32 . . . . 72.23 107.435 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.59 -169.78 2.17 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.343 1.057 . . . . 73.23 109.152 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.364 0 C-N-CA 123.134 0.574 . . . . 61.42 110.614 178.851 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.082 -0.34 . . . . 73.42 110.082 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.13 115.73 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.456 -0.942 . . . . 70.44 108.456 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 62.3 tp -79.24 121.25 24.83 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.349 -0.611 . . . . 65.11 109.349 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.13 139.55 51.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.861 0.864 . . . . 75.2 110.124 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.67 110.36 21.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.426 -1.324 . . . . 75.12 107.426 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -82.11 132.5 35.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.66 -0.496 . . . . 64.13 109.66 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.2 163.45 8.21 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.211 1.004 . . . . 74.32 109.838 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -56.94 148.71 20.43 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 113.24 0.83 . . . . 70.3 113.24 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.699 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 29.0 m-80 -142.39 170.46 15.67 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.917 1.287 . . . . 61.11 109.658 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.5 mt -105.79 -15.52 14.92 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.306 -0.861 . . . . 72.43 111.299 166.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -136.24 110.7 8.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 62.21 109.865 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.4 m -106.63 110.94 23.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.823 0.849 . . . . 42.52 109.581 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -80.81 91.05 5.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.291 0.636 . . . . 73.03 110.402 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.65 147.43 48.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.498 0.719 . . . . 72.21 110.608 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -87.12 0.73 54.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.146 0.978 . . . . 74.13 111.957 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.55 -92.67 1.63 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.267 -0.733 . . . . 12.14 111.267 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.12 132.26 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.532 0.733 . . . . 42.21 109.617 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mt -129.4 112.2 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 105.802 -1.925 . . . . 61.11 105.802 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 t -85.45 27.87 0.79 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.843 0.682 . . . . 55.51 112.843 -171.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.2 p -79.02 119.46 22.19 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.401 -0.592 . . . . 74.51 109.401 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.86 112.43 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 73.02 108.384 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.69 140.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.136 0.574 . . . . 72.43 109.923 -173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -66.4 127.76 29.59 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.597 0.561 . . . . 50.33 112.875 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.88 -32.59 70.86 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.284 1.034 . . . . 71.44 111.982 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -74.29 -22.62 59.21 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.905 0.882 . . . . 73.52 112.311 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 pt -103.98 -12.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.616 0.366 . . . . 65.44 111.234 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 23' ' ' GLY . 75.6 mt -68.5 115.26 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.772 -0.825 . . . . 74.42 108.772 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 -52.29 5.51 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.054 0.942 . . . . 70.31 109.968 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -141.01 142.08 34.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.544 0.738 . . . . 65.43 110.459 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.62 105.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.08 -1.452 . . . . 71.43 107.08 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' HB3' ' HZ3' ' A' ' 47' ' ' TRP . 7.5 tt0 -111.77 122.2 47.16 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.483 0.713 . . . . 72.03 110.096 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.31 123.76 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.688 -0.856 . . . . 75.02 108.688 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.786 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 33.3 p -103.75 121.83 46.76 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 108.906 -0.776 . . . . 72.01 108.906 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.09 154.8 14.71 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.052 2.501 . . . . 74.14 113.931 -171.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.71 169.0 17.2 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.464 2.11 . . . . 72.41 112.573 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.26 -102.66 1.2 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.677 -0.569 . . . . 63.42 111.677 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -81.37 87.42 6.16 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.022 -0.733 . . . . 74.11 109.022 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.699 ' HA2' ' H ' ' A' ' 9' ' ' ASN . . . 150.23 -73.71 0.28 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.564 -0.744 . . . . 50.32 111.35 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.786 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 61.2 m -127.13 155.06 76.66 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.732 0.813 . . . . 74.24 109.711 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.93 -18.17 52.08 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.413 2.075 . . . . 63.51 113.44 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -150.81 171.18 17.61 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.392 0.677 . . . . 71.12 110.495 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 m -79.43 115.56 19.14 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 64.32 109.116 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 23.3 mt-10 -127.49 158.44 37.39 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.626 0.77 . . . . 75.25 108.976 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.0 106.22 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.734 -0.839 . . . . 73.11 108.734 175.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.31 111.49 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.51 0.724 . . . . 74.44 109.871 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.455 HG23 HG23 ' A' ' 27' ' ' ILE . 56.9 mt -95.98 125.25 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.021 0.929 . . . . 73.04 109.836 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.41 ' HZ3' ' HB3' ' A' ' 31' ' ' GLN . 29.8 m-90 -98.63 140.1 33.36 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.902 -0.777 . . . . 73.12 108.902 167.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.0 p -88.64 171.18 10.21 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.847 -0.427 . . . . 63.34 109.847 169.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -71.59 -18.57 62.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.306 0.642 . . . . 73.32 111.442 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.1 mtm -87.42 6.1 35.54 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.903 0.881 . . . . 75.42 110.766 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 63.0 43.74 6.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.183 1.393 . . . . 72.03 112.893 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -91.43 122.88 34.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.662 -1.236 . . . . 64.13 107.662 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.39 111.4 18.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 O-C-N 124.496 1.123 . . . . 72.4 108.255 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.67 145.34 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.853 -1.166 . . . . 64.52 107.853 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.7 m -116.77 150.01 38.99 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.101 -0.703 . . . . 72.01 109.101 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.8 m -141.87 158.57 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.878 0.871 . . . . 71.34 109.615 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -73.59 137.21 77.44 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.808 0.843 . . . . 74.22 110.78 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.34 -16.83 44.2 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.878 2.385 . . . . 73.43 113.789 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.09 2.1 56.59 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.292 0.637 . . . . 75.33 112.444 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 123.82 20.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.938 0.495 . . . . 63.22 109.993 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.08 -33.37 67.86 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.446 0.698 . . . . 74.01 111.88 -172.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.448 ' O ' HD13 ' A' ' 66' ' ' LEU . 54.0 p-90 -63.17 -42.48 99.41 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.247 -0.649 . . . . 73.41 109.247 174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.075 0.95 . . . . 63.41 110.661 176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -60.48 -40.19 90.39 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.648 0.779 . . . . 64.03 111.978 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.53 -45.55 77.15 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.825 0.703 . . . . 74.54 109.983 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 70' ' ' VAL . 10.2 mp -66.65 -48.3 69.83 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.306 -0.861 . . . . 64.54 110.994 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.19 -33.68 69.52 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.676 0.791 . . . . 64.44 111.712 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -84.16 -33.68 24.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.97 0.508 . . . . 75.31 111.385 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -86.38 -15.88 39.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.637 0.775 . . . . 65.44 112.72 -173.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 66' ' ' LEU . 27.1 m -70.5 -11.55 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 112.205 0.446 . . . . 64.22 112.205 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.22 -163.05 0.06 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.472 1.109 . . . . 73.55 111.0 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.1 p -78.69 20.25 0.46 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.358 0.663 . . . . 54.54 112.394 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -63.56 107.53 1.16 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.128 0.971 . . . . 74.44 109.861 173.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.2 p -78.92 141.03 37.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.526 0.731 . . . . 75.15 111.448 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.99 61.48 6.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.047 0.939 . . . . 74.1 109.467 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -68.48 -44.02 75.69 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.291 0.636 . . . . 73.24 110.44 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 p -72.46 87.49 1.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.764 0.826 . . . . 72.4 110.286 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.7 p -119.96 143.47 35.39 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.87 0.868 . . . . 71.54 109.372 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 175.66 10.97 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.528 2.152 . . . . 73.34 112.522 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -120.91 161.14 22.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.983 0.913 . . . . 75.15 110.309 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.67 98.02 49.84 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.115 0.966 . . . . 71.24 109.392 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 129.17 12.45 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.548 2.165 . . . . 62.23 113.06 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.62 128.02 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.251 0.548 . . . . 71.02 110.196 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 t -128.94 128.69 44.27 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.179 0.992 . . . . 54.12 108.58 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.04 149.32 45.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.556 0.743 . . . . 61.23 111.499 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -126.71 125.98 42.71 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.585 -1.265 . . . . 72.35 107.585 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.78 85.92 4.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.228 0.611 . . . . 74.14 109.469 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.85 119.82 9.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.374 1.07 . . . . 63.11 109.336 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.587 0.755 . . . . 38.12 109.583 -178.075 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 tpp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.358 -0.608 . . . . 45.45 109.358 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.46 109.45 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.798 -0.816 . . . . 74.13 108.798 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.8 tp -86.97 118.08 26.11 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.002 -0.74 . . . . 72.1 109.002 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -119.37 156.49 30.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.092 0.957 . . . . 74.21 110.145 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.44 150.38 39.66 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.711 0.804 . . . . 53.3 109.06 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -79.75 97.93 6.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.03 0.532 . . . . 72.2 110.762 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -103.38 -60.92 1.49 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.404 0.681 . . . . 64.0 110.237 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.1 p -122.63 120.97 35.29 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.232 0.539 . . . . 62.34 111.018 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -172.6 155.69 3.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.608 1.563 . . . . 74.22 106.913 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.52 -60.58 2.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.487 -0.931 . . . . 75.42 108.487 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -145.68 140.4 27.24 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.417 -0.811 . . . . 74.5 110.058 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.47 103.95 11.56 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.7 -1.222 . . . . 51.51 107.7 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -83.85 87.5 7.09 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.104 -0.498 . . . . 64.21 111.829 -168.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' HG22 ' A' ' 45' ' ' VAL . 70.8 m -136.81 150.74 48.51 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.37 1.068 . . . . 72.13 108.619 167.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 t -119.47 20.24 12.49 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.758 0.823 . . . . 74.24 110.634 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.74 172.05 12.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.729 -0.549 . . . . 23.32 111.729 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.67 134.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.745 0.307 . . . . 64.54 110.228 -174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.5 120.79 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.315 -0.994 . . . . 73.33 108.315 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 m -87.78 57.88 4.58 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.506 0.67 . . . . 72.52 110.683 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -116.17 131.35 56.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.485 -0.779 . . . . 73.44 109.325 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.93 124.66 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 123.749 0.656 . . . . 75.12 109.397 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.85 127.06 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.677 -0.861 . . . . 71.12 108.677 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -65.2 135.63 37.01 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.778 0.674 . . . . 73.01 113.483 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HG ' HD11 ' A' ' 66' ' ' LEU . 7.6 mp -64.76 -27.32 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.084 0.554 . . . . 75.33 110.355 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -72.7 -20.1 61.28 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.685 -1.143 . . . . 74.54 112.164 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 pt -105.45 -24.31 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 119.198 -0.43 . . . . 74.12 111.951 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 23' ' ' GLY . 88.3 mt -61.09 128.07 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.256 0.622 . . . . 70.3 111.125 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.49 -44.43 4.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.813 0.845 . . . . 75.53 111.371 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -148.37 133.79 18.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.171 0.588 . . . . 74.54 110.084 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.09 106.68 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.017 -1.105 . . . . 61.52 108.017 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.87 126.69 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.862 -0.792 . . . . 74.03 108.862 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -86.15 123.8 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.96 -0.755 . . . . 75.25 108.96 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.647 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 32.9 p -117.12 89.86 31.72 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.96 0.904 . . . . 73.14 110.771 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.66 150.01 39.26 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.438 2.759 . . . . 51.51 111.948 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.02 158.26 52.79 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.085 2.524 . . . . 72.14 113.475 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.49 -136.57 5.16 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.991 -0.844 . . . . 52.54 110.991 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -86.89 73.72 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.367 0.667 . . . . 63.4 109.3 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.32 -63.12 0.32 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.365 -0.694 . . . . 54.25 111.365 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 67.8 m -80.84 115.69 57.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.998 -0.741 . . . . 72.43 108.998 176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.23 -41.97 68.5 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.64 2.227 . . . . 75.44 113.102 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -149.22 172.9 14.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.673 -0.694 . . . . 71.35 111.024 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -70.3 110.46 5.27 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.658 -0.701 . . . . 61.35 109.309 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 41' ' ' LYS . 47.6 mt-10 -142.27 166.36 24.89 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.365 0.666 . . . . 71.14 109.555 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.92 111.02 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.922 -1.14 . . . . 64.31 107.922 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.599 HG22 ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -92.46 120.14 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 122.858 0.463 . . . . 62.41 109.776 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.79 120.62 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.926 0.89 . . . . 74.51 109.714 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -97.21 130.41 44.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.58 -1.267 . . . . 75.42 107.58 168.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.0 p -89.9 168.9 11.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.191 -0.67 . . . . 72.12 109.191 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -68.87 -23.53 64.23 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.915 0.388 . . . . 74.32 110.504 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.3 mtm -75.43 -4.88 42.07 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.306 1.043 . . . . 63.34 111.344 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 74.71 16.64 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 125.777 1.631 . . . . 71.05 112.512 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 129.03 34.72 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.817 0.847 . . . . 74.3 109.265 172.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.67 108.77 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.554 1.141 . . . . 74.14 109.671 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.07 120.24 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.14 0.976 . . . . 72.01 108.468 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 63.8 m -105.07 119.54 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.599 -1.26 . . . . 73.5 107.599 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.8 165.31 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.894 0.878 . . . . 55.31 110.459 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -83.33 145.55 48.79 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.713 0.805 . . . . 72.3 110.337 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.39 -31.94 93.32 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.373 2.716 . . . . 73.31 113.923 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -86.7 9.79 17.73 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.233 0.613 . . . . 74.45 111.792 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.93 129.43 41.39 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 122.895 0.478 . . . . 63.34 109.983 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -58.36 -51.2 70.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.72 1.208 . . . . 74.22 112.187 -168.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -71.86 -29.77 64.73 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.325 1.05 . . . . 72.41 110.437 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.21 -36.73 85.03 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 123.646 0.778 . . . . 61.31 110.787 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -57.18 -39.27 74.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.083 0.553 . . . . 74.03 111.673 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -55.2 -45.52 75.86 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.245 0.966 . . . . 73.22 109.328 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD11 ' HG ' ' A' ' 24' ' ' LEU . 4.3 mm? -66.17 -51.09 61.12 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.311 -0.859 . . . . 43.14 110.978 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.31 -36.0 68.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.783 0.833 . . . . 75.24 111.888 -172.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -84.71 -43.49 14.27 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 122.905 0.128 . . . . 71.04 111.161 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -67.89 -35.23 78.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.638 0.607 . . . . 71.43 112.638 -170.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.2 m -63.05 -30.08 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.011 0.525 . . . . 65.13 111.162 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.6 -73.79 0.31 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.717 -0.845 . . . . 74.34 108.717 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.7 t 179.02 152.28 0.35 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.02 1.328 . . . . 73.13 109.18 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -167.77 169.17 11.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.969 0.907 . . . . 72.53 110.213 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 t -60.66 149.72 34.31 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.395 0.678 . . . . 71.11 109.891 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -50.81 109.19 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.369 1.068 . . . . 71.1 111.152 -170.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 t -121.21 78.77 1.45 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.199 0.999 . . . . 74.44 108.7 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.2 m -141.33 148.06 39.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.04 -0.982 . . . . 71.43 108.956 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.8 p -122.83 151.13 60.3 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.679 0.792 . . . . 64.43 110.061 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.3 138.53 66.77 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.222 1.948 . . . . 72.43 111.517 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 168.69 10.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.562 0.745 . . . . 63.11 111.576 -173.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.03 95.35 34.34 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.164 0.985 . . . . 65.34 109.108 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.22 -65.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.529 2.153 . . . . 54.53 113.242 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.48 135.37 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.122 0.569 . . . . 74.34 110.537 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -129.42 167.54 17.66 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.84 -0.8 . . . . 72.24 108.84 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -73.88 95.62 2.47 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.597 -0.52 . . . . 61.14 109.597 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -80.89 140.97 35.04 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.255 -0.884 . . . . 75.11 110.333 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -77.19 133.16 39.0 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.07 -0.715 . . . . 51.35 109.07 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.39 162.14 36.03 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.148 0.979 . . . . 63.22 109.329 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 C-N-CA 123.729 0.811 . . . . 60.51 109.533 -179.416 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.405 -0.22 . . . . 65.340000000000003 110.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.49 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 3.6 mp -97.21 116.87 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.05 -1.093 . . . . 71.439999999999998 108.05 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.8 tp -83.65 114.38 21.51 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.363 0.665 . . . . 64.140000000000001 109.543 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.31 135.53 39.09 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.135 0.974 . . . . 72.450000000000003 110.078 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.53 110.33 16.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.982 0.913 . . . . 71.239999999999995 108.538 169.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -114.48 140.74 48.48 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 110.013 -0.366 . . . . 64.0 110.013 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -116.2 6.94 13.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.314 0.646 . . . . 74.219999999999999 109.613 171.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.2 p -60.02 115.5 3.48 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 123.53 0.732 . . . . 71.420000000000002 110.338 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -79.39 123.49 27.55 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 123.883 0.873 . . . . 64.310000000000002 110.107 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -166.25 172.28 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.968 0.907 . . . . 72.329999999999998 109.418 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -72.15 90.45 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.073 -0.714 . . . . 74.530000000000001 109.073 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 80.7 m -64.48 112.12 2.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.69 0.796 . . . . 61.409999999999997 110.665 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.0 ttt180 -99.33 104.16 16.04 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.39 1.076 . . . . 72.310000000000002 109.367 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.669 ' SG ' HG22 ' A' ' 45' ' ' VAL . 4.1 t -134.12 122.59 23.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.6 -1.259 . . . . 54.299999999999997 107.6 168.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.404 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 28.3 p -65.05 87.57 0.06 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.16 0.984 . . . . 64.439999999999998 111.978 -175.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.89 -141.29 47.4 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.395 -0.821 . . . . 54.100000000000001 114.109 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -143.02 142.56 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.329 1.452 . . . . 71.349999999999994 107.977 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mt -134.47 128.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 107.651 -1.24 . . . . 62.509999999999998 107.651 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.5 m -91.23 12.57 19.77 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.478 0.711 . . . . 35.350000000000001 111.854 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.8 p -65.64 123.21 19.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.541 0.737 . . . . 50.32 110.041 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -71.52 109.46 3.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.46 -0.941 . . . . 62.409999999999997 108.46 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.2 t -84.62 141.21 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.583 -0.735 . . . . 74.510000000000005 109.261 -175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -62.55 121.66 25.8 Favored Glycine 0 C--N 1.347 1.174 0 O-C-N 123.647 0.592 . . . . 70.340000000000003 112.645 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.62 -28.7 61.03 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.033 0.933 . . . . 71.230000000000004 112.255 -173.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -77.24 -35.31 55.5 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.871 0.468 . . . . 73.340000000000003 110.804 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.4 -12.82 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 119.063 -0.494 . . . . 72.030000000000001 111.477 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 23' ' ' GLY . 67.1 mt -65.79 111.95 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 109.126 -0.694 . . . . 73.340000000000003 109.126 174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -87.09 -54.29 4.4 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.615 0.766 . . . . 71.120000000000005 109.65 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 67.3 mtt85 -146.44 134.06 21.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.717 0.807 . . . . 74.340000000000003 111.006 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.78 105.83 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.551 -1.277 . . . . 72.340000000000003 107.551 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -103.75 120.53 41.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.221 0.609 . . . . 64.409999999999997 110.28 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.82 122.96 39.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 123.35 0.66 . . . . 52.520000000000003 109.272 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 m -108.55 102.43 47.37 Favored Pre-proline 0 C--O 1.25 1.095 0 C-N-CA 124.581 1.152 . . . . 54.549999999999997 108.175 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.1 155.73 27.6 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.6 2.2 . . . . 52.140000000000001 111.714 171.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.13 76.96 0.64 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.769 2.313 . . . . 73.010000000000005 112.698 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.56 175.31 51.67 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.241 -0.89 . . . . 72.120000000000005 113.712 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -73.15 -47.28 45.29 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.713 0.805 . . . . 70.549999999999997 110.626 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.3 -19.21 74.8 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.396 0.435 . . . . 74.109999999999999 113.292 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.0 m -94.55 132.43 28.79 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.011 0.924 . . . . 74.409999999999997 109.351 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.99 -34.68 22.49 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.543 2.162 . . . . 74.540000000000006 113.507 -170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -150.61 174.38 13.05 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.45 0.7 . . . . 72.450000000000003 109.929 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 m -73.02 114.92 11.72 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.903 -1.147 . . . . 65.409999999999997 107.903 169.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -122.73 132.64 54.33 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.031 0.532 . . . . 64.549999999999997 110.027 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -111.95 109.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.327 -0.99 . . . . 71.420000000000002 108.327 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.669 HG22 ' SG ' ' A' ' 14' ' ' CYS . 13.9 t -96.8 108.63 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 109.078 -0.712 . . . . 62.109999999999999 109.078 -173.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.409 HG23 HG23 ' A' ' 27' ' ' ILE . 41.8 mt -95.91 105.82 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.319 -0.623 . . . . 71.140000000000001 109.319 175.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -79.68 137.28 37.02 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.638 -0.875 . . . . 75.299999999999997 108.638 165.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 p -97.77 164.09 12.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.022 -0.535 . . . . 63.210000000000001 110.217 171.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.86 -20.03 63.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.934 0.894 . . . . 72.219999999999999 110.783 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.7 mtt -82.25 -1.97 51.04 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.186 0.994 . . . . 62.409999999999997 111.31 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 75.3 18.91 2.3 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.019 1.728 . . . . 71.420000000000002 113.746 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -79.58 126.03 30.36 Favored 'General case' 0 C--O 1.25 1.102 0 N-CA-C 108.691 -0.855 . . . . 60.409999999999997 108.691 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.38 104.7 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.375 -0.972 . . . . 42.539999999999999 108.375 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 60.8 mt -104.46 139.44 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.492 -0.929 . . . . 72.409999999999997 108.492 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 15' ' ' SER . 73.4 m -113.56 133.05 55.47 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.405 -0.961 . . . . 63.039999999999999 108.405 177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.8 m -132.84 156.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.113 0.565 . . . . 72.239999999999995 109.486 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -79.06 139.6 56.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.345 0.658 . . . . 34.399999999999999 110.611 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.05 -10.62 29.45 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.878 2.385 . . . . 63.409999999999997 113.453 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -101.97 6.46 41.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.629 0.772 . . . . 54.310000000000002 111.873 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.51 19.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.808 0.443 . . . . 70.310000000000002 110.149 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -65.05 -36.52 84.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.414 0.686 . . . . 63.420000000000002 111.597 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -67.63 -35.67 79.35 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.971 0.508 . . . . 70.450000000000003 110.122 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.4 tp -68.28 -40.41 81.85 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 115.536 -0.756 . . . . 60.149999999999999 109.893 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -60.44 -34.47 74.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.564 0.746 . . . . 75.450000000000003 111.414 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -57.43 -46.33 83.67 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.424 0.69 . . . . 74.150000000000006 109.885 172.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.4 mt -68.41 -41.34 80.56 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.658 0.783 . . . . 75.230000000000004 110.849 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.89 -34.23 77.33 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.589 0.756 . . . . 62.119999999999997 110.503 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -85.12 -16.77 39.39 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.997 -0.547 . . . . 71.450000000000003 111.415 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -80.0 -38.99 30.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.865 0.466 . . . . 63.109999999999999 111.141 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.7 m -74.92 -7.76 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.205 0.602 . . . . 63.409999999999997 112.179 -177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -103.14 21.68 15.38 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.415 0.686 . . . . 52.32 110.1 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.8 t -133.94 81.84 1.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.219 1.008 . . . . 73.420000000000002 108.523 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -84.66 -36.76 21.72 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.851 0.86 . . . . 72.200000000000003 109.606 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 37.7 p -85.26 96.44 9.51 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 70.209999999999994 110.04 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.05 165.02 22.04 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.409 0.684 . . . . 71.099999999999994 110.0 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.7 t -75.98 149.37 37.63 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.587 -0.894 . . . . 53.340000000000003 108.587 170.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.5 p -73.78 174.86 7.84 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.383 0.673 . . . . 64.230000000000004 110.545 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -119.04 87.59 34.63 Favored Pre-proline 0 CA--C 1.55 0.973 0 N-CA-C 109.309 -0.626 . . . . 63.109999999999999 109.309 172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.55 -30.42 12.17 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.942 2.428 . . . . 61.439999999999998 111.189 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.57 103.11 0.63 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.803 0.841 . . . . 74.25 109.591 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.49 118.2 62.25 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.456 0.473 . . . . 54.119999999999997 110.318 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.09 6.44 5.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.718 2.278 . . . . 71.239999999999995 112.548 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.01 97.76 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.311 1.044 . . . . 64.150000000000006 108.478 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.9 t -82.8 175.94 9.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.197 -0.911 . . . . 55.009999999999998 109.099 172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -64.78 105.55 1.02 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.127 -0.694 . . . . 73.140000000000001 109.127 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -74.88 161.3 29.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.537 0.735 . . . . 62.409999999999997 110.425 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -60.29 143.57 52.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.805 0.842 . . . . 74.310000000000002 110.764 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.96 171.38 15.28 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.26 0.624 . . . . 73.430000000000007 110.965 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 123.41 0.684 . . . . 44.409999999999997 110.224 178.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 108.057 -1.09 . . . . 61.210000000000001 108.057 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.68 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 24.7 mt -89.85 139.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.159 -0.682 . . . . 74.430000000000007 109.159 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.51 HD22 HG21 ' A' ' 70' ' ' VAL . 58.9 tp -111.86 114.57 27.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.079 0.552 . . . . 74.109999999999999 110.188 -177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -95.72 154.96 16.95 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.788 0.835 . . . . 74.530000000000001 109.977 172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.52 147.94 43.87 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.85 0.86 . . . . 55.039999999999999 108.911 166.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 p80 -80.94 140.39 35.29 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 117.747 0.249 . . . . 60.030000000000001 110.993 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -137.65 -51.23 0.62 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.628 -0.879 . . . . 74.5 108.628 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.2 p -95.62 -10.79 28.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.923 0.889 . . . . 72.129999999999995 111.612 176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.601 ' HB3' ' HB2' ' A' ' 6' ' ' HIS . 46.1 t30 -78.28 99.74 6.41 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.932 0.493 . . . . 74.409999999999997 110.495 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' ' HA2' ' A' ' 38' ' ' GLY . 1.7 tt -120.22 15.1 12.26 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.549 1.139 . . . . 55.049999999999997 109.313 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.5 46.53 0.57 Allowed 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.663 -0.648 . . . . 71.310000000000002 110.822 -167.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.621 ' SG ' HG21 ' A' ' 33' ' ' THR . 60.6 m -57.16 107.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.687 0.795 . . . . 73.340000000000003 111.582 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.96 90.26 4.57 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 106.75 -1.574 . . . . 73.129999999999995 106.75 171.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -113.45 156.41 23.56 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.172 0.989 . . . . 74.319999999999993 110.096 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.5 m -78.95 59.36 2.62 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.658 0.783 . . . . 73.219999999999999 111.3 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 -140.34 41.57 Favored Glycine 0 C--N 1.355 1.628 0 CA-C-N 116.214 -0.448 . . . . 74.019999999999996 112.601 -174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -133.29 132.82 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.297 -1.001 . . . . 74.310000000000002 108.297 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.4 mt -128.08 128.84 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.668 -1.234 . . . . 61.119999999999997 107.668 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.5 m -90.77 18.95 5.88 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.38 0.672 . . . . 74.530000000000001 112.226 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.8 p -78.16 134.2 37.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.22 0.608 . . . . 24.140000000000001 110.144 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.87 111.01 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.763 -0.828 . . . . 75.109999999999999 108.763 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.62 141.09 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 109.057 -0.719 . . . . 64.209999999999994 109.057 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -58.41 113.71 5.14 Favored Glycine 0 C--N 1.359 1.83 0 O-C-N 124.075 0.86 . . . . 74.549999999999997 112.622 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HG ' HD21 ' A' ' 66' ' ' LEU . 8.5 mp -52.72 -41.05 63.6 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.155 0.982 . . . . 72.409999999999997 111.663 -173.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -67.34 -37.02 82.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.833 0.853 . . . . 63.030000000000001 111.519 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.4 pt -86.8 -15.12 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 122.995 0.184 . . . . 70.219999999999999 111.21 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 46' ' ' ILE . 65.3 mt -61.75 110.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 109.511 -0.551 . . . . 75.109999999999999 109.511 171.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -87.71 -55.2 3.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.917 0.887 . . . . 73.030000000000001 110.207 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.68 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 79.2 mtm180 -139.45 153.39 47.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.109 0.564 . . . . 71.049999999999997 111.021 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 46' ' ' ILE . 68.7 mt -139.35 118.74 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.1 1.36 . . . . 63.409999999999997 107.87 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -105.03 122.29 45.56 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.449 -0.574 . . . . 73.430000000000007 109.449 172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 m -88.44 127.95 41.03 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 N-CA-C 109.395 -0.594 . . . . 74.430000000000007 109.395 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.621 HG21 ' SG ' ' A' ' 12' ' ' CYS . 90.9 m -128.48 81.85 69.79 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.577 0.751 . . . . 72.409999999999997 110.311 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.9 156.98 61.62 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.277 1.985 . . . . 54.509999999999998 112.256 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.73 83.2 0.53 Allowed 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.351 2.7 . . . . 71.150000000000006 111.475 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.51 103.35 0.18 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.674 -0.971 . . . . 72.140000000000001 110.674 -176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 t30 60.98 62.1 1.5 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.065 0.946 . . . . 72.209999999999994 110.112 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' HA2' ' HG ' ' A' ' 10' ' ' LEU . . . 167.75 -119.08 0.82 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.191 -0.913 . . . . 70.340000000000003 113.172 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 48.0 m -88.15 151.7 49.45 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 123.934 0.894 . . . . 64.340000000000003 110.802 -174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.4 -39.49 56.06 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 123.663 2.909 . . . . 71.120000000000005 114.306 -168.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -123.22 172.63 8.47 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.269 0.628 . . . . 65.409999999999997 109.707 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 33' ' ' THR . 16.8 m -70.77 115.03 9.45 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.116 0.26 . . . . 44.340000000000003 110.718 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 4.3 mm-40 -108.93 109.8 20.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 107.858 -1.164 . . . . 41.119999999999997 107.858 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.39 102.03 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 106.943 -1.503 . . . . 73.439999999999998 106.943 172.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.625 HG22 ' SG ' ' A' ' 14' ' ' CYS . 17.6 t -97.65 106.9 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.356 -0.979 . . . . 72.040000000000006 108.356 -169.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.447 HG23 HG23 ' A' ' 27' ' ' ILE . 56.6 mt -98.56 107.81 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.279 0.632 . . . . 73.049999999999997 109.68 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -83.64 120.69 26.29 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.467 -0.938 . . . . 74.200000000000003 108.467 168.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.0 p -84.77 162.71 19.5 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.078 -0.712 . . . . 54.32 109.078 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.83 -19.89 65.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.922 0.889 . . . . 75.0 111.425 177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 45.0 mtm -81.02 -2.62 48.74 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.972 0.909 . . . . 72.510000000000005 111.377 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.2 mttp 75.64 15.3 2.67 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.665 1.586 . . . . 54.450000000000003 113.127 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -83.44 123.27 29.52 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.458 -0.571 . . . . 70.109999999999999 109.458 173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -85.9 103.1 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 108.057 -1.09 . . . . 55.140000000000001 108.057 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.54 120.25 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.906 -1.146 . . . . 64.340000000000003 107.906 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.0 m -107.9 130.45 55.02 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.673 -0.862 . . . . 65.299999999999997 108.673 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 165.24 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.373 1.069 . . . . 74.439999999999998 110.063 -173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -88.79 154.24 50.18 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.714 0.806 . . . . 72.310000000000002 109.656 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -68.31 -22.9 39.19 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.383 2.055 . . . . 73.019999999999996 113.391 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -73.49 -17.22 61.25 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.748 0.819 . . . . 74.530000000000001 112.937 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.85 126.22 24.73 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.361 0.664 . . . . 74.340000000000003 111.508 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -72.88 -37.39 67.33 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.894 0.878 . . . . 74.5 112.138 -171.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -62.21 -38.4 89.0 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.046 0.45 . . . . 74.140000000000001 110.004 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.8 tp -68.24 -37.87 81.23 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 114.76 -1.109 . . . . 74.200000000000003 110.922 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -60.23 -37.85 81.6 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.745 0.818 . . . . 74.450000000000003 110.78 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -65.55 -31.41 72.45 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.003 0.521 . . . . 75.439999999999998 111.225 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.57 HD21 ' HG ' ' A' ' 24' ' ' LEU . 91.9 mt -74.96 -38.72 61.64 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.281 0.633 . . . . 74.230000000000004 110.843 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -68.69 -22.27 64.38 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.335 0.654 . . . . 70.140000000000001 110.511 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.8 tpt85 -87.16 -31.86 20.15 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.45 0.7 . . . . 73.319999999999993 111.15 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.51 -25.94 60.66 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 111.861 0.319 . . . . 75.340000000000003 111.861 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG21 HD22 ' A' ' 3' ' ' LEU . 33.2 m -72.28 -13.23 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 120.681 0.277 . . . . 72.409999999999997 110.659 174.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -92.4 157.28 16.68 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.024 0.929 . . . . 62.350000000000001 109.128 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.6 t -70.34 137.91 51.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.636 0.374 . . . . 63.450000000000003 110.458 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -149.37 143.5 25.81 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.215 1.006 . . . . 71.230000000000004 109.448 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.9 m -76.84 99.1 5.06 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.199 -0.455 . . . . 72.349999999999994 110.025 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 75' ' ' LEU . 2.0 pt? -57.49 137.09 56.63 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.77 0.828 . . . . 72.109999999999999 110.388 174.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.7 p -74.37 122.12 22.44 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.642 0.777 . . . . 73.319999999999993 111.534 -172.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 67.3 p -72.2 128.94 37.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.858 0.863 . . . . 74.219999999999999 110.851 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.0 p -80.28 119.73 77.33 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.583 0.753 . . . . 64.329999999999998 110.312 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.37 159.72 52.59 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.134 1.889 . . . . 61.219999999999999 112.15 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -87.82 164.6 15.83 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.185 0.517 . . . . 70.450000000000003 110.62 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.68 77.52 56.15 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.166 -1.05 . . . . 73.310000000000002 108.166 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.86 152.68 47.19 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.43 2.087 . . . . 73.329999999999998 112.789 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 77.5 t -96.53 120.94 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 109.078 -0.712 . . . . 71.239999999999995 109.078 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.9 p -94.76 -71.76 0.65 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.732 0.813 . . . . 72.439999999999998 111.253 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -175.89 149.54 0.93 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.408 0.683 . . . . 74.209999999999994 109.84 -168.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -87.17 148.7 25.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.298 0.639 . . . . 71.040000000000006 110.313 170.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.2 ttm-85 -75.65 102.27 5.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.255 0.622 . . . . 74.329999999999998 110.157 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.36 96.24 3.95 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.755 0.822 . . . . 74.430000000000007 109.518 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.243 0 C-N-CA 123.491 0.716 . . . . 54.140000000000001 109.83 177.392 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 85.3 mtp . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.039 -0.726 . . . . 70.200000000000003 109.039 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.617 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 3.9 mp -92.28 130.02 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 109.308 -0.627 . . . . 74.109999999999999 109.308 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 69.1 tp -85.75 106.57 17.1 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.284 -1.006 . . . . 73.540000000000006 108.284 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 23.5 mm-40 -84.97 116.77 23.56 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.005 0.922 . . . . 72.409999999999997 109.531 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.31 110.18 22.07 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.133 -0.692 . . . . 64.430000000000007 109.133 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -120.97 95.19 4.6 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.714 -0.476 . . . . 74.230000000000004 109.714 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -86.79 -27.85 23.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.861 -0.609 . . . . 72.299999999999997 109.619 173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 90.4 m -100.12 120.05 39.27 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.272 1.029 . . . . 65.420000000000002 108.449 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -146.5 -117.18 0.07 Allowed 'General case' 0 CA--C 1.56 1.351 0 N-CA-C 106.66 -1.607 . . . . 65.409999999999997 106.66 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.67 -54.01 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.669 1.188 . . . . 54.100000000000001 108.216 171.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -159.31 136.65 9.83 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 125.514 1.526 . . . . 65.420000000000002 107.186 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 85.6 m -74.16 104.57 5.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.988 -0.375 . . . . 34.420000000000002 109.988 -176.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -84.44 89.37 7.39 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 121.636 0.731 . . . . 74.140000000000001 110.984 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 t -137.22 157.61 46.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.542 -0.754 . . . . 62.219999999999999 109.952 171.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.6 t -78.71 -22.9 45.95 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.345 0.658 . . . . 73.219999999999999 111.082 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.36 160.61 10.26 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.463 -1.055 . . . . 61.130000000000003 110.463 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.46 135.54 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.718 0.759 . . . . 63.439999999999998 109.249 -170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 54' ' ' ILE . 5.7 mt -110.55 134.1 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.713 -0.847 . . . . 65.439999999999998 108.713 -172.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.2 p -88.2 24.51 1.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.735 0.814 . . . . 71.120000000000005 112.113 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.4 p -89.11 155.99 19.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.711 0.804 . . . . 65.129999999999995 110.719 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.02 111.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 108.623 -0.88 . . . . 73.219999999999999 108.623 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.9 t -87.92 128.42 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.131 -1.063 . . . . 51.409999999999997 108.131 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -70.32 135.33 25.51 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.496 0.498 . . . . 70.409999999999997 113.603 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.72 -31.59 70.88 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.23 0.612 . . . . 55.450000000000003 111.558 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.43 -27.95 66.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.754 0.822 . . . . 63.420000000000002 112.157 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 23' ' ' GLY . 20.1 pt -95.69 -22.49 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 119.489 -0.291 . . . . 63.25 110.721 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 23' ' ' GLY . 82.4 mt -68.53 137.49 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 123.144 0.578 . . . . 72.129999999999995 110.928 177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.1 t70 -109.41 -53.55 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.671 0.788 . . . . 70.409999999999997 110.392 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 90.7 mtm180 -144.26 142.22 30.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.868 0.467 . . . . 72.040000000000006 111.198 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.0 mp -113.52 113.31 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.133 -1.062 . . . . 75.340000000000003 108.133 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 6.9 tt0 -97.34 106.02 18.26 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.79 -0.448 . . . . 73.010000000000005 109.79 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 m -89.78 109.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 N-CA-C 108.622 -0.881 . . . . 75.239999999999995 108.622 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.0 m -105.46 99.75 22.59 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.094 -0.706 . . . . 62.200000000000003 109.094 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.58 159.65 48.39 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.708 2.272 . . . . 75.329999999999998 112.335 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' HB3' ' HA ' ' A' ' 41' ' ' LYS . 73.8 Cg_endo -75.49 149.8 35.23 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.011 2.474 . . . . 75.329999999999998 113.063 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.6 -94.53 0.62 Allowed Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.009 -0.541 . . . . 54.420000000000002 112.51 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -68.83 -50.3 51.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.658 0.783 . . . . 64.540000000000006 111.247 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.09 -73.44 1.18 Allowed Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.44 -0.346 . . . . 54.020000000000003 112.834 -176.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 97.2 m -114.06 154.82 46.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.682 0.793 . . . . 62.299999999999997 109.743 176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.69 -20.68 69.38 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 122.644 2.23 . . . . 75.540000000000006 112.846 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . 60.1 pttt -142.9 166.69 23.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.718 0.807 . . . . 63.439999999999998 109.993 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.488 ' OG1' ' HD3' ' A' ' 35' ' ' PRO . 24.2 m -71.62 124.8 25.51 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.903 0.481 . . . . 73.299999999999997 110.345 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.43 133.64 26.13 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.827 -1.175 . . . . 72.519999999999996 107.827 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 59.8 t -114.75 103.17 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 122.988 0.515 . . . . 53.439999999999998 110.446 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.5 t -93.77 108.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.301 0.64 . . . . 61.109999999999999 109.864 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.97 116.25 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.15 0.58 . . . . 72.109999999999999 109.441 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -83.39 128.23 34.33 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 107.268 -1.382 . . . . 73.150000000000006 107.268 166.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.7 p -85.1 161.56 19.63 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.775 -0.824 . . . . 74.109999999999999 108.775 167.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -74.73 -3.86 34.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.418 0.687 . . . . 70.409999999999997 111.277 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtm -91.1 -1.99 57.67 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.146 0.978 . . . . 72.430000000000007 110.102 169.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 66.74 19.94 10.7 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.231 1.813 . . . . 75.040000000000006 113.102 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -80.21 123.8 28.25 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.318 -0.993 . . . . 64.400000000000006 108.318 166.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.21 102.05 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.631 -0.878 . . . . 62.229999999999997 108.631 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 18' ' ' ILE . 65.7 mt -109.09 122.02 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 107.654 -1.239 . . . . 73.219999999999999 107.654 175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 28.3 p -109.07 146.96 33.14 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.689 -0.856 . . . . 62.25 108.689 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.1 m -137.78 160.94 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.252 1.021 . . . . 74.329999999999998 109.862 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -82.27 149.03 61.05 Favored Pre-proline 0 CA--C 1.556 1.183 0 CA-C-N 115.161 -0.927 . . . . 71.120000000000005 110.066 177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -60.32 -38.35 75.73 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.154 2.569 . . . . 73.510000000000005 113.806 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -75.44 4.53 7.22 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 123.417 0.687 . . . . 73.120000000000005 112.076 -175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.8 115.94 3.42 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.126 -0.694 . . . . 73.099999999999994 109.126 171.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -64.94 -35.71 82.03 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.985 0.914 . . . . 63.32 112.233 -169.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -69.96 -32.92 71.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.895 0.478 . . . . 73.439999999999998 109.95 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.456 HD12 HD23 ' A' ' 66' ' ' LEU . 48.7 tp -65.73 -39.77 91.48 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.363 0.665 . . . . 63.329999999999998 110.349 -175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -64.76 -32.67 74.46 Favored 'General case' 0 C--O 1.243 0.745 0 O-C-N 123.461 0.476 . . . . 72.030000000000001 111.283 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -64.41 -42.95 95.77 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 123.825 0.703 . . . . 62.329999999999998 109.903 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD23 HD12 ' A' ' 63' ' ' LEU . 40.5 tp -62.36 -46.82 86.94 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.843 0.857 . . . . 63.32 111.335 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.98 -37.21 83.81 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.33 0.652 . . . . 75.409999999999997 110.653 -174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -72.84 -35.17 67.21 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.475 -0.33 . . . . 73.430000000000007 110.714 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -68.29 -38.07 81.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.512 0.725 . . . . 70.450000000000003 112.494 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -70.95 -21.07 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 120.695 0.283 . . . . 53.32 111.013 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.15 -27.15 19.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.729 0.812 . . . . 55.43 110.825 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -80.83 162.25 24.1 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.996 0.918 . . . . 73.409999999999997 109.389 175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -73.0 122.86 22.41 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 109.275 -0.639 . . . . 74.310000000000002 109.275 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.7 t -71.87 169.46 15.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.805 0.842 . . . . 71.439999999999998 110.331 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tt -69.14 126.93 31.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.311 -0.626 . . . . 72.010000000000005 109.311 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 t -137.74 160.63 38.7 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.466 1.106 . . . . 61.130000000000003 108.836 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.8 t -68.08 101.21 1.1 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.592 -0.892 . . . . 75.109999999999999 108.592 171.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 72.8 p -74.59 142.74 77.93 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.963 -0.562 . . . . 75.5 109.875 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.6 163.72 31.71 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.08 1.853 . . . . 61.420000000000002 111.43 172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -51.13 114.38 1.18 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.28 1.032 . . . . 74.120000000000005 112.013 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 143.47 98.56 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.896 0.878 . . . . 72.400000000000006 110.356 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.3 158.06 4.02 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.696 2.93 . . . . 63.219999999999999 113.94 -176.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.87 115.38 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.724 0.81 . . . . 72.140000000000001 110.319 -173.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 t -133.13 101.89 5.38 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.081 0.952 . . . . 71.209999999999994 108.675 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -122.21 157.07 32.42 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.438 0.695 . . . . 72.099999999999994 109.78 176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -154.85 120.21 5.02 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.456 -0.942 . . . . 75.530000000000001 108.456 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -105.2 131.21 52.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.399 0.68 . . . . 75.329999999999998 110.112 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -100.54 93.96 5.89 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.146 0.578 . . . . 61.130000000000003 110.202 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.763 0.825 . . . . 72.120000000000005 109.135 178.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HG3' HG22 ' A' ' 27' ' ' ILE . 1.3 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.415 -0.587 . . . . 72.299999999999997 109.415 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.61 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 51.7 mt -77.57 133.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.292 -1.003 . . . . 73.349999999999994 108.292 174.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.3 tp -101.33 111.89 24.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.89 0.476 . . . . 65.400000000000006 110.765 -172.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -87.55 146.29 25.84 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.137 0.975 . . . . 74.239999999999995 109.928 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.88 133.79 55.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.447 0.699 . . . . 64.439999999999998 109.193 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.85 95.73 9.54 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.336 -0.616 . . . . 71.299999999999997 109.336 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -76.69 -59.61 2.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.183 0.593 . . . . 72.230000000000004 110.966 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.6 p -74.58 -72.35 0.29 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.498 -0.556 . . . . 75.430000000000007 109.498 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.8 t30 56.66 89.72 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.47 1.108 . . . . 64.349999999999994 113.733 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 tt -80.06 -61.55 1.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 107.41 -1.329 . . . . 74.219999999999999 107.41 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -133.14 131.92 41.03 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.791 0.836 . . . . 74.140000000000001 109.768 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.781 ' SG ' HG21 ' A' ' 33' ' ' THR . 34.6 m -85.0 103.42 14.02 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.622 -0.881 . . . . 64.140000000000001 108.622 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 3.6 mmp_? -100.85 90.55 4.25 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.721 0.772 . . . . 74.430000000000007 110.775 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.6 t -133.44 161.82 33.51 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 113.974 -1.467 . . . . 74.420000000000002 107.908 166.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.8 m -48.06 -32.35 6.62 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 124.68 1.192 . . . . 73.340000000000003 113.666 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.24 -120.27 1.06 Allowed Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.058 -0.817 . . . . 73.25 111.058 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.28 137.0 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.969 -1.123 . . . . 75.219999999999999 107.969 169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.675 HD12 HG23 ' A' ' 54' ' ' ILE . 9.1 mt -121.01 129.66 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.737 -1.209 . . . . 42.140000000000001 107.737 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.3 m -89.56 20.48 3.94 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.704 0.801 . . . . 64.129999999999995 111.521 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.4 p -93.22 143.16 26.53 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.614 0.766 . . . . 53.539999999999999 110.141 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.94 129.45 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.002 -0.74 . . . . 62.329999999999998 109.002 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 t -98.29 133.55 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.374 -0.972 . . . . 60.409999999999997 108.374 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -70.9 131.15 20.68 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.767 0.667 . . . . 25.210000000000001 113.074 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mp -59.66 -36.13 75.8 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.916 0.886 . . . . 75.329999999999998 110.907 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -27.6 66.29 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.898 0.879 . . . . 75.019999999999996 112.246 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.5 pt -105.44 -20.34 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 118.596 -0.716 . . . . 71.129999999999995 112.428 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 46' ' ' ILE . 69.6 mt -61.46 106.61 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 109.217 -0.66 . . . . 65.140000000000001 109.217 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -85.11 -52.25 6.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.378 1.071 . . . . 72.030000000000001 109.416 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.61 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 77.1 mtm180 -146.61 160.03 42.69 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.74 0.816 . . . . 64.349999999999994 110.25 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 3' ' ' LEU . 68.5 mt -136.51 142.1 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.808 -1.182 . . . . 54.200000000000003 107.808 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.453 ' NE2' ' HH2' ' A' ' 47' ' ' TRP . 6.9 tt0 -124.12 143.94 50.18 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.519 -0.919 . . . . 64.109999999999999 108.519 173.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -113.24 121.01 64.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.84 -0.8 . . . . 52.530000000000001 108.84 173.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.781 HG21 ' SG ' ' A' ' 12' ' ' CYS . 34.7 m -114.28 102.97 55.2 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 122.975 0.51 . . . . 73.430000000000007 109.984 172.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.41 159.54 43.14 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.007 2.471 . . . . 73.329999999999998 112.032 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -71.89 178.68 5.57 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.469 2.113 . . . . 63.340000000000003 112.87 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.18 -29.2 9.08 Favored Glycine 0 N--CA 1.473 1.119 0 CA-C-N 116.446 -0.343 . . . . 75.319999999999993 113.214 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -77.65 -17.57 57.58 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.152 0.581 . . . . 75.420000000000002 111.529 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.3 -42.93 0.67 Allowed Glycine 0 C--N 1.345 1.061 0 N-CA-C 111.421 -0.672 . . . . 45.030000000000001 111.421 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.418 ' SG ' ' N ' ' A' ' 12' ' ' CYS . 82.0 m -75.85 120.39 81.45 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 123.602 0.761 . . . . 71.519999999999996 110.626 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.29 -14.31 31.23 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.257 1.971 . . . . 75.349999999999994 112.93 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -103.35 146.76 27.99 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.292 0.637 . . . . 74.430000000000007 109.949 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.3 m -86.13 114.91 23.37 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.431 -0.951 . . . . 74.420000000000002 108.431 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.16 112.97 19.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.323 0.649 . . . . 72.450000000000003 109.941 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.15 103.39 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.462 -0.94 . . . . 63.43 108.462 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 31' ' ' GLN . 58.4 t -92.56 108.46 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.439999999999998 110.126 -171.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 27' ' ' ILE . 65.2 mt -96.44 120.32 45.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.733 0.813 . . . . 65.109999999999999 109.287 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.453 ' HH2' ' NE2' ' A' ' 31' ' ' GLN . 32.3 m-90 -90.47 130.77 36.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.976 -1.12 . . . . 74.510000000000005 107.976 166.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.4 p -90.16 169.28 11.28 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.883 -0.784 . . . . 55.25 108.883 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.11 -9.39 58.35 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.655 0.782 . . . . 65.409999999999997 111.304 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.8 mtm -88.69 4.66 46.48 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.439 1.095 . . . . 74.409999999999997 110.415 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? 65.49 11.43 7.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.671 1.588 . . . . 71.239999999999995 112.206 -175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.56 122.24 23.6 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.943 -0.762 . . . . 62.229999999999997 108.943 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.61 102.03 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.066 0.946 . . . . 72.409999999999997 108.714 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.675 HG23 HD12 ' A' ' 18' ' ' ILE . 69.1 mt -109.35 113.82 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.617 -1.253 . . . . 75.010000000000005 107.617 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.47 139.59 40.71 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.885 -0.783 . . . . 70.439999999999998 108.885 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.08 163.86 35.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 C-N-CA 124.617 1.167 . . . . 65.219999999999999 109.837 -171.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -84.25 154.82 63.47 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 115.488 -0.778 . . . . 73.310000000000002 110.16 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.48 -22.62 44.77 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.34 2.027 . . . . 61.130000000000003 112.862 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -74.6 -3.63 32.28 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.215 0.82 . . . . 72.329999999999998 113.215 -174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.77 117.01 8.31 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.247 -0.649 . . . . 75.019999999999996 109.247 171.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -73.96 -35.05 64.49 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.124 0.57 . . . . 64.049999999999997 111.312 -174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -58.9 -36.14 74.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.511 0.672 . . . . 72.120000000000005 110.173 174.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.2 tp -68.46 -39.4 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.237 -1.347 . . . . 75.409999999999997 110.689 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -59.08 -33.27 70.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.836 0.454 . . . . 61.32 112.212 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -61.03 -44.64 97.11 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 115.994 -0.548 . . . . 74.140000000000001 110.043 174.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.0 -43.38 87.91 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.548 -0.751 . . . . 71.430000000000007 110.494 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt -64.0 -34.04 77.1 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.048 0.842 . . . . 75.409999999999997 110.875 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -82.5 -31.35 29.32 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.539 0.335 . . . . 74.400000000000006 111.763 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -67.52 -39.21 85.09 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.768 0.427 . . . . 62.140000000000001 111.461 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.8 m -71.83 -11.9 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 122.307 0.243 . . . . 62.340000000000003 111.546 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 67' ' ' LEU . 76.6 mt-30 -90.72 57.63 3.63 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.441 0.696 . . . . 64.420000000000002 109.986 174.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.7 p 46.2 75.84 0.11 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.557 1.543 . . . . 55.109999999999999 114.13 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.26 148.6 25.62 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.865 0.466 . . . . 72.299999999999997 110.333 174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.2 m -76.15 144.57 40.5 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.0 0.92 . . . . 63.509999999999998 111.006 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.1 tp -77.27 123.66 26.77 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.405 0.682 . . . . 73.010000000000005 110.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 p -72.09 108.65 5.41 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.354 0.662 . . . . 72.049999999999997 110.571 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.5 m -65.51 127.46 31.95 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 74.329999999999998 111.207 -176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.1 p -106.25 103.45 45.44 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.722 0.809 . . . . 51.420000000000002 111.286 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.11 123.47 11.94 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.889 2.393 . . . . 61.25 111.406 171.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -83.55 169.08 15.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.475 0.71 . . . . 74.450000000000003 111.827 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.58 110.95 64.79 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.858 0.863 . . . . 62.119999999999997 109.981 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -84.19 153.31 12.52 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.616 2.211 . . . . 64.120000000000005 112.291 175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.3 p -71.87 124.38 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 N-CA-C 109.61 -0.515 . . . . 73.349999999999994 109.61 176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 p -75.56 -70.36 0.43 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.278 0.631 . . . . 65.120000000000005 110.342 -177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -154.69 176.45 12.42 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.024 0.53 . . . . 73.120000000000005 110.37 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -104.99 178.94 4.42 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.551 1.14 . . . . 64.439999999999998 110.18 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -73.55 152.01 40.77 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.781 0.833 . . . . 62.420000000000002 111.619 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -156.4 169.77 23.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.967 0.907 . . . . 64.109999999999999 110.305 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 C-N-CA 123.225 0.61 . . . . 75.420000000000002 109.498 179.177 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.142 -0.688 . . . . 74.430000000000007 109.142 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.1 mm -81.72 137.3 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.979 -0.748 . . . . 71.049999999999997 108.979 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp -110.09 121.55 45.52 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 109.42 -0.585 . . . . 73.150000000000006 109.42 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -117.44 140.07 50.07 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 108.769 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.05 116.3 31.7 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.441 -0.948 . . . . 74.450000000000003 108.441 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.554 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 41.0 t60 -81.13 132.47 35.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.208 0.603 . . . . 73.430000000000007 110.306 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -135.71 -50.07 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.62 0.768 . . . . 71.409999999999997 110.341 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -66.95 158.17 31.47 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.542 0.571 . . . . 64.329999999999998 112.542 -170.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -68.44 4.51 1.32 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.446 1.498 . . . . 64.310000000000002 114.591 -166.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.9 mt -56.5 118.89 5.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.131 -0.692 . . . . 72.319999999999993 109.131 168.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -80.72 124.6 29.17 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.883 0.473 . . . . 64.409999999999997 111.377 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.3 m -59.4 115.15 3.06 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.566 1.146 . . . . 74.209999999999994 111.644 -174.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -112.95 89.39 3.07 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.414 0.686 . . . . 54.329999999999998 109.646 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.49 159.26 42.46 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.129 0.972 . . . . 75.400000000000006 108.593 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.477 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 20.3 m -77.37 64.53 2.76 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.73 0.812 . . . . 62.340000000000003 111.556 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.55 -136.17 49.72 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.246 -0.888 . . . . 44.439999999999998 113.429 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.21 131.49 71.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 107.938 -1.134 . . . . 73.030000000000001 107.938 169.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.7 mt -120.13 134.23 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.553 -1.277 . . . . 74.239999999999995 107.553 -174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.5 p -85.28 20.88 1.85 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.698 0.799 . . . . 73.140000000000001 112.546 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.8 p -79.0 123.82 27.67 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.082 0.553 . . . . 73.129999999999995 109.706 175.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.84 110.75 8.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 107.828 -1.175 . . . . 43.439999999999998 107.828 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.08 133.19 29.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 115.21 -0.905 . . . . 65.409999999999997 109.543 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -59.28 122.99 32.0 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.776 0.672 . . . . 52.43 112.334 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' H ' HD22 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -60.17 -29.7 68.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.163 0.585 . . . . 74.439999999999998 110.675 -174.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -65.98 -35.57 80.94 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.932 0.893 . . . . 64.319999999999993 111.799 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.9 pt -90.57 -21.03 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 118.962 -0.542 . . . . 75.319999999999993 111.217 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 23' ' ' GLY . 70.3 mt -62.26 127.36 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-N 118.597 0.635 . . . . 64.420000000000002 110.172 176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.15 -53.62 2.65 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.2 0.6 . . . . 65.049999999999997 110.413 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -133.28 152.26 51.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.803 0.841 . . . . 73.310000000000002 110.509 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.69 135.95 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.447 1.499 . . . . 74.510000000000005 108.232 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.402 ' NE2' ' HH2' ' A' ' 47' ' ' TRP . 7.7 tt0 -133.74 120.48 20.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.803 0.841 . . . . 74.140000000000001 109.516 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.13 110.27 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 108.887 -0.783 . . . . 73.25 108.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.3 p -96.69 99.55 5.84 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.875 0.87 . . . . 64.409999999999997 109.542 174.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -87.66 164.88 7.75 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 123.114 2.543 . . . . 75.109999999999999 112.719 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.84 52.01 4.06 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.1 2.534 . . . . 52.340000000000003 112.252 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.64 93.4 0.29 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-N 115.32 -0.855 . . . . 63.43 111.073 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 75.2 -69.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.405 1.482 . . . . 74.340000000000003 112.796 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -76.03 -26.59 64.03 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 114.719 0.648 . . . . 70.049999999999997 114.719 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 0.5 OUTLIER -128.62 148.53 68.75 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.086 0.554 . . . . 74.340000000000003 110.071 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.8 -24.66 4.79 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.587 2.191 . . . . 72.310000000000002 113.142 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -142.62 170.95 14.74 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.19 0.596 . . . . 65.010000000000005 110.833 -173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 p -70.21 128.02 34.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.724 0.81 . . . . 63.020000000000003 110.062 166.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -161.25 158.46 27.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.07 0.948 . . . . 70.230000000000004 108.477 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -131.4 131.65 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.569 0.748 . . . . 61.409999999999997 109.043 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 t -103.33 110.58 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.321 1.048 . . . . 73.019999999999996 108.437 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.8 mt -102.71 120.36 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.304 -0.628 . . . . 74.439999999999998 109.304 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.402 ' HH2' ' NE2' ' A' ' 31' ' ' GLN . 27.3 m-90 -92.52 129.4 38.47 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 107.544 -1.28 . . . . 64.439999999999998 107.544 167.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.1 p -91.36 172.73 8.33 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.656 0.265 . . . . 72.209999999999994 110.366 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -66.94 -25.0 66.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.971 0.908 . . . . 73.129999999999995 110.505 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 61.6 mtm -84.94 2.18 44.05 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.267 1.027 . . . . 72.530000000000001 111.342 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? 74.48 4.0 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.5 1.52 . . . . 71.549999999999997 112.667 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -71.84 123.02 21.75 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.258 -0.645 . . . . 54.149999999999999 109.258 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.77 104.73 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.147 -0.933 . . . . 70.040000000000006 108.709 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.6 mt -107.32 130.35 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.495 -1.298 . . . . 74.450000000000003 107.495 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 15' ' ' SER . 9.4 m -107.84 139.01 43.07 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.869 -0.789 . . . . 75.0 108.869 -174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 m -140.13 166.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.78 0.832 . . . . 75.200000000000003 109.542 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -88.31 144.22 33.73 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 122.682 0.393 . . . . 52.0 110.331 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.47 -11.23 29.56 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.435 2.09 . . . . 62.119999999999997 112.672 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -93.38 18.06 10.33 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.025 0.93 . . . . 72.219999999999999 111.644 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.0 123.79 28.64 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.432 -0.581 . . . . 72.120000000000005 109.432 170.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -67.57 -39.34 84.9 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.041 0.537 . . . . 62.43 111.787 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -62.54 -35.77 80.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.698 0.799 . . . . 61.219999999999999 110.467 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 HD12 ' A' ' 66' ' ' LEU . 42.6 tp -72.68 -31.7 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.897 -1.047 . . . . 73.519999999999996 110.351 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -55.34 -28.0 50.9 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.665 0.786 . . . . 64.140000000000001 112.137 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -63.81 -49.5 72.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.411 -0.959 . . . . 73.400000000000006 108.411 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.465 HD11 HD12 ' A' ' 24' ' ' LEU . 72.9 mt -66.7 -44.93 80.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.155 0.982 . . . . 72.140000000000001 111.3 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.8 -41.24 95.22 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.836 0.71 . . . . 73.150000000000006 111.235 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -86.51 -23.13 26.02 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 112.037 0.384 . . . . 73.230000000000004 112.037 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -71.04 -38.25 72.55 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 122.579 0.351 . . . . 72.109999999999999 111.705 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -72.1 -15.44 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.975 0.417 . . . . 62.450000000000003 110.79 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.55 -152.82 0.23 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.583 1.153 . . . . 75.329999999999998 109.108 168.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.6 m -65.65 111.39 3.15 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.059 0.544 . . . . 73.099999999999994 111.087 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -119.5 175.32 5.9 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.432 1.093 . . . . 53.039999999999999 110.265 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.5 p -88.81 110.11 20.75 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.143 0.977 . . . . 74.200000000000003 109.75 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.3 71.15 10.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.441 -0.948 . . . . 75.200000000000003 108.441 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 t -172.41 27.72 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 114.124 -1.398 . . . . 71.209999999999994 108.714 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.8 p -64.8 146.84 54.28 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.399 0.68 . . . . 73.030000000000001 110.908 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.2 p -58.5 143.86 80.06 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 124.202 1.001 . . . . 74.420000000000002 111.83 -172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -51.48 143.96 33.82 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 123.155 2.57 . . . . 74.409999999999997 114.582 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -100.09 168.19 9.98 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.937 0.895 . . . . 71.219999999999999 109.443 175.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.64 114.99 25.89 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.307 0.643 . . . . 73.120000000000005 110.497 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.47 -35.2 73.07 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.6 2.2 . . . . 72.319999999999993 112.25 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.75 138.74 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.243 -1.021 . . . . 62.350000000000001 108.243 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.2 t -152.07 137.52 17.67 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.498 0.719 . . . . 71.439999999999998 109.622 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.23 178.15 6.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.521 0.728 . . . . 73.040000000000006 110.749 173.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 61.79 75.98 0.39 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.234 1.014 . . . . 75.349999999999994 108.732 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.97 103.5 1.51 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.307 -0.86 . . . . 73.219999999999999 109.128 -174.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.9 101.31 0.2 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.696 0.798 . . . . 71.150000000000006 110.433 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 C-N-CA 124.207 1.003 . . . . 61.299999999999997 108.677 -179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 119.555 -0.26 . . . . 75.230000000000004 111.657 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.4 mt -60.59 105.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.469 0.708 . . . . 73.150000000000006 110.627 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.5 tp -79.53 116.79 19.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.615 0.766 . . . . 73.430000000000007 110.025 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -99.89 131.55 45.8 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.149 0.98 . . . . 54.32 110.42 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.95 140.66 29.45 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.212 -1.403 . . . . 72.319999999999993 107.212 162.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -80.27 144.16 33.09 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 110.232 -0.284 . . . . 72.420000000000002 110.232 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -66.91 142.6 57.24 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.484 -0.932 . . . . 73.420000000000002 108.484 163.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 t -49.22 -35.43 17.3 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.917 0.887 . . . . 72.409999999999997 112.72 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -112.72 128.74 56.49 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.476 1.11 . . . . 72.299999999999997 108.701 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -173.5 140.52 0.81 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.829 0.851 . . . . 73.340000000000003 109.211 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.0 94.26 7.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.349 -0.982 . . . . 54.420000000000002 108.349 170.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 81.1 m -59.06 105.26 0.31 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.38 0.672 . . . . 72.340000000000003 111.374 -177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 5.0 mmp_? -104.83 95.18 5.7 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.606 0.717 . . . . 75.319999999999993 109.729 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.0 t -128.92 154.17 46.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.228 -1.351 . . . . 61.130000000000003 109.325 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -82.5 -25.84 33.11 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 121.643 0.735 . . . . 75.310000000000002 110.768 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.42 174.23 13.25 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.038 -1.225 . . . . 63.210000000000001 110.038 -175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -101.16 131.99 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.351 -0.981 . . . . 62.43 108.351 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 mt -129.16 133.51 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 107.587 -1.264 . . . . 72.109999999999999 107.587 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -76.53 8.21 3.75 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 113.21 0.819 . . . . 51.409999999999997 113.21 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 21.1 p -59.98 121.09 10.94 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.786 0.834 . . . . 64.439999999999998 110.246 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.6 t -72.63 108.86 4.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.368 -0.975 . . . . 63.399999999999999 108.368 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.7 t -83.03 137.04 21.64 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-N 115.175 -0.921 . . . . 75.540000000000006 108.977 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.35 123.61 33.72 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 124.063 0.852 . . . . 61.43 112.896 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HG ' HD21 ' A' ' 66' ' ' LEU . 8.5 mp -57.91 -34.25 69.65 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.685 0.794 . . . . 74.099999999999994 111.588 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -74.55 -27.39 60.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.357 0.663 . . . . 72.310000000000002 111.85 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.0 pt -93.82 -10.97 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 119.55 -0.262 . . . . 73.409999999999997 111.079 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.6 mt -68.36 115.58 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 109.385 -0.598 . . . . 73.439999999999998 109.385 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -98.06 -53.94 3.23 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.233 0.613 . . . . 72.329999999999998 110.73 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 5.9 mpt_? -125.99 143.9 50.91 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.784 0.834 . . . . 64.129999999999995 109.947 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.5 mt -129.85 106.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.433 -1.321 . . . . 71.310000000000002 107.433 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -105.7 122.23 45.64 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.121 0.418 . . . . 73.219999999999999 110.483 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.5 m -91.47 122.68 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.768 -0.827 . . . . 73.209999999999994 108.768 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.2 m -131.84 89.85 37.78 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 122.613 0.365 . . . . 73.109999999999999 111.019 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -60.04 158.3 30.42 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.24 2.627 . . . . 74.219999999999999 112.819 167.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.32 154.02 56.19 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.488 2.125 . . . . 75.409999999999997 112.781 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.84 -84.77 0.12 Allowed Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.193 -0.458 . . . . 63.350000000000001 112.331 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -118.3 39.0 3.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.526 1.155 . . . . 75.409999999999997 110.338 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.33 -77.14 0.05 OUTLIER Glycine 0 C--N 1.343 0.945 0 CA-C-N 114.593 -1.185 . . . . 53.329999999999998 112.128 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.6 m -75.8 136.1 70.66 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.026 0.53 . . . . 55.299999999999997 109.96 177.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.55 -10.58 15.88 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.871 2.38 . . . . 73.230000000000004 112.282 173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -145.13 173.13 12.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.352 1.461 . . . . 71.120000000000005 108.882 -174.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.6 m -81.06 113.4 19.22 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.254 -0.647 . . . . 64.040000000000006 109.254 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG3' ' HG3' ' A' ' 41' ' ' LYS . 44.6 mt-10 -118.38 122.83 43.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.683 1.193 . . . . 74.030000000000001 109.328 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.5 102.11 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.911 -1.144 . . . . 74.140000000000001 107.911 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.75 109.08 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 109.372 -0.603 . . . . 64.340000000000003 109.372 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.2 mt -97.58 126.37 50.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 123.967 0.907 . . . . 72.340000000000003 109.501 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.2 m-90 -98.89 131.2 45.16 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.067 -1.086 . . . . 71.049999999999997 108.067 169.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.1 p -85.89 170.62 12.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.799 0.44 . . . . 64.540000000000006 110.234 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -71.62 -13.18 61.68 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.622 0.769 . . . . 73.140000000000001 110.487 175.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 48.4 mtm -82.46 -5.74 58.87 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.371 1.068 . . . . 75.209999999999994 110.565 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 72.82 10.01 5.48 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.917 1.687 . . . . 74.0 112.557 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -77.01 129.96 36.82 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.431 0.692 . . . . 71.299999999999997 110.326 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.93 108.52 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.901 1.28 . . . . 75.150000000000006 110.021 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.0 mt -121.63 127.67 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 107.673 -1.232 . . . . 73.5 107.673 174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 29.3 m -106.58 152.21 24.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.043 -0.725 . . . . 52.310000000000002 109.043 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.14 162.25 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 C-N-CA 123.835 0.854 . . . . 63.240000000000002 108.926 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -75.26 147.61 83.0 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.709 0.804 . . . . 63.130000000000003 110.513 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.33 -21.37 54.37 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.961 2.441 . . . . 64.010000000000005 112.019 176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -85.02 3.64 37.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.722 0.809 . . . . 74.439999999999998 111.776 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.6 12.05 Favored 'General case' 0 C--N 1.359 1.011 0 C-N-CA 122.709 0.404 . . . . 71.430000000000007 110.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -64.57 -47.42 78.78 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.89 1.276 . . . . 41.350000000000001 110.643 -172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -67.41 -32.06 72.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.523 0.729 . . . . 75.299999999999997 111.879 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.87 -43.36 98.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.686 1.195 . . . . 73.230000000000004 111.378 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -58.87 -31.49 68.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.003 0.921 . . . . 73.510000000000005 112.805 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -63.79 -38.93 92.92 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.302 0.641 . . . . 73.140000000000001 110.13 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.527 HD21 ' HG ' ' A' ' 24' ' ' LEU . 9.7 mp -72.99 -41.15 64.62 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.387 -0.824 . . . . 74.519999999999996 110.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.57 -33.26 75.2 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.254 0.622 . . . . 63.020000000000003 111.209 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -82.44 -33.0 28.71 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.828 0.451 . . . . 65.530000000000001 111.634 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 41.8 t60 -65.52 -46.15 80.73 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.062 0.545 . . . . 74.120000000000005 110.895 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.45 -18.48 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.135 0.574 . . . . 43.240000000000002 112.547 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -68.85 -55.97 9.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.192 0.597 . . . . 72.230000000000004 110.479 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.7 t -162.08 144.76 11.54 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.985 0.514 . . . . 54.130000000000003 110.998 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -105.71 135.08 47.77 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.342 1.057 . . . . 75.200000000000003 108.568 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.7 t -107.44 101.93 11.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.1 -1.074 . . . . 70.409999999999997 108.1 171.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.3 tp -79.22 125.7 29.8 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.089 0.555 . . . . 72.530000000000001 110.476 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.5 p -112.85 125.54 54.47 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.178 -1.045 . . . . 74.400000000000006 108.178 168.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.1 p -86.01 137.77 32.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.65 0.38 . . . . 64.010000000000005 110.302 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.0 p -74.92 136.99 73.11 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.811 0.845 . . . . 63.329999999999998 111.205 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.31 148.77 77.56 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.965 2.443 . . . . 63.32 113.005 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -76.28 152.85 36.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.75 0.42 . . . . 74.439999999999998 110.18 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 141.07 35.96 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 115.794 -0.639 . . . . 62.140000000000001 110.265 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.21 168.91 22.0 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.455 2.104 . . . . 72.519999999999996 111.485 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -115.81 134.56 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.069 0.548 . . . . 64.5 109.993 -176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 p -81.06 155.43 26.33 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.153 0.581 . . . . 61.109999999999999 110.944 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -77.25 -168.78 1.19 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.777 0.831 . . . . 74.019999999999996 112.139 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -145.48 163.14 35.59 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.251 1.02 . . . . 74.219999999999999 109.065 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.2 mtm-85 -58.83 146.7 36.34 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.873 0.869 . . . . 65.209999999999994 111.667 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -99.71 -52.62 3.41 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.541 0.736 . . . . 60.439999999999998 109.915 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.958 0 N-CA-C 108.563 -0.903 . . . . 75.120000000000005 108.563 178.146 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.486 -0.931 . . . . 75.510000000000005 108.486 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.0 mt -62.45 96.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.518 0.727 . . . . 75.120000000000005 109.697 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 68.9 tp -80.34 110.59 15.92 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.632 -0.877 . . . . 70.530000000000001 108.632 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -103.92 114.57 28.92 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.363 1.065 . . . . 71.140000000000001 110.33 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.06 117.46 24.04 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.273 -1.38 . . . . 63.240000000000002 107.273 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 10' ' ' LEU . 26.2 t60 -78.46 96.57 5.42 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.367 0.603 . . . . 72.049999999999997 109.623 -171.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -117.24 -25.69 7.01 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.276 1.03 . . . . 73.299999999999997 110.198 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.4 p -68.87 146.65 52.65 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 124.144 0.978 . . . . 74.230000000000004 111.019 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -69.8 89.53 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.949 0.899 . . . . 74.150000000000006 109.049 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.445 ' HB3' ' CE1' ' A' ' 6' ' ' HIS . 6.1 tt -144.18 133.48 23.14 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.493 -1.669 . . . . 74.340000000000003 106.493 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -87.84 107.61 18.76 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.883 0.473 . . . . 73.319999999999993 109.931 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 63.0 m -67.18 111.33 3.87 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.134 0.574 . . . . 62.240000000000002 109.75 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -104.83 90.12 3.38 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 123.493 0.717 . . . . 74.219999999999999 110.313 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.0 t -134.66 147.02 50.05 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.173 -0.922 . . . . 53.43 109.35 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.6 m -91.58 25.37 2.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.873 0.869 . . . . 64.439999999999998 112.044 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.5 174.29 17.87 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 112.125 -0.39 . . . . 63.520000000000003 112.125 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 m -107.9 137.47 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.634 0.774 . . . . 53.229999999999997 110.881 -171.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 5.3 mt -119.74 135.82 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.249 1.02 . . . . 62.109999999999999 108.375 -174.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.5 m -79.74 11.93 2.92 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 113.526 0.936 . . . . 74.519999999999996 113.526 -177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.1 p -57.93 125.93 25.21 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.421 1.088 . . . . 61.140000000000001 111.699 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.17 111.49 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.383 0.611 . . . . 72.120000000000005 109.545 175.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.6 141.55 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.136 0.975 . . . . 63.340000000000003 108.519 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -65.61 123.71 25.41 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 123.67 0.606 . . . . 63.310000000000002 112.363 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.51 -28.13 66.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.989 0.915 . . . . 74.420000000000002 112.281 -170.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -79.22 -25.24 42.68 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.902 0.481 . . . . 75.109999999999999 111.413 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.0 pt -97.09 -14.42 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 119.321 -0.371 . . . . 74.25 111.144 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 23' ' ' GLY . 54.7 mt -63.45 107.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 109.55 -0.537 . . . . 64.140000000000001 109.55 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -96.82 -43.7 7.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.482 0.713 . . . . 65.409999999999997 110.964 -174.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 68.5 mtt180 -140.15 141.16 36.07 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.163 0.985 . . . . 71.420000000000002 109.614 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 46' ' ' ILE . 59.3 mt -130.62 108.08 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.47 1.108 . . . . 51.299999999999997 108.513 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -109.45 120.08 41.4 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.81 0.444 . . . . 54.329999999999998 110.429 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.7 115.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 N-CA-C 108.84 -0.8 . . . . 65.030000000000001 108.84 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.47 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 29.8 p -106.48 122.4 42.1 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.07 0.948 . . . . 50.329999999999998 109.595 -175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 91.8 Cg_endo -81.85 145.2 14.12 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.657 2.238 . . . . 73.409999999999997 112.457 178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 41' ' ' LYS . 55.1 Cg_endo -67.63 147.24 75.83 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.914 2.409 . . . . 74.049999999999997 111.945 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.58 -135.75 5.32 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 116.838 -0.164 . . . . 73.239999999999995 112.789 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -72.32 -53.23 13.01 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.807 0.843 . . . . 73.019999999999996 112.106 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.38 -51.45 8.48 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 111.608 -0.597 . . . . 74.200000000000003 111.608 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 34' ' ' PRO . 8.5 m -108.63 132.99 20.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.907 -0.775 . . . . 72.239999999999995 108.907 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.22 -40.6 18.95 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.848 2.365 . . . . 73.519999999999996 112.829 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 35' ' ' PRO . 19.1 ptpt -149.6 174.35 12.64 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.07 0.948 . . . . 72.129999999999995 109.732 -176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.8 m -66.57 110.89 3.35 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.013 -1.106 . . . . 60.149999999999999 108.013 172.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -128.67 152.17 48.69 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.294 -1.002 . . . . 71.129999999999995 108.294 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.38 102.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 107.468 -1.308 . . . . 71.319999999999993 107.468 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -91.13 109.52 21.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.557 -0.905 . . . . 74.030000000000001 108.557 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG23 HG23 ' A' ' 27' ' ' ILE . 45.1 mt -95.48 113.97 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.328 -0.851 . . . . 73.200000000000003 109.49 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.483 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.3 m-90 -85.22 132.11 34.33 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.373 -1.343 . . . . 75.409999999999997 107.373 167.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.8 p -87.82 169.06 12.38 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.589 -0.523 . . . . 64.540000000000006 109.589 171.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -64.95 -24.05 67.4 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.756 0.822 . . . . 72.230000000000004 111.645 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.5 mtm -91.53 9.36 32.33 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.916 0.886 . . . . 73.319999999999993 110.918 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 70.18 18.16 7.02 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.41 1.484 . . . . 64.25 114.023 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -75.59 122.37 23.83 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.95 -0.759 . . . . 71.519999999999996 108.95 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.64 104.76 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.625 1.17 . . . . 50.210000000000001 108.851 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -111.75 140.53 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.624 -0.88 . . . . 62.310000000000002 108.624 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.8 m -110.4 133.29 53.41 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.494 -0.928 . . . . 43.530000000000001 108.494 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 32.7 m -126.66 153.38 35.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 124.509 1.124 . . . . 74.409999999999997 109.005 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -82.92 139.52 43.02 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 116.01 -0.541 . . . . 74.540000000000006 110.126 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -59.31 -33.59 97.79 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.34 2.693 . . . . 71.219999999999999 113.165 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -89.14 14.72 10.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.403 0.681 . . . . 72.439999999999998 112.337 -174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.83 127.67 33.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.048 0.539 . . . . 73.310000000000002 109.848 175.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -54.78 -49.75 70.15 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.293 1.437 . . . . 73.319999999999993 112.652 -174.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -67.46 -31.05 70.95 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.728 0.811 . . . . 64.109999999999999 110.454 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 49.4 tp -74.78 -38.0 62.25 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.064 -0.971 . . . . 74.310000000000002 110.43 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -57.98 -29.78 65.52 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.805 0.842 . . . . 73.010000000000005 111.733 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -61.37 -52.23 65.48 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.008 0.817 . . . . 74.439999999999998 109.324 172.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.62 -47.87 81.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.17 0.588 . . . . 73.219999999999999 111.739 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.6 mt -57.34 -48.03 80.04 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.805 0.842 . . . . 44.399999999999999 110.395 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -41.14 87.04 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.398 -0.819 . . . . 73.400000000000006 111.311 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -74.98 -47.51 28.97 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.594 0.59 . . . . 73.400000000000006 112.594 -173.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.86 -27.63 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.047 0.539 . . . . 72.409999999999997 112.097 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -91.31 125.48 36.08 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.621 0.769 . . . . 74.209999999999994 108.961 176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m 63.14 32.88 14.9 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.341 1.056 . . . . 65.030000000000001 110.825 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.71 102.24 0.07 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.327 1.451 . . . . 74.400000000000006 110.493 -172.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.7 t -91.6 176.43 6.54 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.326 0.65 . . . . 71.409999999999997 110.291 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -71.85 105.89 3.98 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.708 -0.849 . . . . 62.399999999999999 108.708 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 p -87.3 59.73 5.71 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.182 0.993 . . . . 75.439999999999998 110.611 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.5 t 64.42 178.47 0.18 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.009 1.324 . . . . 75.5 111.538 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.5 p -126.4 151.26 72.31 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.163 0.985 . . . . 73.430000000000007 109.493 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -60.43 135.8 63.58 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.57 2.18 . . . . 73.340000000000003 111.582 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -73.05 168.26 19.42 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.86 0.864 . . . . 73.340000000000003 111.468 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.31 131.01 92.14 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 123.497 0.719 . . . . 74.230000000000004 110.926 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.1 163.27 0.91 Allowed 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.674 2.916 . . . . 73.450000000000003 113.318 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.529 HG22 ' HG2' ' A' ' 85' ' ' LYS . 9.9 p -53.86 130.35 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.079 0.951 . . . . 73.310000000000002 111.518 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.0 m -81.11 19.71 0.88 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.255 0.835 . . . . 63.219999999999999 113.255 -170.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.529 ' HG2' HG22 ' A' ' 83' ' ' VAL . 31.8 mmmt -74.87 142.96 44.05 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.636 0.374 . . . . 64.519999999999996 110.758 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -139.32 110.23 6.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.993 -1.484 . . . . 75.420000000000002 106.993 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -79.98 90.31 5.36 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.764 0.426 . . . . 73.109999999999999 111.568 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.34 85.33 5.17 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.248 -1.019 . . . . 72.230000000000004 108.248 168.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.778 0.831 . . . . 55.0 109.019 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.641 -0.503 . . . . 74.150000000000006 109.641 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mp -72.42 101.59 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 C-N-CA 123.834 0.853 . . . . 71.140000000000001 109.047 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.5 tp -81.2 121.99 26.83 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.416 0.686 . . . . 75.319999999999993 109.665 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -120.06 144.94 47.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.984 0.913 . . . . 71.109999999999999 110.679 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.28 130.96 50.67 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 106.678 -1.601 . . . . 61.530000000000001 106.678 163.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 3.3 p80 -79.16 115.21 18.68 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.388 0.613 . . . . 73.140000000000001 110.074 -171.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -87.29 -29.98 21.21 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.598 0.759 . . . . 72.150000000000006 109.191 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.4 m -70.74 92.43 0.88 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.516 -0.765 . . . . 74.430000000000007 109.141 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -110.7 34.79 3.78 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.489 0.716 . . . . 71.120000000000005 110.186 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.1 mt -78.69 -59.9 2.59 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.89 -0.782 . . . . 75.129999999999995 108.89 172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -149.35 131.08 15.03 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.378 1.071 . . . . 75.200000000000003 109.817 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.3 m -99.99 105.36 17.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.82 -1.178 . . . . 74.010000000000005 107.82 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -89.18 90.18 8.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.889 0.476 . . . . 72.099999999999994 110.604 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 45' ' ' VAL . 91.9 m -134.46 104.46 6.12 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.289 -1.004 . . . . 75.239999999999995 108.289 167.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.8 t -68.0 -16.62 64.13 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.87 0.868 . . . . 73.530000000000001 112.078 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.7 169.99 42.79 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 111.36 -0.696 . . . . 62.140000000000001 111.36 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 m -106.19 132.51 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 108.96 -0.756 . . . . 62.520000000000003 108.96 173.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.2 mt -109.99 117.32 54.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.825 -1.546 . . . . 71.040000000000006 106.825 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.1 t -85.57 14.72 5.27 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.98 0.912 . . . . 63.020000000000003 111.926 -172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.1 m -74.91 141.85 44.07 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.327 1.051 . . . . 74.140000000000001 109.817 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.82 118.61 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 109.009 -0.737 . . . . 73.010000000000005 109.009 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.32 131.89 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.157 -0.683 . . . . 74.230000000000004 109.157 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -64.03 127.84 36.19 Favored Glycine 0 C--N 1.355 1.616 0 CA-C-O 119.578 -0.568 . . . . 73.129999999999995 113.387 -175.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' HG ' HD11 ' A' ' 66' ' ' LEU . 10.2 mp -59.85 -29.13 68.07 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.369 0.668 . . . . 55.420000000000002 111.826 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -68.31 -38.03 81.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.859 0.464 . . . . 43.329999999999998 110.649 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.9 pt -87.3 -22.48 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 118.884 -0.579 . . . . 74.549999999999997 110.913 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 23' ' ' GLY . 65.6 mt -66.59 129.66 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 CA-C-N 118.088 0.404 . . . . 41.43 110.032 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 49' ' ' LYS . 37.8 t70 -119.67 -49.39 2.34 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.369 0.668 . . . . 52.030000000000001 110.654 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 69.5 mtp180 -126.25 137.14 53.49 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.127 0.971 . . . . 73.140000000000001 110.317 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt -128.09 106.8 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.089 -1.078 . . . . 74.219999999999999 108.089 175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -108.97 127.22 53.88 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.893 0.877 . . . . 75.319999999999993 109.644 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.46 130.81 36.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 N-CA-C 109.107 -0.701 . . . . 63.240000000000002 109.107 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.724 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 25.0 p -124.79 81.39 61.52 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.573 0.749 . . . . 74.329999999999998 110.731 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.18 157.72 49.98 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 122.753 2.302 . . . . 70.329999999999998 112.035 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.512 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 71.6 Cg_endo -70.7 161.22 46.81 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.018 2.479 . . . . 63.399999999999999 113.286 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.96 -121.88 1.04 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.199 -0.76 . . . . 64.040000000000006 111.199 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -81.49 -33.41 31.93 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.241 0.616 . . . . 71.209999999999994 110.056 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.69 -60.29 0.99 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-N 116.249 -0.432 . . . . 60.420000000000002 113.889 -174.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.724 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 27.5 m -81.28 122.41 81.23 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 122.994 0.518 . . . . 73.329999999999998 109.675 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.55 -39.25 46.03 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 121.957 1.771 . . . . 74.349999999999994 111.9 167.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -123.16 171.76 9.09 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.249 1.02 . . . . 44.109999999999999 110.98 -170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.9 m -88.22 112.19 22.49 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.133 -1.062 . . . . 74.219999999999999 108.133 168.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.07 167.95 20.89 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.229 1.012 . . . . 63.409999999999997 108.514 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -131.38 116.4 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.452 0.701 . . . . 72.120000000000005 109.161 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG22 ' SG ' ' A' ' 14' ' ' CYS . 48.7 t -91.88 109.3 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.204 0.602 . . . . 72.109999999999999 109.76 -178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.6 mt -97.8 124.43 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.988 0.915 . . . . 74.349999999999994 109.662 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 30.1 m-90 -96.26 125.06 40.51 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.026 -1.102 . . . . 61.439999999999998 108.026 165.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 65.9 p -82.71 159.0 22.68 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.388 -0.967 . . . . 70.319999999999993 108.388 167.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 25.8 pttm -73.75 0.93 11.55 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.221 0.608 . . . . 72.129999999999995 112.338 -176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.8 mtm -101.98 8.89 40.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.114 0.966 . . . . 62.210000000000001 110.331 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 65.84 26.58 11.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.947 1.699 . . . . 71.329999999999998 113.827 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -83.17 123.55 29.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.145 -1.058 . . . . 74.310000000000002 108.145 168.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.6 t -94.44 112.85 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.875 0.87 . . . . 64.150000000000006 109.307 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.0 mt -118.47 128.42 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 108.397 -0.964 . . . . 61.32 108.397 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.3 m -106.51 119.1 38.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.48 -1.304 . . . . 45.399999999999999 107.48 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.54 165.47 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.251 1.02 . . . . 75.030000000000001 110.679 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -88.99 141.04 29.23 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 123.962 0.905 . . . . 71.219999999999999 110.529 -177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.43 -30.62 87.26 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 123.083 2.522 . . . . 64.230000000000004 114.202 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.41 9.55 8.87 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.85 0.685 . . . . 73.010000000000005 112.85 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 119.95 13.28 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 109.709 -0.478 . . . . 52.210000000000001 109.709 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -64.75 -39.62 93.92 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.503 0.721 . . . . 75.420000000000002 110.849 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -62.77 -35.57 80.27 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.485 0.714 . . . . 70.030000000000001 110.584 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.1 tp -67.89 -34.52 76.82 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.016 0.926 . . . . 70.120000000000005 110.192 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -60.58 -29.34 69.12 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.716 0.635 . . . . 72.409999999999997 111.82 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -57.83 -53.2 60.94 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 108.998 -0.741 . . . . 64.209999999999994 108.998 172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.44 HD11 ' HG ' ' A' ' 24' ' ' LEU . 4.1 mm? -63.69 -45.59 89.35 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.727 -1.124 . . . . 74.120000000000005 110.258 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.79 -40.81 98.48 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 124.047 0.842 . . . . 65.230000000000004 111.096 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -82.8 -24.7 33.27 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.23 0.456 . . . . 72.329999999999998 112.23 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -78.91 -32.2 45.63 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.452 0.301 . . . . 72.019999999999996 111.201 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.36 -1.78 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 111.778 0.288 . . . . 75.230000000000004 111.778 175.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -92.12 -176.42 4.37 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.32 1.048 . . . . 72.439999999999998 111.268 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -72.23 83.7 1.03 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.229 1.012 . . . . 71.409999999999997 111.33 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.646 ' HE2' ' HB2' ' A' ' 75' ' ' LEU . 23.6 tptm -164.88 94.07 0.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.957 -1.127 . . . . 75.430000000000007 107.957 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 70.8 m -87.97 37.25 0.8 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.981 0.912 . . . . 70.400000000000006 111.553 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' HB2' ' HE2' ' A' ' 73' ' ' LYS . 97.2 mt -132.77 100.82 5.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.142 0.977 . . . . 74.329999999999998 108.618 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -128.78 -160.23 1.01 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.698 1.199 . . . . 74.439999999999998 108.524 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.4 t -70.38 176.37 4.04 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.92 0.488 . . . . 73.319999999999993 110.275 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.6 p -57.37 132.87 81.47 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 123.302 0.641 . . . . 72.319999999999993 111.193 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.83 145.52 97.08 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.227 2.618 . . . . 74.540000000000006 112.417 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -134.18 166.58 22.44 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.727 0.811 . . . . 71.0 110.882 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.82 120.28 2.86 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.002 1.321 . . . . 53.109999999999999 107.92 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.12 -32.34 94.52 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.472 2.114 . . . . 75.400000000000006 111.557 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 t -110.24 72.53 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 107.414 -1.328 . . . . 63.109999999999999 107.414 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.4 p -76.83 -53.09 8.37 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.858 -0.61 . . . . 70.439999999999998 109.67 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -80.69 124.47 29.05 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.634 -0.876 . . . . 73.129999999999995 108.634 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 59.2 59.63 2.65 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.243 1.017 . . . . 72.209999999999994 109.319 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.09 76.92 0.24 Allowed 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.038 -0.983 . . . . 74.319999999999993 112.705 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.04 135.44 52.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.94 0.896 . . . . 61.350000000000001 111.831 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 C-N-CA 123.996 0.919 . . . . 54.509999999999998 109.47 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mtp . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.973 -0.38 . . . . 75.209999999999994 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mp -96.47 134.96 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 108.213 -1.032 . . . . 74.120000000000005 108.213 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.8 tp -102.45 110.09 21.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.846 0.458 . . . . 71.439999999999998 110.126 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -98.34 145.75 26.39 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.953 0.901 . . . . 73.200000000000003 110.252 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.09 113.9 21.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.211 1.004 . . . . 65.349999999999994 108.68 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -80.97 136.19 35.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.116 0.566 . . . . 73.310000000000002 110.333 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -151.4 -25.77 0.2 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.252 -0.885 . . . . 73.349999999999994 109.818 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.8 p -65.36 119.36 10.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.905 0.482 . . . . 62.149999999999999 110.644 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -63.86 93.57 0.09 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.124 0.969 . . . . 62.030000000000001 110.854 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.1 tt -152.34 136.36 16.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.242 -1.392 . . . . 74.219999999999999 107.242 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 12.1 mptt -51.55 102.55 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.519 1.137 . . . . 75.310000000000002 110.387 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.9 104.49 2.51 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.577 -0.527 . . . . 74.340000000000003 109.577 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -83.98 88.31 7.15 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.21 -1.033 . . . . 61.130000000000003 108.21 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -135.67 125.39 25.44 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.465 -1.243 . . . . 71.340000000000003 108.48 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -79.91 76.24 6.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.314 0.646 . . . . 71.200000000000003 110.285 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.54 -127.0 43.68 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.0 -1.0 . . . . 32.539999999999999 112.933 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -142.9 136.11 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.566 1.146 . . . . 55.229999999999997 108.534 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.3 mt -118.36 120.11 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 107.94 -1.133 . . . . 75.310000000000002 107.94 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 p -91.44 30.95 1.21 Allowed 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.833 0.853 . . . . 73.329999999999998 112.573 -172.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.3 p -90.35 143.43 26.76 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.286 0.634 . . . . 71.299999999999997 109.615 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -70.81 134.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 123.969 0.793 . . . . 73.030000000000001 109.872 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.66 132.37 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 108.584 -0.895 . . . . 73.030000000000001 108.584 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -68.83 133.41 27.08 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.523 0.515 . . . . 73.150000000000006 112.677 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.13 -25.09 67.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.72 0.808 . . . . 50.149999999999999 111.441 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -72.33 -35.84 68.7 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.46 0.704 . . . . 70.549999999999997 110.425 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.0 pt -87.9 -18.29 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 117.846 0.294 . . . . 60.210000000000001 110.812 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 23' ' ' GLY . 64.5 mt -68.61 121.22 17.47 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 123.103 0.561 . . . . 65.420000000000002 109.938 174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -99.82 -49.3 4.4 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 123.321 0.649 . . . . 65.109999999999999 109.813 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -138.11 149.88 46.34 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 64.030000000000001 110.281 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 46' ' ' ILE . 59.3 mt -137.82 112.98 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.17 1.388 . . . . 73.239999999999995 108.018 178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -108.29 114.47 28.36 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.075 0.55 . . . . 73.099999999999994 109.585 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.7 m -87.26 133.71 29.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.523 -0.917 . . . . 51.520000000000003 108.523 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.412 HG21 ' SG ' ' A' ' 39' ' ' CYS . 10.0 t -135.09 141.18 37.14 Favored Pre-proline 0 C--O 1.252 1.2 0 N-CA-C 112.37 0.507 . . . . 75.430000000000007 112.37 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.62 174.57 12.01 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 123.538 2.825 . . . . 61.539999999999999 112.517 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.16 55.14 5.49 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 122.859 2.372 . . . . 41.210000000000001 112.1 173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.62 -168.51 41.37 Favored Glycine 0 C--O 1.246 0.878 0 N-CA-C 110.948 -0.861 . . . . 53.32 110.948 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.4 m120 58.2 30.84 20.0 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.363 1.065 . . . . 71.239999999999995 111.965 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 125.06 -33.68 3.62 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.818 -0.628 . . . . 72.340000000000003 112.806 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 33' ' ' THR . 60.8 m -98.91 141.27 22.61 Favored Pre-proline 0 N--CA 1.479 1.004 0 C-N-CA 123.304 0.642 . . . . 62.219999999999999 110.265 -177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.76 -32.09 24.07 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.586 2.191 . . . . 74.049999999999997 112.799 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -144.08 172.28 13.11 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.538 0.735 . . . . 43.119999999999997 109.848 -173.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.4 m -68.65 115.2 7.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.249 -0.648 . . . . 64.310000000000002 109.249 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -133.22 156.12 48.09 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 109.455 -0.572 . . . . 70.25 109.455 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.9 t -129.67 105.64 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.381 -1.34 . . . . 72.120000000000005 107.381 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.2 t -94.96 109.72 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 115.654 -0.703 . . . . 71.420000000000002 109.378 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 30' ' ' ILE . 43.5 mt -97.83 116.99 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.794 0.838 . . . . 74.109999999999999 110.033 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.0 m-90 -90.56 137.71 32.14 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.317 -0.994 . . . . 73.430000000000007 108.317 168.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' HE1' ' A' ' 50' ' ' MET . 45.9 p -98.03 173.49 7.02 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.601 0.36 . . . . 61.350000000000001 111.214 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.98 -22.78 62.14 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.614 0.765 . . . . 62.340000000000003 110.98 176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.462 ' HE1' ' HB ' ' A' ' 48' ' ' THR . 4.4 mpp? -76.84 -3.1 36.7 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.494 0.718 . . . . 71.239999999999995 111.09 170.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt 76.02 12.81 2.8 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.068 1.747 . . . . 53.229999999999997 112.947 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -76.82 136.86 38.95 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 122.74 0.416 . . . . 64.0 110.218 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.9 t -85.99 102.62 11.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 O-C-N 124.558 1.161 . . . . 72.349999999999994 108.787 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.3 mt -98.25 138.72 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.246 -1.02 . . . . 74.430000000000007 108.246 172.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 99.5 m -107.9 134.01 51.43 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.105 -1.443 . . . . 64.120000000000005 107.105 170.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.23 152.97 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 122.837 0.455 . . . . 65.319999999999993 109.844 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -75.7 135.43 71.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 115.107 -0.951 . . . . 74.329999999999998 110.643 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.98 -5.73 15.33 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.554 2.169 . . . . 72.299999999999997 112.969 176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -86.89 -18.46 30.8 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.297 0.639 . . . . 74.540000000000006 111.539 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -53.2 122.07 8.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.565 0.746 . . . . 74.239999999999995 112.088 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.12 -47.32 86.42 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.574 1.15 . . . . 62.409999999999997 111.066 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -58.98 -38.04 78.2 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 124.097 0.873 . . . . 74.120000000000005 110.54 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.6 tp -68.56 -30.83 69.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.476 1.11 . . . . 72.239999999999995 111.595 -174.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -60.6 -43.16 97.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.368 0.667 . . . . 73.099999999999994 112.283 -175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 74.5 mtm180 -64.45 -27.05 68.73 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.5 0.5 . . . . 75.420000000000002 111.336 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.42 -46.13 42.07 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.367 -0.605 . . . . 72.5 109.367 174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.22 -27.5 67.24 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.877 0.871 . . . . 73.349999999999994 111.108 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -81.98 -56.42 3.97 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.156 0.582 . . . . 72.400000000000006 111.026 172.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -78.1 -15.08 59.2 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 113.21 0.818 . . . . 74.519999999999996 113.21 -162.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.5 m -67.16 -32.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.06 0.846 . . . . 74.340000000000003 110.591 173.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -86.23 113.33 22.16 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.477 -0.935 . . . . 53.149999999999999 108.477 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 70.6 m 62.03 42.58 9.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.829 1.251 . . . . 61.030000000000001 111.178 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -44.61 117.03 1.17 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.162 1.385 . . . . 71.200000000000003 112.715 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 p -97.72 157.93 15.78 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.383 1.073 . . . . 73.340000000000003 110.066 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.59 129.01 36.5 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.11 -0.7 . . . . 70.540000000000006 109.11 173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.3 t -138.43 24.86 2.68 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.918 0.887 . . . . 75.439999999999998 109.499 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.1 t -145.74 174.18 11.43 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 115.273 -0.876 . . . . 53.43 109.64 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 37.3 p -63.15 127.13 90.53 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 123.59 0.756 . . . . 63.32 110.061 174.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.35 86.74 1.13 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.487 2.125 . . . . 61.109999999999999 112.167 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -77.19 170.57 16.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.729 -1.123 . . . . 74.209999999999994 110.39 174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.39 111.74 15.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.383 0.673 . . . . 74.420000000000002 109.707 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.3 -176.49 2.99 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.492 2.128 . . . . 74.530000000000001 110.96 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.4 88.81 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 107.642 -1.244 . . . . 70.340000000000003 107.642 175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -68.81 89.29 0.39 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.694 -1.139 . . . . 63.219999999999999 111.166 -171.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -103.42 -162.16 0.89 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.511 1.124 . . . . 74.209999999999994 109.053 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -70.29 112.42 6.61 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.53 -0.544 . . . . 71.140000000000001 109.53 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -69.26 145.39 53.15 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.144 1.378 . . . . 64.439999999999998 111.4 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.18 149.54 27.87 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.924 0.89 . . . . 73.340000000000003 111.324 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 C-N-CA 124.201 1.0 . . . . 61.219999999999999 108.835 179.096 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 108.611 -0.885 . . . . 63.310000000000002 108.611 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.586 ' HB ' ' HG3' ' A' ' 29' ' ' ARG . 3.8 mp -67.88 104.44 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 123.694 0.621 . . . . 70.329999999999998 109.436 -176.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD22 HG21 ' A' ' 70' ' ' VAL . 37.3 tp -80.24 117.2 20.81 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 109.023 -0.732 . . . . 74.430000000000007 109.023 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -105.93 148.62 27.44 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 123.875 0.87 . . . . 74.0 110.323 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.41 142.93 26.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 114.634 -1.166 . . . . 62.100000000000001 108.033 168.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.438 ' CE1' ' SG ' ' A' ' 12' ' ' CYS . 63.7 t60 -81.09 137.9 35.97 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.992 -0.373 . . . . 73.129999999999995 109.992 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -115.27 157.38 23.85 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.914 0.885 . . . . 74.519999999999996 109.923 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.2 m -61.2 -40.84 95.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.991 0.916 . . . . 72.329999999999998 111.55 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -84.6 67.15 9.88 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.812 0.815 . . . . 74.109999999999999 109.257 177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 tt -170.23 97.36 0.27 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 106.89 -1.522 . . . . 52.130000000000003 106.89 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -68.88 137.3 53.75 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.441 0.696 . . . . 72.450000000000003 110.612 175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' SG ' HG21 ' A' ' 33' ' ' THR . 73.1 m -101.82 102.96 13.64 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.854 -0.424 . . . . 72.310000000000002 109.854 177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -115.3 88.95 2.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.18 0.592 . . . . 65.450000000000003 109.646 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.6 t -134.95 158.65 43.76 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.975 -0.75 . . . . 64.340000000000003 108.975 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.2 m -67.54 -27.17 66.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 112.57 -175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.51 -156.83 27.14 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.022 -0.831 . . . . 74.340000000000003 111.022 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.75 136.61 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 109.27 -0.641 . . . . 75.040000000000006 109.27 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.638 HD12 HG23 ' A' ' 54' ' ' ILE . 46.4 mt -103.94 134.93 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.1 0.96 . . . . 72.239999999999995 109.548 -172.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -85.88 28.19 0.81 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.559 1.143 . . . . 61.509999999999998 113.094 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 75.3 p -109.55 145.39 36.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.099 0.56 . . . . 74.010000000000005 110.866 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.79 111.67 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.634 -1.247 . . . . 63.210000000000001 107.634 168.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.5 t -82.44 128.25 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.394 -0.965 . . . . 73.219999999999999 108.394 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 26' ' ' ILE . . . -58.99 126.94 44.11 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.803 0.69 . . . . 64.430000000000007 112.688 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' HG ' HD11 ' A' ' 66' ' ' LEU . 9.1 mp -59.98 -31.59 70.05 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.416 0.686 . . . . 71.019999999999996 111.509 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.59 -37.35 82.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.33 0.652 . . . . 72.0 111.205 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 23' ' ' GLY . 20.9 pt -82.97 -24.19 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-O 119.634 -0.222 . . . . 73.439999999999998 110.541 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.64 120.1 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.447 0.699 . . . . 71.420000000000002 110.653 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -101.67 -40.92 6.76 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.424 0.69 . . . . 75.310000000000002 110.796 175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.586 ' HG3' ' HB ' ' A' ' 2' ' ' ILE . 14.3 ttm180 -152.79 135.81 15.58 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.827 -0.435 . . . . 73.299999999999997 109.827 -163.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 46' ' ' ILE . 67.4 mt -133.47 113.39 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.76 1.224 . . . . 73.219999999999999 109.079 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -109.69 125.63 52.85 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.925 0.49 . . . . 62.229999999999997 109.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.1 t -86.35 111.75 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.871 -0.789 . . . . 41.219999999999999 108.871 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.632 HG21 ' SG ' ' A' ' 12' ' ' CYS . 71.5 m -110.5 106.48 57.9 Favored Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 124.008 0.923 . . . . 62.409999999999997 111.185 -176.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -66.96 162.55 37.48 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.01 2.473 . . . . 71.420000000000002 112.765 166.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -85.43 152.74 10.53 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.514 2.142 . . . . 74.510000000000005 111.791 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 -146.34 9.65 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.962 -0.455 . . . . 14.1 111.962 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -71.78 -53.59 12.88 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.245 0.618 . . . . 72.030000000000001 111.466 -176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.25 -27.2 72.15 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.347 0.499 . . . . 73.420000000000002 114.347 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.422 ' SG ' ' NE2' ' A' ' 6' ' ' HIS . 60.3 m -127.79 116.06 20.8 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.457 0.703 . . . . 74.329999999999998 109.933 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.61 -20.88 46.54 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.327 2.018 . . . . 63.329999999999998 113.895 -172.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -143.85 169.97 16.78 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.413 0.685 . . . . 53.340000000000003 111.554 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -86.98 117.26 25.59 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.782 0.833 . . . . 63.340000000000003 109.055 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -137.09 159.24 42.49 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.215 0.606 . . . . 75.140000000000001 109.385 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.6 t -124.87 104.13 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.202 -1.777 . . . . 64.239999999999995 106.202 169.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.83 107.39 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.617 -0.882 . . . . 75.530000000000001 108.617 -167.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 30' ' ' ILE . 52.1 mt -96.98 114.08 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 114.764 -1.107 . . . . 75.129999999999995 109.563 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' HB2' ' HB3' ' A' ' 29' ' ' ARG . 31.1 m-90 -86.73 125.71 34.08 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.35 -1.352 . . . . 72.310000000000002 107.35 166.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.6 p -84.04 162.8 20.23 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.61 -0.515 . . . . 64.329999999999998 109.61 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -21.84 64.38 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.602 0.761 . . . . 53.43 111.149 175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.1 mtm -84.73 -1.5 56.33 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.101 1.361 . . . . 72.310000000000002 111.421 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 70.28 19.94 6.36 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.528 1.531 . . . . 72.219999999999999 113.357 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.42 126.91 32.75 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.359 -0.608 . . . . 74.030000000000001 109.359 168.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.9 t -89.01 105.68 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.058 0.943 . . . . 74.310000000000002 108.916 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.638 HG23 HD12 ' A' ' 18' ' ' ILE . 73.1 mt -111.84 117.75 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.387 1.075 . . . . 63.100000000000001 108.416 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.7 m -105.95 125.52 51.09 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 108.068 -1.086 . . . . 60.109999999999999 108.068 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.83 165.97 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.713 0.805 . . . . 63.310000000000002 110.541 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.09 142.4 55.47 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.767 0.827 . . . . 71.340000000000003 110.765 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.77 -11.78 32.8 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.471 2.114 . . . . 60.450000000000003 113.304 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -86.2 -6.48 58.98 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.387 0.675 . . . . 75.120000000000005 111.314 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.14 114.89 2.34 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 109.158 -0.682 . . . . 62.409999999999997 109.158 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -36.18 73.47 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.748 0.819 . . . . 65.129999999999995 110.173 -170.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -61.92 -35.54 78.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.422 0.689 . . . . 72.310000000000002 110.423 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.24 -28.55 68.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.577 1.151 . . . . 74.319999999999993 111.048 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -61.53 -26.95 68.26 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.813 0.845 . . . . 62.109999999999999 111.954 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -56.27 -50.06 72.44 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.441 0.696 . . . . 75.150000000000006 109.674 170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.414 HD11 ' HG ' ' A' ' 24' ' ' LEU . 3.7 mm? -69.2 -45.07 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.323 1.014 . . . . 74.230000000000004 110.301 -174.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.58 -34.07 76.24 Favored 'General case' 0 CA--C 1.549 0.91 0 O-C-N 124.089 0.868 . . . . 63.219999999999999 111.178 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -89.68 -22.34 22.3 Favored 'General case' 0 CA--C 1.559 1.324 0 N-CA-C 112.518 0.562 . . . . 75.230000000000004 112.518 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.4 -38.3 41.93 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.875 0.47 . . . . 73.430000000000007 111.124 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 3' ' ' LEU . 35.7 m -63.07 -32.65 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 121.291 0.567 . . . . 74.310000000000002 110.727 173.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -68.6 152.55 45.21 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.269 171.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -64.46 81.28 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.813 0.845 . . . . 64.430000000000007 112.428 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -84.28 -79.3 0.22 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.833 0.853 . . . . 73.099999999999994 109.401 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.7 p 176.32 163.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.947 1.299 . . . . 64.040000000000006 110.129 -175.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.1 108.0 19.58 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.684 0.794 . . . . 73.099999999999994 108.887 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.8 t -56.44 125.42 21.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.2 1.0 . . . . 71.239999999999995 109.978 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.9 m -61.86 99.37 0.12 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.142 0.977 . . . . 62.240000000000002 111.93 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.7 p -74.07 115.63 44.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.761 0.824 . . . . 54.420000000000002 109.895 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -65.63 163.43 30.28 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.566 2.177 . . . . 73.219999999999999 113.044 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -67.56 134.31 51.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.979 0.912 . . . . 71.549999999999997 110.752 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.22 140.21 63.83 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.342 1.057 . . . . 50.229999999999997 112.122 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.08 -16.46 40.44 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.687 2.258 . . . . 74.439999999999998 111.957 176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.5 p -114.18 81.79 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 107.581 -1.266 . . . . 63.539999999999999 107.581 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 t -73.12 -51.45 17.94 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.601 -1.181 . . . . 50.450000000000003 110.026 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -100.24 147.87 25.26 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.553 0.741 . . . . 73.409999999999997 110.545 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -153.13 177.48 10.77 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.343 1.057 . . . . 74.299999999999997 109.31 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -74.04 79.23 1.71 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.779 0.8 . . . . 65.150000000000006 109.31 173.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -164.67 162.08 21.17 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.688 1.195 . . . . 60.409999999999997 109.16 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 C-N-CA 123.609 0.764 . . . . 51.119999999999997 109.091 -177.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.829 0.347 . . . . 64.049999999999997 110.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.3 mt -137.78 119.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.5 1.12 . . . . 74.049999999999997 108.249 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 70' ' ' VAL . 60.2 tp -90.78 107.38 19.15 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.41 -0.589 . . . . 64.239999999999995 109.41 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -83.11 142.69 31.07 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.351 0.661 . . . . 71.340000000000003 109.349 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.31 115.99 26.93 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.46 -0.941 . . . . 72.099999999999994 108.46 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.627 ' HE1' ' HB3' ' A' ' 10' ' ' LEU . 17.9 t60 -84.08 102.51 12.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.019 0.528 . . . . 65.299999999999997 110.173 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -104.92 -54.43 2.5 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.813 -0.81 . . . . 73.439999999999998 108.813 170.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.6 p -66.35 140.5 58.09 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.792 0.837 . . . . 64.219999999999999 111.479 -172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -63.13 119.56 9.77 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.63 0.772 . . . . 43.520000000000003 111.012 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.627 ' HB3' ' HE1' ' A' ' 6' ' ' HIS . 6.2 tt -157.98 134.33 9.52 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 106.316 -1.735 . . . . 63.109999999999999 106.316 -176.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.18 94.7 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.251 0.969 . . . . 65.409999999999997 110.693 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.9 m -74.02 102.25 4.11 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.622 0.769 . . . . 53.039999999999999 109.688 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -87.82 90.52 8.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.46 0.648 . . . . 71.010000000000005 110.325 -176.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG22 ' A' ' 45' ' ' VAL . 73.0 m -135.62 95.96 3.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.403 -1.271 . . . . 75.329999999999998 107.866 166.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.7 m -82.88 -4.47 58.17 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.869 0.867 . . . . 71.5 111.545 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.6 160.59 29.05 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.983 -0.847 . . . . 45.100000000000001 110.983 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.64 134.61 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 109.077 -0.712 . . . . 52.409999999999997 109.077 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.27 120.72 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.17 -1.419 . . . . 74.129999999999995 107.17 -174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.5 m -83.16 3.44 30.84 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 64.239999999999995 112.523 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.7 p -70.4 128.28 35.64 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.439 0.695 . . . . 72.310000000000002 110.47 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.71 109.07 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 108.003 -1.11 . . . . 34.119999999999997 108.003 175.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -84.83 142.05 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.822 -0.807 . . . . 72.209999999999994 108.822 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.03 129.51 21.06 Favored Glycine 0 C--N 1.348 1.206 0 O-C-N 123.413 0.446 . . . . 53.210000000000001 113.766 -173.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 66' ' ' LEU . 9.6 mp -61.41 -24.41 66.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.042 0.937 . . . . 63.130000000000003 112.096 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -70.98 -34.81 71.77 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.572 0.749 . . . . 75.109999999999999 111.033 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.3 pt -95.72 -17.21 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.492 0.317 . . . . 71.239999999999995 111.759 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 92.2 mt -72.24 125.77 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 109.796 -0.446 . . . . 74.519999999999996 109.796 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -118.52 -45.44 2.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.521 -0.309 . . . . 75.319999999999993 111.553 175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 77.7 mtt180 -125.06 125.17 43.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.912 -0.403 . . . . 71.230000000000004 109.912 -169.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.88 110.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.498 1.119 . . . . 74.209999999999994 108.189 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -104.38 124.54 49.39 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 122.911 0.484 . . . . 63.350000000000001 110.208 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 m -85.01 119.81 34.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.0 -1.111 . . . . 73.120000000000005 108.0 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.739 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 36.8 p -108.11 91.53 8.1 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.9 0.88 . . . . 61.140000000000001 109.863 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.67 162.47 41.16 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.11 2.54 . . . . 72.340000000000003 112.085 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -77.92 -167.76 0.52 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.283 1.989 . . . . 65.239999999999995 111.934 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.54 -126.52 7.79 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.793 -0.523 . . . . 64.310000000000002 111.793 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -81.38 -11.82 59.16 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.684 0.793 . . . . 74.150000000000006 111.268 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.58 -80.23 0.52 Allowed Glycine 0 C--N 1.35 1.308 0 O-C-N 123.626 0.579 . . . . 63.520000000000003 112.461 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.739 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 66.4 m -128.79 162.4 51.79 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.106 0.963 . . . . 65.040000000000006 110.7 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -58.98 -36.89 96.0 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.581 2.187 . . . . 63.140000000000001 113.829 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -128.3 166.63 18.25 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.728 0.811 . . . . 72.219999999999999 110.254 -176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m -88.42 111.19 21.5 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.22 -1.03 . . . . 75.209999999999994 108.22 170.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -147.56 172.53 13.86 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.446 1.098 . . . . 74.109999999999999 108.187 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -131.17 124.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.86 0.864 . . . . 74.430000000000007 109.117 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG22 ' SG ' ' A' ' 14' ' ' CYS . 27.3 t -92.37 143.3 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.811 0.844 . . . . 73.409999999999997 109.0 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.6 116.47 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.111 0.965 . . . . 73.150000000000006 108.55 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.578 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 31.1 m-90 -93.71 124.56 37.78 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 108.88 -0.785 . . . . 73.530000000000001 108.88 166.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.4 p -80.97 173.25 12.8 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.037 0.836 . . . . 75.019999999999996 109.93 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -72.78 -17.92 61.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.769 0.827 . . . . 72.430000000000007 110.865 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.6 mtm -83.75 0.0 49.08 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.287 1.035 . . . . 70.340000000000003 110.637 172.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 76.68 11.52 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.976 1.71 . . . . 75.140000000000001 112.904 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -77.87 134.73 37.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.747 0.419 . . . . 70.010000000000005 111.31 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -91.56 103.82 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 O-C-N 125.039 1.462 . . . . 63.130000000000003 108.594 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.9 mt -112.6 121.54 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 107.631 -1.248 . . . . 74.439999999999998 107.631 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 87.0 m -105.16 138.52 41.23 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.715 -0.846 . . . . 50.25 108.715 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.9 m -134.95 165.55 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.318 1.447 . . . . 72.109999999999999 109.195 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -82.54 147.08 55.04 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 119.215 -0.422 . . . . 73.230000000000004 109.967 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.76 -19.24 64.34 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.685 2.257 . . . . 73.219999999999999 112.337 176.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -90.79 14.38 13.72 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.59 0.756 . . . . 53.399999999999999 111.747 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.76 15.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 109.0 -0.741 . . . . 63.240000000000002 109.0 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -59.13 -44.76 92.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.136 0.974 . . . . 72.409999999999997 112.744 -173.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -63.74 -42.52 97.84 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.44 0.696 . . . . 75.049999999999997 110.229 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.79 -34.44 71.48 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.632 1.208 . . . . 72.230000000000004 111.33 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.555 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 79.6 mm-40 -55.56 -46.03 77.22 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.618 0.574 . . . . 74.530000000000001 111.518 177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -59.41 -30.15 68.26 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.789 0.436 . . . . 52.350000000000001 111.022 177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 24' ' ' LEU . 9.3 mp -78.69 -39.49 36.52 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.797 0.839 . . . . 64.230000000000004 110.688 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.0 -26.23 66.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.935 0.894 . . . . 73.310000000000002 110.319 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 6.3 mmt180 -90.74 -28.14 18.47 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.898 0.479 . . . . 71.209999999999994 111.164 173.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 73' ' ' LYS . 64.5 t-80 -62.29 -34.24 76.2 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.289 0.636 . . . . 73.230000000000004 110.882 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 HG21 HD22 ' A' ' 3' ' ' LEU . 32.1 m -68.51 -15.87 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 116.085 -0.507 . . . . 71.519999999999996 111.91 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.02 41.9 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.731 0.812 . . . . 74.019999999999996 111.198 171.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t 52.27 64.79 1.71 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.962 1.305 . . . . 41.140000000000001 111.438 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 69' ' ' HIS . 55.3 tptt -67.13 134.4 51.71 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.163 -0.926 . . . . 73.510000000000005 110.185 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 73.5 p -75.17 168.1 20.63 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.67 0.788 . . . . 74.430000000000007 113.119 -172.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 pp -121.7 171.67 8.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.344 1.058 . . . . 72.129999999999995 111.315 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -114.07 -176.12 2.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.689 0.796 . . . . 74.329999999999998 110.038 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.9 m -131.02 142.9 50.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.336 1.054 . . . . 61.350000000000001 108.909 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.2 p -110.98 136.71 20.77 Favored Pre-proline 0 CA--C 1.553 1.062 0 N-CA-C 109.142 -0.688 . . . . 63.43 109.142 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.51 175.3 3.57 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.412 2.075 . . . . 74.120000000000005 113.395 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -79.92 155.28 27.81 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.491 -0.777 . . . . 53.450000000000003 111.058 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.64 149.42 93.21 Favored Pre-proline 0 N--CA 1.481 1.112 0 C-N-CA 124.62 1.168 . . . . 62.329999999999998 110.82 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.81 154.14 63.75 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 121.815 1.677 . . . . 61.299999999999997 111.569 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -56.4 128.33 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.458 0.703 . . . . 72.219999999999999 112.113 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 t -85.13 155.3 21.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 109.212 -0.662 . . . . 53.140000000000001 109.212 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -102.56 140.05 37.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.485 0.314 . . . . 74.129999999999995 110.669 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -112.64 138.36 49.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.458 1.103 . . . . 65.510000000000005 108.996 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -75.63 103.99 5.98 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.56 0.744 . . . . 71.349999999999994 109.521 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.88 85.2 7.39 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.534 -0.543 . . . . 61.140000000000001 109.534 174.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.905 -0.776 . . . . 54.020000000000003 108.905 177.427 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 108.782 -0.822 . . . . 51.43 108.782 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 52.5 mt -76.51 109.84 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.966 -0.383 . . . . 73.239999999999995 109.966 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.2 tp -82.52 108.18 15.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.763 0.425 . . . . 74.010000000000005 110.223 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -90.93 118.56 30.42 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 109.563 -0.532 . . . . 53.039999999999999 109.563 174.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.86 106.56 15.63 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.993 -1.114 . . . . 71.239999999999995 107.993 174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -124.5 136.74 54.25 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.94 0.896 . . . . 53.5 109.414 -172.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -100.14 169.23 9.3 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.504 1.122 . . . . 70.430000000000007 108.29 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.3 p -49.2 112.14 0.59 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.842 0.857 . . . . 71.400000000000006 112.913 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.416 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 27.6 t-20 -69.8 169.35 13.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.809 0.844 . . . . 74.299999999999997 108.807 166.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 tt -45.55 -43.18 11.74 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.168 0.987 . . . . 65.140000000000001 110.036 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -167.99 107.7 0.54 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.054 0.942 . . . . 74.25 109.481 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.575 ' SG ' HG21 ' A' ' 33' ' ' THR . 75.4 m -73.51 115.83 13.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.115 0.566 . . . . 72.549999999999997 109.952 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -72.74 90.85 1.43 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.285 0.634 . . . . 72.239999999999995 111.686 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.563 ' SG ' HG22 ' A' ' 45' ' ' VAL . 91.4 m -134.2 112.52 11.16 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.782 -1.192 . . . . 54.100000000000001 107.782 164.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 69.0 p -60.94 -35.07 75.76 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.962 0.905 . . . . 73.129999999999995 110.532 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.54 -176.65 37.84 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.054 -0.975 . . . . 60.409999999999997 111.692 175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 m -111.15 135.1 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.065 0.946 . . . . 75.340000000000003 109.224 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.4 132.49 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.403 0.681 . . . . 75.510000000000005 109.35 -173.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.7 m -97.1 48.3 1.05 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.869 0.868 . . . . 43.119999999999997 111.388 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.5 p -109.6 129.7 55.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.417 0.687 . . . . 64.150000000000006 109.51 175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.6 t -72.95 111.73 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.539 -0.912 . . . . 64.430000000000007 108.539 176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.7 t -76.06 145.04 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 123.676 0.79 . . . . 74.200000000000003 109.61 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.489 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -61.4 120.04 20.93 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 119.65 -0.528 . . . . 71.530000000000001 111.821 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.1 -23.95 65.88 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.906 0.883 . . . . 72.219999999999999 112.239 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -72.64 -34.4 67.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.826 0.85 . . . . 75.120000000000005 111.059 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 pt -95.75 -18.78 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 118.844 -0.598 . . . . 61.130000000000003 111.527 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 23' ' ' GLY . 64.6 mt -60.86 107.48 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 108.946 -0.761 . . . . 44.530000000000001 108.946 176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -98.49 -55.3 2.79 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.821 -0.627 . . . . 75.319999999999993 110.745 -171.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 47.5 mtm180 -137.79 125.07 21.74 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.473 0.709 . . . . 74.439999999999998 109.838 -175.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -107.43 106.58 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.221 -1.029 . . . . 44.43 108.221 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -104.85 117.32 33.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.212 0.605 . . . . 74.329999999999998 109.551 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.45 135.94 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.561 -0.533 . . . . 74.319999999999993 109.561 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.575 HG21 ' SG ' ' A' ' 12' ' ' CYS . 18.8 m -130.57 127.56 22.36 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 109.545 -0.539 . . . . 73.140000000000001 109.545 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.17 171.87 15.61 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.439 2.093 . . . . 35.32 111.658 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -85.0 -173.65 1.52 Allowed 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.499 2.132 . . . . 70.209999999999994 111.993 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.63 -133.84 8.25 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 119.55 -0.583 . . . . 65.099999999999994 111.827 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -91.57 119.46 31.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.935 0.494 . . . . 73.140000000000001 109.898 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.76 -90.43 0.53 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.822 -0.911 . . . . 25.23 110.822 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 9' ' ' ASN . 34.2 m -84.13 112.52 41.66 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.281 -1.007 . . . . 51.240000000000002 108.281 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.54 -20.98 15.34 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.353 2.035 . . . . 72.439999999999998 113.32 -169.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -104.13 155.34 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.025 0.53 . . . . 73.140000000000001 110.233 -171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.9 m -82.93 111.5 18.87 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 104.959 -2.237 . . . . 70.540000000000006 104.959 160.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.35 131.58 18.46 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.114 0.483 . . . . 75.099999999999994 110.32 -163.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.2 t -110.63 109.37 28.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.512 -0.922 . . . . 73.340000000000003 108.512 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.563 HG22 ' SG ' ' A' ' 14' ' ' CYS . 44.4 t -92.79 108.48 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.647 0.779 . . . . 74.040000000000006 109.274 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.3 mt -102.11 116.29 45.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.179 0.992 . . . . 55.049999999999997 109.535 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.6 m-90 -88.57 137.05 32.67 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.876 -0.787 . . . . 71.540000000000006 108.876 167.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 p -95.93 173.22 7.55 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 115.583 -0.735 . . . . 73.519999999999996 110.184 172.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -68.53 -23.51 64.54 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.705 0.802 . . . . 75.209999999999994 111.19 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 59.9 mtm -85.83 5.81 30.95 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.847 0.859 . . . . 72.430000000000007 110.828 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 67.14 23.26 9.61 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.117 1.367 . . . . 71.140000000000001 113.129 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -76.37 125.39 29.1 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.769 -0.826 . . . . 73.439999999999998 108.769 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.5 t -85.37 105.76 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 124.543 1.152 . . . . 73.420000000000002 108.27 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -113.73 117.75 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.386 -0.968 . . . . 72.430000000000007 108.386 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.39 117.62 34.62 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.375 -1.343 . . . . 54.039999999999999 107.375 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.3 m -110.24 162.29 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.963 0.905 . . . . 53.140000000000001 110.45 -173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -85.31 138.5 36.42 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-N 115.635 -0.711 . . . . 73.519999999999996 110.594 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.85 -19.77 35.24 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.294 2.663 . . . . 53.409999999999997 114.26 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -73.42 -18.0 61.19 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.824 0.45 . . . . 73.420000000000002 110.258 -178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -55.32 116.69 2.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.713 0.805 . . . . 75.230000000000004 111.663 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -68.51 -40.68 80.73 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.307 1.043 . . . . 75.200000000000003 111.133 -173.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 47.3 p-90 -60.9 -39.56 89.77 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.376 0.67 . . . . 75.209999999999994 109.622 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 62.7 tp -66.35 -45.26 80.78 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-N 114.952 -1.022 . . . . 53.350000000000001 110.34 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -61.71 -42.46 98.98 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 123.932 0.77 . . . . 72.129999999999995 109.831 -177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -60.23 -39.81 87.99 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.661 -0.7 . . . . 74.019999999999996 110.728 174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 70' ' ' VAL . 55.5 tp -72.32 -33.91 67.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 115.262 -0.881 . . . . 64.430000000000007 111.003 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 63' ' ' LEU . 91.5 mt -68.63 -35.31 77.12 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.508 0.723 . . . . 54.530000000000001 109.874 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -68.41 -41.65 80.13 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.275 0.63 . . . . 72.340000000000003 110.276 172.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -69.45 -32.56 71.58 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.677 -0.692 . . . . 71.340000000000003 112.222 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 66' ' ' LEU . 30.3 m -74.47 -19.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 122.169 -0.332 . . . . 64.129999999999995 111.502 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -83.27 -58.35 2.88 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.471 0.709 . . . . 74.340000000000003 109.39 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.4 t -111.46 104.69 13.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.306 1.042 . . . . 72.129999999999995 108.762 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -127.45 115.7 19.3 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.0 0.92 . . . . 74.430000000000007 109.897 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 51.7 p -131.8 161.33 33.18 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 124.659 1.184 . . . . 74.400000000000006 107.935 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.3 tp 61.91 55.15 2.65 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.945 0.879 . . . . 74.120000000000005 109.417 -174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.6 p -76.64 77.09 3.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.203 -0.908 . . . . 53.329999999999998 109.382 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 p -73.18 97.92 2.5 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.169 -0.923 . . . . 64.120000000000005 110.925 -174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 48.8 m -140.05 103.99 6.76 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.997 0.919 . . . . 74.25 108.644 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.16 154.0 28.61 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.847 2.365 . . . . 75.530000000000001 112.327 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -68.54 97.44 0.78 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.874 -0.787 . . . . 72.099999999999994 108.874 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.68 136.5 96.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.238 -0.892 . . . . 74.200000000000003 110.782 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.07 -17.49 31.67 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.209 1.939 . . . . 41.439999999999998 111.886 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG13 HH21 ' A' ' 87' ' ' ARG . 96.2 t -82.9 104.88 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.04 0.936 . . . . 71.430000000000007 109.088 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.7 m -73.67 124.4 25.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.196 0.598 . . . . 62.340000000000003 110.198 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -67.92 144.38 55.26 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.72 0.808 . . . . 74.239999999999995 110.87 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 66.27 85.09 0.15 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.21 1.404 . . . . 73.150000000000006 109.423 -165.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.469 HH21 HG13 ' A' ' 83' ' ' VAL . 32.4 ttm180 -88.85 124.85 34.58 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.751 -0.833 . . . . 55.539999999999999 108.751 176.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.71 74.19 8.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.429 0.691 . . . . 62.399999999999999 109.147 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 C-N-CA 124.741 1.216 . . . . 74.409999999999997 108.537 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.925 0.393 . . . . 72.109999999999999 110.373 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.652 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 70.0 mt -122.94 110.04 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.754 -0.832 . . . . 65.150000000000006 108.754 173.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.4 tp -82.25 114.03 20.47 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.907 -0.775 . . . . 71.340000000000003 108.907 175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -103.69 144.93 30.8 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.549 0.739 . . . . 63.210000000000001 110.026 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.96 115.38 30.35 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.622 0.769 . . . . 62.310000000000002 109.529 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 33' ' ' THR . 10.1 t60 -80.89 96.94 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.512 -0.551 . . . . 73.450000000000003 109.512 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -106.76 -11.19 15.85 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 115.273 -0.876 . . . . 72.420000000000002 109.426 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 p -70.79 104.86 3.01 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.241 0.617 . . . . 73.400000000000006 110.197 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.5 ' HB2' ' HA3' ' A' ' 38' ' ' GLY . 4.1 p-10 -82.01 26.6 0.51 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.632 1.173 . . . . 75.400000000000006 112.224 -177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 mt -75.21 -167.52 0.64 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.029 1.332 . . . . 74.400000000000006 110.328 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -56.83 92.61 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.597 0.713 . . . . 74.319999999999993 110.238 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 35.3 m -72.62 101.64 3.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.77 -0.826 . . . . 72.299999999999997 108.77 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -102.06 102.69 13.21 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.239 -0.891 . . . . 73.019999999999996 110.4 -168.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.0 t -103.79 156.32 17.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.959 -1.019 . . . . 62.219999999999999 109.448 170.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 27.8 t -99.15 5.66 46.76 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.483 0.713 . . . . 75.019999999999996 111.169 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 55' ' ' CYS . . . 89.59 157.15 32.79 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.069 -0.812 . . . . 74.540000000000006 111.069 -170.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.89 131.35 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 118.131 0.966 . . . . 72.530000000000001 109.664 -169.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 HG23 ' A' ' 54' ' ' ILE . 12.7 mt -122.44 135.75 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 108.956 -0.757 . . . . 74.430000000000007 108.956 -171.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.1 p -76.31 16.15 0.5 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.375 0.88 . . . . 61.420000000000002 113.375 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 25.6 p -77.24 113.59 15.16 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.311 0.645 . . . . 70.140000000000001 110.521 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.8 t -68.22 109.9 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.649 -1.241 . . . . 75.329999999999998 107.649 169.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.1 t -78.82 138.16 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.8 -0.815 . . . . 61.530000000000001 108.8 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -60.46 128.68 46.04 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.967 0.792 . . . . 44.409999999999997 112.938 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.0 -24.97 67.67 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.446 0.698 . . . . 65.200000000000003 111.602 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -78.1 -20.19 52.7 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.643 0.777 . . . . 64.409999999999997 111.416 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 pt -109.36 -11.9 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-O 118.983 -0.532 . . . . 75.209999999999994 112.307 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.0 mt -63.64 108.75 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.162 -0.681 . . . . 72.129999999999995 109.162 173.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -89.22 -53.9 4.35 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.256 0.623 . . . . 71.340000000000003 109.997 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.652 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 47.2 mtt180 -140.45 148.24 40.87 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.719 -0.673 . . . . 65.120000000000005 110.67 -175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 46' ' ' ILE . 67.3 mt -130.68 107.85 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 107.809 -1.182 . . . . 70.219999999999999 107.809 173.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -101.22 122.55 43.85 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.766 -0.457 . . . . 61.409999999999997 109.766 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 m -97.74 120.72 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.687 -0.688 . . . . 64.040000000000006 110.304 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.403 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . 60.1 m -104.99 103.31 40.78 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.395 1.078 . . . . 64.540000000000006 109.185 175.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.52 162.97 30.08 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.822 2.348 . . . . 60.210000000000001 112.296 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.81 91.12 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.494 0 C-N-CA 122.866 2.377 . . . . 73.219999999999999 112.436 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.62 -111.1 3.56 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.926 -0.579 . . . . 64.439999999999998 112.713 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -146.33 -50.98 0.22 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.796 0.838 . . . . 71.5 109.967 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 9' ' ' ASN . . . -63.49 -36.09 92.9 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 116.211 -0.449 . . . . 63.299999999999997 113.956 -175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.4 m -86.16 137.56 34.99 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.177 0.591 . . . . 62.020000000000003 109.879 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.45 -18.28 38.54 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.476 2.117 . . . . 64.239999999999995 112.537 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -151.02 172.62 15.43 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.642 0.777 . . . . 73.150000000000006 110.991 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.2 m -86.09 133.63 33.87 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.876 -1.056 . . . . 74.049999999999997 108.612 167.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -151.82 145.67 25.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.545 0.338 . . . . 70.129999999999995 110.308 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -124.18 106.46 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.558 -0.905 . . . . 54.109999999999999 108.558 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.09 110.99 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.227 0.611 . . . . 75.310000000000002 109.636 -173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG12 HG12 ' A' ' 30' ' ' ILE . 53.7 mt -95.35 126.5 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.879 0.871 . . . . 72.120000000000005 109.829 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -98.64 139.06 34.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.337 -0.616 . . . . 73.430000000000007 109.337 168.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -87.86 173.3 9.03 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 123.801 0.688 . . . . 45.450000000000003 109.898 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.37 -19.24 61.05 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.037 0.535 . . . . 73.319999999999993 111.226 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.4 mtm -81.51 -2.8 51.12 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.701 0.801 . . . . 71.209999999999994 110.409 170.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 71.55 21.82 4.32 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.043 1.737 . . . . 74.140000000000001 112.512 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -74.85 137.22 41.68 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.186 0.594 . . . . 71.530000000000001 109.807 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.2 t -99.39 111.98 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.795 1.238 . . . . 75.219999999999999 109.469 -173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.456 HG23 HD12 ' A' ' 18' ' ' ILE . 70.6 mt -124.51 144.58 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.077 -1.082 . . . . 71.340000000000003 108.077 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 80.7 m -107.65 156.96 18.48 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.036 -0.727 . . . . 53.039999999999999 109.036 169.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.4 153.05 25.84 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.422 1.089 . . . . 65.219999999999999 109.011 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 60' ' ' ALA . 21.2 p-10 -71.43 133.78 84.92 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.864 0.466 . . . . 71.450000000000003 109.977 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HB2' ' HD2' ' A' ' 59' ' ' ARG . 58.7 Cg_exo -51.26 -34.77 50.53 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.059 2.506 . . . . 74.319999999999993 114.178 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HD2' ' HB2' ' A' ' 58' ' ' PRO . 6.2 mpt_? -95.67 22.42 7.21 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.924 0.489 . . . . 73.25 111.544 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.477 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . . . -69.24 131.54 45.07 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 109.578 -0.527 . . . . 63.130000000000003 109.578 172.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -60.24 -51.05 71.21 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.996 0.918 . . . . 64.0 110.916 -176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -61.95 -36.66 82.07 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.576 -0.738 . . . . 71.420000000000002 111.107 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 60.9 tp -64.96 -45.15 86.93 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.659 0.599 . . . . 42.329999999999998 110.871 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -63.71 -30.98 72.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.086 0.554 . . . . 75.299999999999997 111.142 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -65.74 -39.28 90.96 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.113 -0.494 . . . . 73.340000000000003 110.136 172.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.36 -41.49 76.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.222 0.609 . . . . 74.439999999999998 111.014 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.58 -35.49 80.34 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.506 0.722 . . . . 72.409999999999997 110.139 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -74.14 -37.72 63.98 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.787 0.835 . . . . 72.120000000000005 111.291 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -66.77 -51.31 57.29 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.182 0.593 . . . . 72.019999999999996 111.926 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -68.28 -22.39 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 122.684 0.394 . . . . 71.019999999999996 111.355 -177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -82.75 1.93 36.4 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 123.687 0.795 . . . . 41.119999999999997 111.468 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.2 t 75.41 103.56 0.07 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.279 1.432 . . . . 55.420000000000002 111.852 172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -137.83 -77.31 0.38 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.778 1.231 . . . . 55.32 109.294 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.2 t -163.69 154.87 16.39 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.67 0.788 . . . . 72.519999999999996 109.946 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.67 134.69 52.79 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.478 0.711 . . . . 72.329999999999998 109.14 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -81.03 135.27 35.82 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.581 0.752 . . . . 42.240000000000002 109.042 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.9 m -68.35 101.09 1.15 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.015 0.526 . . . . 72.0 109.935 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.0 p -56.42 118.41 21.86 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.98 0.912 . . . . 73.540000000000006 110.795 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.63 150.49 60.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.924 2.416 . . . . 73.420000000000002 113.112 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -63.87 118.31 8.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.534 0.734 . . . . 62.109999999999999 110.172 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 79.57 36.95 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.081 0.952 . . . . 72.0 108.795 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.64 154.41 44.35 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.737 2.291 . . . . 64.239999999999995 112.542 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.5 t -78.89 111.95 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.362 -0.977 . . . . 64.439999999999998 108.362 175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 m -81.22 159.81 24.46 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.983 0.913 . . . . 53.299999999999997 111.063 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.77 121.7 15.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.823 0.849 . . . . 63.399999999999999 111.206 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -149.81 138.5 20.87 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.508 1.123 . . . . 75.430000000000007 108.795 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.9 88.05 5.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 106.731 -1.581 . . . . 65.310000000000002 106.731 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.39 -61.89 1.47 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.543 0.737 . . . . 74.099999999999994 109.692 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.456 0 C-N-CA 124.852 1.261 . . . . 61.350000000000001 110.775 -177.191 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HE1' ' HG ' ' A' ' 24' ' ' LEU . 3.4 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.499 0.185 . . . . 73.239999999999995 111.499 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.9 mt -87.43 140.36 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.252 0.621 . . . . 73.450000000000003 109.534 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 70' ' ' VAL . 59.2 tp -112.18 122.69 48.44 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 109.387 -0.597 . . . . 72.310000000000002 109.387 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -120.4 157.01 30.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.602 1.561 . . . . 75.299999999999997 110.363 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.13 144.7 30.96 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.78 -0.822 . . . . 72.120000000000005 108.78 165.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -82.28 108.0 15.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.972 0.509 . . . . 74.019999999999996 111.592 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -88.02 166.34 14.54 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.395 -0.965 . . . . 72.530000000000001 108.395 165.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.0 p 58.18 83.61 0.11 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.988 1.715 . . . . 54.409999999999997 110.801 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.87 28.68 0.41 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.878 1.271 . . . . 72.140000000000001 112.281 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.57 -54.56 34.21 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.961 0.904 . . . . 74.349999999999994 109.389 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -156.44 149.09 23.71 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.493 0.717 . . . . 74.310000000000002 109.584 176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.1 m -109.31 125.2 52.07 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.596 -0.89 . . . . 74.140000000000001 108.596 168.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -108.21 86.55 2.31 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.033 0.444 . . . . 73.129999999999995 110.913 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG22 ' A' ' 45' ' ' VAL . 88.8 m -137.39 97.54 3.49 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.65 1.18 . . . . 64.340000000000003 108.733 167.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 57.4 p -73.62 -42.16 61.83 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.442 0.697 . . . . 65.25 110.549 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.5 133.52 10.12 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.62 -0.992 . . . . 62.100000000000001 110.62 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 m -113.55 132.92 61.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 CA-C-N 117.576 0.688 . . . . 71.140000000000001 109.519 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 56' ' ' VAL . 23.6 pt -131.7 115.48 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.382 1.073 . . . . 74.450000000000003 108.441 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -91.4 37.63 0.95 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.734 0.778 . . . . 73.450000000000003 110.446 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 46.7 p -70.08 134.4 48.17 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.593 -1.185 . . . . 64.140000000000001 108.137 170.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.73 112.47 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-O 121.455 0.645 . . . . 64.239999999999995 110.35 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.5 t -92.53 138.94 18.87 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.095 -1.076 . . . . 74.439999999999998 108.095 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -64.13 125.82 32.76 Favored Glycine 0 C--N 1.35 1.345 0 O-C-N 123.796 0.685 . . . . 71.420000000000002 112.226 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' HG ' ' HE1' ' A' ' 1' ' ' MET . 10.4 mp -61.68 -23.32 66.02 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.752 0.821 . . . . 75.010000000000005 111.616 -177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -64.26 -38.76 92.18 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.485 1.114 . . . . 64.030000000000001 110.395 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.5 pt -101.19 -12.41 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.934 -174.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 23' ' ' GLY . 83.9 mt -67.02 113.12 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 109.417 -0.586 . . . . 63.399999999999999 109.417 173.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -89.2 -55.4 3.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.312 1.045 . . . . 74.030000000000001 110.809 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -142.23 149.29 39.43 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.568 0.747 . . . . 62.530000000000001 110.634 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 46' ' ' ILE . 62.2 mt -136.09 107.22 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.657 1.583 . . . . 65.219999999999999 106.864 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -118.66 121.93 41.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.264 0.626 . . . . 74.200000000000003 109.491 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.26 113.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.578 -0.527 . . . . 70.340000000000003 109.578 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.667 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 61.2 p -97.02 116.36 66.02 Favored Pre-proline 0 CA--C 1.57 1.75 0 C-N-CA 123.912 0.885 . . . . 73.510000000000005 110.028 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -76.73 148.9 29.3 Favored 'Trans proline' 0 C--N 1.393 2.896 0 C-N-CA 123.233 2.622 . . . . 72.400000000000006 114.18 -172.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.16 -172.79 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.405 2.736 . . . . 72.230000000000004 113.941 -174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.74 -115.71 4.4 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.669 -0.696 . . . . 64.209999999999994 112.389 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -76.19 -31.18 58.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.821 0.448 . . . . 65.420000000000002 111.595 -177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.53 -69.08 1.43 Allowed Glycine 0 C--N 1.352 1.437 0 O-C-N 123.716 0.635 . . . . 74.219999999999999 111.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.667 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 3.5 m -105.46 153.37 39.81 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.657 0.783 . . . . 73.010000000000005 108.959 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.29 -28.73 47.13 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 122.188 1.926 . . . . 61.340000000000003 112.009 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -147.0 169.5 19.08 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.866 1.666 . . . . 72.200000000000003 107.438 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -74.27 114.71 12.94 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.424 -0.954 . . . . 71.349999999999994 108.424 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.79 157.75 30.34 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.036 -0.727 . . . . 73.109999999999999 109.036 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.0 t -131.17 111.58 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.073 -1.084 . . . . 75.329999999999998 108.073 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG22 ' SG ' ' A' ' 14' ' ' CYS . 58.6 t -91.05 108.54 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 109.054 -0.721 . . . . 72.219999999999999 109.054 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HG12 HG12 ' A' ' 30' ' ' ILE . 55.9 mt -100.38 123.11 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 108.944 -0.762 . . . . 63.229999999999997 108.944 177.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -92.36 133.49 35.81 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.801 -1.185 . . . . 72.239999999999995 107.801 167.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.6 p -93.99 168.27 11.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.229 -0.656 . . . . 73.140000000000001 109.229 169.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.29 -16.75 64.45 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.65 0.78 . . . . 72.239999999999995 111.168 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.1 mtm -80.38 -5.23 56.11 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.44 1.096 . . . . 74.109999999999999 110.766 177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm 69.42 15.88 8.33 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.672 1.589 . . . . 73.019999999999996 112.038 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -81.71 122.48 27.71 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 108.57 -0.9 . . . . 53.119999999999997 108.57 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.6 t -85.12 100.92 8.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 107.918 -1.142 . . . . 65.120000000000005 107.918 178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -101.31 118.23 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.669 -1.234 . . . . 72.200000000000003 107.669 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.58 134.18 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.841 -1.17 . . . . 65.349999999999994 107.841 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 18' ' ' ILE . 22.8 m -126.64 164.47 26.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.194 0.998 . . . . 70.310000000000002 108.756 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -83.64 158.88 62.11 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.299 -0.63 . . . . 72.329999999999998 109.299 170.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.36 -12.66 32.13 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.417 2.078 . . . . 74.420000000000002 112.274 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -83.95 -2.87 57.39 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.683 0.793 . . . . 73.219999999999999 111.932 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.9 121.06 12.56 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 122.866 0.466 . . . . 61.520000000000003 110.298 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -63.67 -46.76 84.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.46 1.104 . . . . 75.510000000000005 111.059 -173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.448 ' O ' HD13 ' A' ' 66' ' ' LEU . 57.5 p-90 -60.45 -36.75 78.98 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.843 -1.071 . . . . 75.049999999999997 110.772 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 39.9 tp -64.34 -39.55 94.1 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.877 0.871 . . . . 61.520000000000003 111.618 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -58.91 -36.49 74.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.122 0.569 . . . . 55.409999999999997 112.103 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -59.03 -44.45 91.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.858 -1.064 . . . . 72.340000000000003 109.901 174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 62' ' ' TRP . 8.5 mp -68.01 -44.55 76.28 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.09 0.956 . . . . 74.129999999999995 110.618 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.4 mt -61.68 -35.33 77.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.909 0.883 . . . . 54.229999999999997 110.834 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -78.82 -39.99 34.08 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.229 0.611 . . . . 72.349999999999994 111.321 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -73.79 -16.09 61.17 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.088 0.773 . . . . 74.519999999999996 113.088 -173.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 3' ' ' LEU . 35.2 m -86.68 -11.06 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 117.743 0.247 . . . . 75.420000000000002 111.654 175.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -93.32 -102.82 0.13 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.013 0.525 . . . . 71.409999999999997 112.094 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.0 m -97.78 4.2 49.86 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.876 0.87 . . . . 55.299999999999997 112.097 -168.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -54.88 126.06 22.77 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.681 0.792 . . . . 64.230000000000004 110.006 176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 m -57.08 127.85 34.03 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.368 1.067 . . . . 75.010000000000005 111.642 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.97 164.5 15.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.078 -0.341 . . . . 54.340000000000003 110.078 172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.1 m 64.99 179.67 0.18 Allowed 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.651 1.18 . . . . 62.219999999999999 111.885 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.6 t -164.51 -173.16 2.94 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.716 -0.846 . . . . 74.439999999999998 108.716 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.4 p -60.73 137.98 93.22 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.478 -0.773 . . . . 71.319999999999993 110.025 172.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -51.99 155.37 8.72 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.002 2.468 . . . . 71.319999999999993 113.708 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -62.06 140.52 58.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.023 0.929 . . . . 74.400000000000006 110.135 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 137.22 91.64 Favored Pre-proline 0 N--CA 1.485 1.281 0 O-C-N 123.74 0.65 . . . . 54.32 111.144 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -51.48 107.5 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.021 2.481 . . . . 74.099999999999994 113.146 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.5 p -163.23 128.56 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.188 0.995 . . . . 64.430000000000007 109.149 177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 p -107.85 141.29 39.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.326 0.651 . . . . 65.299999999999997 109.332 174.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -67.64 122.55 18.29 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.83 0.852 . . . . 54.219999999999999 108.749 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -83.27 153.64 24.56 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.99 0.916 . . . . 75.329999999999998 111.48 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 tpt180 -73.86 -39.06 64.23 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.254 -0.884 . . . . 70.140000000000001 109.678 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -172.56 102.56 0.15 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.036 0.934 . . . . 75.140000000000001 109.583 175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.261 0 C-N-CA 123.397 0.679 . . . . 51.549999999999997 109.255 176.134 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' HG12 ' A' ' 70' ' ' VAL . 41.0 tpp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.743 0.306 . . . . 75.030000000000001 110.718 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mp -76.43 134.91 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.531 0.732 . . . . 73.010000000000005 109.47 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.1 tp -91.55 129.51 37.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.235 0.614 . . . . 72.310000000000002 109.76 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -115.41 152.82 32.18 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.683 1.193 . . . . 74.010000000000005 110.46 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.6 152.58 36.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.612 1.165 . . . . 71.329999999999998 108.952 175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -79.59 97.06 6.34 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 122.319 1.057 . . . . 75.349999999999994 110.289 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.83 -1.84 31.33 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.715 -1.129 . . . . 41.539999999999999 109.872 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -71.88 -63.36 1.15 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.017 0.927 . . . . 75.340000000000003 109.22 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.7 t30 53.63 64.46 1.83 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.457 1.103 . . . . 74.140000000000001 111.425 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.1 mt -133.26 -168.29 2.07 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.607 1.163 . . . . 64.420000000000002 108.943 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -61.18 86.46 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.059 0.933 . . . . 74.540000000000006 109.615 164.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 64.6 m -61.6 113.35 2.66 Favored 'General case' 0 C--N 1.35 0.627 0 CA-C-N 114.137 -1.392 . . . . 70.329999999999998 110.406 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -104.37 95.51 5.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.875 0.87 . . . . 60.530000000000001 110.188 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.526 ' SG ' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -133.84 159.22 41.31 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 107.78 -1.193 . . . . 72.329999999999998 107.78 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.484 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 13.3 m -59.84 -12.44 7.5 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.543 1.312 . . . . 73.140000000000001 114.543 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.64 -104.7 3.19 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.612 -0.995 . . . . 60.25 110.612 -173.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.5 t -129.06 135.18 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 117.617 0.709 . . . . 73.310000000000002 109.752 174.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.89 134.43 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 N-CA-C 107.082 -1.451 . . . . 74.540000000000006 107.082 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.7 t -82.77 13.6 3.74 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.347 0.659 . . . . 54.439999999999998 112.699 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.3 p -83.08 123.47 29.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.964 0.506 . . . . 70.200000000000003 111.635 -174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.4 t -75.49 114.38 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.924 -1.139 . . . . 71.129999999999995 107.924 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.2 t -98.41 131.78 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.913 0.885 . . . . 63.5 109.528 -172.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.57 137.26 27.13 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.958 0.786 . . . . 54.009999999999998 113.552 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 -31.27 72.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.189 0.995 . . . . 64.239999999999995 111.2 -171.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -63.49 -33.07 74.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.552 -1.203 . . . . 74.239999999999995 112.086 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.4 pt -99.8 -17.62 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 119.328 -0.368 . . . . 64.209999999999994 111.087 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -62.7 115.24 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 109.197 -0.668 . . . . 64.099999999999994 109.197 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -98.3 -53.45 3.35 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.818 0.847 . . . . 74.430000000000007 109.857 -177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -140.58 145.18 36.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.749 0.819 . . . . 73.409999999999997 110.601 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.9 107.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.242 1.017 . . . . 73.439999999999998 109.183 174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HG2' HG23 ' A' ' 33' ' ' THR . 7.2 tt0 -95.75 130.89 42.52 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.713 0.405 . . . . 45.509999999999998 111.003 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -86.76 114.33 25.88 Favored 'Isoleucine or valine' 0 C--O 1.248 0.979 0 N-CA-C 108.684 -0.858 . . . . 72.209999999999994 108.684 171.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.608 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 21.5 p -117.69 82.42 16.21 Favored Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 123.844 0.857 . . . . 73.209999999999994 110.694 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -65.61 161.86 36.79 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.289 2.659 . . . . 74.430000000000007 113.091 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -78.78 175.93 10.44 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.821 2.347 . . . . 60.210000000000001 112.109 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 119.66 -114.66 2.8 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.692 -0.686 . . . . 60.149999999999999 112.34 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -69.21 -24.82 64.08 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.562 0.745 . . . . 73.420000000000002 112.174 -170.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.68 -84.41 1.36 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 111.775 -0.53 . . . . 45.5 111.775 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.608 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 56.4 m -70.34 143.29 90.52 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.337 0.655 . . . . 24.129999999999999 110.898 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.47 -10.25 14.7 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.465 2.11 . . . . 74.109999999999999 112.899 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -151.0 160.36 43.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.340000000000003 110.817 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.7 m -79.03 116.09 19.12 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.888 -0.412 . . . . 71.329999999999998 109.888 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -132.14 149.39 52.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.641 0.776 . . . . 71.0 109.934 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.59 108.87 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 106.779 -1.563 . . . . 55.539999999999999 106.779 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG22 ' SG ' ' A' ' 14' ' ' CYS . 23.7 t -92.07 133.87 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 123.945 0.898 . . . . 73.329999999999998 108.929 -172.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt -127.36 106.83 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.117 0.967 . . . . 74.299999999999997 108.638 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.4 m-90 -81.59 124.3 29.41 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.834 -1.173 . . . . 75.310000000000002 107.834 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.5 p -91.92 169.4 10.7 Favored 'General case' 0 C--O 1.243 0.719 0 O-C-N 123.641 0.588 . . . . 74.129999999999995 110.057 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.57 -13.62 61.44 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.994 0.918 . . . . 74.209999999999994 111.249 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.3 mtt -95.26 12.78 27.75 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.213 1.005 . . . . 73.549999999999997 110.838 174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? 73.64 2.56 4.29 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 125.579 1.552 . . . . 74.430000000000007 113.759 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -71.26 124.36 24.33 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.214 0.461 . . . . 61.109999999999999 109.859 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.6 t -90.55 101.81 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.523 -1.288 . . . . 64.319999999999993 107.523 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.42 136.42 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.641 1.176 . . . . 75.540000000000006 108.006 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 15' ' ' SER . 11.3 m -126.06 127.82 46.43 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.32 -0.993 . . . . 71.409999999999997 108.32 -172.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.52 161.45 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 43.420000000000002 110.868 -168.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -86.62 144.03 36.86 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 123.944 0.898 . . . . 75.409999999999997 110.345 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.2 -6.95 20.0 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.756 2.304 . . . . 64.409999999999997 113.752 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -23.28 38.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.371 0.668 . . . . 64.129999999999995 110.752 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.08 120.8 8.06 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.638 0.775 . . . . 62.039999999999999 111.315 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -63.27 -47.36 82.7 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 125.195 1.398 . . . . 73.129999999999995 111.916 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -55.96 -39.87 72.41 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.619 0.768 . . . . 75.450000000000003 110.116 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.3 tp -72.34 -38.92 68.5 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 114.039 -1.437 . . . . 73.109999999999999 111.344 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -58.04 -42.62 85.77 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.515 0.726 . . . . 54.109999999999999 109.992 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.3 mtm105 -60.66 -36.46 78.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.303 -0.862 . . . . 72.25 110.884 177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 mt -76.78 -39.73 50.59 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.619 0.768 . . . . 75.310000000000002 111.237 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.7 mt -64.94 -35.55 81.53 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.4 0.68 . . . . 74.239999999999995 110.051 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -73.53 -47.5 40.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.15 -0.932 . . . . 73.230000000000004 109.615 175.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -63.25 -47.92 80.38 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.616 0.766 . . . . 74.200000000000003 111.932 -171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.453 HG12 ' SD ' ' A' ' 1' ' ' MET . 23.1 m -69.96 -22.27 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 122.882 0.473 . . . . 74.420000000000002 111.283 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -90.75 -30.79 16.84 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.781 0.832 . . . . 71.310000000000002 110.929 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 t -86.32 -74.53 0.42 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.802 0.841 . . . . 74.0 109.206 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -176.62 160.77 2.03 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.507 0.723 . . . . 74.510000000000005 110.933 -177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.2 p -109.66 -177.44 3.28 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.094 0.958 . . . . 54.030000000000001 109.514 170.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 pp -145.0 -178.9 6.28 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.403 0.681 . . . . 44.240000000000002 109.843 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.8 t -72.67 97.18 2.12 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.274 -0.639 . . . . 71.129999999999995 109.274 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.3 t -81.57 179.27 7.91 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.345 1.058 . . . . 75.409999999999997 110.319 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.6 p -65.19 147.69 98.4 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 118.634 -0.698 . . . . 60.329999999999998 110.52 176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.48 108.72 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 C-N-CA 124.074 3.183 . . . . 75.040000000000006 112.756 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -126.19 -178.34 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.649 1.18 . . . . 64.340000000000003 109.37 -169.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.98 140.88 97.65 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 123.441 0.697 . . . . 44.310000000000002 111.058 178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -50.61 146.5 19.88 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 123.635 2.89 . . . . 75.140000000000001 114.697 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.5 t -79.42 117.41 25.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.905 -1.146 . . . . 60.350000000000001 107.905 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 78.9 p -60.79 144.76 51.85 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.369 0.668 . . . . 64.200000000000003 110.244 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.23 87.97 0.18 Allowed 'General case' 0 C--N 1.349 0.575 0 CA-C-O 121.664 0.745 . . . . 55.310000000000002 110.394 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -103.97 160.45 14.81 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.866 -1.061 . . . . 70.209999999999994 108.802 175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -69.04 115.87 8.83 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.012 -0.736 . . . . 64.230000000000004 109.012 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.89 -67.85 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.994 -0.743 . . . . 72.510000000000005 108.994 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 N-CA-C 108.313 -0.995 . . . . 75.049999999999997 108.313 175.067 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.416 HD12 ' HG2' ' A' ' 29' ' ' ARG . 30.8 mt -120.24 132.19 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.661 1.184 . . . . 43.229999999999997 108.047 176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.8 tp -106.6 125.59 51.19 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.68 -0.859 . . . . 62.149999999999999 108.68 170.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -119.43 114.9 23.02 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.627 0.771 . . . . 73.030000000000001 109.598 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.88 121.11 27.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.676 -1.602 . . . . 61.32 106.676 161.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.47 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 2.0 p80 -80.11 100.02 8.02 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.695 0.759 . . . . 74.400000000000006 109.795 -172.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -70.43 -38.65 74.6 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.222 -1.029 . . . . 70.099999999999994 108.222 168.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.6 p -68.64 93.39 0.51 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.537 -1.21 . . . . 74.510000000000005 110.269 174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -82.03 66.15 7.47 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.838 0.827 . . . . 71.540000000000006 109.434 174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.8 mt -83.29 -177.96 6.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.059 -0.973 . . . . 64.340000000000003 108.848 173.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -71.95 94.92 1.51 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.078 -0.712 . . . . 53.219999999999999 109.078 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.0 m -67.04 100.45 0.75 Allowed 'General case' 0 C--N 1.353 0.723 0 CA-C-O 121.254 0.55 . . . . 64.530000000000001 109.679 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.57 87.75 3.45 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.244 1.018 . . . . 71.209999999999994 108.485 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.64 158.95 43.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.782 -1.192 . . . . 54.32 107.782 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.519 ' N ' ' SG ' ' A' ' 55' ' ' CYS . 19.0 m -61.65 1.95 0.21 Allowed 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 114.389 1.255 . . . . 71.340000000000003 114.389 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.54 -93.82 1.75 Allowed Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.508 -0.637 . . . . 74.120000000000005 111.508 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.91 132.5 63.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.993 -0.743 . . . . 70.230000000000004 108.993 174.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.4 mt -118.65 129.07 75.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 106.202 -1.777 . . . . 74.340000000000003 106.202 175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 p -82.82 34.79 0.45 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.775 0.83 . . . . 70.019999999999996 112.315 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.4 p -110.23 133.74 52.93 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.793 0.837 . . . . 74.329999999999998 110.25 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.46 117.54 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 108.089 -1.078 . . . . 63.020000000000003 108.089 167.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.9 t -84.01 136.42 22.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 109.286 -0.635 . . . . 71.040000000000006 109.286 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -61.47 119.08 16.95 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 124.095 0.872 . . . . 54.240000000000002 113.048 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' HG ' HD11 ' A' ' 66' ' ' LEU . 9.3 mp -62.68 -16.51 57.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.791 0.836 . . . . 74.030000000000001 112.102 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -84.51 -36.49 22.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.979 0.912 . . . . 71.209999999999994 110.789 174.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 pt -85.45 -15.72 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 119.592 -0.242 . . . . 71.140000000000001 111.364 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 23' ' ' GLY . 89.9 mt -68.94 131.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.5 0.591 . . . . 63.450000000000003 110.858 176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -122.75 -48.43 2.03 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.342 0.657 . . . . 60.219999999999999 111.202 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 47' ' ' TRP . 19.1 mtp180 -126.04 129.03 48.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.841 0.457 . . . . 74.099999999999994 110.4 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.3 mt -122.12 107.68 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.066 1.346 . . . . 70.510000000000005 108.143 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -105.19 122.66 46.37 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.096 -0.705 . . . . 72.129999999999995 109.096 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.57 131.69 33.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 108.669 -0.863 . . . . 63.030000000000001 108.669 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.47 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 90.3 m -124.48 85.11 56.32 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.776 0.83 . . . . 71.439999999999998 110.759 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -67.5 145.58 71.21 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.258 1.972 . . . . 73.540000000000006 110.111 160.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.74 140.31 46.34 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 121.977 1.784 . . . . 71.519999999999996 112.217 -174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.49 -169.13 20.22 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 111.746 -0.542 . . . . 55.219999999999999 111.746 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -73.58 77.99 1.48 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.957 0.884 . . . . 71.219999999999999 110.583 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 152.45 -52.45 0.48 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.491 -1.231 . . . . 73.150000000000006 110.794 -173.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -101.67 113.05 65.92 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 123.334 0.654 . . . . 63.43 109.827 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.41 -16.21 9.56 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.621 2.214 . . . . 54.219999999999999 113.361 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -103.2 146.72 28.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.566 0.746 . . . . 73.200000000000003 110.798 -172.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.3 m -89.5 112.07 23.14 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.678 -1.601 . . . . 71.219999999999999 106.678 160.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.63 170.61 21.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.537 0.735 . . . . 74.340000000000003 110.215 -169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.7 t -132.82 120.72 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 63.32 108.368 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.3 110.58 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 N-CA-C 109.249 -0.649 . . . . 71.409999999999997 109.249 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.7 mt -103.9 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 60.119999999999997 109.828 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 31.4 m-90 -91.74 117.42 29.74 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.545 -1.28 . . . . 74.209999999999994 107.545 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.8 p -89.27 172.99 8.65 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.847 0.356 . . . . 71.140000000000001 111.164 178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.32 -16.46 61.89 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.313 1.445 . . . . 60.130000000000003 110.842 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.406 ' HB2' ' HD3' ' A' ' 52' ' ' LYS . 70.7 mtp -96.93 3.72 51.95 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.363 1.065 . . . . 71.049999999999997 110.649 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 66.41 26.57 10.1 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.573 1.549 . . . . 64.439999999999998 112.684 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HD3' ' HB2' ' A' ' 50' ' ' MET . 4.4 mptp? -83.74 124.12 30.56 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.827 -0.805 . . . . 72.209999999999994 108.827 169.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.1 t -90.56 105.74 16.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.265 -1.013 . . . . 74.040000000000006 108.265 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.25 126.7 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 108.984 -0.746 . . . . 72.230000000000004 108.984 -176.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 15' ' ' SER . 2.4 m -108.92 120.96 44.06 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 108.028 -1.101 . . . . 65.439999999999998 108.028 -173.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.03 166.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.793 0.837 . . . . 60.420000000000002 109.522 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -77.74 146.15 72.14 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-O 119.391 -0.337 . . . . 70.319999999999993 110.404 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -51.75 -34.78 55.73 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.232 2.622 . . . . 62.039999999999999 113.72 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.7 11.28 11.28 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.65 0.982 . . . . 75.420000000000002 113.65 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.93 123.56 19.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 118.149 0.431 . . . . 72.239999999999995 109.99 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -65.7 -45.63 82.05 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.192 0.997 . . . . 51.420000000000002 112.414 -170.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -61.88 -33.69 74.66 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.191 0.596 . . . . 53.219999999999999 110.668 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.1 tp -68.92 -33.98 74.64 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 115.138 -0.937 . . . . 73.340000000000003 110.676 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -59.46 -33.33 71.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.495 0.718 . . . . 74.230000000000004 112.235 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -64.33 -37.23 86.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.66 0.784 . . . . 72.219999999999999 110.392 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 24' ' ' LEU . 85.0 mt -79.0 -36.05 41.89 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.135 0.974 . . . . 74.409999999999997 111.158 -178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.3 -33.01 74.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.76 0.824 . . . . 74.0 109.658 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.74 -51.05 45.57 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.61 -0.885 . . . . 63.439999999999998 108.61 174.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -61.71 -50.03 74.06 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.23 0.956 . . . . 64.129999999999995 112.438 -171.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.66 -32.18 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.811 0.445 . . . . 72.409999999999997 111.396 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -86.03 177.88 7.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.898 0.879 . . . . 75.340000000000003 110.579 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.0 t 59.11 26.94 15.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.71 1.204 . . . . 72.209999999999994 110.65 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? 64.37 112.58 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.395 1.478 . . . . 71.0 110.134 -166.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.6 t -67.24 105.5 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.064 0.459 . . . . 53.130000000000003 109.903 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.2 tp -106.45 139.81 40.34 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.486 1.114 . . . . 74.25 108.832 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 t -74.31 132.87 42.46 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.341 -0.614 . . . . 53.329999999999998 109.341 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -98.94 11.5 38.71 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.96 0.904 . . . . 73.010000000000005 110.949 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.2 p -61.77 126.6 87.4 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.265 0.626 . . . . 72.349999999999994 109.712 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.0 -163.52 0.22 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.805 2.337 . . . . 71.329999999999998 112.519 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -142.9 157.05 44.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.833 0.853 . . . . 73.420000000000002 109.685 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.96 128.23 28.19 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.591 0.756 . . . . 71.540000000000006 109.537 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -80.87 177.34 8.08 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.87 2.38 . . . . 75.430000000000007 110.603 172.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 p -71.67 125.43 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 108.849 -0.797 . . . . 74.239999999999995 108.849 173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.4 p -119.6 79.8 1.48 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.788 0.804 . . . . 64.150000000000006 110.401 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -77.57 90.43 3.92 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.218 -1.03 . . . . 70.019999999999996 108.218 169.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -78.49 83.6 4.68 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.59 -1.186 . . . . 64.25 109.042 -175.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -78.64 128.93 34.15 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 70.109999999999999 109.955 176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.98 171.1 7.55 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.033 0.933 . . . . 73.219999999999999 109.646 172.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.014 0 N-CA-C 109.385 -0.598 . . . . 65.219999999999999 109.385 174.677 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.7 mtp . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 109.266 -0.642 . . . . 54.049999999999997 109.266 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.479 ' HB ' ' HD3' ' A' ' 29' ' ' ARG . 78.1 mt -107.05 118.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.577 -0.898 . . . . 74.450000000000003 108.577 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.2 tp -79.32 116.61 19.67 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.262 -1.014 . . . . 63.340000000000003 108.262 174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -115.65 131.36 56.96 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.223 -1.028 . . . . 74.25 108.223 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.91 124.37 46.92 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.249 -1.019 . . . . 74.450000000000003 108.249 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 33' ' ' THR . 4.4 p80 -82.79 117.48 22.72 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.346 0.593 . . . . 75.129999999999995 109.864 -178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -104.14 -18.91 14.34 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.223 1.009 . . . . 71.150000000000006 109.337 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 33.2 m -86.66 135.84 33.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.547 1.139 . . . . 72.409999999999997 109.741 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -71.9 138.7 48.35 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.375 0.67 . . . . 74.310000000000002 109.933 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -158.22 171.69 19.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.859 0.863 . . . . 70.219999999999999 109.681 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -69.76 91.3 0.62 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.835 -0.62 . . . . 73.409999999999997 109.474 175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.3 m -66.04 112.14 3.71 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.627 -0.879 . . . . 51.229999999999997 108.627 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' NE ' HG11 ' A' ' 53' ' ' VAL . 13.5 ptm180 -112.56 89.92 3.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.016 0.913 . . . . 74.310000000000002 112.121 -161.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.0 t -132.11 95.18 3.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.792 -1.095 . . . . 74.329999999999998 108.075 169.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t -99.12 8.17 45.15 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.808 0.843 . . . . 64.129999999999995 110.231 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.62 139.2 2.58 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 110.41 -1.076 . . . . 43.299999999999997 110.41 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -104.23 134.18 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.249 -0.648 . . . . 62.32 109.249 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 22.9 mt -108.06 124.68 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.374 -0.973 . . . . 72.25 108.374 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.7 m -85.23 27.56 0.79 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.855 0.862 . . . . 53.100000000000001 112.529 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.4 p -88.91 129.28 35.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.67 0.788 . . . . 70.140000000000001 109.798 174.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.8 t -73.8 111.17 8.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.127 -1.434 . . . . 71.019999999999996 107.127 167.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.61 131.5 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.898 -0.779 . . . . 64.129999999999995 108.898 -176.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.0 131.76 39.68 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.548 -0.584 . . . . 54.109999999999999 112.62 -178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -57.79 -30.51 65.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.922 0.889 . . . . 64.200000000000003 112.427 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.6 -40.27 96.49 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.792 0.837 . . . . 51.340000000000003 110.88 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.8 pt -98.05 -12.56 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-N 116.21 -0.45 . . . . 70.310000000000002 111.333 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 107.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.191 0 N-CA-C 107.884 -1.154 . . . . 73.510000000000005 107.884 169.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -97.7 -46.97 5.79 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.258 0.623 . . . . 63.450000000000003 110.267 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HD3' ' HB ' ' A' ' 2' ' ' ILE . 7.3 tpp180 -142.67 125.4 15.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.746 0.819 . . . . 72.519999999999996 109.55 -174.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -114.23 105.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 107.776 -1.194 . . . . 72.129999999999995 107.776 171.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -98.28 119.45 36.98 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.137 -0.32 . . . . 73.120000000000005 110.137 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.13 127.31 40.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 107.897 -1.149 . . . . 72.109999999999999 107.897 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.59 ' HB ' ' HG3' ' A' ' 43' ' ' GLU . 67.6 m -124.75 93.53 45.93 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 115.432 -0.804 . . . . 65.349999999999994 110.291 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.57 154.65 70.93 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.136 2.557 . . . . 75.340000000000003 112.124 169.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -74.55 166.34 29.62 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.886 2.39 . . . . 72.310000000000002 112.697 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.6 -168.12 39.5 Favored Glycine 0 N--CA 1.466 0.674 0 CA-C-N 115.53 -0.759 . . . . 44.210000000000001 111.397 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.96 -28.05 68.7 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.251 0.621 . . . . 72.109999999999999 110.303 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.74 -67.39 1.39 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.812 -0.631 . . . . 73.299999999999997 112.305 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.0 m -71.92 117.77 60.93 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 122.747 0.419 . . . . 72.430000000000007 111.18 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.44 -16.63 21.62 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.291 1.994 . . . . 72.420000000000002 113.005 -175.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -149.52 170.1 19.4 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.224 1.01 . . . . 61.5 110.274 -175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.6 m -86.27 126.07 34.04 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.171 -1.048 . . . . 53.200000000000003 108.171 166.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.59 ' HG3' ' HB ' ' A' ' 33' ' ' THR . 5.4 pt-20 -148.63 157.48 43.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.211 1.004 . . . . 34.399999999999999 109.308 -171.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -130.81 110.5 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.908 -1.145 . . . . 74.010000000000005 107.908 176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.1 t -97.94 109.51 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 109.894 -0.41 . . . . 63.530000000000001 109.894 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.2 mt -95.89 118.42 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.629 0.772 . . . . 63.109999999999999 109.768 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -93.1 135.77 33.98 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.033 -0.728 . . . . 72.129999999999995 109.033 167.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 67.5 p -87.55 170.05 11.65 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 123.357 0.41 . . . . 53.32 110.149 170.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -63.36 -27.55 69.39 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.225 0.61 . . . . 54.329999999999998 111.18 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.6 mtm -80.1 1.79 26.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.546 1.138 . . . . 75.530000000000001 111.543 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.8 mttm 66.74 31.5 7.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.08 1.752 . . . . 73.409999999999997 112.406 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -81.25 123.31 28.37 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.342 -0.984 . . . . 73.129999999999995 108.342 170.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG11 ' NE ' ' A' ' 13' ' ' ARG . 21.5 t -82.99 105.33 12.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 O-C-N 124.64 1.213 . . . . 74.129999999999995 108.67 175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -109.75 136.12 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.967 -1.123 . . . . 71.209999999999994 107.967 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 49.0 t -109.53 145.73 35.82 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.993 -0.743 . . . . 62.25 108.993 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.44 155.92 13.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.162 1.385 . . . . 64.519999999999996 108.221 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -92.39 148.2 35.97 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 122.869 0.468 . . . . 65.109999999999999 110.319 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.47 -5.86 17.04 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.664 2.243 . . . . 73.299999999999997 112.813 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -79.24 -23.49 43.67 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.922 0.889 . . . . 72.310000000000002 111.144 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.17 119.86 7.61 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.405 0.682 . . . . 52.219999999999999 110.209 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -65.03 -44.0 90.54 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.659 0.783 . . . . 62.229999999999997 112.052 -169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -59.18 -38.09 78.95 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.541 0.737 . . . . 74.209999999999994 110.217 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.8 tp -72.86 -37.3 67.41 Favored 'General case' 0 C--N 1.35 0.611 0 CA-C-N 114.95 -1.023 . . . . 73.420000000000002 110.678 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -61.12 -35.56 77.38 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.407 0.683 . . . . 73.099999999999994 109.363 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -60.44 -39.79 88.78 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.778 0.831 . . . . 74.409999999999997 110.732 176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 77.0 mt -70.09 -51.24 33.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.279 -0.873 . . . . 64.430000000000007 109.507 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.29 -24.2 66.24 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.191 0.997 . . . . 72.450000000000003 111.525 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -76.95 -54.39 6.63 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.739 1.216 . . . . 61.340000000000003 110.419 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.404 ' NE2' ' HB3' ' A' ' 75' ' ' LEU . 50.9 t-80 -84.99 -20.11 31.02 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.073 0.768 . . . . 70.439999999999998 113.073 -167.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.5 m -65.91 -30.61 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 118.084 0.402 . . . . 73.530000000000001 110.687 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -64.05 152.07 41.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.611 0.765 . . . . 73.140000000000001 109.639 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.3 t -50.32 89.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.585 1.154 . . . . 63.439999999999998 112.759 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -132.31 175.01 9.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.735 1.214 . . . . 73.319999999999993 110.084 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.2 t -102.39 165.52 11.07 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.304 -0.862 . . . . 60.25 109.798 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HB3' ' NE2' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -163.97 152.58 13.41 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.923 0.889 . . . . 74.120000000000005 109.606 175.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 p -101.26 136.35 41.24 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.238 -1.023 . . . . 75.430000000000007 108.238 168.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.9 p -76.39 148.8 37.11 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.83 -0.433 . . . . 52.350000000000001 109.83 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 p -103.6 112.34 65.57 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.924 0.89 . . . . 74.299999999999997 110.089 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.49 125.39 4.42 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.926 2.417 . . . . 60.399999999999999 112.136 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.93 150.87 35.92 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.909 0.484 . . . . 55.049999999999997 110.011 -178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.76 107.84 4.04 Favored Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 108.459 -0.941 . . . . 41.509999999999998 108.459 169.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.97 130.16 22.35 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.182 1.921 . . . . 63.229999999999997 112.661 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 p -61.6 126.63 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.251 0.548 . . . . 72.140000000000001 110.242 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.5 m -103.34 64.99 0.84 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.824 -0.806 . . . . 53.25 108.824 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -105.04 115.88 31.01 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.123 -0.944 . . . . 65.329999999999998 108.603 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -83.06 128.09 34.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.974 -0.75 . . . . 64.430000000000007 108.974 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -74.54 90.73 2.25 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 122.628 0.371 . . . . 64.549999999999997 110.167 -177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 69.94 20.86 6.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.064 1.346 . . . . 61.210000000000001 113.798 171.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 124.744 1.217 . . . . 73.120000000000005 112.276 177.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.824 -0.435 . . . . 74.329999999999998 109.824 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 29' ' ' ARG . 41.4 mt -107.36 132.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.176 0.99 . . . . 61.32 108.412 176.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.49 108.75 20.34 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.222 -0.659 . . . . 55.509999999999998 109.222 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -81.89 140.83 33.87 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.16 0.584 . . . . 73.140000000000001 109.538 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.42 ' HB1' ' HE2' ' A' ' 7' ' ' TYR . . . -118.29 117.4 29.01 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.034 0.934 . . . . 75.340000000000003 108.744 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.465 ' HE1' ' HB2' ' A' ' 10' ' ' LEU . 52.4 t60 -95.91 97.89 9.99 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.317 0.647 . . . . 74.219999999999999 110.477 -174.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' A' ' 5' ' ' ALA . 96.4 m-85 -121.4 -2.6 9.49 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.216 1.006 . . . . 73.200000000000003 110.918 175.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.4 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 38.5 p -86.98 133.35 33.59 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.863 0.865 . . . . 73.209999999999994 109.831 175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -68.6 86.27 0.31 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.309 0.643 . . . . 62.240000000000002 110.521 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.465 ' HB2' ' HE1' ' A' ' 6' ' ' HIS . 54.3 mt -122.34 172.65 8.16 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.375 1.07 . . . . 54.450000000000003 108.87 175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -92.84 97.88 11.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.613 0.765 . . . . 74.409999999999997 109.102 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 38.2 m -73.65 106.16 5.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.145 -0.687 . . . . 71.200000000000003 109.145 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -99.53 95.84 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.008 0.432 . . . . 64.150000000000006 110.942 -174.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 45' ' ' VAL . 86.3 m -130.06 115.67 17.43 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.866 0.866 . . . . 74.219999999999999 109.694 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.3 m -71.14 87.6 0.79 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.351 0.66 . . . . 72.219999999999999 110.282 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.42 -155.82 52.6 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.504 -0.771 . . . . 45.399999999999999 112.537 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.4 136.61 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 108.938 -0.764 . . . . 75.439999999999998 108.938 173.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.68 114.64 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.024 -1.102 . . . . 74.430000000000007 108.024 -175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.9 t -89.07 29.28 1.07 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.854 0.861 . . . . 53.149999999999999 111.72 -173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -81.75 123.72 29.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.111 0.564 . . . . 72.030000000000001 109.663 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.1 109.81 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 107.963 -1.125 . . . . 61.439999999999998 107.963 168.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.15 134.64 27.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 108.194 -1.039 . . . . 71.129999999999995 108.194 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.434 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -59.21 119.18 16.88 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.832 0.708 . . . . 61.130000000000003 112.693 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' HD21 ' A' ' 66' ' ' LEU . 9.2 mp -58.49 -30.07 66.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.246 0.618 . . . . 72.530000000000001 111.181 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -69.21 -34.09 74.34 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.609 0.763 . . . . 61.340000000000003 112.226 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.0 pt -95.05 -8.0 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 119.301 -0.38 . . . . 74.439999999999998 111.843 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 23' ' ' GLY . 68.2 mt -70.27 130.46 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 109.149 -0.686 . . . . 75.329999999999998 109.149 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -114.09 -53.64 2.66 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.925 -0.58 . . . . 54.43 109.621 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.442 ' HG2' ' HB ' ' A' ' 2' ' ' ILE . 70.4 mtt180 -135.21 147.89 49.48 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.679 0.791 . . . . 70.430000000000007 110.048 -173.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -138.98 126.53 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.708 1.203 . . . . 64.109999999999999 108.726 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.531 HE21 ' HH2' ' A' ' 47' ' ' TRP . 7.8 tt0 -110.19 125.77 53.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.279 0.632 . . . . 74.400000000000006 109.637 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.7 m -97.55 121.97 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 109.318 -0.623 . . . . 54.119999999999997 109.318 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.9 m -113.98 102.12 54.54 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.091 0.956 . . . . 72.230000000000004 109.473 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.82 160.34 33.59 Favored 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 123.758 2.972 . . . . 70.109999999999999 112.905 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.41 -11.6 18.96 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.72 2.28 . . . . 54.530000000000001 113.29 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.97 159.73 20.39 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.396 -1.082 . . . . 74.299999999999997 110.396 172.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.42 77.11 0.14 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.415 1.086 . . . . 65.109999999999999 110.589 -175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 8' ' ' THR . . . 144.83 -93.53 0.17 Allowed Glycine 0 C--O 1.237 0.292 0 CA-C-N 115.592 -0.731 . . . . 71.129999999999995 111.557 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -129.81 145.02 55.35 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.949 0.9 . . . . 63.219999999999999 109.732 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -59.72 -24.46 75.71 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.874 2.383 . . . . 64.319999999999993 114.692 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtmm -102.55 153.78 19.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.016 0.526 . . . . 74.310000000000002 110.692 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.5 p -82.14 114.04 20.4 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.612 -0.885 . . . . 74.129999999999995 108.612 172.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -133.95 135.74 43.73 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.683 0.793 . . . . 72.439999999999998 109.92 -172.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 67.9 t -118.39 103.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.916 -0.772 . . . . 75.209999999999994 108.916 175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG22 ' SG ' ' A' ' 14' ' ' CYS . 36.6 t -94.57 107.23 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.837 -0.801 . . . . 71.329999999999998 108.837 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.67 134.56 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.735 0.814 . . . . 73.200000000000003 109.608 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.531 ' HH2' HE21 ' A' ' 31' ' ' GLN . 26.8 m-90 -107.37 132.43 53.16 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.921 -1.14 . . . . 75.230000000000004 107.921 166.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -80.78 177.77 8.82 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.49 -0.559 . . . . 71.230000000000004 109.49 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -68.03 -30.27 69.46 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.688 0.395 . . . . 53.109999999999999 110.945 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.42 ' N ' ' SD ' ' A' ' 50' ' ' MET . 3.1 mpp? -81.08 2.69 26.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.854 0.862 . . . . 72.010000000000005 110.895 174.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt 72.91 25.04 2.48 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.769 1.628 . . . . 74.120000000000005 112.933 171.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -77.75 125.77 29.84 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.616 -0.513 . . . . 54.119999999999997 109.616 173.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.03 112.48 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.401 1.08 . . . . 75.519999999999996 109.732 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.35 120.16 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.442 -1.318 . . . . 75.409999999999997 107.442 173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 84.3 m -104.89 116.54 32.15 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.096 -1.076 . . . . 72.140000000000001 108.096 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.1 m -109.97 164.32 6.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 C-N-CA 124.201 1.001 . . . . 74.519999999999996 109.912 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -78.82 146.18 68.02 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 116.076 -0.511 . . . . 73.150000000000006 109.816 173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.68 -29.6 69.41 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.329 2.019 . . . . 64.439999999999998 112.503 177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -81.2 9.52 6.78 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 112.461 0.541 . . . . 74.420000000000002 112.461 -176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.2 127.66 32.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.898 0.479 . . . . 65.120000000000005 110.022 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -66.57 -42.23 87.35 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.203 1.401 . . . . 73.409999999999997 111.703 -166.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -68.65 -37.72 79.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.612 1.165 . . . . 71.450000000000003 111.013 177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.5 -29.46 70.73 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.717 1.207 . . . . 72.099999999999994 111.345 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.524 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 90.9 mm-40 -54.77 -38.38 67.14 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.987 0.915 . . . . 72.409999999999997 112.32 -178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -60.23 -41.54 93.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.649 0.779 . . . . 64.25 110.337 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.439 HD21 ' HG ' ' A' ' 24' ' ' LEU . 63.8 mt -70.51 -37.71 74.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.083 -0.962 . . . . 70.319999999999993 110.651 178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.36 -30.65 71.08 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.26 0.624 . . . . 74.329999999999998 111.383 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 64' ' ' GLN . 9.0 mmt180 -87.31 -29.52 21.54 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.24 0.216 . . . . 64.319999999999993 110.673 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.507 ' HE1' ' HB3' ' A' ' 75' ' ' LEU . 81.7 t60 -73.31 -32.88 64.86 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 112.188 -179.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -73.52 -4.5 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.631 0.372 . . . . 74.450000000000003 111.899 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -100.87 -160.3 0.79 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.02 1.328 . . . . 73.310000000000002 110.358 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.0 t -68.58 79.67 0.28 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.426 0.69 . . . . 64.329999999999998 110.238 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -153.77 120.11 5.48 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.122 0.969 . . . . 73.540000000000006 108.649 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.0 t -78.75 -179.68 6.67 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.271 1.028 . . . . 73.510000000000005 110.867 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.507 ' HB3' ' HE1' ' A' ' 69' ' ' HIS . 3.5 pp -138.15 175.29 9.71 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.232 1.013 . . . . 71.239999999999995 109.309 174.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.2 p -118.74 129.79 55.45 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.994 -0.743 . . . . 74.540000000000006 108.994 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 47.7 p -67.65 122.78 18.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.062 0.545 . . . . 74.109999999999999 109.868 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.0 p -75.36 147.4 82.47 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.037 0.935 . . . . 72.0 110.604 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.46 82.33 1.41 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.532 2.155 . . . . 54.210000000000001 111.338 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -133.8 176.29 8.7 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.54 1.136 . . . . 62.439999999999998 109.815 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.96 96.26 2.31 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 107.557 -1.275 . . . . 73.420000000000002 107.557 164.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.2 169.58 17.87 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.563 2.175 . . . . 72.439999999999998 113.391 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 96.2 t -76.27 135.53 26.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 107.801 -1.185 . . . . 72.239999999999995 107.801 172.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.5 t -55.35 106.37 0.23 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.221 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -86.71 104.57 16.22 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.192 -0.67 . . . . 75.120000000000005 109.192 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -82.74 96.53 8.2 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.973 -1.121 . . . . 75.150000000000006 107.973 175.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -139.37 110.55 6.92 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.435 -1.32 . . . . 72.230000000000004 107.435 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.59 -169.78 2.17 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 124.343 1.057 . . . . 73.230000000000004 109.152 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 1.364 0 C-N-CA 123.134 0.574 . . . . 61.420000000000002 110.614 178.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 110.082 -0.34 . . . . 73.420000000000002 110.082 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.13 115.73 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 108.456 -0.942 . . . . 70.439999999999998 108.456 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 62.3 tp -79.24 121.25 24.83 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.349 -0.611 . . . . 65.109999999999999 109.349 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.13 139.55 51.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.861 0.864 . . . . 75.200000000000003 110.124 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.67 110.36 21.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.426 -1.324 . . . . 75.120000000000005 107.426 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -82.11 132.5 35.25 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.66 -0.496 . . . . 64.129999999999995 109.66 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -62.2 163.45 8.21 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.211 1.004 . . . . 74.319999999999993 109.838 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.9 t -56.94 148.71 20.43 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 113.24 0.83 . . . . 70.299999999999997 113.24 -173.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.699 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 29.0 m-80 -142.39 170.46 15.67 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.917 1.287 . . . . 61.109999999999999 109.658 -178.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 56.5 mt -105.79 -15.52 14.92 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 115.306 -0.861 . . . . 72.430000000000007 111.299 166.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -136.24 110.7 8.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 62.210000000000001 109.865 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.4 m -106.63 110.94 23.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.823 0.849 . . . . 42.520000000000003 109.581 176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -80.81 91.05 5.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.291 0.636 . . . . 73.030000000000001 110.402 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -135.65 147.43 48.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.498 0.719 . . . . 72.209999999999994 110.608 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.0 p -87.12 0.73 54.81 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.146 0.978 . . . . 74.129999999999995 111.957 174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.55 -92.67 1.63 Allowed Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.267 -0.733 . . . . 12.140000000000001 111.267 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.12 132.26 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.532 0.733 . . . . 42.210000000000001 109.617 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.3 mt -129.4 112.2 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 105.802 -1.925 . . . . 61.109999999999999 105.802 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 t -85.45 27.87 0.79 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 112.843 0.682 . . . . 55.509999999999998 112.843 -171.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.2 p -79.02 119.46 22.19 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.401 -0.592 . . . . 74.510000000000005 109.401 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -68.86 112.43 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 N-CA-C 108.384 -0.969 . . . . 73.019999999999996 108.384 171.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.69 140.91 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.136 0.574 . . . . 72.430000000000007 109.923 -173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -66.4 127.76 29.59 Favored Glycine 0 C--N 1.356 1.645 0 O-C-N 123.597 0.561 . . . . 50.329999999999998 112.875 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.4 mp -59.88 -32.59 70.86 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.284 1.034 . . . . 71.439999999999998 111.982 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -74.29 -22.62 59.21 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.905 0.882 . . . . 73.519999999999996 112.311 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 pt -103.98 -12.94 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 122.616 0.366 . . . . 65.439999999999998 111.234 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 23' ' ' GLY . 75.6 mt -68.5 115.26 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.772 -0.825 . . . . 74.420000000000002 108.772 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 -52.29 5.51 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.054 0.942 . . . . 70.310000000000002 109.968 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -141.01 142.08 34.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.544 0.738 . . . . 65.430000000000007 110.459 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.4 mt -122.62 105.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 107.08 -1.452 . . . . 71.430000000000007 107.08 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' HB3' ' HZ3' ' A' ' 47' ' ' TRP . 7.5 tt0 -111.77 122.2 47.16 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.483 0.713 . . . . 72.030000000000001 110.096 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.3 t -87.31 123.76 40.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 108.688 -0.856 . . . . 75.019999999999996 108.688 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.786 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 33.3 p -103.75 121.83 46.76 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 108.906 -0.776 . . . . 72.010000000000005 108.906 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.09 154.8 14.71 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 123.052 2.501 . . . . 74.140000000000001 113.931 -171.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -80.71 169.0 17.2 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.464 2.11 . . . . 72.409999999999997 112.573 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.26 -102.66 1.2 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.677 -0.569 . . . . 63.420000000000002 111.677 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -81.37 87.42 6.16 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.022 -0.733 . . . . 74.109999999999999 109.022 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.699 ' HA2' ' H ' ' A' ' 9' ' ' ASN . . . 150.23 -73.71 0.28 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.564 -0.744 . . . . 50.32 111.35 -179.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.786 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 61.2 m -127.13 155.06 76.66 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 123.732 0.813 . . . . 74.239999999999995 109.711 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.93 -18.17 52.08 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.413 2.075 . . . . 63.509999999999998 113.44 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -150.81 171.18 17.61 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.392 0.677 . . . . 71.120000000000005 110.495 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 m -79.43 115.56 19.14 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.116 -0.698 . . . . 64.319999999999993 109.116 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 23.3 mt-10 -127.49 158.44 37.39 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.626 0.77 . . . . 75.25 108.976 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.0 106.22 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.734 -0.839 . . . . 73.109999999999999 108.734 175.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.31 111.49 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.51 0.724 . . . . 74.439999999999998 109.871 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.455 HG23 HG23 ' A' ' 27' ' ' ILE . 56.9 mt -95.98 125.25 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.021 0.929 . . . . 73.040000000000006 109.836 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.41 ' HZ3' ' HB3' ' A' ' 31' ' ' GLN . 29.8 m-90 -98.63 140.1 33.36 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.902 -0.777 . . . . 73.120000000000005 108.902 167.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 78.0 p -88.64 171.18 10.21 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.847 -0.427 . . . . 63.340000000000003 109.847 169.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -71.59 -18.57 62.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.306 0.642 . . . . 73.319999999999993 111.442 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 64.1 mtm -87.42 6.1 35.54 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.903 0.881 . . . . 75.420000000000002 110.766 172.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 63.0 43.74 6.42 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.183 1.393 . . . . 72.030000000000001 112.893 176.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -91.43 122.88 34.41 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.662 -1.236 . . . . 64.129999999999995 107.662 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.39 111.4 18.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 O-C-N 124.496 1.123 . . . . 72.400000000000006 108.255 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.67 145.34 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.853 -1.166 . . . . 64.519999999999996 107.853 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.7 m -116.77 150.01 38.99 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.101 -0.703 . . . . 72.010000000000005 109.101 169.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.8 m -141.87 158.57 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.878 0.871 . . . . 71.340000000000003 109.615 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -73.59 137.21 77.44 Favored Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 123.808 0.843 . . . . 74.219999999999999 110.78 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.34 -16.83 44.2 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.878 2.385 . . . . 73.430000000000007 113.789 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -91.09 2.1 56.59 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.292 0.637 . . . . 75.329999999999998 112.444 -178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.03 123.82 20.46 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.938 0.495 . . . . 63.219999999999999 109.993 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -72.08 -33.37 67.86 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.446 0.698 . . . . 74.010000000000005 111.88 -172.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.448 ' O ' HD13 ' A' ' 66' ' ' LEU . 54.0 p-90 -63.17 -42.48 99.41 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.247 -0.649 . . . . 73.409999999999997 109.247 174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 124.075 0.95 . . . . 63.409999999999997 110.661 176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 80.5 mm-40 -60.48 -40.19 90.39 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.648 0.779 . . . . 64.030000000000001 111.978 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.53 -45.55 77.15 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.825 0.703 . . . . 74.540000000000006 109.983 174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 70' ' ' VAL . 10.2 mp -66.65 -48.3 69.83 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.306 -0.861 . . . . 64.540000000000006 110.994 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.19 -33.68 69.52 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.676 0.791 . . . . 64.439999999999998 111.712 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -84.16 -33.68 24.19 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.97 0.508 . . . . 75.310000000000002 111.385 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -86.38 -15.88 39.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.637 0.775 . . . . 65.439999999999998 112.72 -173.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 66' ' ' LEU . 27.1 m -70.5 -11.55 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 112.205 0.446 . . . . 64.219999999999999 112.205 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.22 -163.05 0.06 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 124.472 1.109 . . . . 73.549999999999997 111.0 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 62.1 p -78.69 20.25 0.46 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.358 0.663 . . . . 54.539999999999999 112.394 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -63.56 107.53 1.16 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.128 0.971 . . . . 74.439999999999998 109.861 173.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 69.2 p -78.92 141.03 37.94 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.526 0.731 . . . . 75.150000000000006 111.448 -175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.99 61.48 6.37 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.047 0.939 . . . . 74.099999999999994 109.467 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.7 t -68.48 -44.02 75.69 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.291 0.636 . . . . 73.239999999999995 110.44 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 p -72.46 87.49 1.18 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.764 0.826 . . . . 72.400000000000006 110.286 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.7 p -119.96 143.47 35.39 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 123.87 0.868 . . . . 71.540000000000006 109.372 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 175.66 10.97 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.528 2.152 . . . . 73.340000000000003 112.522 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -120.91 161.14 22.07 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.983 0.913 . . . . 75.150000000000006 110.309 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.67 98.02 49.84 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.115 0.966 . . . . 71.239999999999995 109.392 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 129.17 12.45 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.548 2.165 . . . . 62.229999999999997 113.06 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.62 128.02 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 CA-C-O 121.251 0.548 . . . . 71.019999999999996 110.196 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 t -128.94 128.69 44.27 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.179 0.992 . . . . 54.119999999999997 108.58 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.04 149.32 45.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.556 0.743 . . . . 61.229999999999997 111.499 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -126.71 125.98 42.71 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.585 -1.265 . . . . 72.349999999999994 107.585 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.78 85.92 4.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.228 0.611 . . . . 74.140000000000001 109.469 -175.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.85 119.82 9.37 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.374 1.07 . . . . 63.109999999999999 109.336 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.587 0.755 . . . . 38.119999999999997 109.583 -178.075 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 tpp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.358 -0.608 . . . . 45.450000000000003 109.358 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.46 109.45 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 108.798 -0.816 . . . . 74.129999999999995 108.798 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 45.8 tp -86.97 118.08 26.11 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.002 -0.74 . . . . 72.099999999999994 109.002 174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -119.37 156.49 30.0 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.092 0.957 . . . . 74.209999999999994 110.145 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.44 150.38 39.66 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.711 0.804 . . . . 53.299999999999997 109.06 170.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -79.75 97.93 6.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.03 0.532 . . . . 72.200000000000003 110.762 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -103.38 -60.92 1.49 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.404 0.681 . . . . 64.0 110.237 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 34.1 p -122.63 120.97 35.29 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.232 0.539 . . . . 62.340000000000003 111.018 -176.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -172.6 155.69 3.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.608 1.563 . . . . 74.219999999999999 106.913 176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.5 tt -71.52 -60.58 2.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.487 -0.931 . . . . 75.420000000000002 108.487 176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -145.68 140.4 27.24 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.417 -0.811 . . . . 74.5 110.058 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 3.2 m -81.47 103.95 11.56 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 107.7 -1.222 . . . . 51.509999999999998 107.7 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -83.85 87.5 7.09 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.104 -0.498 . . . . 64.209999999999994 111.829 -168.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' SG ' HG22 ' A' ' 45' ' ' VAL . 70.8 m -136.81 150.74 48.51 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.37 1.068 . . . . 72.129999999999995 108.619 167.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.4 t -119.47 20.24 12.49 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.758 0.823 . . . . 74.239999999999995 110.634 -175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.74 172.05 12.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 111.729 -0.549 . . . . 23.32 111.729 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.67 134.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 120.745 0.307 . . . . 64.540000000000006 110.228 -174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.5 120.79 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 108.315 -0.994 . . . . 73.329999999999998 108.315 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.7 m -87.78 57.88 4.58 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.506 0.67 . . . . 72.519999999999996 110.683 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -116.17 131.35 56.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.485 -0.779 . . . . 73.439999999999998 109.325 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.93 124.66 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 O-C-N 123.749 0.656 . . . . 75.120000000000005 109.397 172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.85 127.06 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 N-CA-C 108.677 -0.861 . . . . 71.120000000000005 108.677 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' ILE . . . -65.2 135.63 37.01 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.778 0.674 . . . . 73.010000000000005 113.483 -176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HG ' HD11 ' A' ' 66' ' ' LEU . 7.6 mp -64.76 -27.32 68.82 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.084 0.554 . . . . 75.329999999999998 110.355 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -72.7 -20.1 61.28 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.685 -1.143 . . . . 74.540000000000006 112.164 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 pt -105.45 -24.31 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 119.198 -0.43 . . . . 74.120000000000005 111.951 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 23' ' ' GLY . 88.3 mt -61.09 128.07 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.256 0.622 . . . . 70.299999999999997 111.125 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.49 -44.43 4.5 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.813 0.845 . . . . 75.530000000000001 111.371 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.3 ttm105 -148.37 133.79 18.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.171 0.588 . . . . 74.540000000000006 110.084 -169.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -125.09 106.68 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 108.017 -1.105 . . . . 61.520000000000003 108.017 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.87 126.69 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.862 -0.792 . . . . 74.030000000000001 108.862 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.1 m -86.15 123.8 39.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.96 -0.755 . . . . 75.25 108.96 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.647 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 32.9 p -117.12 89.86 31.72 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 123.96 0.904 . . . . 73.140000000000001 110.771 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.66 150.01 39.26 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.438 2.759 . . . . 51.509999999999998 111.948 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.02 158.26 52.79 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.085 2.524 . . . . 72.140000000000001 113.475 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.49 -136.57 5.16 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.991 -0.844 . . . . 52.539999999999999 110.991 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -86.89 73.72 9.89 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.367 0.667 . . . . 63.399999999999999 109.3 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.32 -63.12 0.32 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.365 -0.694 . . . . 54.25 111.365 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.647 ' SG ' ' HB ' ' A' ' 33' ' ' THR . 67.8 m -80.84 115.69 57.37 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.998 -0.741 . . . . 72.430000000000007 108.998 176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -53.23 -41.97 68.5 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.64 2.227 . . . . 75.439999999999998 113.102 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.446 ' HG3' ' HG3' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -149.22 172.9 14.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.673 -0.694 . . . . 71.349999999999994 111.024 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 m -70.3 110.46 5.27 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.658 -0.701 . . . . 61.350000000000001 109.309 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 41' ' ' LYS . 47.6 mt-10 -142.27 166.36 24.89 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.365 0.666 . . . . 71.140000000000001 109.555 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.7 t -130.92 111.02 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 107.922 -1.14 . . . . 64.310000000000002 107.922 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.599 HG22 ' SG ' ' A' ' 14' ' ' CYS . 12.9 t -92.46 120.14 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 122.858 0.463 . . . . 62.409999999999997 109.776 -171.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.79 120.62 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.926 0.89 . . . . 74.510000000000005 109.714 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -97.21 130.41 44.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.58 -1.267 . . . . 75.420000000000002 107.58 168.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.0 p -89.9 168.9 11.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.191 -0.67 . . . . 72.120000000000005 109.191 171.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -68.87 -23.53 64.23 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 120.915 0.388 . . . . 74.319999999999993 110.504 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.3 mtm -75.43 -4.88 42.07 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.306 1.043 . . . . 63.340000000000003 111.344 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 74.71 16.64 3.06 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 125.777 1.631 . . . . 71.049999999999997 112.512 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.09 129.03 34.72 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.817 0.847 . . . . 74.299999999999997 109.265 172.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -102.67 108.77 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.554 1.141 . . . . 74.140000000000001 109.671 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.2 mt -117.07 120.24 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 124.14 0.976 . . . . 72.010000000000005 108.468 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 63.8 m -105.07 119.54 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.599 -1.26 . . . . 73.5 107.599 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.8 165.31 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.894 0.878 . . . . 55.310000000000002 110.459 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -83.33 145.55 48.79 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.713 0.805 . . . . 72.299999999999997 110.337 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -60.39 -31.94 93.32 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.373 2.716 . . . . 73.310000000000002 113.923 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -86.7 9.79 17.73 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.233 0.613 . . . . 74.450000000000003 111.792 -174.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.93 129.43 41.39 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 122.895 0.478 . . . . 63.340000000000003 109.983 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -58.36 -51.2 70.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 124.72 1.208 . . . . 74.219999999999999 112.187 -168.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -71.86 -29.77 64.73 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.325 1.05 . . . . 72.409999999999997 110.437 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.0 tp -64.21 -36.73 85.03 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 123.646 0.778 . . . . 61.310000000000002 110.787 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -57.18 -39.27 74.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.083 0.553 . . . . 74.030000000000001 111.673 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -55.2 -45.52 75.86 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.245 0.966 . . . . 73.219999999999999 109.328 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD11 ' HG ' ' A' ' 24' ' ' LEU . 4.3 mm? -66.17 -51.09 61.12 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.311 -0.859 . . . . 43.140000000000001 110.978 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.6 mt -56.31 -36.0 68.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.783 0.833 . . . . 75.239999999999995 111.888 -172.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -84.71 -43.49 14.27 Favored 'General case' 0 CA--C 1.548 0.885 0 O-C-N 122.905 0.128 . . . . 71.040000000000006 111.161 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -67.89 -35.23 78.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.638 0.607 . . . . 71.430000000000007 112.638 -170.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 32.2 m -63.05 -30.08 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.011 0.525 . . . . 65.129999999999995 111.162 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.6 -73.79 0.31 Allowed 'General case' 0 CA--C 1.553 1.06 0 N-CA-C 108.717 -0.845 . . . . 74.340000000000003 108.717 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.7 t 179.02 152.28 0.35 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.02 1.328 . . . . 73.129999999999995 109.18 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -167.77 169.17 11.87 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.969 0.907 . . . . 72.530000000000001 110.213 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.4 t -60.66 149.72 34.31 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.395 0.678 . . . . 71.109999999999999 109.891 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -50.81 109.19 0.29 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.369 1.068 . . . . 71.099999999999994 111.152 -170.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 t -121.21 78.77 1.45 Allowed 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.199 0.999 . . . . 74.439999999999998 108.7 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 59.2 m -141.33 148.06 39.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.04 -0.982 . . . . 71.430000000000007 108.956 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 40.8 p -122.83 151.13 60.3 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.679 0.792 . . . . 64.430000000000007 110.061 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.3 138.53 66.77 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.222 1.948 . . . . 72.430000000000007 111.517 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.75 168.69 10.17 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.562 0.745 . . . . 63.109999999999999 111.576 -173.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.03 95.35 34.34 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.164 0.985 . . . . 65.340000000000003 109.108 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.22 -65.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.529 2.153 . . . . 54.530000000000001 113.242 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.0 t -110.48 135.37 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.122 0.569 . . . . 74.340000000000003 110.537 -171.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.3 t -129.42 167.54 17.66 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.84 -0.8 . . . . 72.239999999999995 108.84 173.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -73.88 95.62 2.47 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.597 -0.52 . . . . 61.140000000000001 109.597 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -80.89 140.97 35.04 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.255 -0.884 . . . . 75.109999999999999 110.333 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -77.19 133.16 39.0 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.07 -0.715 . . . . 51.350000000000001 109.07 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.39 162.14 36.03 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.148 0.979 . . . . 63.219999999999999 109.329 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 C-N-CA 123.729 0.811 . . . . 60.509999999999998 109.533 -179.416 . . . . . . . . 0 0 . 1 stop_ save_